data_1fov_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fov _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.3 t -127.62 128.02 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 118.854 0.752 . . . . 0.0 109.79 -171.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.13 145.34 45.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 124.095 0.872 . . . . 0.0 109.599 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -139.47 115.59 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -75.4 144.68 42.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -147.23 172.14 14.29 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.279 1.032 . . . . 0.0 113.2 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.15 173.97 11.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.637 169.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -49.68 -39.54 36.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.125 2.57 . . . . 0.0 111.331 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.7 p -133.62 88.25 2.46 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -168.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.1 t -148.81 86.66 5.69 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.05 -37.16 78.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.291 1.994 . . . . 0.0 110.394 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -73.45 -24.78 60.27 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.143 -0.973 . . . . 0.0 111.549 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.1 m -63.14 -51.96 64.4 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 120.264 1.393 . . . . 0.0 108.968 169.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.75 -41.93 74.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.912 -1.042 . . . . 0.0 111.053 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -54.45 -56.04 22.82 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.345 1.429 . . . . 0.0 110.924 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.98 -49.34 76.49 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.393 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.786 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.16 90.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.003 0.82 . . . . 0.0 110.19 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 tt -64.99 -47.68 76.66 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.551 0.614 . . . . 0.0 109.468 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.9 -35.01 79.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.386 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 m -75.18 -28.94 60.25 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.65 0.78 . . . . 0.0 111.631 174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -40.15 92.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.359 0.982 . . . . 0.0 109.328 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -73.35 -25.57 60.66 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.766 -1.209 . . . . 0.0 108.921 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.5 32.32 59.84 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.889 1.709 . . . . 0.0 111.03 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.69 171.37 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.281 0.562 . . . . 0.0 110.117 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.08 121.64 42.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -141.73 165.02 28.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.578 1.151 . . . . 0.0 110.131 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.53 144.62 35.94 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.181 1.392 . . . . 0.0 108.385 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.57 143.72 44.92 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.444 1.498 . . . . 0.0 108.068 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.44 103.56 16.4 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.912 1.285 . . . . 0.0 110.0 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.92 144.35 27.25 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.854 1.703 . . . . 0.0 110.26 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 122.131 0.967 . . . . 0.0 109.994 172.883 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.341 0.115 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -67.64 -39.12 84.64 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.296 -1.502 . . . . 0.0 108.751 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -63.07 -40.78 98.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.506 0.723 . . . . 0.0 109.962 171.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -52.77 -45.7 67.24 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.425 0.557 . . . . 0.0 109.934 172.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.51 -24.96 66.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 113.366 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mt -65.0 -54.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.51 -36.98 85.57 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 119.605 -0.236 . . . . 0.0 110.843 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -75.66 -56.28 4.84 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.541 0.736 . . . . 0.0 111.282 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -91.09 -38.73 12.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.596 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.84 38.55 89.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -148.05 -58.09 0.24 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.359 1.464 . . . . 0.0 110.696 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.259 3.6 m 83.16 10.87 0.52 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.729 1.612 . . . . 0.0 111.909 171.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 81.1 p -109.35 171.89 7.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.454 2.702 . . . . 0.0 108.129 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -140.19 166.02 26.49 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.56 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.28 148.7 64.84 Favored 'Cis proline' 0 CA--C 1.509 -0.738 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 -6.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -138.02 108.17 6.41 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.28 145.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 125.271 1.607 . . . . 0.0 107.083 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -128.36 124.15 35.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.806 2.842 . . . . 0.0 103.793 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.0 mm -120.96 117.99 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.255 0.6 OUTLIER 49.32 52.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.335 1.454 . . . . 0.0 110.659 -172.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.03 0.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.62 2.768 . . . . 0.0 114.329 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -86.59 108.17 18.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.253 1.421 . . . . 0.0 107.244 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -63.1 109.3 1.46 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.943 0.897 . . . . 0.0 109.071 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.38 -56.44 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.79 0.836 . . . . 0.0 109.292 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.1 -141.72 12.94 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.04 -165.8 30.16 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 118.885 1.343 . . . . 0.0 113.343 -168.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.0 -43.21 91.46 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.241 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.84 -35.84 82.41 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.733 0.697 . . . . 0.0 109.823 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -45.86 70.25 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.734 1.613 . . . . 0.0 111.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.45 -48.51 79.32 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 127.471 2.309 . . . . 0.0 111.363 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -69.51 -29.4 67.01 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -44.17 81.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.156 0.582 . . . . 0.0 110.941 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.77 -37.74 71.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.403 1.001 . . . . 0.0 110.801 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.38 -40.82 89.92 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.185 -0.947 . . . . 0.0 111.97 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.19 68.12 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.742 1.217 . . . . 0.0 112.171 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -89.22 3.84 50.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.814 1.246 . . . . 0.0 112.445 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 18.3 69.33 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.424 0.557 . . . . 0.0 112.154 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.86 -12.4 43.54 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.643 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.5 tp -73.65 -49.17 27.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.262 1.031 . . . . 0.0 109.511 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.87 -51.77 73.81 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.424 1.49 . . . . 0.0 112.33 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.36 -8.5 23.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.803 2.335 . . . . 0.0 114.707 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 mt -91.07 -49.52 6.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 N--CA 1.464 0.229 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -173.544 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.8 t -126.84 132.88 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -136.59 127.37 27.32 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -168.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 tt -128.73 110.77 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.01 143.52 45.52 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -147.54 179.9 7.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.433 1.093 . . . . 0.0 111.725 -171.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.15 -172.56 4.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.245 -1.534 . . . . 0.0 107.929 168.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.491 ' HG3' ' H ' ' A' ' 10' ' ' THR . 1.1 pt-20 -35.76 -64.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.664 3.586 . . . . 0.0 111.259 170.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.491 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 14.7 t -134.13 124.21 25.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.0 t -169.6 101.11 0.47 Allowed Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.44 -35.73 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.971 1.781 . . . . 0.0 109.872 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -73.27 -32.8 64.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.778 -0.576 . . . . 0.0 109.811 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -61.59 -51.14 69.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.043 0.838 . . . . 0.0 109.15 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -54.54 -45.75 73.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.562 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -59.71 -49.77 76.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.525 1.511 . . . . 0.0 111.688 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.51 94.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.61 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -57.26 -51.52 69.03 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.495 1.043 . . . . 0.0 109.819 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.83 -22.58 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.655 0.782 . . . . 0.0 111.599 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -75.98 -50.61 14.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.101 1.36 . . . . 0.0 110.011 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.03 -42.52 98.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.25 1.02 . . . . 0.0 111.021 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.3 m -67.52 -28.14 67.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.809 1.644 . . . . 0.0 110.995 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -42.56 99.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -84.25 -6.55 59.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.004 0.82 . . . . 0.0 112.081 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.46 34.73 80.05 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 124.659 1.123 . . . . 0.0 111.901 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.0 m -90.65 157.44 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 123.331 0.653 . . . . 0.0 110.912 -169.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -95.4 98.99 10.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -106.51 165.92 10.93 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.822 0.849 . . . . 0.0 108.781 169.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.22 144.19 31.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.178 1.791 . . . . 0.0 106.407 168.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.71 144.84 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mt -129.94 69.77 81.83 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.937 1.295 . . . . 0.0 108.495 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.58 140.3 47.03 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 N-CA-C 108.59 -1.35 . . . . 0.0 108.59 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 pt . . . . . 0 N--CA 1.468 0.45 0 C-N-CA 124.478 1.111 . . . . 0.0 111.324 170.867 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.225 -0.204 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -54.27 -44.59 72.0 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 168.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -73.01 -42.33 63.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.163 0.585 . . . . 0.0 109.965 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.67 -32.1 72.26 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.659 -0.65 . . . . 0.0 110.956 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.4 ttp -55.75 -16.01 3.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.873 1.269 . . . . 0.0 113.235 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.73 -70.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 170.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -66.91 -27.6 67.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 120.194 1.361 . . . . 0.0 112.314 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.2 -50.87 62.37 Favored 'General case' 0 CA--C 1.524 -0.047 0 CA-C-N 119.17 0.895 . . . . 0.0 109.735 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 p -105.31 -31.89 8.86 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.671 1.123 . . . . 0.0 112.875 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.93 24.29 75.77 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 121.452 -0.78 . . . . 0.0 112.196 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -136.36 -53.13 0.73 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.99 1.316 . . . . 0.0 110.573 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m 75.72 2.66 3.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.448 1.099 . . . . 0.0 110.927 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 p -84.22 177.15 8.31 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.99 3.316 . . . . 0.0 107.873 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.5 161.12 60.84 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.129 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.26 166.51 79.75 Favored 'Cis proline' 0 N--CA 1.456 -0.698 0 CA-C-N 119.396 0.82 . . . . 0.0 110.675 -10.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -132.94 104.29 6.49 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 168.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.22 142.78 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.338 2.255 . . . . 0.0 106.871 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.1 mt -132.83 119.66 38.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.281 14.8 m-20 45.6 45.51 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.805 0.812 . . . . 0.0 112.566 -169.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.37 -0.16 2.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.557 2.743 . . . . 0.0 114.249 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.24 109.58 7.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.9 113.48 3.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.9 mm -77.38 -55.02 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 108.872 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.68 -144.91 13.02 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.28 -163.67 26.5 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.421 2.438 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -57.17 -47.62 80.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.107 0.953 . . . . 0.0 112.022 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -64.77 -33.46 76.03 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.181 0.446 . . . . 0.0 109.939 -170.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.0 -44.57 72.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.924 1.69 . . . . 0.0 110.914 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.72 -51.13 70.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.889 1.276 . . . . 0.0 109.806 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.41 -30.33 70.06 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -40.97 85.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.138 1.375 . . . . 0.0 112.327 169.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.0 tp -56.25 -45.71 79.91 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.8 1.637 . . . . 0.0 110.322 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.83 -34.68 77.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.965 0.506 . . . . 0.0 112.106 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.15 -15.58 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.772 1.229 . . . . 0.0 112.135 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -5.25 59.23 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.368 1.067 . . . . 0.0 111.224 168.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.07 15.83 70.05 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -168.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.57 -9.34 55.07 Favored Glycine 0 C--N 1.341 0.843 0 C-N-CA 124.697 1.142 . . . . 0.0 112.868 -170.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.4 tp -73.94 -47.93 34.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.329 1.065 . . . . 0.0 109.844 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -54.78 35.84 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.892 1.277 . . . . 0.0 112.156 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.21 -1.91 8.86 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.396 2.064 . . . . 0.0 113.889 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.38 -3.13 19.9 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.806 1.243 . . . . 0.0 111.428 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--O 1.237 0.421 0 C-N-CA 124.971 1.308 . . . . 0.0 111.303 -178.217 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.1 t -133.72 120.07 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 119.355 0.98 . . . . 0.0 108.844 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -129.52 146.97 51.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.14 0.976 . . . . 0.0 109.462 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 tt -140.72 118.37 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 124.509 1.124 . . . . 0.0 108.226 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -78.94 135.58 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.25 1.02 . . . . 0.0 108.812 171.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -144.11 -177.18 5.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.456 1.502 . . . . 0.0 111.501 -168.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -157.5 177.67 11.16 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 119.661 -1.899 . . . . 0.0 107.889 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.66 -25.23 38.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.836 1.654 . . . . 0.0 112.325 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.89 120.6 20.6 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 172.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.0 t -167.77 93.68 0.65 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.022 0.929 . . . . 0.0 111.342 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.11 -39.63 30.45 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.509 2.14 . . . . 0.0 112.033 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -73.58 -29.21 62.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.316 1.871 . . . . 0.0 110.084 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -59.3 -52.71 64.47 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 119.924 1.238 . . . . 0.0 108.239 169.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -54.56 -40.14 68.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.254 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -59.84 -54.01 51.21 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.004 1.274 . . . . 0.0 111.777 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.19 93.12 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.862 -0.523 . . . . 0.0 110.233 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -63.48 -36.51 84.0 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.202 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -26.77 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 120.268 1.394 . . . . 0.0 110.906 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.05 -55.14 11.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.87 -43.27 93.49 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.001 1.32 . . . . 0.0 112.081 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -69.94 -30.81 68.29 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.496 1.118 . . . . 0.0 109.674 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -66.05 -39.87 90.47 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.474 1.033 . . . . 0.0 109.593 169.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -73.72 -9.35 58.57 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.222 0.919 . . . . 0.0 110.763 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.0 81.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 125.603 1.573 . . . . 0.0 110.446 172.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.0 m -90.55 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.596 0.713 . . . . 0.0 112.838 -168.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.3 p -105.75 116.92 32.75 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.69 1.996 . . . . 0.0 105.792 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -134.78 167.75 20.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -112.73 133.36 54.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.24 111.53 20.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.438 1.895 . . . . 0.0 107.424 -168.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.85 102.37 50.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.328 1.451 . . . . 0.0 111.381 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.85 137.0 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.01 2.474 . . . . 0.0 113.892 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.5 mt . . . . . 0 N--CA 1.452 -0.356 0 C-N-CA 127.322 2.249 . . . . 0.0 107.365 -179.137 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.224 -0.28 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.996 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -60.63 -59.34 5.55 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.54 1.064 . . . . 0.0 108.581 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.07 -41.88 89.05 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.393 0.433 . . . . 0.0 110.908 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.61 -56.19 15.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.386 1.474 . . . . 0.0 109.558 173.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.3 ttm -67.12 -26.35 66.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.837 -0.54 . . . . 0.0 112.184 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.38 -54.28 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -60.83 -46.46 90.47 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.93 1.241 . . . . 0.0 112.245 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -79.88 -30.75 40.24 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 117.431 -1.271 . . . . 0.0 112.508 -169.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.2 p -116.15 -27.79 6.78 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.078 1.308 . . . . 0.0 113.458 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.03 23.88 53.04 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.482 1.037 . . . . 0.0 113.497 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -130.52 -57.9 1.05 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.271 1.035 . . . . 0.0 110.186 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.263 3.4 m 74.23 37.78 0.58 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 123.237 1.494 . . . . 0.0 110.989 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.1 p -142.09 176.91 8.59 Favored 'General case' 0 C--N 1.329 -0.325 1 C-N-CA 132.27 4.228 . . . . 0.0 105.902 -176.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -132.71 160.17 69.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.35 167.87 78.59 Favored 'Cis proline' 0 CA--C 1.534 0.514 0 N-CA-C 110.233 -0.718 . . . . 0.0 110.233 -10.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -130.47 96.21 4.07 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 168.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.15 144.26 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -133.04 125.1 28.92 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.561 2.744 . . . . 0.0 104.964 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.7 mm -125.28 120.99 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.92 40.89 26.17 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.722 1.249 . . . . 0.0 111.789 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.31 0.28 0.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.874 2.87 . . . . 0.0 114.45 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.7 121.07 20.18 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -75.01 98.86 3.71 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.41 -49.21 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 -132.19 6.8 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.51 -178.16 45.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.474 1.035 . . . . 0.0 111.264 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -54.23 -42.95 70.43 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.437 -1.037 . . . . 0.0 110.721 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -34.77 71.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.856 0.862 . . . . 0.0 111.87 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -71.69 -44.22 64.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.194 0.598 . . . . 0.0 110.993 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -62.13 -48.6 79.42 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.309 1.044 . . . . 0.0 110.619 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -59.77 -39.26 84.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.125 1.77 . . . . 0.0 109.197 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.1 81.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.189 0.596 . . . . 0.0 110.976 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 tp -56.66 -45.32 81.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.969 0.804 . . . . 0.0 110.121 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.58 -38.78 91.45 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.984 0.914 . . . . 0.0 112.181 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.32 69.77 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.429 0.559 . . . . 0.0 110.716 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -5.44 56.47 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.083 -1.011 . . . . 0.0 110.58 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.94 21.28 79.09 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.275 -0.89 . . . . 0.0 111.081 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.24 -28.19 28.59 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.12 0.96 . . . . 0.0 111.662 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.4 tp -74.21 -50.87 17.29 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.324 1.062 . . . . 0.0 110.81 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.46 -55.77 20.36 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.791 0.836 . . . . 0.0 113.133 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.7 11.86 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.825 2.35 . . . . 0.0 113.427 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.7 mt -112.35 -2.87 14.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.15 1.38 . . . . 0.0 110.396 168.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 110.088 170.171 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.5 t -106.02 133.92 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.71 144.27 33.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 123.854 0.721 . . . . 0.0 109.56 -169.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.73 117.44 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.468 0.707 . . . . 0.0 110.142 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -78.04 140.3 39.13 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -146.99 177.46 9.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.045 0.938 . . . . 0.0 112.487 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 -177.06 6.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.942 1.297 . . . . 0.0 110.899 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.57 -24.27 3.12 Favored 'General case' 0 CA--C 1.52 -0.187 1 C-N-CA 132.555 4.342 . . . . 0.0 114.538 -168.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -133.32 -83.47 0.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.9 t 33.99 75.99 0.43 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.752 2.021 . . . . 0.0 112.173 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.66 -24.28 74.83 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.362 2.041 . . . . 0.0 111.34 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -73.1 -37.46 66.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.957 1.253 . . . . 0.0 109.71 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -60.7 -46.86 88.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -54.39 -50.6 67.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.173 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -54.47 -49.73 69.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.14 1.336 . . . . 0.0 110.919 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.07 39.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.173 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -60.09 -32.05 70.6 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.617 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.91 75.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.736 1.153 . . . . 0.0 109.271 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.75 -44.66 93.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.4 -40.77 77.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.633 -174.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -71.57 -31.93 67.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.966 0.803 . . . . 0.0 110.745 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -62.64 -44.92 95.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.426 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 3.8 mmpt? -73.7 -15.71 61.22 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.52 0.6 . . . . 0.0 110.416 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.34 18.85 78.92 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.768 1.652 . . . . 0.0 112.546 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.59 160.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 118.278 1.039 . . . . 0.0 111.746 -168.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.7 m -94.56 120.98 35.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -134.16 -172.66 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.531 1.933 . . . . 0.0 107.693 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.45 137.0 48.42 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -109.62 135.57 50.37 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.498 0.719 . . . . 0.0 109.092 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.11 77.27 75.56 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.632 1.173 . . . . 0.0 108.962 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.53 152.4 80.39 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.794 2.33 . . . . 0.0 110.868 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 CA--C 1.541 0.63 0 C-N-CA 124.794 1.238 . . . . 0.0 112.507 177.582 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -82.85 -43.31 16.76 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -60.61 -33.48 72.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.07 -38.1 72.79 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.493 -0.755 . . . . 0.0 110.296 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -20.61 62.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.942 0.897 . . . . 0.0 111.643 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.1 mt -73.58 -42.65 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.26 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -30.74 37.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.982 1.719 . . . . 0.0 112.258 173.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -44.97 66.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.387 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.51 -11.77 3.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -168.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.01 -20.22 47.21 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.613 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -138.56 148.03 43.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.29 1.545 . . . . 0.0 111.811 -169.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -88.17 -5.9 58.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 131.37 3.868 . . . . 0.0 113.189 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -76.56 168.52 19.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.22 1.408 . . . . 0.0 111.35 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.62 166.17 21.08 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.615 0.766 . . . . 0.0 110.15 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.14 155.42 73.42 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.224 1.116 . . . . 0.0 109.589 -8.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -134.1 91.92 2.88 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -86.17 150.49 3.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -141.75 145.51 34.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.369 2.668 . . . . 0.0 108.523 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.71 116.49 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 43.55 51.64 6.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.741 1.616 . . . . 0.0 112.133 -172.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.3 -0.07 2.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.87 2.468 . . . . 0.0 114.234 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -75.5 108.86 8.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -65.82 110.19 2.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.79 -58.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.33 -143.69 11.6 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -173.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.62 -172.49 41.14 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.635 2.064 . . . . 0.0 111.327 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -56.38 -46.2 80.21 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.93 -0.747 . . . . 0.0 111.154 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.74 -32.0 73.36 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.959 0.345 . . . . 0.0 110.436 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.56 -46.0 64.35 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.692 0.758 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.2 -50.21 74.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.852 1.261 . . . . 0.0 111.004 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -68.31 -28.65 67.36 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.61 82.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 110.447 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.7 tp -56.7 -46.05 81.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.735 1.152 . . . . 0.0 109.926 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.51 -43.29 89.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.635 0.774 . . . . 0.0 111.259 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.15 63.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.943 0.897 . . . . 0.0 112.123 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.87 6.84 26.5 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.232 1.413 . . . . 0.0 111.713 169.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.93 17.92 68.1 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.043 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.08 -8.53 41.53 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.862 1.331 . . . . 0.0 113.008 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -75.24 -55.48 5.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.877 1.338 . . . . 0.0 109.5 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -50.99 74.53 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.68 -17.69 30.01 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.928 2.419 . . . . 0.0 114.806 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -104.8 -1.52 25.99 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.996 1.318 . . . . 0.0 111.115 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 N--CA 1.465 0.278 0 O-C-N 120.322 -1.486 . . . . 0.0 112.005 177.345 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.03 99.41 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.45 148.06 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.583 0.552 . . . . 0.0 111.58 -168.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.97 114.94 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -74.31 140.37 44.84 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -150.82 172.65 15.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.905 1.682 . . . . 0.0 110.832 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.41 174.81 12.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.782 1.233 . . . . 0.0 107.862 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -18.87 61.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.1 1.36 . . . . 0.0 113.842 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 106.75 7.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -167.0 85.63 0.83 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.664 0.786 . . . . 0.0 108.932 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.78 -33.91 96.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.633 1.555 . . . . 0.0 111.424 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -73.46 -27.57 61.48 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.769 -1.207 . . . . 0.0 109.832 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.47 -49.32 74.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.023 -1.048 . . . . 0.0 108.93 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.75 -46.55 74.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.946 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -54.56 -52.77 61.05 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 120.225 1.375 . . . . 0.0 111.335 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.23 71.35 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.527 0.603 . . . . 0.0 110.39 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -58.54 -38.1 77.08 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.39 0.996 . . . . 0.0 111.474 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.98 95.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.112 0.565 . . . . 0.0 109.706 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 tp -62.55 -48.28 80.18 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.139 0.576 . . . . 0.0 109.875 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.1 mt -65.09 -42.14 94.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 110.734 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 t -65.12 -36.34 83.95 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.512 1.125 . . . . 0.0 110.226 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.3 t -70.22 -34.4 72.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.219 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -80.92 -5.29 57.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.462 1.028 . . . . 0.0 111.424 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 23.32 77.11 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 124.609 1.1 . . . . 0.0 111.686 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.86 162.93 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 118.181 0.991 . . . . 0.0 110.283 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -100.53 113.54 26.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 172.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.76 170.18 16.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.124 1.77 . . . . 0.0 109.207 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -123.44 140.81 52.63 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.61 143.0 39.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.18 113.83 23.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.09 158.76 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.927 2.418 . . . . 0.0 110.393 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mm . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.849 1.26 . . . . 0.0 110.778 170.472 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.3 -45.21 94.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.959 1.254 . . . . 0.0 110.339 168.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.7 -39.55 93.84 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.779 0.718 . . . . 0.0 110.098 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -58.01 -36.96 73.43 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.605 -0.684 . . . . 0.0 110.377 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.8 ttm -64.4 -16.05 61.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.922 1.689 . . . . 0.0 112.513 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.28 -58.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -55.08 -50.13 69.93 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.403 0.62 . . . . 0.0 110.567 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.74 -39.99 73.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.426 -168.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.8 p -112.03 -25.37 9.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 112.865 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.0 21.73 63.97 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.353 -168.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -136.54 -57.03 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.307 1.554 . . . . 0.0 113.011 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 79.3 -6.34 1.86 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 129.755 3.222 . . . . 0.0 113.612 -172.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.4 p -73.79 176.4 6.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.772 2.029 . . . . 0.0 107.92 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.3 159.42 63.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 O-C-N 121.849 -0.532 . . . . 0.0 110.033 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.36 165.79 81.94 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 125.591 -0.587 . . . . 0.0 111.395 -5.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -132.89 104.44 6.58 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 168.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.12 141.79 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -127.69 128.76 45.98 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 128.332 2.653 . . . . 0.0 104.953 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.44 104.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 52.22 52.14 14.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.295 1.038 . . . . 0.0 109.175 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.19 -13.49 0.9 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 130.565 3.546 . . . . 0.0 114.428 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -74.7 108.75 7.65 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -67.55 110.24 3.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -74.25 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.14 -145.9 13.82 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -168.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.78 -168.74 36.67 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.169 1.366 . . . . 0.0 112.016 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -61.51 -39.98 92.96 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.682 -0.893 . . . . 0.0 110.214 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.54 -35.92 82.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -65.7 -45.78 81.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.941 1.296 . . . . 0.0 110.701 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.26 -48.32 70.85 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 126.188 1.795 . . . . 0.0 111.087 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -64.96 -34.68 79.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.705 1.202 . . . . 0.0 109.541 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.17 77.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.233 0.613 . . . . 0.0 110.824 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.62 -39.33 73.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.858 0.863 . . . . 0.0 109.839 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.24 -34.18 70.54 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.527 -0.733 . . . . 0.0 112.722 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.28 -34.05 75.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.224 1.009 . . . . 0.0 110.781 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -90.53 6.77 42.18 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 124.799 1.24 . . . . 0.0 112.888 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.95 3.86 52.95 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.273 0.939 . . . . 0.0 112.463 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.12 -17.62 80.22 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.376 0.988 . . . . 0.0 112.047 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.54 -40.39 61.75 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.242 1.017 . . . . 0.0 111.61 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -56.21 24.83 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.154 0.982 . . . . 0.0 112.398 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.49 16.32 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.197 3.264 . . . . 0.0 112.227 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.3 mt -115.96 -17.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.038 -1.039 . . . . 0.0 111.967 171.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 N--CA 1.468 0.427 0 CA-C-N 119.534 1.061 . . . . 0.0 112.527 -175.801 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -133.48 142.96 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 119.866 1.212 . . . . 0.0 108.159 170.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -140.87 120.57 13.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.27 14.2 tt -134.72 101.75 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.609 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -77.58 141.97 39.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.984 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -147.5 -176.97 5.45 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.261 1.425 . . . . 0.0 112.442 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.19 -170.01 2.62 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.393 -1.442 . . . . 0.0 108.241 169.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.32 -5.98 12.49 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -140.9 -119.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.423 1.489 . . . . 0.0 107.911 -168.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t 58.52 85.68 0.18 Allowed Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 127.451 2.3 . . . . 0.0 111.284 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.94 -38.88 86.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.174 2.583 . . . . 0.0 112.941 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -74.22 -34.19 63.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.205 1.366 . . . . 0.0 110.925 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.57 -48.14 81.92 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.61 1.095 . . . . 0.0 109.108 169.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -60.79 -39.65 89.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.073 -1.442 . . . . 0.0 110.97 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 23.9 mmt85 -54.3 -53.0 59.71 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.831 1.65 . . . . 0.0 109.699 173.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.95 79.57 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.354 0.525 . . . . 0.0 110.968 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -62.51 -40.2 95.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.248 0.931 . . . . 0.0 111.051 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.06 99.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.826 0.851 . . . . 0.0 109.75 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.54 -52.43 65.42 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.97 -36.5 83.5 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.373 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 m -69.46 -34.6 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.211 0.605 . . . . 0.0 110.773 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -64.7 -38.08 89.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.428 0.691 . . . . 0.0 109.337 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -86.06 0.14 54.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.932 -0.48 . . . . 0.0 111.453 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.02 21.4 69.72 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.721 2.105 . . . . 0.0 111.416 169.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -74.5 163.2 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -169.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -99.07 118.1 35.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -143.73 166.68 24.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.471 1.908 . . . . 0.0 109.512 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -113.57 140.15 48.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -109.08 145.23 36.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.451 1.9 . . . . 0.0 106.674 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -128.19 83.26 66.63 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 108.669 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.52 142.03 98.27 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.321 2.014 . . . . 0.0 109.193 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.466 0.37 0 CA-C-N 120.222 1.374 . . . . 0.0 107.855 168.372 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -59.45 -48.93 79.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -56.67 -46.76 80.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.352 1.061 . . . . 0.0 110.258 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -55.98 -33.03 64.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.112 0.565 . . . . 0.0 110.926 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ttp -62.79 -12.92 27.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.848 1.259 . . . . 0.0 113.967 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mt -63.91 -55.21 23.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -71.97 -36.24 69.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.2 -0.937 . . . . 0.0 111.776 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -35.16 80.17 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.259 -1.353 . . . . 0.0 112.289 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -129.04 -16.14 4.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.086 1.312 . . . . 0.0 114.355 -170.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.7 -5.65 11.09 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.044 -1.42 . . . . 0.0 113.458 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.68 -54.59 2.5 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.89 1.845 . . . . 0.0 111.69 -169.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m 86.1 -9.91 0.71 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.867 3.267 . . . . 0.0 111.823 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.9 p -74.06 176.66 6.31 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 130.486 3.515 . . . . 0.0 109.441 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.02 158.84 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.642 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.73 156.95 98.91 Favored 'Cis proline' 0 C--N 1.349 0.559 0 CA-C-N 120.248 1.124 . . . . 0.0 111.482 0.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -130.0 99.42 5.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.84 142.15 13.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -129.3 141.66 51.04 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 128.339 2.655 . . . . 0.0 105.575 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.86 136.49 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.09 35.97 26.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.028 0.931 . . . . 0.0 111.052 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.78 -0.21 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.659 2.384 . . . . 0.0 114.476 -173.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -80.83 121.33 25.82 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -63.76 119.38 9.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 mm -82.77 -66.73 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.7 -125.2 1.87 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.24 -172.18 14.06 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.858 2.171 . . . . 0.0 110.771 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 36.4 t80 -56.02 -46.0 78.93 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.081 -173.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.48 -36.9 81.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.847 1.203 . . . . 0.0 110.447 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.8 -51.08 64.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.185 0.994 . . . . 0.0 109.727 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.73 -48.86 75.35 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.401 2.281 . . . . 0.0 111.393 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -61.29 -42.09 98.06 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.12 0.968 . . . . 0.0 109.018 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.27 96.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.955 0.798 . . . . 0.0 110.884 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.7 tp -56.68 -41.21 76.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.232 0.924 . . . . 0.0 110.58 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.69 -37.93 79.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.687 -0.633 . . . . 0.0 112.282 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.49 -25.23 66.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.605 1.162 . . . . 0.0 111.363 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -73.8 -20.72 60.38 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.377 1.071 . . . . 0.0 110.148 172.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.77 27.01 59.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -168.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.86 -9.11 23.28 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.192 1.377 . . . . 0.0 112.753 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -74.77 -42.59 57.88 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.854 1.327 . . . . 0.0 109.4 170.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -56.35 29.59 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.632 1.573 . . . . 0.0 109.543 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.64 -8.24 23.15 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.525 2.15 . . . . 0.0 113.957 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.5 -58.48 2.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.235 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 111.737 -172.767 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.234 0.284 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.41 97.52 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -102.62 122.11 43.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.259 19.7 tt -129.75 107.96 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.527 0.679 . . . . 0.0 112.208 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -74.04 149.74 41.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.664 1.186 . . . . 0.0 110.926 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.452 ' CG2' ' HZ2' ' A' ' 18' ' ' LYS . 82.0 p -155.42 -177.66 6.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.036 1.335 . . . . 0.0 113.3 -169.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -173.77 4.55 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 168.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.26 -25.9 25.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.43 2.692 . . . . 0.0 114.711 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -138.82 -82.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.4 t 45.43 88.35 0.1 Allowed Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.349 1.86 . . . . 0.0 110.841 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 43.67 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 125.062 3.841 . . . . 0.0 113.415 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.21 -50.23 0.38 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 131.164 3.786 . . . . 0.0 105.243 171.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.08 -50.54 66.56 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.657 1.183 . . . . 0.0 110.69 170.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -51.49 -55.24 19.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.342 1.027 . . . . 0.0 109.801 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -54.04 -47.24 71.79 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.858 0.863 . . . . 0.0 111.456 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.2 66.44 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.553 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HZ2' ' CG2' ' A' ' 7' ' ' THR . 0.0 OUTLIER -61.11 -30.8 70.58 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.534 1.516 . . . . 0.0 115.058 174.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.35 93.27 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 119.911 1.232 . . . . 0.0 108.867 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.38 -53.83 52.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.764 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.2 -37.65 87.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.398 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -73.73 -28.45 61.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.615 0.643 . . . . 0.0 110.193 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -68.61 -28.84 67.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.197 0.908 . . . . 0.0 110.501 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -89.97 -8.32 51.97 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.853 1.206 . . . . 0.0 111.567 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.36 25.59 72.53 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.804 1.669 . . . . 0.0 111.963 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.2 m -73.94 158.63 5.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 121.876 -0.779 . . . . 0.0 112.963 -168.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 107.63 8.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.161 1.784 . . . . 0.0 108.824 168.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -135.07 170.25 16.19 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.428 1.091 . . . . 0.0 108.147 172.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -118.32 135.57 54.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.02 135.98 41.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.67 117.84 33.87 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -84.17 155.06 12.78 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.392 2.062 . . . . 0.0 111.184 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt . . . . . 0 CA--C 1.54 0.585 0 C-N-CA 125.297 1.439 . . . . 0.0 108.832 168.19 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.09 -45.42 67.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.209 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.66 -28.87 67.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.465 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.89 -41.56 87.47 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.783 0.72 . . . . 0.0 109.248 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -60.76 -22.33 63.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.127 -0.983 . . . . 0.0 113.414 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.48 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -68.82 -27.09 65.54 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.366 0.984 . . . . 0.0 112.588 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -74.21 -40.18 62.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.326 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.3 p -124.32 -21.52 4.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -3.54 10.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.156 1.836 . . . . 0.0 113.791 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -90.92 -70.64 0.67 Allowed 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 119.413 1.607 . . . . 0.0 114.004 -168.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 p 83.0 -8.55 1.14 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.877 3.271 . . . . 0.0 110.719 -168.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 p -74.13 171.02 14.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.873 1.269 . . . . 0.0 107.9 169.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 161.19 40.97 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.165 0.986 . . . . 0.0 110.072 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 159.2 88.82 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.687 0.567 . . . . 0.0 110.937 -4.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.42 99.99 5.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 174.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.1 142.5 13.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -128.38 135.73 49.95 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.996 2.518 . . . . 0.0 104.577 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -130.67 110.24 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 14.0 m-20 43.04 63.74 1.41 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.803 1.241 . . . . 0.0 111.981 -168.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.78 -10.54 0.48 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.605 2.762 . . . . 0.0 113.636 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -84.94 108.18 17.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -62.78 114.53 3.67 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.947 0.899 . . . . 0.0 109.059 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.0 -65.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.396 1.078 . . . . 0.0 110.267 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.85 -138.03 5.83 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -169.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.46 -166.28 12.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.752 1.644 . . . . 0.0 111.595 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.61 -39.6 77.23 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 118.35 1.075 . . . . 0.0 112.706 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -61.08 -44.13 97.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.652 0.66 . . . . 0.0 109.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.18 -38.72 91.39 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.678 -0.639 . . . . 0.0 111.296 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.62 -43.5 76.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.637 1.175 . . . . 0.0 111.131 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.65 -32.59 62.31 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.04 87.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.948 0.499 . . . . 0.0 109.719 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 tp -56.52 -44.06 80.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.817 0.735 . . . . 0.0 110.308 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -37.79 88.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.992 0.517 . . . . 0.0 111.884 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.51 -35.03 79.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.659 -0.65 . . . . 0.0 111.026 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -78.58 -1.0 31.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 21.21 75.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.672 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.65 -7.1 56.99 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.058 -0.857 . . . . 0.0 112.094 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.93 -50.03 12.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.317 1.059 . . . . 0.0 108.972 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.94 -53.52 20.91 Favored Pre-proline 0 N--CA 1.464 0.263 0 C-N-CA 125.872 1.669 . . . . 0.0 113.993 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.94 -16.83 36.96 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 121.255 1.484 . . . . 0.0 113.037 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.29 -1.87 55.58 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.573 1.149 . . . . 0.0 110.921 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.232 0.172 0 C-N-CA 125.314 1.446 . . . . 0.0 108.737 170.085 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.4 t -136.16 88.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -91.27 143.6 26.48 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.38 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt -140.44 113.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.115 0.483 . . . . 0.0 110.651 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.69 124.21 26.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.763 0.825 . . . . 0.0 109.1 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -142.22 169.05 18.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.6 0.76 . . . . 0.0 111.236 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.86 174.4 15.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.961 1.304 . . . . 0.0 109.483 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.69 -68.63 0.3 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.599 1.56 . . . . 0.0 109.856 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.7 m -86.22 90.63 8.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.8 t -155.52 91.15 2.82 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.43 -44.74 30.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.579 2.186 . . . . 0.0 110.959 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -73.3 -27.13 61.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.631 -0.668 . . . . 0.0 110.501 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -60.81 -57.0 14.5 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.676 1.126 . . . . 0.0 109.368 170.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -54.47 -42.4 70.64 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.828 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -56.71 -51.64 68.02 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.126 1.33 . . . . 0.0 111.624 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.22 77.88 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.452 0.569 . . . . 0.0 110.887 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -58.33 -41.4 84.52 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.939 0.791 . . . . 0.0 110.562 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.96 77.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.611 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.07 -48.75 77.31 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.201 0.91 . . . . 0.0 108.859 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.93 -44.39 85.28 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 122.002 -0.436 . . . . 0.0 111.314 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.2 m -64.12 -35.64 81.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.937 0.495 . . . . 0.0 110.487 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -68.13 -34.16 75.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.601 0.761 . . . . 0.0 110.371 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -76.27 -13.39 60.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.93 0.786 . . . . 0.0 111.17 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.79 42.4 70.53 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.63 161.85 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.456 0.703 . . . . 0.0 110.447 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 p -87.7 137.07 32.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -150.22 168.41 24.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.433 1.493 . . . . 0.0 108.187 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -114.89 147.62 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -115.66 142.93 46.07 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.06 92.9 47.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.81 147.65 44.85 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.974 2.449 . . . . 0.0 110.455 -169.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 mt . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 125.404 1.482 . . . . 0.0 109.725 174.672 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 120.363 0.125 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -74.37 -56.91 4.33 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -22.82 63.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.834 0.743 . . . . 0.0 111.818 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -55.78 -27.63 52.0 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.805 -1.184 . . . . 0.0 111.586 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.2 ttm -52.52 -22.76 5.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 113.325 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.91 -45.52 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.882 0.873 . . . . 0.0 109.217 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -75.07 -35.38 61.83 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 121.05 1.75 . . . . 0.0 111.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -66.8 -42.28 86.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.79 -10.53 1.81 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.793 1.237 . . . . 0.0 113.232 -168.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.99 1.25 84.84 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.998 -168.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -130.9 -161.71 1.15 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.977 2.388 . . . . 0.0 110.376 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.76 8.35 0.3 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.844 2.458 . . . . 0.0 110.55 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.04 158.34 18.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.759 2.823 . . . . 0.0 110.314 -173.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.31 166.58 24.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -167.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.52 168.95 68.73 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 119.898 0.999 . . . . 0.0 110.043 -7.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.76 102.81 5.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.0 136.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.51 95.58 4.73 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 168.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.1 mm -90.08 111.86 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 52.0 60.84 3.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.929 1.292 . . . . 0.0 113.011 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.47 15.54 6.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.301 1.441 . . . . 0.0 113.282 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.26 109.72 14.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -60.32 112.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 108.909 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.9 mm -76.67 -73.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.51 -138.44 6.82 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.2 -171.09 47.2 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.899 1.714 . . . . 0.0 111.677 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -62.3 -36.97 83.77 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.489 -1.243 . . . . 0.0 110.944 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.76 -43.94 94.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.721 1.146 . . . . 0.0 109.14 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.3 -46.72 79.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.987 1.315 . . . . 0.0 109.701 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.51 -47.97 76.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 126.444 1.898 . . . . 0.0 111.869 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -67.01 -33.3 75.25 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.016 0.926 . . . . 0.0 108.599 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.07 82.33 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.493 1.042 . . . . 0.0 111.217 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -56.52 -44.08 80.43 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.931 0.787 . . . . 0.0 110.317 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.5 -36.14 80.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.689 1.196 . . . . 0.0 111.812 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.84 -26.29 65.08 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.584 1.154 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -20.52 60.5 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.129 0.572 . . . . 0.0 111.201 170.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.95 7.03 88.65 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -168.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.4 -9.42 84.93 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 117.967 0.884 . . . . 0.0 111.685 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.3 tp -74.51 -39.16 62.57 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.243 1.021 . . . . 0.0 110.302 170.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.74 -53.14 27.38 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 -4.96 13.89 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.509 2.139 . . . . 0.0 113.527 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.5 mt -114.47 3.1 14.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.997 1.719 . . . . 0.0 110.982 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--O 1.235 0.33 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.659 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.0 t -130.49 120.67 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 168.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -135.57 128.37 31.12 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -131.33 109.39 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -73.92 138.07 44.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -149.19 -179.44 7.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.222 1.409 . . . . 0.0 110.818 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.14 173.94 12.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -66.72 -16.36 64.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -136.97 127.42 26.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 168.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 t -168.5 95.45 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.67 -39.61 90.15 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.669 2.246 . . . . 0.0 112.618 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.79 -30.04 56.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.819 0.736 . . . . 0.0 111.09 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.37 -51.37 70.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.73 1.15 . . . . 0.0 108.672 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -57.73 -40.57 79.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.966 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -54.54 -54.48 40.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.577 1.535 . . . . 0.0 110.833 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.57 68.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.336 0.516 . . . . 0.0 110.702 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -61.67 -34.05 75.05 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.388 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.72 69.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.36 -49.35 76.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.477 0.711 . . . . 0.0 109.462 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -66.89 -41.78 86.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.261 0.625 . . . . 0.0 111.032 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -69.28 -31.94 70.78 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.6 m -68.47 -33.49 74.26 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.322 0.965 . . . . 0.0 111.271 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -74.97 -11.27 60.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.613 0.642 . . . . 0.0 110.757 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.21 16.22 76.92 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.274 1.416 . . . . 0.0 112.158 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 m -74.18 162.9 4.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 117.796 0.798 . . . . 0.0 110.99 -168.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.45 106.74 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.081 1.752 . . . . 0.0 108.136 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -134.25 169.33 17.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.224 1.41 . . . . 0.0 110.357 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -117.39 145.18 44.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.621 1.568 . . . . 0.0 107.435 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -114.01 150.15 34.33 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -134.2 88.02 32.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.609 1.564 . . . . 0.0 108.767 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.07 152.73 46.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.907 1.738 . . . . 0.0 111.855 -168.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.2 pt . . . . . 0 C--N 1.332 -0.183 0 C-N-CA 126.131 1.772 . . . . 0.0 109.421 168.746 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.275 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -48.14 33.73 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.252 0.933 . . . . 0.0 109.012 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.23 -40.88 87.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.146 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.23 -44.31 83.69 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.671 0.788 . . . . 0.0 109.704 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.6 ttm -60.29 -18.32 48.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.868 1.267 . . . . 0.0 111.956 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -68.65 -58.58 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -61.25 -40.82 95.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.554 1.524 . . . . 0.0 111.886 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -67.03 -44.29 80.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.879 0.872 . . . . 0.0 111.565 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -126.39 -27.03 3.23 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.25 -21.36 5.13 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.692 2.568 . . . . 0.0 113.168 -168.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -87.68 -60.59 1.93 Allowed 'General case' 0 C--O 1.231 0.089 0 C-N-CA 124.45 1.1 . . . . 0.0 113.25 -168.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.3 p 75.38 15.86 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.954 2.102 . . . . 0.0 113.324 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.0 p -96.64 176.23 6.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.911 1.284 . . . . 0.0 108.484 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -136.65 154.11 76.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.139 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.11 156.02 91.2 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.604 -0.998 . . . . 0.0 110.18 -11.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.35 93.79 4.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 mp -81.51 143.39 12.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -130.09 127.0 38.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 129.635 3.174 . . . . 0.0 105.037 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.4 mt -130.67 126.5 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.38 55.73 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.527 2.331 . . . . 0.0 110.492 -168.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 67.04 -7.96 0.46 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 129.692 3.197 . . . . 0.0 114.175 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -81.08 117.6 21.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -172.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -63.66 101.58 0.36 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -74.07 -59.32 3.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.709 1.203 . . . . 0.0 109.49 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.48 -141.13 10.8 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.98 -170.44 32.43 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.032 1.301 . . . . 0.0 111.174 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -62.1 -40.03 94.49 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.758 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.5 -40.09 85.92 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.772 0.714 . . . . 0.0 110.015 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.77 -48.71 73.54 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.306 1.443 . . . . 0.0 110.085 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.31 -47.63 85.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.117 1.767 . . . . 0.0 111.374 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -66.13 -35.31 80.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.062 0.945 . . . . 0.0 109.228 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.34 -47.17 85.41 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.787 0.722 . . . . 0.0 110.512 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.61 -45.75 81.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.717 0.807 . . . . 0.0 110.649 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.59 -43.63 97.14 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.819 1.248 . . . . 0.0 111.394 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -25.0 67.84 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.491 0.717 . . . . 0.0 110.661 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.25 3.2 55.45 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.529 1.132 . . . . 0.0 110.669 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.7 20.89 53.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.349 0.976 . . . . 0.0 111.941 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.0 63.14 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 118.527 1.163 . . . . 0.0 111.451 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 tp -78.33 -53.18 7.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.657 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -53.25 32.24 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 127.165 2.186 . . . . 0.0 113.88 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -69.25 -1.49 8.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.846 1.697 . . . . 0.0 112.968 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 99.0 mt -112.36 -3.34 14.54 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.051 1.74 . . . . 0.0 111.727 170.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 125.509 1.523 . . . . 0.0 114.245 179.7 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.371 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.17 132.05 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -133.02 141.86 48.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.49 1.516 . . . . 0.0 107.179 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 tt -136.99 125.42 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -103.04 127.62 50.22 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.675 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.8 p -141.08 177.62 7.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.822 1.249 . . . . 0.0 109.747 -173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.55 -173.47 3.97 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.895 -1.128 . . . . 0.0 108.631 173.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -50.13 -56.77 9.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.938 1.695 . . . . 0.0 109.299 169.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -85.33 -173.58 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.638 1.175 . . . . 0.0 109.698 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t 96.34 81.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 129.664 3.186 . . . . 0.0 108.266 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.33 -27.69 71.69 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.341 2.028 . . . . 0.0 112.062 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -73.31 -31.21 63.88 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.4 -0.813 . . . . 0.0 109.185 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.7 m -61.65 -48.03 82.7 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.029 -1.044 . . . . 0.0 110.245 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -53.35 -51.79 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.713 -0.66 . . . . 0.0 109.809 170.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -54.47 -43.94 72.14 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.126 0.876 . . . . 0.0 112.753 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.72 68.1 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.361 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.46 -37.17 74.92 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.425 1.466 . . . . 0.0 110.809 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.76 -39.23 90.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.116 0.566 . . . . 0.0 110.852 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tt -65.35 -45.92 82.24 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -41.09 96.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.796 0.725 . . . . 0.0 111.282 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 -36.92 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 m -72.46 -29.53 63.74 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.961 0.801 . . . . 0.0 112.68 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mmmp? -75.29 -15.2 60.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.198 0.908 . . . . 0.0 110.377 169.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.07 47.18 61.0 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.24 170.72 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.231 0.613 . . . . 0.0 110.641 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -104.44 117.12 33.38 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.061 1.744 . . . . 0.0 108.104 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -134.35 163.39 29.76 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.606 0.763 . . . . 0.0 110.182 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -95.61 139.54 31.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.48 133.74 55.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.77 106.96 31.55 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.88 1.272 . . . . 0.0 107.931 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.02 153.21 41.49 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.92 1.746 . . . . 0.0 108.828 173.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 mm . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 123.55 0.74 . . . . 0.0 110.799 174.313 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 tptt . . . . . 0 CA--C 1.516 -0.363 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -55.45 -49.93 71.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 110.057 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -68.55 -31.71 71.12 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.103 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -61.03 -39.13 88.6 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.247 1.385 . . . . 0.0 110.476 169.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 ttm -56.04 -12.59 1.52 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.841 1.657 . . . . 0.0 112.303 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mt -63.98 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -69.47 -20.05 63.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.835 1.652 . . . . 0.0 112.168 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -21.55 61.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.312 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.1 p -134.76 -15.65 2.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.012 1.733 . . . . 0.0 114.982 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.85 69.12 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.023 1.297 . . . . 0.0 112.167 -168.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.55 -72.94 0.66 Allowed 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 125.346 1.459 . . . . 0.0 110.084 -169.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 86.63 -4.78 0.71 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 130.797 3.639 . . . . 0.0 111.616 -168.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.5 p -106.2 162.85 13.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.566 1.547 . . . . 0.0 108.073 -172.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.99 163.05 42.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.226 0.61 . . . . 0.0 109.95 -168.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -65.43 161.67 70.05 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.082 1.065 . . . . 0.0 112.387 -4.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -139.57 140.66 37.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.564 168.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 146.98 30.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 168.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -122.16 133.74 54.74 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.6 mt -136.99 120.94 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 51.09 43.5 29.04 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.521 1.128 . . . . 0.0 109.192 -168.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.21 -3.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.866 2.466 . . . . 0.0 114.797 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -83.03 114.89 21.59 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.402 1.881 . . . . 0.0 108.416 -173.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -64.95 113.39 3.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.461 1.028 . . . . 0.0 108.589 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -82.93 -74.45 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.486 1.114 . . . . 0.0 109.03 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.16 -145.83 14.1 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 119.169 0.895 . . . . 0.0 113.683 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.6 -171.71 47.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.72 2.105 . . . . 0.0 113.474 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.9 -40.28 68.97 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.462 -1.611 . . . . 0.0 110.039 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -34.29 74.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.283 175.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -67.54 -49.13 64.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.569 0.699 . . . . 0.0 110.59 171.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.49 -42.71 96.87 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.926 1.29 . . . . 0.0 111.757 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.59 -37.22 68.2 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.01 85.71 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.295 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -56.22 -47.74 77.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.531 1.059 . . . . 0.0 110.894 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.43 -33.68 76.09 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.594 -0.691 . . . . 0.0 111.738 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.04 60.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.472 1.109 . . . . 0.0 112.516 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 1.51 44.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.897 1.226 . . . . 0.0 110.982 168.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.37 23.17 77.83 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -171.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.35 -3.78 29.1 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.04 -1.422 . . . . 0.0 113.403 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 tp -80.5 -48.25 13.07 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.441 1.621 . . . . 0.0 108.342 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -49.78 85.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.717 1.207 . . . . 0.0 113.158 -174.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 -28.59 53.62 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 CA-C-N 122.22 1.829 . . . . 0.0 112.636 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.85 -14.34 58.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.008 0.822 . . . . 0.0 111.837 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--O 1.236 0.388 0 C-N-CA 126.779 2.032 . . . . 0.0 109.395 -174.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.7 t -94.71 135.4 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -129.15 139.9 51.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 tt -139.54 120.04 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.846 0.355 . . . . 0.0 110.256 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -92.33 132.29 36.84 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.0 p -140.72 168.72 19.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.156 0.982 . . . . 0.0 111.521 -169.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.11 -179.45 7.33 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.785 -1.197 . . . . 0.0 110.521 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -53.59 -39.56 64.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 128.175 2.59 . . . . 0.0 113.52 -168.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -134.25 105.83 6.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -155.93 80.09 4.04 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.754 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -57.71 -33.94 97.47 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.242 1.961 . . . . 0.0 112.139 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -73.54 -28.89 62.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.393 1.451 . . . . 0.0 110.175 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.19 -53.16 61.06 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -53.21 -44.74 68.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.345 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -54.39 -62.2 1.81 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.779 1.172 . . . . 0.0 110.712 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -46.16 91.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -63.08 -34.97 78.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.292 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.36 77.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.341 0.973 . . . . 0.0 110.407 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.24 -52.84 63.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.796 0.725 . . . . 0.0 109.149 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.91 -43.33 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.027 0.531 . . . . 0.0 111.191 -170.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -64.9 -35.05 79.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.304 0.642 . . . . 0.0 110.131 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.7 m -73.08 -30.72 63.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.629 0.649 . . . . 0.0 112.492 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -74.29 -10.73 59.88 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.508 1.123 . . . . 0.0 109.767 172.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.03 46.05 60.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.82 175.99 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.426 1.09 . . . . 0.0 110.227 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.5 m -133.49 99.29 4.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.593 1.187 . . . . 0.0 108.08 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -92.03 165.64 13.09 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 128.382 2.673 . . . . 0.0 107.911 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -97.3 138.44 34.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -115.92 136.29 53.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.547 0.739 . . . . 0.0 109.419 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.64 106.17 20.92 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.761 1.625 . . . . 0.0 110.439 -168.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.97 144.79 19.15 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.577 1.518 . . . . 0.0 111.992 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.4 mm . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 168.002 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.571 0.224 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -54.09 -62.78 1.43 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.065 1.746 . . . . 0.0 109.218 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.08 -21.48 56.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.165 0.439 . . . . 0.0 111.149 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.98 -32.28 70.69 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.461 -0.774 . . . . 0.0 109.842 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ttp -59.95 -20.89 60.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.06 -1.025 . . . . 0.0 112.681 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.27 -58.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -19.42 64.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.015 . . . . 0.0 112.165 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -91.42 -56.02 3.29 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.77 -1.206 . . . . 0.0 110.931 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.0 p -90.32 -21.91 21.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.926 1.239 . . . . 0.0 113.834 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.66 22.22 63.77 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.963 -0.909 . . . . 0.0 112.204 -168.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -136.17 -57.72 0.76 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.155 1.477 . . . . 0.0 112.723 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.283 0.0 OUTLIER 67.88 -0.15 2.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.912 2.085 . . . . 0.0 113.872 -171.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.9 p -76.87 176.28 8.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.282 1.833 . . . . 0.0 107.507 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.58 158.99 73.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.99 -0.444 . . . . 0.0 111.786 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.07 167.4 78.84 Favored 'Cis proline' 0 C--N 1.347 0.454 0 N-CA-C 109.605 -0.96 . . . . 0.0 109.605 -11.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -128.83 112.08 13.76 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -99.7 143.15 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -134.84 142.31 46.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 128.693 2.797 . . . . 0.0 105.536 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.7 mt -138.5 119.09 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.256 1.2 m-20 52.71 37.53 23.9 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.956 0.884 . . . . 0.0 111.306 -168.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 62.98 2.84 1.08 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.719 2.408 . . . . 0.0 114.382 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -73.79 119.31 17.84 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -69.08 107.74 3.29 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 108.978 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.5 mm -73.94 -63.79 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.41 -138.13 5.7 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.77 -165.06 30.38 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.592 2.044 . . . . 0.0 111.14 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -57.66 -46.15 84.6 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.885 -0.773 . . . . 0.0 110.541 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.03 -32.38 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.679 0.792 . . . . 0.0 109.604 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -73.16 -45.02 59.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.87 1.268 . . . . 0.0 111.957 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.33 -53.69 55.31 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.93 -39.23 80.98 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.68 -46.44 89.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.894 0.878 . . . . 0.0 112.55 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 tp -56.82 -46.71 81.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.762 1.164 . . . . 0.0 110.919 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.26 -38.9 92.68 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.636 1.174 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.895 0.878 . . . . 0.0 111.659 172.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.09 -0.68 57.72 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.909 1.284 . . . . 0.0 112.084 170.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.88 4.12 13.28 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.194 0.907 . . . . 0.0 112.985 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.79 -3.78 89.2 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 119.306 1.553 . . . . 0.0 112.265 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.5 tp -74.25 -51.47 15.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.988 1.315 . . . . 0.0 109.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -56.08 22.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.457 1.503 . . . . 0.0 112.235 -170.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.85 -4.82 15.84 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.205 1.937 . . . . 0.0 113.375 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -100.71 -0.54 37.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.352 0.978 . . . . 0.0 111.107 172.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.23 0.074 0 C-N-CA 125.648 1.579 . . . . 0.0 113.726 -174.471 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.155 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.92 134.35 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.42 150.78 46.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.3 tt -144.27 110.71 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.233 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.52 124.53 28.58 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 107.614 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -144.25 169.16 18.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.39 1.076 . . . . 0.0 112.347 -171.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.76 173.94 10.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.036 1.335 . . . . 0.0 109.138 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.38 -28.81 68.51 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.106 1.762 . . . . 0.0 111.695 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -133.33 110.18 9.87 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.8 91.43 0.67 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 124.946 1.298 . . . . 0.0 108.578 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.12 -40.21 62.61 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.661 2.241 . . . . 0.0 111.049 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.51 -31.93 63.97 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.921 -1.112 . . . . 0.0 110.672 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m -61.98 -46.18 90.38 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 119.185 0.902 . . . . 0.0 109.507 170.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -55.48 -47.71 75.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.335 -0.84 . . . . 0.0 109.997 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -56.08 -50.09 71.98 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.659 1.118 . . . . 0.0 111.158 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.1 -53.95 50.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.634 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -61.75 -36.03 79.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.795 0.725 . . . . 0.0 110.856 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -47.68 82.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.64 -49.5 77.28 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.58 -39.84 84.86 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.051 -0.406 . . . . 0.0 111.217 -174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -67.97 -34.04 75.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.879 0.763 . . . . 0.0 110.276 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -69.72 -27.97 65.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.499 1.045 . . . . 0.0 111.657 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -80.94 -11.53 59.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.215 1.006 . . . . 0.0 110.547 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.94 43.56 49.11 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.762 1.172 . . . . 0.0 110.779 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -98.91 169.04 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.966 0.888 . . . . 0.0 112.066 -170.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.41 128.39 35.92 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.839 2.056 . . . . 0.0 105.819 169.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -155.14 164.51 38.73 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -112.69 139.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.359 1.864 . . . . 0.0 106.875 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.08 146.99 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.66 125.29 19.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.14 138.42 18.08 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.192 1.261 . . . . 0.0 109.578 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 169.329 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -61.84 -50.9 70.42 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.146 0.978 . . . . 0.0 108.669 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -41.53 90.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.288 1.435 . . . . 0.0 111.536 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.46 -33.31 75.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.392 0.677 . . . . 0.0 110.839 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.8 ttp -63.98 -26.28 68.51 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.569 -0.707 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -67.05 -53.44 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 6.89 0.09 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.551 1.94 . . . . 0.0 114.675 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.34 -28.72 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 120.643 1.565 . . . . 0.0 112.703 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -116.02 -22.1 9.15 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.157 1.344 . . . . 0.0 112.898 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -9.64 0.88 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.083 1.802 . . . . 0.0 113.465 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -91.24 -56.12 3.27 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.512 1.156 . . . . 0.0 111.378 -169.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 80.99 -1.53 1.78 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.005 1.322 . . . . 0.0 111.605 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.2 p -80.18 177.09 9.19 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 131.262 3.825 . . . . 0.0 108.58 168.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.84 159.23 71.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.5 166.9 80.66 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-O 121.718 0.632 . . . . 0.0 111.391 -8.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -126.34 100.28 6.21 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 102.098 -3.297 . . . . 0.0 102.098 168.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mp -87.37 146.67 6.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -137.01 150.88 48.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.334 2.254 . . . . 0.0 107.453 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.9 mt -135.86 109.04 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 51.57 43.69 29.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.636 -1.29 . . . . 0.0 110.764 -169.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.04 -1.78 2.88 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.013 2.925 . . . . 0.0 114.665 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.93 103.09 4.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.995 1.718 . . . . 0.0 106.826 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -66.62 109.04 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.11 -59.24 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.95 -133.28 6.81 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.71 -175.13 38.38 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.372 1.463 . . . . 0.0 111.601 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.45 -41.69 81.03 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.557 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.98 -34.83 78.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.565 0.62 . . . . 0.0 110.799 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -66.33 -48.29 70.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 109.773 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.28 -43.75 97.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.351 1.061 . . . . 0.0 111.161 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.73 -37.7 73.51 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.41 94.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.793 0.724 . . . . 0.0 110.711 170.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.79 -49.13 76.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.395 0.998 . . . . 0.0 110.573 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -36.92 78.11 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 111.51 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.55 -22.44 63.55 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.39 -3.58 56.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.55 1.14 . . . . 0.0 110.018 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.53 37.95 92.9 Favored Glycine 0 C--O 1.225 -0.406 0 O-C-N 120.634 -1.291 . . . . 0.0 110.192 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.07 -1.57 58.31 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.845 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.21 -67.77 0.77 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.935 1.294 . . . . 0.0 108.847 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.296 0.0 OUTLIER -45.07 -51.25 24.45 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-O 116.564 -1.684 . . . . 0.0 114.263 177.284 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.65 3.67 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 CA-C-N 123.526 2.295 . . . . 0.0 113.612 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -109.83 -38.61 5.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.36 0.982 . . . . 0.0 110.258 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 CA--C 1.535 0.392 0 O-C-N 121.201 -0.937 . . . . 0.0 113.124 178.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.214 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.1 t -131.51 107.01 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.19 128.77 44.03 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -169.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -130.22 104.89 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.153 0.502 . . . . 0.0 109.908 -171.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -74.95 131.21 40.5 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -143.39 -179.42 6.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.402 0.681 . . . . 0.0 112.146 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 175.94 9.0 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.93 1.692 . . . . 0.0 108.815 168.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -18.68 4.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.271 3.028 . . . . 0.0 115.168 -169.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -137.02 -83.92 0.34 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 168.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 t 56.73 97.5 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.687 1.595 . . . . 0.0 112.463 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.91 42.85 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.777 2.985 . . . . 0.0 113.907 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -150.6 -42.83 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.771 2.828 . . . . 0.0 106.046 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -53.83 -50.52 66.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 109.548 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -52.73 -51.46 60.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.562 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.432 ' HD3' ' CE2' ' A' ' 65' ' ' TYR . 18.0 mtt-85 -56.69 -50.22 72.79 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.563 0.62 . . . . 0.0 110.786 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.19 -43.55 94.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.982 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.33 -47.12 84.76 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.081 1.309 . . . . 0.0 110.261 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.95 79.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.67 0.388 . . . . 0.0 110.46 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.28 -46.71 82.47 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.606 0.763 . . . . 0.0 110.17 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.53 -38.43 89.62 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.204 0.602 . . . . 0.0 110.005 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -64.35 -35.43 80.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.401 0.68 . . . . 0.0 110.793 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 t -67.3 -35.35 79.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.734 0.814 . . . . 0.0 109.65 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -80.58 -6.77 58.76 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.588 0.631 . . . . 0.0 111.937 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.01 28.59 66.34 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.148 0.885 . . . . 0.0 111.462 170.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.15 167.7 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 121.907 -0.76 . . . . 0.0 112.241 -168.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.3 p -98.49 130.12 45.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -145.91 164.27 32.52 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.434 1.094 . . . . 0.0 108.176 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -104.94 136.52 44.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.189 2.195 . . . . 0.0 107.17 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -116.39 139.14 50.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.644 1.178 . . . . 0.0 109.337 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.26 87.81 49.72 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 125.045 1.338 . . . . 0.0 110.702 -169.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.79 141.85 67.31 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.185 1.923 . . . . 0.0 111.701 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 124.938 1.295 . . . . 0.0 112.214 170.826 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.627 0.251 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -59.0 -43.58 91.5 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 120.76 -1.213 . . . . 0.0 110.733 170.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.06 -22.47 55.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.732 0.696 . . . . 0.0 111.869 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -60.25 -24.07 64.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.917 1.235 . . . . 0.0 109.714 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.7 tpp -54.44 -26.66 32.23 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.922 0.783 . . . . 0.0 112.372 173.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -74.38 -40.92 49.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -77.55 -31.36 53.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.443 -0.785 . . . . 0.0 112.208 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -74.9 -38.5 61.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 112.665 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.8 p -133.27 -12.31 2.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -168.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.21 -8.47 70.72 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.945 -168.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -127.54 -161.93 1.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.703 1.752 . . . . 0.0 111.337 -168.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.3 m -155.68 -23.79 0.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.708 2.403 . . . . 0.0 109.948 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.6 p -74.08 163.01 28.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.93 1.692 . . . . 0.0 110.857 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.65 161.97 53.65 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 0.0 109.135 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.98 153.8 84.29 Favored 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.242 1.122 . . . . 0.0 112.116 2.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -130.63 103.37 6.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 105.761 -1.941 . . . . 0.0 105.761 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.65 146.87 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 168.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.91 119.25 27.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 168.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -125.28 129.41 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.697 1.59 . . . . 0.0 107.53 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 48.0 32.82 3.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.639 1.975 . . . . 0.0 110.102 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.26 4.68 4.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 131.107 3.763 . . . . 0.0 115.793 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.84 123.45 24.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -65.13 113.97 4.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.88 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.183 0.993 . . . . 0.0 109.546 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.08 -136.83 8.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -168.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.02 -175.93 43.86 Favored Glycine 0 CA--C 1.521 0.456 0 O-C-N 124.231 0.607 . . . . 0.0 112.483 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.432 ' CE2' ' HD3' ' A' ' 16' ' ' ARG . 2.9 t80 -52.02 -49.71 62.84 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.603 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.3 -25.15 65.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.357 0.663 . . . . 0.0 110.627 -170.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -71.39 -51.88 21.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.528 1.131 . . . . 0.0 110.426 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -51.22 69.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.892 1.277 . . . . 0.0 110.012 176.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -51.05 -38.97 54.73 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.138 1.375 . . . . 0.0 111.413 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.0 91.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 117.882 -1.056 . . . . 0.0 111.746 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.75 -51.02 70.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.467 1.03 . . . . 0.0 109.131 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.79 -42.79 80.09 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.373 1.069 . . . . 0.0 110.433 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -22.81 61.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.175 0.99 . . . . 0.0 112.566 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -88.58 4.47 46.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.188 0.995 . . . . 0.0 112.26 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.85 71.59 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.592 0.633 . . . . 0.0 112.243 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.79 -17.1 80.19 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.477 1.138 . . . . 0.0 112.056 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.3 tp -77.95 -39.73 41.74 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.004 0.902 . . . . 0.0 110.68 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.26 -56.22 22.1 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.269 1.428 . . . . 0.0 109.921 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.56 -0.75 8.72 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.5 2.133 . . . . 0.0 113.508 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.56 -9.9 15.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 112.26 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 126.258 1.823 . . . . 0.0 112.623 -179.305 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.632 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.7 t -125.43 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.3 135.91 52.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 tt -135.0 107.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.282 0.563 . . . . 0.0 110.49 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -73.57 136.14 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.401 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 73.2 p -141.29 179.07 6.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.135 1.374 . . . . 0.0 109.106 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.37 -179.62 7.84 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -48.62 -29.96 4.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.773 3.229 . . . . 0.0 113.924 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -138.41 86.55 2.17 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.203 1.001 . . . . 0.0 111.044 -173.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -156.75 91.23 2.51 Favored Pre-proline 0 CA--C 1.539 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 110.354 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.18 -27.55 72.85 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.361 2.041 . . . . 0.0 112.067 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -73.46 -29.47 62.55 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 7' ' ' THR . 74.1 m -66.75 -47.74 71.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.178 0.899 . . . . 0.0 108.902 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.19 -53.68 26.17 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.784 168.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -53.61 55.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.6 1.091 . . . . 0.0 111.174 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.34 76.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.936 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -60.61 -39.8 89.5 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.672 1.124 . . . . 0.0 110.935 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.3 68.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.208 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp -66.2 -54.34 26.38 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.61 -35.37 80.29 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -68.97 -35.31 76.59 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 109.66 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -74.04 -11.6 60.37 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.14 -0.975 . . . . 0.0 112.167 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -92.28 -27.4 17.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.519 1.054 . . . . 0.0 108.59 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.33 54.03 7.17 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.93 167.47 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.295 0.638 . . . . 0.0 112.088 -172.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.7 m -82.55 120.18 25.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.375 . . . . 0.0 107.308 169.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.87 169.7 17.55 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 109.286 169.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.45 147.29 44.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.77 155.08 28.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.641 0.655 . . . . 0.0 110.557 170.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.49 93.86 27.81 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 124.651 1.181 . . . . 0.0 108.848 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.84 145.98 91.18 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.221 1.948 . . . . 0.0 109.063 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 118.761 0.709 . . . . 0.0 109.1 168.677 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt . . . . . 0 C--O 1.231 0.115 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -67.11 -52.07 46.38 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -32.37 73.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.964 0.802 . . . . 0.0 109.41 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -23.42 66.33 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.291 -0.88 . . . . 0.0 111.917 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.44 -26.38 19.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.002 0.819 . . . . 0.0 112.308 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.39 -56.7 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -61.67 7.51 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.437 2.295 . . . . 0.0 116.125 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.12 -32.2 0.47 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.057 1.299 . . . . 0.0 110.517 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.3 p -129.29 -10.35 4.67 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.476 1.489 . . . . 0.0 113.108 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.84 -14.86 34.85 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.657 1.599 . . . . 0.0 114.322 -171.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.57 ' NH1' ' HG1' ' A' ' 51' ' ' THR . 43.6 mtp180 -131.99 162.44 30.71 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 126.211 1.804 . . . . 0.0 109.01 -169.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -105.45 4.46 30.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 112.645 170.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.57 ' HG1' ' NH1' ' A' ' 49' ' ' ARG . 12.2 p -73.69 175.26 7.33 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.877 1.271 . . . . 0.0 109.8 172.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.98 164.49 29.34 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.976 1.31 . . . . 0.0 110.509 176.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.51 162.12 80.81 Favored 'Cis proline' 0 N--CA 1.454 -0.807 0 CA-C-N 119.151 0.732 . . . . 0.0 110.503 -7.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -127.36 99.6 5.71 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.85 139.82 16.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.22 129.29 47.52 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 128.988 2.915 . . . . 0.0 104.935 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.63 123.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 53.75 30.14 10.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.452 1.024 . . . . 0.0 111.476 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.3 -1.11 2.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.722 3.209 . . . . 0.0 114.691 -172.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -73.95 114.39 12.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.316 1.846 . . . . 0.0 108.055 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -69.85 106.64 3.22 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.667 -0.645 . . . . 0.0 110.045 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.4 mm -73.96 -63.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.786 0.835 . . . . 0.0 109.04 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.87 -142.13 9.84 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.23 -173.31 38.78 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.472 1.51 . . . . 0.0 111.384 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.83 -38.83 76.3 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.598 -0.942 . . . . 0.0 110.625 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.54 -41.82 95.25 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.433 0.693 . . . . 0.0 110.276 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.58 -48.56 66.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.437 1.095 . . . . 0.0 110.052 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -49.86 71.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.861 1.264 . . . . 0.0 110.3 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -67.91 -27.78 66.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.83 69.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.188 0.995 . . . . 0.0 111.674 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.7 tp -56.34 -41.43 76.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.052 1.296 . . . . 0.0 109.94 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.62 -35.48 77.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.274 1.03 . . . . 0.0 112.845 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.95 -29.06 68.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.375 0.534 . . . . 0.0 110.809 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 -74.59 -10.76 59.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.177 0.991 . . . . 0.0 110.784 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.56 3.65 54.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.094 -0.837 . . . . 0.0 111.427 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.9 -6.08 89.25 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.916 1.246 . . . . 0.0 112.368 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 tp -73.5 -44.36 58.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.56 -46.99 99.77 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-O 116.7 -1.619 . . . . 0.0 113.494 -169.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 -12.63 35.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.541 1.943 . . . . 0.0 113.087 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -99.67 0.05 41.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.168 0.894 . . . . 0.0 111.506 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.234 0.239 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -173.844 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.5 t -139.47 118.84 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -113.88 147.22 38.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.319 1.047 . . . . 0.0 108.324 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.65 110.45 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.279 0.491 . . . . 0.0 111.284 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -79.94 140.02 36.83 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.654 -0.654 . . . . 0.0 110.713 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -152.81 178.58 9.49 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.311 2.645 . . . . 0.0 109.223 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.24 -173.56 4.28 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 119.608 -1.933 . . . . 0.0 110.322 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.03 -35.31 24.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.949 1.7 . . . . 0.0 111.578 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -138.27 160.44 39.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.678 2.391 . . . . 0.0 105.651 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 t 163.61 105.9 0.02 OUTLIER Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 127.733 2.413 . . . . 0.0 106.603 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.53 -40.38 30.91 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.846 2.364 . . . . 0.0 110.628 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -73.38 -26.83 61.16 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.99 -1.069 . . . . 0.0 110.306 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.2 m -64.87 -45.14 87.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.24 -0.913 . . . . 0.0 109.805 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -56.11 -47.62 77.72 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.827 -1.083 . . . . 0.0 110.124 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -54.24 -52.64 60.72 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.05 1.295 . . . . 0.0 111.199 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.38 -49.83 75.32 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.686 -0.634 . . . . 0.0 112.037 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -64.43 -32.63 74.33 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.035 0.834 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.52 -28.24 69.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.006 0.821 . . . . 0.0 110.951 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -60.3 2.65 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.02 -41.63 83.56 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.589 0.755 . . . . 0.0 111.356 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -67.77 -26.77 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.047 0.539 . . . . 0.0 110.702 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m -75.98 -29.29 58.18 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.551 -0.718 . . . . 0.0 111.183 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -77.42 -17.3 58.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.852 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.73 43.45 94.14 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.77 156.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.467 0.651 . . . . 0.0 111.575 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.06 117.63 22.98 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -134.13 163.66 29.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 168.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -103.62 144.05 31.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.33 146.86 42.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.88 134.48 26.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -95.38 162.83 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.559 2.172 . . . . 0.0 113.012 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.288 1.2 mt . . . . . 0 C--O 1.236 0.374 0 C-N-CA 126.623 1.969 . . . . 0.0 108.196 167.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -86.07 -60.82 1.9 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.76 -32.76 72.05 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 124.054 0.846 . . . . 0.0 111.339 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.01 -40.01 79.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.105 -0.372 . . . . 0.0 110.988 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -70.33 -17.88 63.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 121.136 -0.977 . . . . 0.0 112.597 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.32 -56.52 13.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 168.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.6 -25.52 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.615 0.766 . . . . 0.0 112.271 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -95.33 -33.62 12.47 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.625 -1.655 . . . . 0.0 113.107 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.5 p -124.07 -24.95 4.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.564 1.984 . . . . 0.0 114.876 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.73 -10.08 20.11 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.073 2.273 . . . . 0.0 114.486 -169.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -94.54 -63.94 1.13 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -168.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 86.71 0.42 0.56 Allowed 'General case' 0 CA--C 1.54 0.567 1 C-N-CA 131.844 4.058 . . . . 0.0 111.718 -168.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.4 p -111.4 161.52 16.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.465 1.506 . . . . 0.0 108.225 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.71 166.8 23.4 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 125.531 1.532 . . . . 0.0 113.833 -168.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.52 163.55 77.73 Favored 'Cis proline' 0 C--N 1.354 0.864 0 CA-C-N 120.847 1.338 . . . . 0.0 110.638 -2.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -146.03 84.48 1.65 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -168.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.61 142.1 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -137.1 85.16 2.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.021 2.128 . . . . 0.0 105.913 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.7 mt -92.93 132.41 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.42 24.61 2.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.408 1.083 . . . . 0.0 110.882 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.65 12.88 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.762 2.025 . . . . 0.0 115.562 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.49 128.0 33.08 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 168.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -69.48 114.05 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mm -76.13 -58.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.524 1.13 . . . . 0.0 110.461 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -157.72 27.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -169.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.34 -168.63 43.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.819 1.676 . . . . 0.0 110.96 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -62.63 -43.98 97.43 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.271 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.63 -34.48 77.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.598 1.09 . . . . 0.0 110.307 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -70.19 -46.32 64.85 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.115 0.966 . . . . 0.0 109.996 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.28 -50.13 74.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 127.543 2.337 . . . . 0.0 111.528 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -67.54 -29.27 68.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -40.3 71.82 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.54 169.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 tp -56.31 -41.43 75.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.956 1.253 . . . . 0.0 109.762 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.43 -32.39 73.99 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.69 -30.68 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.308 -0.87 . . . . 0.0 111.427 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -80.14 -5.15 55.5 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.821 0.737 . . . . 0.0 110.944 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.48 19.12 79.59 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.372 -0.682 . . . . 0.0 111.436 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.34 -3.5 65.0 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.306 1.053 . . . . 0.0 112.646 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.48 -50.92 7.31 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.637 1.219 . . . . 0.0 110.283 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -44.46 99.64 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.247 -176.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.14 7.43 3.31 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 123.311 2.218 . . . . 0.0 113.003 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.18 -2.13 13.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.535 1.534 . . . . 0.0 110.428 168.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.331 -0.229 0 C-N-CA 126.185 1.794 . . . . 0.0 110.903 177.468 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.18 89.72 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.55 135.18 37.24 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.875 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -136.64 113.14 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 124.462 1.105 . . . . 0.0 109.128 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.88 142.23 46.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.887 0.875 . . . . 0.0 108.779 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -150.01 166.1 30.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.056 1.342 . . . . 0.0 110.669 -169.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 176.55 12.54 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.891 -1.13 . . . . 0.0 108.715 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -30.13 62.31 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.763 2.425 . . . . 0.0 113.853 -170.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 109.66 9.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -164.89 84.94 1.11 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -63.67 -26.1 68.89 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.836 1.691 . . . . 0.0 111.986 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -73.43 -30.48 63.24 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.074 -1.016 . . . . 0.0 109.419 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -66.33 -43.96 84.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 119.23 0.923 . . . . 0.0 108.968 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -53.25 -47.8 68.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.94 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -54.8 -59.3 4.91 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.598 1.545 . . . . 0.0 112.076 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.16 89.71 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.069 0.395 . . . . 0.0 110.27 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.771 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.26 99.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -59.66 -49.69 76.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.707 0.685 . . . . 0.0 110.229 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.99 -43.51 95.47 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.265 1.026 . . . . 0.0 111.048 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -59.03 -42.73 90.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.717 0.807 . . . . 0.0 109.167 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 t -69.69 -30.93 68.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.113 0.965 . . . . 0.0 110.416 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -78.18 -15.48 58.79 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.154 0.888 . . . . 0.0 111.453 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 47.95 23.58 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 124.991 1.282 . . . . 0.0 110.043 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 m -104.43 171.5 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.038 0.535 . . . . 0.0 112.271 -170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.4 p -94.35 126.99 39.95 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.32 170.4 16.38 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.433 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -128.92 124.43 35.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.617 1.567 . . . . 0.0 108.105 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -116.68 113.58 40.22 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.33 146.94 20.02 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.159 1.906 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 125.495 1.518 . . . . 0.0 109.743 175.71 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm . . . . . 0 C--O 1.222 -0.383 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -56.99 -50.74 71.78 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.118 0.872 . . . . 0.0 109.191 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.54 -30.28 68.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.299 0.499 . . . . 0.0 110.888 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.79 -37.77 88.61 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.868 -0.52 . . . . 0.0 110.507 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.2 ttm -61.94 -18.95 62.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.681 1.592 . . . . 0.0 112.36 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.59 -57.94 9.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -59.17 -44.29 92.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.101 -0.374 . . . . 0.0 111.15 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.55 -34.39 72.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.828 -171.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -121.16 -21.68 6.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.8 1.182 . . . . 0.0 114.029 -171.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.52 8.79 57.0 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.703 -168.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -129.89 -52.4 1.14 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.255 1.528 . . . . 0.0 112.708 -170.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m 76.72 6.97 3.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.297 1.439 . . . . 0.0 111.492 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.6 p -86.13 173.2 10.0 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 110.076 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.1 154.01 64.21 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 122.793 0.437 . . . . 0.0 110.856 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.68 157.67 81.47 Favored 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 106.574 -2.125 . . . . 0.0 106.574 -11.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -136.3 118.64 15.67 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 169.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.42 145.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 O-C-N 125.118 1.511 . . . . 0.0 107.499 -174.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -137.1 111.59 8.62 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.396 2.678 . . . . 0.0 105.903 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -103.46 111.6 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.34 56.02 8.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.327 1.451 . . . . 0.0 107.809 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.27 -14.09 0.41 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.152 3.381 . . . . 0.0 114.24 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -77.83 112.58 14.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.693 0.797 . . . . 0.0 109.565 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.53 105.73 3.2 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.281 1.032 . . . . 0.0 110.394 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -74.42 -53.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.103 0.961 . . . . 0.0 108.659 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.54 -139.84 14.4 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -170.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.28 -173.29 47.31 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.011 1.767 . . . . 0.0 114.207 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -54.68 -50.89 67.16 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 122.225 -0.574 . . . . 0.0 110.238 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -73.77 -17.98 61.03 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.055 0.388 . . . . 0.0 110.717 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.39 -48.51 55.87 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 109.385 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -60.29 -49.77 76.29 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.814 1.646 . . . . 0.0 111.108 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.34 -37.68 81.4 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.606 1.562 . . . . 0.0 110.806 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.67 -44.22 78.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.678 0.791 . . . . 0.0 111.223 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.3 tp -56.58 -43.99 80.6 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 110.396 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.08 -35.58 81.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.021 0.528 . . . . 0.0 111.577 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.02 -26.47 66.79 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.905 0.482 . . . . 0.0 111.946 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -4.85 47.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.296 -0.877 . . . . 0.0 112.437 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.4 29.08 70.59 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.15 -28.3 13.76 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 118.339 1.07 . . . . 0.0 111.446 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -73.6 -52.5 13.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.045 0.923 . . . . 0.0 109.045 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.49 -55.92 22.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.23 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -9.27 25.4 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 122.135 1.798 . . . . 0.0 114.056 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 mt -83.41 -46.85 12.06 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 120.031 1.287 . . . . 0.0 108.813 169.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.8 mt . . . . . 0 C--O 1.239 0.531 0 C-N-CA 124.462 1.105 . . . . 0.0 113.921 -176.77 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.368 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.9 t -130.36 130.29 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -130.17 144.29 51.27 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.86 1.264 . . . . 0.0 108.67 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 tt -141.49 113.21 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.116 0.484 . . . . 0.0 110.058 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -73.8 129.28 37.59 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -141.18 174.52 10.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.41 1.484 . . . . 0.0 110.75 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 173.47 11.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.76 -20.72 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.672 0.789 . . . . 0.0 112.128 -174.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 t -133.49 77.85 1.74 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.815 1.646 . . . . 0.0 107.411 -168.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.6 87.34 4.83 Favored Pre-proline 0 N--CA 1.443 -0.78 0 C-N-CA 124.764 1.226 . . . . 0.0 108.289 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.17 -31.0 92.57 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.65 1.567 . . . . 0.0 111.362 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.46 -36.49 65.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.56 1.527 . . . . 0.0 110.806 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.7 m -58.0 -46.42 85.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -60.23 -43.8 95.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.09 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.85 -51.81 64.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.163 1.801 . . . . 0.0 110.89 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 -55.98 27.15 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.923 0.889 . . . . 0.0 110.129 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -63.29 -29.75 71.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.28 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.55 -46.08 87.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.345 0.975 . . . . 0.0 109.228 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.0 -40.57 95.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.058 0.845 . . . . 0.0 110.235 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.44 -40.43 97.13 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.374 -0.828 . . . . 0.0 111.07 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -67.74 -30.43 69.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 110.678 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -71.23 -34.41 70.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.962 0.905 . . . . 0.0 111.238 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -73.79 -17.93 61.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.516 0.598 . . . . 0.0 109.474 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.92 23.11 67.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.137 1.351 . . . . 0.0 111.751 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 m -89.92 157.13 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 118.068 0.934 . . . . 0.0 112.751 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -85.22 136.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 168.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.45 165.81 28.28 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.48 1.912 . . . . 0.0 106.012 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -107.02 140.18 40.23 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.7 145.22 30.39 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -128.3 118.49 20.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 151.93 54.2 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.451 1.434 . . . . 0.0 108.984 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 125.463 1.505 . . . . 0.0 110.034 170.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp . . . . . 0 C--O 1.227 -0.129 0 N-CA-C 111.303 0.112 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -58.93 -53.23 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.793 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.03 -28.12 64.17 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.676 1.125 . . . . 0.0 112.424 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.6 -39.39 76.73 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.019 0.827 . . . . 0.0 108.94 169.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -65.32 -26.0 67.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.443 -0.785 . . . . 0.0 110.996 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.0 mt -74.27 -46.41 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.13 -63.79 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.332 0.969 . . . . 0.0 109.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -64.62 -42.56 95.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.704 2.402 . . . . 0.0 112.806 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -1.2 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -168.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.45 46.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.284 0.947 . . . . 0.0 113.251 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -136.72 -167.5 2.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.433 1.493 . . . . 0.0 109.6 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 p -155.9 3.46 0.17 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 129.565 3.146 . . . . 0.0 109.911 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.6 p -101.0 175.94 5.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.133 2.573 . . . . 0.0 110.343 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.93 158.21 62.59 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.6 163.09 82.3 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.776 -1.344 . . . . 0.0 108.639 -11.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.92 98.84 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 171.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.13 145.07 8.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -131.91 132.18 43.37 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 126.861 2.064 . . . . 0.0 106.04 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.54 122.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 169.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 41.66 47.22 3.37 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.554 1.542 . . . . 0.0 112.486 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.96 3.46 4.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.543 2.337 . . . . 0.0 114.539 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -75.88 105.78 7.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -62.41 122.79 16.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -92.24 -75.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.74 -138.78 5.77 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 -162.25 19.61 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 126.504 2.002 . . . . 0.0 111.027 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -61.34 -42.07 98.08 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.089 0.945 . . . . 0.0 110.666 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.16 -38.52 91.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.392 0.433 . . . . 0.0 110.341 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.07 -48.86 64.42 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.411 1.084 . . . . 0.0 109.968 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -54.29 -52.21 62.17 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 126.581 1.953 . . . . 0.0 110.571 172.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -68.75 -37.95 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.3 99.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.686 -0.673 . . . . 0.0 111.213 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.82 -42.43 79.59 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.057 1.298 . . . . 0.0 110.399 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.57 -37.51 87.81 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.274 1.03 . . . . 0.0 110.957 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.0 -21.82 65.03 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.425 -0.797 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -82.58 -7.23 59.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.876 1.271 . . . . 0.0 111.168 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.03 19.96 68.4 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.41 8.49 66.72 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.429 1.115 . . . . 0.0 112.014 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -110.3 -52.8 2.75 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.986 1.314 . . . . 0.0 109.192 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.33 -55.63 9.53 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.517 1.527 . . . . 0.0 113.782 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.53 -12.54 31.61 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.67 1.58 . . . . 0.0 113.216 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.98 -10.55 18.88 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.038 0.935 . . . . 0.0 111.34 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 119.415 1.007 . . . . 0.0 112.319 174.665 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.9 t -123.88 128.96 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -122.87 121.91 37.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -168.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.25 18.6 tt -133.17 102.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 121.823 0.82 . . . . 0.0 110.935 -169.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.08 136.2 43.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -143.67 175.71 9.77 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.833 1.653 . . . . 0.0 110.793 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 173.52 11.52 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.872 1.669 . . . . 0.0 107.343 168.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -29.46 68.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.655 0.782 . . . . 0.0 111.915 -174.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -87.79 -129.08 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 168.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.9 t 74.73 88.05 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.563 2.345 . . . . 0.0 111.058 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.73 -36.74 83.27 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.198 1.932 . . . . 0.0 110.992 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -73.55 -27.08 61.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.482 -0.761 . . . . 0.0 111.151 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -63.13 -49.83 72.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -55.5 -46.87 76.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.313 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -54.84 -52.87 61.39 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 119.261 0.937 . . . . 0.0 111.374 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.56 -51.84 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.275 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -60.61 -34.96 75.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.714 1.143 . . . . 0.0 111.551 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.89 82.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.658 0.663 . . . . 0.0 110.068 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.38 -46.59 86.06 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.044 0.938 . . . . 0.0 110.077 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.26 -45.32 73.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.453 1.101 . . . . 0.0 111.329 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -69.5 -27.69 65.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.083 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -63.6 -41.95 98.29 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.049 0.84 . . . . 0.0 109.696 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -74.65 -6.63 49.77 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.627 0.649 . . . . 0.0 111.596 175.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.57 27.28 72.78 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.68 171.69 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 117.501 0.65 . . . . 0.0 110.476 -172.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 m -102.04 131.26 48.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -140.96 173.1 11.8 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.691 0.796 . . . . 0.0 108.883 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -125.24 126.65 45.49 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 128.101 2.56 . . . . 0.0 105.69 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.23 140.0 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -124.88 116.4 26.2 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.092 . . . . 0.0 110.799 -168.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -68.55 146.01 66.24 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.016 1.81 . . . . 0.0 109.115 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.465 0.304 0 C-N-CA 124.33 1.052 . . . . 0.0 110.864 169.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt . . . . . 0 C--O 1.224 -0.254 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -74.03 -32.64 63.44 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.633 1.106 . . . . 0.0 110.47 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.17 -43.39 67.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.695 169.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -62.21 -31.51 72.05 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.696 -0.628 . . . . 0.0 110.435 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.2 -19.86 63.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.605 -1.31 . . . . 0.0 112.484 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -64.1 -58.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.33 -31.8 72.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.917 1.687 . . . . 0.0 111.016 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -95.33 -40.89 9.3 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.381 1.473 . . . . 0.0 112.83 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -103.34 -26.71 12.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.285 1.402 . . . . 0.0 112.526 -173.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.7 33.2 76.53 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.47 -1.183 . . . . 0.0 112.063 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -143.66 -52.6 0.35 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.23 1.515 . . . . 0.0 113.335 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.406 62.5 p 68.29 4.99 4.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.483 2.713 . . . . 0.0 115.51 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -81.44 176.08 10.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.97 160.72 54.53 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.328 168.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.1 160.35 86.18 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.65 0.911 . . . . 0.0 112.078 -0.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.75 99.64 5.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 168.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.59 141.5 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 171.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.69 136.31 49.55 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 129.228 3.011 . . . . 0.0 105.248 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.3 mt -128.89 110.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 46.0 48.8 12.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.866 0.866 . . . . 0.0 111.814 -169.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.71 -6.74 1.86 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 129.531 3.132 . . . . 0.0 114.8 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.06 105.65 5.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -70.14 105.71 3.02 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.85 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.67 -144.03 13.09 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 -169.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.04 -161.04 24.59 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.986 1.755 . . . . 0.0 111.177 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -61.52 -45.58 93.61 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 121.808 -0.819 . . . . 0.0 110.496 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.44 -27.19 65.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.842 0.746 . . . . 0.0 109.2 -169.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.99 -55.32 11.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.288 2.235 . . . . 0.0 110.229 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.08 -47.33 86.32 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.302 1.841 . . . . 0.0 111.061 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.76 -41.22 90.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.219 1.408 . . . . 0.0 108.831 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.79 -34.96 76.43 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.004 0.82 . . . . 0.0 112.494 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.68 -51.96 66.75 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.992 1.269 . . . . 0.0 110.662 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -66.15 -28.01 68.46 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.146 0.978 . . . . 0.0 111.267 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.17 -8.58 56.41 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.481 -1.387 . . . . 0.0 112.328 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.37 -3.53 28.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.715 170.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.07 18.71 79.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.143 0.883 . . . . 0.0 110.913 -171.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.38 -1.32 69.19 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.546 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.3 -46.07 7.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.035 1.417 . . . . 0.0 111.044 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER -47.64 -49.24 57.05 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 174.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.72 -5.62 14.78 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 CA-C-N 121.905 1.716 . . . . 0.0 113.234 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.77 -55.82 2.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.723 1.209 . . . . 0.0 109.519 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.236 0.362 0 C-N-CA 125.82 1.648 . . . . 0.0 114.764 -169.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.68 160.95 5.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -154.42 112.91 3.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.81 110.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 118.512 0.596 . . . . 0.0 112.561 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -89.62 124.49 34.61 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -141.36 173.2 11.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.808 0.843 . . . . 0.0 111.336 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 -178.19 5.51 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.973 -1.079 . . . . 0.0 111.145 -172.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -31.55 68.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.958 1.303 . . . . 0.0 112.065 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -134.17 148.5 50.94 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t 163.8 89.87 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 129.288 3.035 . . . . 0.0 106.125 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.92 -30.7 90.49 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 111.533 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.32 -31.97 64.32 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.264 -0.897 . . . . 0.0 110.02 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -65.09 -46.72 79.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -51.85 -52.3 50.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.404 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -54.26 -50.33 67.48 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.194 1.361 . . . . 0.0 111.751 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.25 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.721 0.692 . . . . 0.0 111.472 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -62.46 -37.21 85.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.489 1.041 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.81 98.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.516 0.726 . . . . 0.0 109.604 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.5 -48.53 80.51 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.59 0.632 . . . . 0.0 109.529 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.63 -38.23 90.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.164 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.6 m -69.92 -30.64 68.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.5 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.6 m -66.22 -36.28 82.62 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 120.262 1.392 . . . . 0.0 110.202 172.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -77.15 -12.93 60.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.848 -0.533 . . . . 0.0 111.673 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.75 26.65 71.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.73 168.31 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.326 1.063 . . . . 0.0 109.779 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -91.62 124.13 35.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 170.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -150.13 168.46 23.89 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 122.638 0.375 . . . . 0.0 111.37 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -132.47 132.57 42.85 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.06 148.37 38.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.157 0.911 . . . . 0.0 109.646 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.27 92.65 31.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 125.272 1.429 . . . . 0.0 109.221 -168.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.11 129.38 21.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.181 2.588 . . . . 0.0 109.692 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.705 0 C-N-CA 125.008 1.323 . . . . 0.0 109.474 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 ttt-85 -78.78 -50.42 11.36 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.8 -26.41 68.34 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.771 0.714 . . . . 0.0 110.897 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.17 -51.76 68.22 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.2 ttp -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -65.08 -51.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.643 -1.286 . . . . 0.0 108.908 169.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -57.57 -36.49 71.75 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.308 0.958 . . . . 0.0 112.282 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -92.32 -28.84 16.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.623 -169.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -124.17 -18.49 5.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.833 1.197 . . . . 0.0 112.855 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.98 -16.08 1.64 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.843 1.687 . . . . 0.0 112.734 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -91.57 -71.02 0.66 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 126.45 1.9 . . . . 0.0 112.453 -168.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.385 0.6 OUTLIER 71.72 1.73 4.0 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 129.984 3.314 . . . . 0.0 113.903 -168.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.4 p -74.28 176.32 6.78 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.607 1.563 . . . . 0.0 107.716 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.09 158.95 74.53 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.8 161.42 79.51 Favored 'Cis proline' 0 C--N 1.348 0.519 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 -11.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.14 97.37 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 170.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mp -89.94 146.42 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -131.56 148.55 52.63 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.284 3.034 . . . . 0.0 106.11 170.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.88 116.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 168.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 62.31 40.7 11.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 110.279 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 75.0 -8.64 1.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.666 3.187 . . . . 0.0 114.246 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -74.35 101.12 3.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.63 1.972 . . . . 0.0 105.872 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -60.98 106.34 0.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.3 mm -74.36 -56.61 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.263 1.025 . . . . 0.0 108.847 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.61 -141.9 12.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.14 -169.67 26.02 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.053 1.787 . . . . 0.0 111.334 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -57.17 -42.51 81.28 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.526 -0.985 . . . . 0.0 111.437 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.45 -37.85 88.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.248 0.476 . . . . 0.0 109.786 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.0 -47.35 74.79 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.652 1.181 . . . . 0.0 109.901 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -55.19 29.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.337 1.855 . . . . 0.0 110.31 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.75 -34.5 77.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.79 88.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.189 0.904 . . . . 0.0 111.912 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.84 -46.35 81.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.875 1.216 . . . . 0.0 110.28 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.67 -41.03 98.86 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.16 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.92 71.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.71 1.204 . . . . 0.0 110.94 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -17.1 61.1 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.119 0.968 . . . . 0.0 110.439 176.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 25.62 41.28 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -169.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.86 -7.19 48.09 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.62 -1.1 . . . . 0.0 113.322 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.19 -48.77 8.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.985 1.392 . . . . 0.0 108.442 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.48 96.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.204 1.402 . . . . 0.0 112.111 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 -12.06 34.45 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 123.266 2.202 . . . . 0.0 113.238 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.43 -48.82 4.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.814 0.846 . . . . 0.0 110.181 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 N--CA 1.463 0.193 0 C-N-CA 125.669 1.588 . . . . 0.0 114.58 -168.197 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.43 90.15 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -104.64 124.67 49.75 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.531 -1.668 . . . . 0.0 108.328 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -126.82 101.85 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 0.0 111.389 -171.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.467 ' HH ' ' NH1' ' A' ' 46' ' ' ARG . 62.5 m-85 -73.82 142.38 46.14 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.433 -0.792 . . . . 0.0 109.14 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.9 p -151.6 171.09 18.15 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.53 1.132 . . . . 0.0 111.199 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 174.04 11.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.499 1.52 . . . . 0.0 107.138 168.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -38.4 68.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.084 1.354 . . . . 0.0 113.057 -168.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.64 145.11 48.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t 172.69 103.45 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.561 2.344 . . . . 0.0 104.793 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -65.93 -30.11 48.88 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.148 1.899 . . . . 0.0 110.853 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -73.63 -37.23 65.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.021 0.929 . . . . 0.0 110.43 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -61.65 -47.36 85.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.855 0.752 . . . . 0.0 109.043 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -53.48 -53.42 51.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.02 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.48 -50.75 70.85 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.867 1.212 . . . . 0.0 112.068 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.02 -49.83 66.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.77 0.714 . . . . 0.0 110.9 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -61.71 -37.2 83.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.495 1.043 . . . . 0.0 110.787 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.68 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.043 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.81 -48.61 81.01 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.36 -42.15 79.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.438 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.5 m -70.91 -30.64 67.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.957 0.798 . . . . 0.0 111.056 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -70.31 -35.44 73.67 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.313 0.961 . . . . 0.0 110.824 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -75.08 -15.09 60.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.234 0.925 . . . . 0.0 110.704 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.38 24.43 75.16 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.334 1.445 . . . . 0.0 112.206 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.9 m -83.14 154.78 3.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.22 1.01 . . . . 0.0 110.35 -172.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 m -81.2 115.51 20.64 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.249 1.82 . . . . 0.0 107.931 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -137.49 175.91 9.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 109.157 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -124.85 144.51 50.27 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.019 2.527 . . . . 0.0 106.561 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -116.14 152.44 33.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.633 0.652 . . . . 0.0 110.363 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.32 81.28 61.2 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.29 1.036 . . . . 0.0 109.735 -172.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.14 148.26 84.94 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.362 2.041 . . . . 0.0 112.074 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 pt . . . . . 0 CA--C 1.533 0.296 0 C-N-CA 126.412 1.885 . . . . 0.0 110.636 169.585 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . 0.259 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.48 -45.98 88.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.259 -1.526 . . . . 0.0 110.898 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -29.91 70.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.902 -177.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -55.76 -37.48 68.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.819 0.848 . . . . 0.0 110.465 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.1 ttm -61.89 -18.39 60.01 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.333 1.053 . . . . 0.0 112.782 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.49 -65.53 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -59.74 -28.16 67.12 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 121.476 1.944 . . . . 0.0 112.295 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.467 ' NH1' ' HH ' ' A' ' 6' ' ' TYR . 11.8 mmt85 -68.45 -45.08 73.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.604 176.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.3 p -121.72 -22.69 5.74 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.94 5.22 79.45 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.702 1.62 . . . . 0.0 112.376 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -124.85 -55.37 1.61 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.779 2.289 . . . . 0.0 114.951 -168.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.378 0.7 OUTLIER 69.15 13.67 8.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.676 2.79 . . . . 0.0 114.707 -173.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.9 p -75.99 175.59 8.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.113 1.765 . . . . 0.0 109.109 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.94 164.43 32.12 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.857 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.85 159.92 78.84 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.377 1.17 . . . . 0.0 109.639 -9.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -136.43 103.11 5.16 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 172.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 143.74 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 171.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -133.53 119.31 19.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.125 1.77 . . . . 0.0 106.369 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.16 97.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 49.44 65.71 1.32 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.193 0.997 . . . . 0.0 111.054 -168.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 73.23 -13.99 0.66 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 128.444 2.698 . . . . 0.0 114.488 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -74.81 96.8 3.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.736 2.414 . . . . 0.0 108.457 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -64.03 110.55 2.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.94 -64.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.31 -145.14 14.07 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.21 -163.96 38.85 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.232 1.396 . . . . 0.0 111.798 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -65.15 -41.5 94.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.095 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.27 -45.26 80.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.033 0.833 . . . . 0.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -63.93 -48.33 77.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.666 1.186 . . . . 0.0 110.097 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.51 -48.58 78.93 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.85 1.26 . . . . 0.0 111.893 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.24 -33.82 75.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 123.589 0.756 . . . . 0.0 109.313 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -43.18 83.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.931 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.5 -44.91 81.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.18 1.355 . . . . 0.0 110.543 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.7 -42.08 91.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.048 0.539 . . . . 0.0 111.22 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.14 70.52 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.769 -0.582 . . . . 0.0 110.373 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -73.85 -19.77 60.63 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.898 1.279 . . . . 0.0 109.291 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 23.7 68.81 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.7 -13.53 40.39 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.769 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.4 -49.2 12.72 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.665 1.233 . . . . 0.0 109.8 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.96 -54.34 20.9 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 112.502 -173.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.0 3.09 5.35 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.898 2.398 . . . . 0.0 113.275 -175.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.2 mt -110.67 -3.86 15.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.958 -1.089 . . . . 0.0 110.571 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 C--O 1.233 0.197 0 C-N-CA 123.943 0.897 . . . . 0.0 112.391 -179.147 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.35 93.54 9.56 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.897 0.879 . . . . 0.0 110.513 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.3 t -127.62 128.02 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 118.854 0.752 . . . . 0.0 109.79 -171.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.13 145.34 45.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 124.095 0.872 . . . . 0.0 109.599 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -139.47 115.59 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -75.4 144.68 42.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -147.23 172.14 14.29 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.279 1.032 . . . . 0.0 113.2 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.15 173.97 11.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.637 169.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -49.68 -39.54 36.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.125 2.57 . . . . 0.0 111.331 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.7 p -133.62 88.25 2.46 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -168.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.1 t -148.81 86.66 5.69 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.05 -37.16 78.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.291 1.994 . . . . 0.0 110.394 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -73.45 -24.78 60.27 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.143 -0.973 . . . . 0.0 111.549 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.1 m -63.14 -51.96 64.4 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 120.264 1.393 . . . . 0.0 108.968 169.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.75 -41.93 74.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.912 -1.042 . . . . 0.0 111.053 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -54.45 -56.04 22.82 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.345 1.429 . . . . 0.0 110.924 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.98 -49.34 76.49 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.393 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.786 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.16 90.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.003 0.82 . . . . 0.0 110.19 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 tt -64.99 -47.68 76.66 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.551 0.614 . . . . 0.0 109.468 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.9 -35.01 79.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.386 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 m -75.18 -28.94 60.25 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.65 0.78 . . . . 0.0 111.631 174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -40.15 92.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.359 0.982 . . . . 0.0 109.328 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -73.35 -25.57 60.66 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.766 -1.209 . . . . 0.0 108.921 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.5 32.32 59.84 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.889 1.709 . . . . 0.0 111.03 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.69 171.37 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.281 0.562 . . . . 0.0 110.117 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.08 121.64 42.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -141.73 165.02 28.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.578 1.151 . . . . 0.0 110.131 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.53 144.62 35.94 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.181 1.392 . . . . 0.0 108.385 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.57 143.72 44.92 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.444 1.498 . . . . 0.0 108.068 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.44 103.56 16.4 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.912 1.285 . . . . 0.0 110.0 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.92 144.35 27.25 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.854 1.703 . . . . 0.0 110.26 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 mt -104.72 6.73 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 122.131 0.967 . . . . 0.0 109.994 172.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.66 95.67 2.88 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.369 2.267 . . . . 0.0 108.903 -171.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.14 -1.87 84.97 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.875 0.75 . . . . 0.0 113.243 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -83.4 168.47 16.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.623 1.569 . . . . 0.0 107.299 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.1 -47.31 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.37 2.268 . . . . 0.0 108.267 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.9 83.61 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.784 1.174 . . . . 0.0 111.039 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -81.09 -17.64 49.34 Favored 'General case' 0 N--CA 1.462 0.152 0 O-C-N 120.708 -1.245 . . . . 0.0 111.079 174.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -67.64 -39.12 84.64 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.296 -1.502 . . . . 0.0 108.751 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -63.07 -40.78 98.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.506 0.723 . . . . 0.0 109.962 171.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -52.77 -45.7 67.24 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.425 0.557 . . . . 0.0 109.934 172.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.51 -24.96 66.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 113.366 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mt -65.0 -54.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.51 -36.98 85.57 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 119.605 -0.236 . . . . 0.0 110.843 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -75.66 -56.28 4.84 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.541 0.736 . . . . 0.0 111.282 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -91.09 -38.73 12.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.596 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.84 38.55 89.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -148.05 -58.09 0.24 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.359 1.464 . . . . 0.0 110.696 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.259 3.6 m 83.16 10.87 0.52 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.729 1.612 . . . . 0.0 111.909 171.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 81.1 p -109.35 171.89 7.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.454 2.702 . . . . 0.0 108.129 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -140.19 166.02 26.49 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.56 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.28 148.7 64.84 Favored 'Cis proline' 0 CA--C 1.509 -0.738 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 -6.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -138.02 108.17 6.41 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.28 145.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 125.271 1.607 . . . . 0.0 107.083 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -128.36 124.15 35.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.806 2.842 . . . . 0.0 103.793 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.0 mm -120.96 117.99 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.255 0.6 OUTLIER 49.32 52.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.335 1.454 . . . . 0.0 110.659 -172.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.03 0.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.62 2.768 . . . . 0.0 114.329 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -86.59 108.17 18.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.253 1.421 . . . . 0.0 107.244 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -63.1 109.3 1.46 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.943 0.897 . . . . 0.0 109.071 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.38 -56.44 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.79 0.836 . . . . 0.0 109.292 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.1 -141.72 12.94 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.04 -165.8 30.16 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 118.885 1.343 . . . . 0.0 113.343 -168.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.0 -43.21 91.46 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.241 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.84 -35.84 82.41 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.733 0.697 . . . . 0.0 109.823 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -45.86 70.25 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.734 1.613 . . . . 0.0 111.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.45 -48.51 79.32 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 127.471 2.309 . . . . 0.0 111.363 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -69.51 -29.4 67.01 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -44.17 81.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.156 0.582 . . . . 0.0 110.941 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.77 -37.74 71.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.403 1.001 . . . . 0.0 110.801 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.38 -40.82 89.92 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.185 -0.947 . . . . 0.0 111.97 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.19 68.12 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.742 1.217 . . . . 0.0 112.171 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -89.22 3.84 50.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.814 1.246 . . . . 0.0 112.445 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 18.3 69.33 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.424 0.557 . . . . 0.0 112.154 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.86 -12.4 43.54 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.643 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.5 tp -73.65 -49.17 27.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.262 1.031 . . . . 0.0 109.511 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.87 -51.77 73.81 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.424 1.49 . . . . 0.0 112.33 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.36 -8.5 23.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.803 2.335 . . . . 0.0 114.707 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 mt -91.07 -49.52 6.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mt -82.59 -22.31 34.86 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-N 120.07 1.304 . . . . 0.0 109.209 -168.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 121.0 19.76 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 169.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.8 t -126.84 132.88 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -136.59 127.37 27.32 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -168.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 tt -128.73 110.77 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.01 143.52 45.52 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -147.54 179.9 7.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.433 1.093 . . . . 0.0 111.725 -171.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.15 -172.56 4.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.245 -1.534 . . . . 0.0 107.929 168.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.491 ' HG3' ' H ' ' A' ' 10' ' ' THR . 1.1 pt-20 -35.76 -64.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.664 3.586 . . . . 0.0 111.259 170.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.491 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 14.7 t -134.13 124.21 25.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.0 t -169.6 101.11 0.47 Allowed Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.44 -35.73 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.971 1.781 . . . . 0.0 109.872 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -73.27 -32.8 64.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.778 -0.576 . . . . 0.0 109.811 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -61.59 -51.14 69.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.043 0.838 . . . . 0.0 109.15 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -54.54 -45.75 73.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.562 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -59.71 -49.77 76.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.525 1.511 . . . . 0.0 111.688 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.51 94.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.61 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -57.26 -51.52 69.03 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.495 1.043 . . . . 0.0 109.819 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.83 -22.58 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.655 0.782 . . . . 0.0 111.599 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -75.98 -50.61 14.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.101 1.36 . . . . 0.0 110.011 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.03 -42.52 98.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.25 1.02 . . . . 0.0 111.021 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.3 m -67.52 -28.14 67.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.809 1.644 . . . . 0.0 110.995 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -42.56 99.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -84.25 -6.55 59.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.004 0.82 . . . . 0.0 112.081 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.46 34.73 80.05 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 124.659 1.123 . . . . 0.0 111.901 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.0 m -90.65 157.44 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 123.331 0.653 . . . . 0.0 110.912 -169.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -95.4 98.99 10.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -106.51 165.92 10.93 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.822 0.849 . . . . 0.0 108.781 169.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.22 144.19 31.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.178 1.791 . . . . 0.0 106.407 168.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.71 144.84 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mt -129.94 69.77 81.83 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.937 1.295 . . . . 0.0 108.495 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.58 140.3 47.03 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 N-CA-C 108.59 -1.35 . . . . 0.0 108.59 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 pt -98.98 -2.71 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.478 1.111 . . . . 0.0 111.324 170.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.3 -24.83 66.7 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.467 1.507 . . . . 0.0 114.104 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.88 34.94 2.15 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.12 1.819 . . . . 0.0 110.738 169.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -144.71 74.86 1.43 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.999 1.32 . . . . 0.0 108.886 -172.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.52 -17.28 64.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.72 -62.28 1.6 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.343 0.974 . . . . 0.0 109.877 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.84 -13.5 59.87 Favored 'General case' 0 C--O 1.225 -0.204 0 O-C-N 121.816 -0.552 . . . . 0.0 110.798 -174.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -54.27 -44.59 72.0 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 168.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -73.01 -42.33 63.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.163 0.585 . . . . 0.0 109.965 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.67 -32.1 72.26 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.659 -0.65 . . . . 0.0 110.956 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.4 ttp -55.75 -16.01 3.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.873 1.269 . . . . 0.0 113.235 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.73 -70.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 170.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -66.91 -27.6 67.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 120.194 1.361 . . . . 0.0 112.314 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.2 -50.87 62.37 Favored 'General case' 0 CA--C 1.524 -0.047 0 CA-C-N 119.17 0.895 . . . . 0.0 109.735 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 p -105.31 -31.89 8.86 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.671 1.123 . . . . 0.0 112.875 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.93 24.29 75.77 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 121.452 -0.78 . . . . 0.0 112.196 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -136.36 -53.13 0.73 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.99 1.316 . . . . 0.0 110.573 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m 75.72 2.66 3.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.448 1.099 . . . . 0.0 110.927 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 p -84.22 177.15 8.31 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.99 3.316 . . . . 0.0 107.873 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.5 161.12 60.84 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.129 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.26 166.51 79.75 Favored 'Cis proline' 0 N--CA 1.456 -0.698 0 CA-C-N 119.396 0.82 . . . . 0.0 110.675 -10.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -132.94 104.29 6.49 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 168.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.22 142.78 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.338 2.255 . . . . 0.0 106.871 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.1 mt -132.83 119.66 38.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.281 14.8 m-20 45.6 45.51 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.805 0.812 . . . . 0.0 112.566 -169.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.37 -0.16 2.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.557 2.743 . . . . 0.0 114.249 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.24 109.58 7.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.9 113.48 3.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.9 mm -77.38 -55.02 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 108.872 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.68 -144.91 13.02 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.28 -163.67 26.5 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.421 2.438 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -57.17 -47.62 80.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.107 0.953 . . . . 0.0 112.022 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -64.77 -33.46 76.03 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.181 0.446 . . . . 0.0 109.939 -170.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.0 -44.57 72.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.924 1.69 . . . . 0.0 110.914 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.72 -51.13 70.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.889 1.276 . . . . 0.0 109.806 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.41 -30.33 70.06 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -40.97 85.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.138 1.375 . . . . 0.0 112.327 169.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.0 tp -56.25 -45.71 79.91 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.8 1.637 . . . . 0.0 110.322 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.83 -34.68 77.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.965 0.506 . . . . 0.0 112.106 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.15 -15.58 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.772 1.229 . . . . 0.0 112.135 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -5.25 59.23 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.368 1.067 . . . . 0.0 111.224 168.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.07 15.83 70.05 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -168.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.57 -9.34 55.07 Favored Glycine 0 C--N 1.341 0.843 0 C-N-CA 124.697 1.142 . . . . 0.0 112.868 -170.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.4 tp -73.94 -47.93 34.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.329 1.065 . . . . 0.0 109.844 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -54.78 35.84 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.892 1.277 . . . . 0.0 112.156 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.21 -1.91 8.86 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.396 2.064 . . . . 0.0 113.889 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.38 -3.13 19.9 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.806 1.243 . . . . 0.0 111.428 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.6 mt -137.65 18.25 2.88 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.971 1.308 . . . . 0.0 111.303 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp . . . . . 0 C--O 1.246 0.902 0 CA-C-O 116.686 -1.626 . . . . 0.0 108.412 174.253 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.62 123.11 26.21 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.197 0.908 . . . . 0.0 109.031 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.1 t -133.72 120.07 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 119.355 0.98 . . . . 0.0 108.844 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -129.52 146.97 51.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.14 0.976 . . . . 0.0 109.462 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 tt -140.72 118.37 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 124.509 1.124 . . . . 0.0 108.226 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -78.94 135.58 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.25 1.02 . . . . 0.0 108.812 171.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -144.11 -177.18 5.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.456 1.502 . . . . 0.0 111.501 -168.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -157.5 177.67 11.16 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 119.661 -1.899 . . . . 0.0 107.889 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.66 -25.23 38.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.836 1.654 . . . . 0.0 112.325 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.89 120.6 20.6 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 172.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.0 t -167.77 93.68 0.65 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.022 0.929 . . . . 0.0 111.342 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.11 -39.63 30.45 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.509 2.14 . . . . 0.0 112.033 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -73.58 -29.21 62.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.316 1.871 . . . . 0.0 110.084 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -59.3 -52.71 64.47 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 119.924 1.238 . . . . 0.0 108.239 169.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -54.56 -40.14 68.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.254 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -59.84 -54.01 51.21 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.004 1.274 . . . . 0.0 111.777 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.19 93.12 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.862 -0.523 . . . . 0.0 110.233 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -63.48 -36.51 84.0 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.202 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -26.77 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 120.268 1.394 . . . . 0.0 110.906 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.05 -55.14 11.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.87 -43.27 93.49 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.001 1.32 . . . . 0.0 112.081 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -69.94 -30.81 68.29 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.496 1.118 . . . . 0.0 109.674 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -66.05 -39.87 90.47 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.474 1.033 . . . . 0.0 109.593 169.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -73.72 -9.35 58.57 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.222 0.919 . . . . 0.0 110.763 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.0 81.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 125.603 1.573 . . . . 0.0 110.446 172.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.0 m -90.55 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.596 0.713 . . . . 0.0 112.838 -168.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.3 p -105.75 116.92 32.75 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.69 1.996 . . . . 0.0 105.792 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -134.78 167.75 20.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -112.73 133.36 54.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.24 111.53 20.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.438 1.895 . . . . 0.0 107.424 -168.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.85 102.37 50.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.328 1.451 . . . . 0.0 111.381 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.85 137.0 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.01 2.474 . . . . 0.0 113.892 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.468 ' HA ' HD22 ' A' ' 36' ' ' ASN . 15.5 mt -117.86 49.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 127.322 2.249 . . . . 0.0 107.365 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.81 53.55 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.39 1.876 . . . . 0.0 111.63 174.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.73 22.29 39.68 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 119.44 -2.038 . . . . 0.0 113.851 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.468 HD22 ' HA ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -83.4 125.54 31.79 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 -168.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.02 -29.07 68.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.081 0.855 . . . . 0.0 112.049 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.14 -50.04 71.99 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.671 1.188 . . . . 0.0 110.081 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -18.53 50.39 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.996 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -60.63 -59.34 5.55 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.54 1.064 . . . . 0.0 108.581 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.07 -41.88 89.05 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.393 0.433 . . . . 0.0 110.908 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.61 -56.19 15.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.386 1.474 . . . . 0.0 109.558 173.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.3 ttm -67.12 -26.35 66.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.837 -0.54 . . . . 0.0 112.184 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.38 -54.28 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -60.83 -46.46 90.47 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.93 1.241 . . . . 0.0 112.245 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -79.88 -30.75 40.24 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 117.431 -1.271 . . . . 0.0 112.508 -169.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.2 p -116.15 -27.79 6.78 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.078 1.308 . . . . 0.0 113.458 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.03 23.88 53.04 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.482 1.037 . . . . 0.0 113.497 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -130.52 -57.9 1.05 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.271 1.035 . . . . 0.0 110.186 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.263 3.4 m 74.23 37.78 0.58 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 123.237 1.494 . . . . 0.0 110.989 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.1 p -142.09 176.91 8.59 Favored 'General case' 0 C--N 1.329 -0.325 1 C-N-CA 132.27 4.228 . . . . 0.0 105.902 -176.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -132.71 160.17 69.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.35 167.87 78.59 Favored 'Cis proline' 0 CA--C 1.534 0.514 0 N-CA-C 110.233 -0.718 . . . . 0.0 110.233 -10.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -130.47 96.21 4.07 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 168.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.15 144.26 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -133.04 125.1 28.92 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.561 2.744 . . . . 0.0 104.964 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.7 mm -125.28 120.99 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.92 40.89 26.17 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.722 1.249 . . . . 0.0 111.789 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.31 0.28 0.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.874 2.87 . . . . 0.0 114.45 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.7 121.07 20.18 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -75.01 98.86 3.71 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.41 -49.21 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 -132.19 6.8 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.51 -178.16 45.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.474 1.035 . . . . 0.0 111.264 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -54.23 -42.95 70.43 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.437 -1.037 . . . . 0.0 110.721 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -34.77 71.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.856 0.862 . . . . 0.0 111.87 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -71.69 -44.22 64.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.194 0.598 . . . . 0.0 110.993 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -62.13 -48.6 79.42 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.309 1.044 . . . . 0.0 110.619 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -59.77 -39.26 84.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.125 1.77 . . . . 0.0 109.197 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.1 81.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.189 0.596 . . . . 0.0 110.976 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 tp -56.66 -45.32 81.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.969 0.804 . . . . 0.0 110.121 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.58 -38.78 91.45 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.984 0.914 . . . . 0.0 112.181 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.32 69.77 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.429 0.559 . . . . 0.0 110.716 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -5.44 56.47 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.083 -1.011 . . . . 0.0 110.58 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.94 21.28 79.09 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.275 -0.89 . . . . 0.0 111.081 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.24 -28.19 28.59 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.12 0.96 . . . . 0.0 111.662 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.4 tp -74.21 -50.87 17.29 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.324 1.062 . . . . 0.0 110.81 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.46 -55.77 20.36 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.791 0.836 . . . . 0.0 113.133 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.7 11.86 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.825 2.35 . . . . 0.0 113.427 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.7 mt -112.35 -2.87 14.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.15 1.38 . . . . 0.0 110.396 168.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.5 mt -126.06 10.37 7.54 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 110.088 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HE2' ' CA ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.913 0 C-N-CA 127.745 2.418 . . . . 0.0 107.126 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.47 94.03 2.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 164.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.5 t -106.02 133.92 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.71 144.27 33.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 123.854 0.721 . . . . 0.0 109.56 -169.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.73 117.44 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.468 0.707 . . . . 0.0 110.142 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -78.04 140.3 39.13 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -146.99 177.46 9.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.045 0.938 . . . . 0.0 112.487 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 -177.06 6.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.942 1.297 . . . . 0.0 110.899 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.57 -24.27 3.12 Favored 'General case' 0 CA--C 1.52 -0.187 1 C-N-CA 132.555 4.342 . . . . 0.0 114.538 -168.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -133.32 -83.47 0.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.9 t 33.99 75.99 0.43 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.752 2.021 . . . . 0.0 112.173 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.66 -24.28 74.83 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.362 2.041 . . . . 0.0 111.34 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -73.1 -37.46 66.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.957 1.253 . . . . 0.0 109.71 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -60.7 -46.86 88.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -54.39 -50.6 67.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.173 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -54.47 -49.73 69.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.14 1.336 . . . . 0.0 110.919 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.07 39.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.173 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -60.09 -32.05 70.6 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.617 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.91 75.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.736 1.153 . . . . 0.0 109.271 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.75 -44.66 93.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.4 -40.77 77.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.633 -174.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -71.57 -31.93 67.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.966 0.803 . . . . 0.0 110.745 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -62.64 -44.92 95.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.426 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 3.8 mmpt? -73.7 -15.71 61.22 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.52 0.6 . . . . 0.0 110.416 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.34 18.85 78.92 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.768 1.652 . . . . 0.0 112.546 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.59 160.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 118.278 1.039 . . . . 0.0 111.746 -168.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.7 m -94.56 120.98 35.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -134.16 -172.66 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.531 1.933 . . . . 0.0 107.693 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.45 137.0 48.42 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -109.62 135.57 50.37 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.498 0.719 . . . . 0.0 109.092 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.11 77.27 75.56 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.632 1.173 . . . . 0.0 108.962 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.53 152.4 80.39 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.794 2.33 . . . . 0.0 110.868 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pt -133.52 22.72 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.794 1.238 . . . . 0.0 112.507 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 36' ' ' ASN . 75.9 m-20 -70.07 138.65 52.24 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.03 -13.81 0.9 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.612 1.101 . . . . 0.0 114.707 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 34' ' ' ASP . 5.4 t30 -83.88 177.49 8.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 128.513 2.725 . . . . 0.0 109.485 -171.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.26 -45.23 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.167 1.787 . . . . 0.0 108.4 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.75 57.78 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.069 0.85 . . . . 0.0 110.971 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -78.13 -6.77 55.76 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.449 -0.782 . . . . 0.0 112.426 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -82.85 -43.31 16.76 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -60.61 -33.48 72.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.07 -38.1 72.79 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.493 -0.755 . . . . 0.0 110.296 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -20.61 62.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.942 0.897 . . . . 0.0 111.643 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.1 mt -73.58 -42.65 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.26 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -30.74 37.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.982 1.719 . . . . 0.0 112.258 173.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -44.97 66.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.387 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.51 -11.77 3.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -168.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.01 -20.22 47.21 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.613 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -138.56 148.03 43.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.29 1.545 . . . . 0.0 111.811 -169.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -88.17 -5.9 58.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 131.37 3.868 . . . . 0.0 113.189 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -76.56 168.52 19.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.22 1.408 . . . . 0.0 111.35 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.62 166.17 21.08 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.615 0.766 . . . . 0.0 110.15 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.14 155.42 73.42 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.224 1.116 . . . . 0.0 109.589 -8.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -134.1 91.92 2.88 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -86.17 150.49 3.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -141.75 145.51 34.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.369 2.668 . . . . 0.0 108.523 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.71 116.49 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 43.55 51.64 6.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.741 1.616 . . . . 0.0 112.133 -172.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.3 -0.07 2.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.87 2.468 . . . . 0.0 114.234 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -75.5 108.86 8.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -65.82 110.19 2.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.79 -58.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.33 -143.69 11.6 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -173.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.62 -172.49 41.14 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.635 2.064 . . . . 0.0 111.327 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -56.38 -46.2 80.21 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.93 -0.747 . . . . 0.0 111.154 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.74 -32.0 73.36 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.959 0.345 . . . . 0.0 110.436 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.56 -46.0 64.35 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.692 0.758 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.2 -50.21 74.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.852 1.261 . . . . 0.0 111.004 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -68.31 -28.65 67.36 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.61 82.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 110.447 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.7 tp -56.7 -46.05 81.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.735 1.152 . . . . 0.0 109.926 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.51 -43.29 89.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.635 0.774 . . . . 0.0 111.259 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.15 63.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.943 0.897 . . . . 0.0 112.123 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.87 6.84 26.5 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.232 1.413 . . . . 0.0 111.713 169.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.93 17.92 68.1 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.043 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.08 -8.53 41.53 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.862 1.331 . . . . 0.0 113.008 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -75.24 -55.48 5.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.877 1.338 . . . . 0.0 109.5 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -50.99 74.53 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.68 -17.69 30.01 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.928 2.419 . . . . 0.0 114.806 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -104.8 -1.52 25.99 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.996 1.318 . . . . 0.0 111.115 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -117.83 16.85 14.35 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.322 -1.486 . . . . 0.0 112.005 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.25 2.22 . . . . 0.0 112.859 -168.086 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.57 93.98 3.93 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.03 99.41 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.45 148.06 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.583 0.552 . . . . 0.0 111.58 -168.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.97 114.94 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -74.31 140.37 44.84 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -150.82 172.65 15.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.905 1.682 . . . . 0.0 110.832 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.41 174.81 12.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.782 1.233 . . . . 0.0 107.862 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -18.87 61.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.1 1.36 . . . . 0.0 113.842 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 106.75 7.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -167.0 85.63 0.83 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.664 0.786 . . . . 0.0 108.932 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.78 -33.91 96.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.633 1.555 . . . . 0.0 111.424 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -73.46 -27.57 61.48 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.769 -1.207 . . . . 0.0 109.832 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.47 -49.32 74.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.023 -1.048 . . . . 0.0 108.93 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.75 -46.55 74.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.946 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -54.56 -52.77 61.05 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 120.225 1.375 . . . . 0.0 111.335 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.23 71.35 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.527 0.603 . . . . 0.0 110.39 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -58.54 -38.1 77.08 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.39 0.996 . . . . 0.0 111.474 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.98 95.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.112 0.565 . . . . 0.0 109.706 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 tp -62.55 -48.28 80.18 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.139 0.576 . . . . 0.0 109.875 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.1 mt -65.09 -42.14 94.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 110.734 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 t -65.12 -36.34 83.95 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.512 1.125 . . . . 0.0 110.226 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.3 t -70.22 -34.4 72.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.219 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -80.92 -5.29 57.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.462 1.028 . . . . 0.0 111.424 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 23.32 77.11 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 124.609 1.1 . . . . 0.0 111.686 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.86 162.93 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 118.181 0.991 . . . . 0.0 110.283 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -100.53 113.54 26.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 172.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.76 170.18 16.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.124 1.77 . . . . 0.0 109.207 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -123.44 140.81 52.63 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.61 143.0 39.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.18 113.83 23.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.09 158.76 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.927 2.418 . . . . 0.0 110.393 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mm -125.97 -9.69 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.849 1.26 . . . . 0.0 110.778 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.04 119.76 11.95 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 168.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.9 -34.3 1.9 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.247 0.927 . . . . 0.0 112.729 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.475 HD22 ' HB3' ' A' ' 39' ' ' LYS . 10.1 t30 -87.45 53.98 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 123.336 1.541 . . . . 0.0 107.831 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 -18.74 63.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.154 -1.591 . . . . 0.0 110.973 168.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.03 -69.69 0.1 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.991 1.716 . . . . 0.0 109.657 169.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HB3' HD22 ' A' ' 36' ' ' ASN . 6.2 ttmm -74.79 -12.24 60.35 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.407 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.3 -45.21 94.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.959 1.254 . . . . 0.0 110.339 168.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.7 -39.55 93.84 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.779 0.718 . . . . 0.0 110.098 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -58.01 -36.96 73.43 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.605 -0.684 . . . . 0.0 110.377 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.8 ttm -64.4 -16.05 61.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.922 1.689 . . . . 0.0 112.513 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.28 -58.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -55.08 -50.13 69.93 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.403 0.62 . . . . 0.0 110.567 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.74 -39.99 73.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.426 -168.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.8 p -112.03 -25.37 9.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 112.865 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.0 21.73 63.97 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.353 -168.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -136.54 -57.03 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.307 1.554 . . . . 0.0 113.011 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 79.3 -6.34 1.86 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 129.755 3.222 . . . . 0.0 113.612 -172.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.4 p -73.79 176.4 6.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.772 2.029 . . . . 0.0 107.92 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.3 159.42 63.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 O-C-N 121.849 -0.532 . . . . 0.0 110.033 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.36 165.79 81.94 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 125.591 -0.587 . . . . 0.0 111.395 -5.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -132.89 104.44 6.58 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 168.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.12 141.79 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -127.69 128.76 45.98 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 128.332 2.653 . . . . 0.0 104.953 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.44 104.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 52.22 52.14 14.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.295 1.038 . . . . 0.0 109.175 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.19 -13.49 0.9 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 130.565 3.546 . . . . 0.0 114.428 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -74.7 108.75 7.65 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -67.55 110.24 3.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -74.25 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.14 -145.9 13.82 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -168.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.78 -168.74 36.67 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.169 1.366 . . . . 0.0 112.016 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -61.51 -39.98 92.96 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.682 -0.893 . . . . 0.0 110.214 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.54 -35.92 82.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -65.7 -45.78 81.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.941 1.296 . . . . 0.0 110.701 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.26 -48.32 70.85 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 126.188 1.795 . . . . 0.0 111.087 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -64.96 -34.68 79.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.705 1.202 . . . . 0.0 109.541 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.17 77.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.233 0.613 . . . . 0.0 110.824 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.62 -39.33 73.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.858 0.863 . . . . 0.0 109.839 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.24 -34.18 70.54 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.527 -0.733 . . . . 0.0 112.722 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.28 -34.05 75.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.224 1.009 . . . . 0.0 110.781 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -90.53 6.77 42.18 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 124.799 1.24 . . . . 0.0 112.888 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.95 3.86 52.95 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.273 0.939 . . . . 0.0 112.463 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.12 -17.62 80.22 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.376 0.988 . . . . 0.0 112.047 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.54 -40.39 61.75 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.242 1.017 . . . . 0.0 111.61 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -56.21 24.83 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.154 0.982 . . . . 0.0 112.398 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.49 16.32 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.197 3.264 . . . . 0.0 112.227 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.3 mt -115.96 -17.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.038 -1.039 . . . . 0.0 111.967 171.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -111.79 23.04 14.29 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.534 1.061 . . . . 0.0 112.527 -175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.255 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 C-N-CA 127.282 2.233 . . . . 0.0 115.73 -168.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.44 0.638 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.46 142.75 46.83 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 164.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -133.48 142.96 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 119.866 1.212 . . . . 0.0 108.159 170.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -140.87 120.57 13.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.27 14.2 tt -134.72 101.75 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.609 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -77.58 141.97 39.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.984 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -147.5 -176.97 5.45 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.261 1.425 . . . . 0.0 112.442 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.19 -170.01 2.62 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.393 -1.442 . . . . 0.0 108.241 169.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.32 -5.98 12.49 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -140.9 -119.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.423 1.489 . . . . 0.0 107.911 -168.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t 58.52 85.68 0.18 Allowed Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 127.451 2.3 . . . . 0.0 111.284 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.94 -38.88 86.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.174 2.583 . . . . 0.0 112.941 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -74.22 -34.19 63.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.205 1.366 . . . . 0.0 110.925 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.57 -48.14 81.92 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.61 1.095 . . . . 0.0 109.108 169.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -60.79 -39.65 89.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.073 -1.442 . . . . 0.0 110.97 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 23.9 mmt85 -54.3 -53.0 59.71 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.831 1.65 . . . . 0.0 109.699 173.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.95 79.57 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.354 0.525 . . . . 0.0 110.968 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -62.51 -40.2 95.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.248 0.931 . . . . 0.0 111.051 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.06 99.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.826 0.851 . . . . 0.0 109.75 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.54 -52.43 65.42 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.97 -36.5 83.5 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.373 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 m -69.46 -34.6 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.211 0.605 . . . . 0.0 110.773 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -64.7 -38.08 89.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.428 0.691 . . . . 0.0 109.337 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -86.06 0.14 54.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.932 -0.48 . . . . 0.0 111.453 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.02 21.4 69.72 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.721 2.105 . . . . 0.0 111.416 169.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -74.5 163.2 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -169.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -99.07 118.1 35.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -143.73 166.68 24.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.471 1.908 . . . . 0.0 109.512 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -113.57 140.15 48.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -109.08 145.23 36.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.451 1.9 . . . . 0.0 106.674 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -128.19 83.26 66.63 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 108.669 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.52 142.03 98.27 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.321 2.014 . . . . 0.0 109.193 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.1 mt -84.72 -28.3 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 120.222 1.374 . . . . 0.0 107.855 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -56.3 113.0 1.39 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 169.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.11 -0.53 81.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.847 1.689 . . . . 0.0 113.856 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -144.47 38.45 1.25 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.624 1.57 . . . . 0.0 110.266 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.63 63.99 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.85 1.66 . . . . 0.0 108.541 168.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.87 -59.82 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 128.001 2.52 . . . . 0.0 107.153 -169.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -69.46 -15.03 63.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 118.476 -1.29 . . . . 0.0 109.615 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -59.45 -48.93 79.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -56.67 -46.76 80.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.352 1.061 . . . . 0.0 110.258 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -55.98 -33.03 64.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.112 0.565 . . . . 0.0 110.926 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ttp -62.79 -12.92 27.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.848 1.259 . . . . 0.0 113.967 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mt -63.91 -55.21 23.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -71.97 -36.24 69.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.2 -0.937 . . . . 0.0 111.776 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -35.16 80.17 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.259 -1.353 . . . . 0.0 112.289 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -129.04 -16.14 4.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.086 1.312 . . . . 0.0 114.355 -170.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.7 -5.65 11.09 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.044 -1.42 . . . . 0.0 113.458 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.68 -54.59 2.5 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.89 1.845 . . . . 0.0 111.69 -169.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m 86.1 -9.91 0.71 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.867 3.267 . . . . 0.0 111.823 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.9 p -74.06 176.66 6.31 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 130.486 3.515 . . . . 0.0 109.441 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.02 158.84 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.642 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.73 156.95 98.91 Favored 'Cis proline' 0 C--N 1.349 0.559 0 CA-C-N 120.248 1.124 . . . . 0.0 111.482 0.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -130.0 99.42 5.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.84 142.15 13.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -129.3 141.66 51.04 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 128.339 2.655 . . . . 0.0 105.575 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.86 136.49 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.09 35.97 26.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.028 0.931 . . . . 0.0 111.052 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.78 -0.21 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.659 2.384 . . . . 0.0 114.476 -173.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -80.83 121.33 25.82 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -63.76 119.38 9.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 mm -82.77 -66.73 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.7 -125.2 1.87 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.24 -172.18 14.06 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.858 2.171 . . . . 0.0 110.771 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 36.4 t80 -56.02 -46.0 78.93 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.081 -173.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.48 -36.9 81.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.847 1.203 . . . . 0.0 110.447 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.8 -51.08 64.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.185 0.994 . . . . 0.0 109.727 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.73 -48.86 75.35 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.401 2.281 . . . . 0.0 111.393 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -61.29 -42.09 98.06 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.12 0.968 . . . . 0.0 109.018 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.27 96.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.955 0.798 . . . . 0.0 110.884 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.7 tp -56.68 -41.21 76.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.232 0.924 . . . . 0.0 110.58 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.69 -37.93 79.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.687 -0.633 . . . . 0.0 112.282 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.49 -25.23 66.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.605 1.162 . . . . 0.0 111.363 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -73.8 -20.72 60.38 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.377 1.071 . . . . 0.0 110.148 172.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.77 27.01 59.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -168.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.86 -9.11 23.28 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.192 1.377 . . . . 0.0 112.753 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -74.77 -42.59 57.88 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.854 1.327 . . . . 0.0 109.4 170.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -56.35 29.59 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.632 1.573 . . . . 0.0 109.543 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.64 -8.24 23.15 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.525 2.15 . . . . 0.0 113.957 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.5 -58.48 2.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mt -63.68 -54.38 36.57 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 111.737 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.5 mttt . . . . . 0 C--O 1.246 0.909 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.56 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.468 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.778 -0.082 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.63 98.75 2.92 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 158.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.41 97.52 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -102.62 122.11 43.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.259 19.7 tt -129.75 107.96 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.527 0.679 . . . . 0.0 112.208 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -74.04 149.74 41.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.664 1.186 . . . . 0.0 110.926 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.452 ' CG2' ' HZ2' ' A' ' 18' ' ' LYS . 82.0 p -155.42 -177.66 6.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.036 1.335 . . . . 0.0 113.3 -169.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -173.77 4.55 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 168.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.26 -25.9 25.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.43 2.692 . . . . 0.0 114.711 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -138.82 -82.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.4 t 45.43 88.35 0.1 Allowed Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.349 1.86 . . . . 0.0 110.841 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 43.67 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 125.062 3.841 . . . . 0.0 113.415 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.21 -50.23 0.38 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 131.164 3.786 . . . . 0.0 105.243 171.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.08 -50.54 66.56 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.657 1.183 . . . . 0.0 110.69 170.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -51.49 -55.24 19.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.342 1.027 . . . . 0.0 109.801 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -54.04 -47.24 71.79 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.858 0.863 . . . . 0.0 111.456 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.2 66.44 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.553 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HZ2' ' CG2' ' A' ' 7' ' ' THR . 0.0 OUTLIER -61.11 -30.8 70.58 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.534 1.516 . . . . 0.0 115.058 174.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.35 93.27 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 119.911 1.232 . . . . 0.0 108.867 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.38 -53.83 52.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.764 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.2 -37.65 87.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.398 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -73.73 -28.45 61.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.615 0.643 . . . . 0.0 110.193 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -68.61 -28.84 67.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.197 0.908 . . . . 0.0 110.501 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -89.97 -8.32 51.97 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.853 1.206 . . . . 0.0 111.567 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.36 25.59 72.53 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.804 1.669 . . . . 0.0 111.963 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.2 m -73.94 158.63 5.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 121.876 -0.779 . . . . 0.0 112.963 -168.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 107.63 8.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.161 1.784 . . . . 0.0 108.824 168.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -135.07 170.25 16.19 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.428 1.091 . . . . 0.0 108.147 172.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -118.32 135.57 54.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.02 135.98 41.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.67 117.84 33.87 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -84.17 155.06 12.78 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.392 2.062 . . . . 0.0 111.184 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt -134.4 0.55 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.297 1.439 . . . . 0.0 108.832 168.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.95 105.8 4.0 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 168.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.66 20.65 68.33 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.216 0.912 . . . . 0.0 114.247 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -113.78 153.75 28.55 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 118.758 1.279 . . . . 0.0 108.39 169.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.95 -28.35 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.753 1.621 . . . . 0.0 109.79 -172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.43 -49.23 78.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.784 0.72 . . . . 0.0 110.299 169.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -85.62 -8.39 58.28 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.318 -0.864 . . . . 0.0 112.376 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.09 -45.42 67.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.209 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.66 -28.87 67.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.465 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.89 -41.56 87.47 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.783 0.72 . . . . 0.0 109.248 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -60.76 -22.33 63.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.127 -0.983 . . . . 0.0 113.414 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.48 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -68.82 -27.09 65.54 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.366 0.984 . . . . 0.0 112.588 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -74.21 -40.18 62.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.326 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.3 p -124.32 -21.52 4.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -3.54 10.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.156 1.836 . . . . 0.0 113.791 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -90.92 -70.64 0.67 Allowed 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 119.413 1.607 . . . . 0.0 114.004 -168.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 p 83.0 -8.55 1.14 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.877 3.271 . . . . 0.0 110.719 -168.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 p -74.13 171.02 14.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.873 1.269 . . . . 0.0 107.9 169.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 161.19 40.97 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.165 0.986 . . . . 0.0 110.072 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 159.2 88.82 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.687 0.567 . . . . 0.0 110.937 -4.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.42 99.99 5.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 174.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.1 142.5 13.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -128.38 135.73 49.95 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.996 2.518 . . . . 0.0 104.577 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -130.67 110.24 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' OD1' ' HA ' ' A' ' 1' ' ' ALA 0.27 14.0 m-20 43.04 63.74 1.41 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.803 1.241 . . . . 0.0 111.981 -168.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.78 -10.54 0.48 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.605 2.762 . . . . 0.0 113.636 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -84.94 108.18 17.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -62.78 114.53 3.67 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.947 0.899 . . . . 0.0 109.059 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.0 -65.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.396 1.078 . . . . 0.0 110.267 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.85 -138.03 5.83 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -169.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.46 -166.28 12.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.752 1.644 . . . . 0.0 111.595 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.61 -39.6 77.23 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 118.35 1.075 . . . . 0.0 112.706 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -61.08 -44.13 97.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.652 0.66 . . . . 0.0 109.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.18 -38.72 91.39 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.678 -0.639 . . . . 0.0 111.296 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.62 -43.5 76.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.637 1.175 . . . . 0.0 111.131 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.65 -32.59 62.31 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.04 87.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.948 0.499 . . . . 0.0 109.719 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 tp -56.52 -44.06 80.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.817 0.735 . . . . 0.0 110.308 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -37.79 88.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.992 0.517 . . . . 0.0 111.884 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.51 -35.03 79.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.659 -0.65 . . . . 0.0 111.026 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -78.58 -1.0 31.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 21.21 75.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.672 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.65 -7.1 56.99 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.058 -0.857 . . . . 0.0 112.094 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.93 -50.03 12.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.317 1.059 . . . . 0.0 108.972 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.94 -53.52 20.91 Favored Pre-proline 0 N--CA 1.464 0.263 0 C-N-CA 125.872 1.669 . . . . 0.0 113.993 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.94 -16.83 36.96 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 121.255 1.484 . . . . 0.0 113.037 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.29 -1.87 55.58 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.573 1.149 . . . . 0.0 110.921 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.1 mt -122.18 44.0 2.72 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.314 1.446 . . . . 0.0 108.737 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 tttt . . . . . 0 C--O 1.248 1.014 0 C-N-CA 125.908 1.683 . . . . 0.0 107.465 169.442 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.468 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.71 135.35 33.96 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 158.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.4 t -136.16 88.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -91.27 143.6 26.48 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.38 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt -140.44 113.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.115 0.483 . . . . 0.0 110.651 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.69 124.21 26.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.763 0.825 . . . . 0.0 109.1 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -142.22 169.05 18.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.6 0.76 . . . . 0.0 111.236 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.86 174.4 15.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.961 1.304 . . . . 0.0 109.483 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.69 -68.63 0.3 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.599 1.56 . . . . 0.0 109.856 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.7 m -86.22 90.63 8.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.8 t -155.52 91.15 2.82 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.43 -44.74 30.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.579 2.186 . . . . 0.0 110.959 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -73.3 -27.13 61.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.631 -0.668 . . . . 0.0 110.501 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -60.81 -57.0 14.5 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.676 1.126 . . . . 0.0 109.368 170.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -54.47 -42.4 70.64 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.828 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -56.71 -51.64 68.02 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.126 1.33 . . . . 0.0 111.624 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.22 77.88 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.452 0.569 . . . . 0.0 110.887 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -58.33 -41.4 84.52 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.939 0.791 . . . . 0.0 110.562 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.96 77.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.611 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.07 -48.75 77.31 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.201 0.91 . . . . 0.0 108.859 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.93 -44.39 85.28 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 122.002 -0.436 . . . . 0.0 111.314 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.2 m -64.12 -35.64 81.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.937 0.495 . . . . 0.0 110.487 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -68.13 -34.16 75.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.601 0.761 . . . . 0.0 110.371 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -76.27 -13.39 60.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.93 0.786 . . . . 0.0 111.17 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.79 42.4 70.53 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.63 161.85 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.456 0.703 . . . . 0.0 110.447 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 p -87.7 137.07 32.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -150.22 168.41 24.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.433 1.493 . . . . 0.0 108.187 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -114.89 147.62 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -115.66 142.93 46.07 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.06 92.9 47.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.81 147.65 44.85 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.974 2.449 . . . . 0.0 110.455 -169.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.429 ' HA ' HD21 ' A' ' 36' ' ' ASN . 21.2 mt -121.5 -2.08 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.404 1.482 . . . . 0.0 109.725 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -63.8 122.19 15.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.959 -1.088 . . . . 0.0 108.573 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 21.48 79.71 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 119.447 -0.641 . . . . 0.0 112.546 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' A' ' 33' ' ' ILE . 2.9 t30 -128.78 165.62 20.59 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.933 1.293 . . . . 0.0 110.216 -171.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.01 -49.79 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.148 2.179 . . . . 0.0 108.404 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.21 -50.88 68.27 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.331 0.514 . . . . 0.0 111.363 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -78.03 -8.74 58.58 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.841 -1.162 . . . . 0.0 110.925 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -74.37 -56.91 4.33 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -22.82 63.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.834 0.743 . . . . 0.0 111.818 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -55.78 -27.63 52.0 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.805 -1.184 . . . . 0.0 111.586 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.2 ttm -52.52 -22.76 5.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 113.325 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.91 -45.52 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.882 0.873 . . . . 0.0 109.217 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -75.07 -35.38 61.83 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 121.05 1.75 . . . . 0.0 111.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -66.8 -42.28 86.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.79 -10.53 1.81 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.793 1.237 . . . . 0.0 113.232 -168.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.99 1.25 84.84 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.998 -168.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -130.9 -161.71 1.15 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.977 2.388 . . . . 0.0 110.376 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.76 8.35 0.3 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.844 2.458 . . . . 0.0 110.55 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.04 158.34 18.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.759 2.823 . . . . 0.0 110.314 -173.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.31 166.58 24.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -167.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.52 168.95 68.73 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 119.898 0.999 . . . . 0.0 110.043 -7.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.76 102.81 5.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.0 136.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.51 95.58 4.73 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 168.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.1 mm -90.08 111.86 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER 52.0 60.84 3.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.929 1.292 . . . . 0.0 113.011 -179.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.47 15.54 6.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.301 1.441 . . . . 0.0 113.282 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.26 109.72 14.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -60.32 112.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 108.909 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.9 mm -76.67 -73.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.51 -138.44 6.82 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.2 -171.09 47.2 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.899 1.714 . . . . 0.0 111.677 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -62.3 -36.97 83.77 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.489 -1.243 . . . . 0.0 110.944 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.76 -43.94 94.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.721 1.146 . . . . 0.0 109.14 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.3 -46.72 79.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.987 1.315 . . . . 0.0 109.701 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.51 -47.97 76.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 126.444 1.898 . . . . 0.0 111.869 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -67.01 -33.3 75.25 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.016 0.926 . . . . 0.0 108.599 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.07 82.33 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.493 1.042 . . . . 0.0 111.217 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -56.52 -44.08 80.43 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.931 0.787 . . . . 0.0 110.317 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.5 -36.14 80.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.689 1.196 . . . . 0.0 111.812 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.84 -26.29 65.08 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.584 1.154 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -20.52 60.5 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.129 0.572 . . . . 0.0 111.201 170.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.95 7.03 88.65 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -168.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.4 -9.42 84.93 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 117.967 0.884 . . . . 0.0 111.685 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.3 tp -74.51 -39.16 62.57 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.243 1.021 . . . . 0.0 110.302 170.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.74 -53.14 27.38 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 -4.96 13.89 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.509 2.139 . . . . 0.0 113.527 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.5 mt -114.47 3.1 14.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.997 1.719 . . . . 0.0 110.982 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.3 mt -137.71 7.55 2.77 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.6 tttt . . . . . 0 C--O 1.247 0.941 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -177.724 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 121.443 0.64 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.2 134.34 38.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.406 2.683 . . . . 0.0 105.54 163.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.0 t -130.49 120.67 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 168.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -135.57 128.37 31.12 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -131.33 109.39 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -73.92 138.07 44.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -149.19 -179.44 7.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.222 1.409 . . . . 0.0 110.818 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.14 173.94 12.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -66.72 -16.36 64.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -136.97 127.42 26.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 168.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 t -168.5 95.45 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.67 -39.61 90.15 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.669 2.246 . . . . 0.0 112.618 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.79 -30.04 56.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.819 0.736 . . . . 0.0 111.09 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.37 -51.37 70.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.73 1.15 . . . . 0.0 108.672 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -57.73 -40.57 79.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.966 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -54.54 -54.48 40.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.577 1.535 . . . . 0.0 110.833 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.57 68.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.336 0.516 . . . . 0.0 110.702 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -61.67 -34.05 75.05 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.388 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.72 69.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.36 -49.35 76.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.477 0.711 . . . . 0.0 109.462 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -66.89 -41.78 86.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.261 0.625 . . . . 0.0 111.032 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -69.28 -31.94 70.78 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.6 m -68.47 -33.49 74.26 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.322 0.965 . . . . 0.0 111.271 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -74.97 -11.27 60.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.613 0.642 . . . . 0.0 110.757 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.21 16.22 76.92 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.274 1.416 . . . . 0.0 112.158 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 m -74.18 162.9 4.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 117.796 0.798 . . . . 0.0 110.99 -168.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.45 106.74 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.081 1.752 . . . . 0.0 108.136 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -134.25 169.33 17.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.224 1.41 . . . . 0.0 110.357 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -117.39 145.18 44.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.621 1.568 . . . . 0.0 107.435 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -114.01 150.15 34.33 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -134.2 88.02 32.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.609 1.564 . . . . 0.0 108.767 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.07 152.73 46.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.907 1.738 . . . . 0.0 111.855 -168.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.2 pt -126.65 47.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 126.131 1.772 . . . . 0.0 109.421 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -58.26 -143.36 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.779 3.232 . . . . 0.0 109.141 168.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.6 64.09 0.63 Allowed Glycine 0 CA--C 1.531 1.065 0 O-C-N 119.024 -2.298 . . . . 0.0 109.833 169.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.483 HD22 ' CG ' ' A' ' 39' ' ' LYS . 4.5 t30 -153.76 91.41 1.47 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.753 2.021 . . . . 0.0 108.783 -168.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.61 -22.39 66.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.75 -1.119 . . . . 0.0 113.877 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.2 -54.04 43.68 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 120.568 1.531 . . . . 0.0 109.822 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' CG ' HD22 ' A' ' 36' ' ' ASN . 0.0 OUTLIER -67.89 -23.56 65.13 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.017 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -48.14 33.73 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.252 0.933 . . . . 0.0 109.012 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.23 -40.88 87.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.146 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.23 -44.31 83.69 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.671 0.788 . . . . 0.0 109.704 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.6 ttm -60.29 -18.32 48.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.868 1.267 . . . . 0.0 111.956 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -68.65 -58.58 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -61.25 -40.82 95.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.554 1.524 . . . . 0.0 111.886 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -67.03 -44.29 80.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.879 0.872 . . . . 0.0 111.565 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -126.39 -27.03 3.23 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.25 -21.36 5.13 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.692 2.568 . . . . 0.0 113.168 -168.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -87.68 -60.59 1.93 Allowed 'General case' 0 C--O 1.231 0.089 0 C-N-CA 124.45 1.1 . . . . 0.0 113.25 -168.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.3 p 75.38 15.86 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.954 2.102 . . . . 0.0 113.324 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.0 p -96.64 176.23 6.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.911 1.284 . . . . 0.0 108.484 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -136.65 154.11 76.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.139 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.11 156.02 91.2 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.604 -0.998 . . . . 0.0 110.18 -11.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.35 93.79 4.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 mp -81.51 143.39 12.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -130.09 127.0 38.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 129.635 3.174 . . . . 0.0 105.037 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.4 mt -130.67 126.5 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.38 55.73 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.527 2.331 . . . . 0.0 110.492 -168.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 67.04 -7.96 0.46 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 129.692 3.197 . . . . 0.0 114.175 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -81.08 117.6 21.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -172.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -63.66 101.58 0.36 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -74.07 -59.32 3.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.709 1.203 . . . . 0.0 109.49 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.48 -141.13 10.8 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.98 -170.44 32.43 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.032 1.301 . . . . 0.0 111.174 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -62.1 -40.03 94.49 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.758 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.5 -40.09 85.92 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.772 0.714 . . . . 0.0 110.015 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.77 -48.71 73.54 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.306 1.443 . . . . 0.0 110.085 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.31 -47.63 85.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.117 1.767 . . . . 0.0 111.374 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -66.13 -35.31 80.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.062 0.945 . . . . 0.0 109.228 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.34 -47.17 85.41 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.787 0.722 . . . . 0.0 110.512 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.61 -45.75 81.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.717 0.807 . . . . 0.0 110.649 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.59 -43.63 97.14 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.819 1.248 . . . . 0.0 111.394 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -25.0 67.84 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.491 0.717 . . . . 0.0 110.661 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.25 3.2 55.45 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.529 1.132 . . . . 0.0 110.669 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.7 20.89 53.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.349 0.976 . . . . 0.0 111.941 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.0 63.14 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 118.527 1.163 . . . . 0.0 111.451 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 tp -78.33 -53.18 7.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.657 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -53.25 32.24 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 127.165 2.186 . . . . 0.0 113.88 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -69.25 -1.49 8.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.846 1.697 . . . . 0.0 112.968 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 99.0 mt -112.36 -3.34 14.54 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.051 1.74 . . . . 0.0 111.727 170.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mt -123.07 4.7 9.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.509 1.523 . . . . 0.0 114.245 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.185 0 C-N-CA 125.341 1.456 . . . . 0.0 108.429 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.41 93.58 7.24 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.17 132.05 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -133.02 141.86 48.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.49 1.516 . . . . 0.0 107.179 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 tt -136.99 125.42 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -103.04 127.62 50.22 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.675 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.8 p -141.08 177.62 7.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.822 1.249 . . . . 0.0 109.747 -173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.55 -173.47 3.97 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.895 -1.128 . . . . 0.0 108.631 173.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -50.13 -56.77 9.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.938 1.695 . . . . 0.0 109.299 169.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -85.33 -173.58 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.638 1.175 . . . . 0.0 109.698 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t 96.34 81.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 129.664 3.186 . . . . 0.0 108.266 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.33 -27.69 71.69 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.341 2.028 . . . . 0.0 112.062 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -73.31 -31.21 63.88 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.4 -0.813 . . . . 0.0 109.185 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.7 m -61.65 -48.03 82.7 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.029 -1.044 . . . . 0.0 110.245 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -53.35 -51.79 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.713 -0.66 . . . . 0.0 109.809 170.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -54.47 -43.94 72.14 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.126 0.876 . . . . 0.0 112.753 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.72 68.1 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.361 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.46 -37.17 74.92 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.425 1.466 . . . . 0.0 110.809 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.76 -39.23 90.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.116 0.566 . . . . 0.0 110.852 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tt -65.35 -45.92 82.24 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -41.09 96.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.796 0.725 . . . . 0.0 111.282 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 -36.92 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 m -72.46 -29.53 63.74 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.961 0.801 . . . . 0.0 112.68 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mmmp? -75.29 -15.2 60.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.198 0.908 . . . . 0.0 110.377 169.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.07 47.18 61.0 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.24 170.72 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.231 0.613 . . . . 0.0 110.641 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -104.44 117.12 33.38 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.061 1.744 . . . . 0.0 108.104 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -134.35 163.39 29.76 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.606 0.763 . . . . 0.0 110.182 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -95.61 139.54 31.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.48 133.74 55.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.77 106.96 31.55 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.88 1.272 . . . . 0.0 107.931 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.02 153.21 41.49 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.92 1.746 . . . . 0.0 108.828 173.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 mm -116.5 -12.76 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.55 0.74 . . . . 0.0 110.799 174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -69.34 116.03 9.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.05 18.34 74.54 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.751 -1.027 . . . . 0.0 112.628 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -135.45 39.7 2.85 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 123.509 1.623 . . . . 0.0 106.67 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.17 -16.41 63.96 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 119.982 -1.699 . . . . 0.0 113.696 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.66 81.65 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.835 1.198 . . . . 0.0 109.508 169.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -66.43 -34.55 78.19 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.729 -0.607 . . . . 0.0 111.345 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -55.45 -49.93 71.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 110.057 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -68.55 -31.71 71.12 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.103 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -61.03 -39.13 88.6 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.247 1.385 . . . . 0.0 110.476 169.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 ttm -56.04 -12.59 1.52 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.841 1.657 . . . . 0.0 112.303 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mt -63.98 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -69.47 -20.05 63.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.835 1.652 . . . . 0.0 112.168 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -21.55 61.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.312 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.1 p -134.76 -15.65 2.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.012 1.733 . . . . 0.0 114.982 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.85 69.12 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.023 1.297 . . . . 0.0 112.167 -168.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.55 -72.94 0.66 Allowed 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 125.346 1.459 . . . . 0.0 110.084 -169.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 86.63 -4.78 0.71 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 130.797 3.639 . . . . 0.0 111.616 -168.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.5 p -106.2 162.85 13.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.566 1.547 . . . . 0.0 108.073 -172.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.99 163.05 42.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.226 0.61 . . . . 0.0 109.95 -168.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -65.43 161.67 70.05 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.082 1.065 . . . . 0.0 112.387 -4.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -139.57 140.66 37.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.564 168.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 146.98 30.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 168.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -122.16 133.74 54.74 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.6 mt -136.99 120.94 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 51.09 43.5 29.04 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.521 1.128 . . . . 0.0 109.192 -168.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.21 -3.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.866 2.466 . . . . 0.0 114.797 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -83.03 114.89 21.59 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.402 1.881 . . . . 0.0 108.416 -173.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -64.95 113.39 3.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.461 1.028 . . . . 0.0 108.589 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -82.93 -74.45 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.486 1.114 . . . . 0.0 109.03 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.16 -145.83 14.1 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 119.169 0.895 . . . . 0.0 113.683 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.6 -171.71 47.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.72 2.105 . . . . 0.0 113.474 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.9 -40.28 68.97 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.462 -1.611 . . . . 0.0 110.039 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -34.29 74.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.283 175.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -67.54 -49.13 64.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.569 0.699 . . . . 0.0 110.59 171.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.49 -42.71 96.87 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.926 1.29 . . . . 0.0 111.757 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.59 -37.22 68.2 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.01 85.71 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.295 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -56.22 -47.74 77.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.531 1.059 . . . . 0.0 110.894 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.43 -33.68 76.09 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.594 -0.691 . . . . 0.0 111.738 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.04 60.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.472 1.109 . . . . 0.0 112.516 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 1.51 44.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.897 1.226 . . . . 0.0 110.982 168.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.37 23.17 77.83 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -171.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.35 -3.78 29.1 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.04 -1.422 . . . . 0.0 113.403 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 tp -80.5 -48.25 13.07 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.441 1.621 . . . . 0.0 108.342 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -49.78 85.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.717 1.207 . . . . 0.0 113.158 -174.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 -28.59 53.62 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 CA-C-N 122.22 1.829 . . . . 0.0 112.636 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.85 -14.34 58.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.008 0.822 . . . . 0.0 111.837 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.2 -97.27 0.17 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.779 2.032 . . . . 0.0 109.395 -174.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.3 mttt . . . . . 0 C--O 1.25 1.118 0 C-N-CA 129.248 3.019 . . . . 0.0 107.141 -176.644 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.99 93.86 2.29 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.158 0.89 . . . . 0.0 113.02 -171.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.7 t -94.71 135.4 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -129.15 139.9 51.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 tt -139.54 120.04 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.846 0.355 . . . . 0.0 110.256 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -92.33 132.29 36.84 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.0 p -140.72 168.72 19.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.156 0.982 . . . . 0.0 111.521 -169.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.11 -179.45 7.33 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.785 -1.197 . . . . 0.0 110.521 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -53.59 -39.56 64.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 128.175 2.59 . . . . 0.0 113.52 -168.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -134.25 105.83 6.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -155.93 80.09 4.04 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.754 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -57.71 -33.94 97.47 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.242 1.961 . . . . 0.0 112.139 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -73.54 -28.89 62.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.393 1.451 . . . . 0.0 110.175 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.19 -53.16 61.06 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -53.21 -44.74 68.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.345 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -54.39 -62.2 1.81 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.779 1.172 . . . . 0.0 110.712 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -46.16 91.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -63.08 -34.97 78.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.292 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.36 77.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.341 0.973 . . . . 0.0 110.407 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.24 -52.84 63.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.796 0.725 . . . . 0.0 109.149 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.91 -43.33 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.027 0.531 . . . . 0.0 111.191 -170.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -64.9 -35.05 79.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.304 0.642 . . . . 0.0 110.131 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.7 m -73.08 -30.72 63.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.629 0.649 . . . . 0.0 112.492 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -74.29 -10.73 59.88 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.508 1.123 . . . . 0.0 109.767 172.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.03 46.05 60.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.82 175.99 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.426 1.09 . . . . 0.0 110.227 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.5 m -133.49 99.29 4.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.593 1.187 . . . . 0.0 108.08 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -92.03 165.64 13.09 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 128.382 2.673 . . . . 0.0 107.911 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -97.3 138.44 34.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -115.92 136.29 53.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.547 0.739 . . . . 0.0 109.419 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.64 106.17 20.92 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.761 1.625 . . . . 0.0 110.439 -168.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.97 144.79 19.15 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.577 1.518 . . . . 0.0 111.992 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.4 mm -101.05 -15.8 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -66.99 132.61 48.28 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.12 12.03 59.74 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.699 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -125.83 138.24 53.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.473 1.636 . . . . 0.0 108.405 -174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.95 55.44 0.19 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.724 2.01 . . . . 0.0 105.735 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.12 -51.89 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.092 2.157 . . . . 0.0 108.906 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -86.21 -7.87 58.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.779 1.172 . . . . 0.0 110.614 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -54.09 -62.78 1.43 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.065 1.746 . . . . 0.0 109.218 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.08 -21.48 56.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.165 0.439 . . . . 0.0 111.149 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.98 -32.28 70.69 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.461 -0.774 . . . . 0.0 109.842 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ttp -59.95 -20.89 60.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.06 -1.025 . . . . 0.0 112.681 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.27 -58.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -19.42 64.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.015 . . . . 0.0 112.165 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -91.42 -56.02 3.29 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.77 -1.206 . . . . 0.0 110.931 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.0 p -90.32 -21.91 21.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.926 1.239 . . . . 0.0 113.834 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.66 22.22 63.77 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.963 -0.909 . . . . 0.0 112.204 -168.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -136.17 -57.72 0.76 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.155 1.477 . . . . 0.0 112.723 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.283 0.0 OUTLIER 67.88 -0.15 2.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.912 2.085 . . . . 0.0 113.872 -171.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.9 p -76.87 176.28 8.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.282 1.833 . . . . 0.0 107.507 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.58 158.99 73.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.99 -0.444 . . . . 0.0 111.786 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.07 167.4 78.84 Favored 'Cis proline' 0 C--N 1.347 0.454 0 N-CA-C 109.605 -0.96 . . . . 0.0 109.605 -11.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -128.83 112.08 13.76 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -99.7 143.15 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -134.84 142.31 46.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 128.693 2.797 . . . . 0.0 105.536 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.7 mt -138.5 119.09 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.256 1.2 m-20 52.71 37.53 23.9 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.956 0.884 . . . . 0.0 111.306 -168.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 62.98 2.84 1.08 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.719 2.408 . . . . 0.0 114.382 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -73.79 119.31 17.84 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -69.08 107.74 3.29 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 108.978 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.5 mm -73.94 -63.79 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.41 -138.13 5.7 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.77 -165.06 30.38 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.592 2.044 . . . . 0.0 111.14 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -57.66 -46.15 84.6 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.885 -0.773 . . . . 0.0 110.541 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.03 -32.38 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.679 0.792 . . . . 0.0 109.604 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -73.16 -45.02 59.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.87 1.268 . . . . 0.0 111.957 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.33 -53.69 55.31 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.93 -39.23 80.98 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.68 -46.44 89.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.894 0.878 . . . . 0.0 112.55 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 tp -56.82 -46.71 81.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.762 1.164 . . . . 0.0 110.919 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.26 -38.9 92.68 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.636 1.174 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.895 0.878 . . . . 0.0 111.659 172.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.09 -0.68 57.72 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.909 1.284 . . . . 0.0 112.084 170.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.88 4.12 13.28 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.194 0.907 . . . . 0.0 112.985 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.79 -3.78 89.2 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 119.306 1.553 . . . . 0.0 112.265 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.5 tp -74.25 -51.47 15.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.988 1.315 . . . . 0.0 109.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -56.08 22.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.457 1.503 . . . . 0.0 112.235 -170.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.85 -4.82 15.84 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.205 1.937 . . . . 0.0 113.375 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -100.71 -0.54 37.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.352 0.978 . . . . 0.0 111.107 172.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.55 3.02 3.27 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 125.648 1.579 . . . . 0.0 113.726 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.8 mttp . . . . . 0 C--O 1.248 0.982 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.906 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 118.272 -0.871 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.85 93.57 2.18 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 172.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.92 134.35 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.42 150.78 46.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.3 tt -144.27 110.71 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.233 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.52 124.53 28.58 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 107.614 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -144.25 169.16 18.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.39 1.076 . . . . 0.0 112.347 -171.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.76 173.94 10.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.036 1.335 . . . . 0.0 109.138 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.38 -28.81 68.51 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.106 1.762 . . . . 0.0 111.695 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -133.33 110.18 9.87 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.8 91.43 0.67 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 124.946 1.298 . . . . 0.0 108.578 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.12 -40.21 62.61 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.661 2.241 . . . . 0.0 111.049 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.51 -31.93 63.97 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.921 -1.112 . . . . 0.0 110.672 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m -61.98 -46.18 90.38 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 119.185 0.902 . . . . 0.0 109.507 170.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -55.48 -47.71 75.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.335 -0.84 . . . . 0.0 109.997 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -56.08 -50.09 71.98 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.659 1.118 . . . . 0.0 111.158 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.1 -53.95 50.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.634 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -61.75 -36.03 79.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.795 0.725 . . . . 0.0 110.856 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -47.68 82.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.64 -49.5 77.28 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.58 -39.84 84.86 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.051 -0.406 . . . . 0.0 111.217 -174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -67.97 -34.04 75.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.879 0.763 . . . . 0.0 110.276 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -69.72 -27.97 65.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.499 1.045 . . . . 0.0 111.657 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -80.94 -11.53 59.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.215 1.006 . . . . 0.0 110.547 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.94 43.56 49.11 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.762 1.172 . . . . 0.0 110.779 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -98.91 169.04 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.966 0.888 . . . . 0.0 112.066 -170.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.41 128.39 35.92 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.839 2.056 . . . . 0.0 105.819 169.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -155.14 164.51 38.73 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -112.69 139.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.359 1.864 . . . . 0.0 106.875 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.08 146.99 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.66 125.29 19.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.14 138.42 18.08 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.192 1.261 . . . . 0.0 109.578 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -121.24 6.33 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.42 73.78 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.781 2.033 . . . . 0.0 111.09 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.43 11.17 67.75 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.163 1.84 . . . . 0.0 114.725 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . 0.282 0.0 OUTLIER -83.59 102.82 12.44 Favored 'General case' 0 C--O 1.241 0.648 1 N-CA-C 96.389 -5.412 . . . . 0.0 96.389 -177.654 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.59 -33.95 64.39 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -168.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.43 -55.06 38.12 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 119.374 0.988 . . . . 0.0 110.221 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -71.86 -25.74 62.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.48 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -61.84 -50.9 70.42 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.146 0.978 . . . . 0.0 108.669 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -41.53 90.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.288 1.435 . . . . 0.0 111.536 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.46 -33.31 75.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.392 0.677 . . . . 0.0 110.839 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.8 ttp -63.98 -26.28 68.51 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.569 -0.707 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -67.05 -53.44 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 6.89 0.09 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.551 1.94 . . . . 0.0 114.675 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.34 -28.72 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 120.643 1.565 . . . . 0.0 112.703 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -116.02 -22.1 9.15 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.157 1.344 . . . . 0.0 112.898 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -9.64 0.88 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.083 1.802 . . . . 0.0 113.465 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -91.24 -56.12 3.27 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.512 1.156 . . . . 0.0 111.378 -169.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 80.99 -1.53 1.78 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.005 1.322 . . . . 0.0 111.605 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.2 p -80.18 177.09 9.19 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 131.262 3.825 . . . . 0.0 108.58 168.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.84 159.23 71.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.5 166.9 80.66 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-O 121.718 0.632 . . . . 0.0 111.391 -8.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -126.34 100.28 6.21 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 102.098 -3.297 . . . . 0.0 102.098 168.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mp -87.37 146.67 6.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -137.01 150.88 48.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.334 2.254 . . . . 0.0 107.453 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.9 mt -135.86 109.04 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 51.57 43.69 29.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.636 -1.29 . . . . 0.0 110.764 -169.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.04 -1.78 2.88 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.013 2.925 . . . . 0.0 114.665 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.93 103.09 4.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.995 1.718 . . . . 0.0 106.826 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -66.62 109.04 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.11 -59.24 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.95 -133.28 6.81 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.71 -175.13 38.38 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.372 1.463 . . . . 0.0 111.601 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.45 -41.69 81.03 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.557 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.98 -34.83 78.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.565 0.62 . . . . 0.0 110.799 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -66.33 -48.29 70.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 109.773 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.28 -43.75 97.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.351 1.061 . . . . 0.0 111.161 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.73 -37.7 73.51 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.41 94.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.793 0.724 . . . . 0.0 110.711 170.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.79 -49.13 76.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.395 0.998 . . . . 0.0 110.573 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -36.92 78.11 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 111.51 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.55 -22.44 63.55 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.39 -3.58 56.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.55 1.14 . . . . 0.0 110.018 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.53 37.95 92.9 Favored Glycine 0 C--O 1.225 -0.406 0 O-C-N 120.634 -1.291 . . . . 0.0 110.192 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.07 -1.57 58.31 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.845 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.21 -67.77 0.77 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.935 1.294 . . . . 0.0 108.847 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.296 0.0 OUTLIER -45.07 -51.25 24.45 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-O 116.564 -1.684 . . . . 0.0 114.263 177.284 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.65 3.67 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 CA-C-N 123.526 2.295 . . . . 0.0 113.612 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -109.83 -38.61 5.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.36 0.982 . . . . 0.0 110.258 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.79 -16.1 56.17 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.201 -0.937 . . . . 0.0 113.124 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp . . . . . 0 C--O 1.25 1.079 0 C-N-CA 124.992 1.317 . . . . 0.0 107.889 171.662 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.62 93.6 6.15 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.1 t -131.51 107.01 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.19 128.77 44.03 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -169.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -130.22 104.89 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.153 0.502 . . . . 0.0 109.908 -171.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -74.95 131.21 40.5 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -143.39 -179.42 6.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.402 0.681 . . . . 0.0 112.146 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 175.94 9.0 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.93 1.692 . . . . 0.0 108.815 168.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -18.68 4.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.271 3.028 . . . . 0.0 115.168 -169.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -137.02 -83.92 0.34 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 168.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 t 56.73 97.5 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.687 1.595 . . . . 0.0 112.463 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.91 42.85 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.777 2.985 . . . . 0.0 113.907 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -150.6 -42.83 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.771 2.828 . . . . 0.0 106.046 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -53.83 -50.52 66.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 109.548 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -52.73 -51.46 60.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.562 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.432 ' HD3' ' CE2' ' A' ' 65' ' ' TYR . 18.0 mtt-85 -56.69 -50.22 72.79 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.563 0.62 . . . . 0.0 110.786 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.19 -43.55 94.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.982 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.33 -47.12 84.76 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.081 1.309 . . . . 0.0 110.261 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.95 79.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.67 0.388 . . . . 0.0 110.46 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.28 -46.71 82.47 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.606 0.763 . . . . 0.0 110.17 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.53 -38.43 89.62 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.204 0.602 . . . . 0.0 110.005 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -64.35 -35.43 80.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.401 0.68 . . . . 0.0 110.793 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 t -67.3 -35.35 79.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.734 0.814 . . . . 0.0 109.65 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -80.58 -6.77 58.76 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.588 0.631 . . . . 0.0 111.937 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.01 28.59 66.34 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.148 0.885 . . . . 0.0 111.462 170.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.15 167.7 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 121.907 -0.76 . . . . 0.0 112.241 -168.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.3 p -98.49 130.12 45.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -145.91 164.27 32.52 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.434 1.094 . . . . 0.0 108.176 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -104.94 136.52 44.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.189 2.195 . . . . 0.0 107.17 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -116.39 139.14 50.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.644 1.178 . . . . 0.0 109.337 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.26 87.81 49.72 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 125.045 1.338 . . . . 0.0 110.702 -169.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.79 141.85 67.31 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.185 1.923 . . . . 0.0 111.701 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt -121.18 8.92 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.938 1.295 . . . . 0.0 112.214 170.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -66.38 107.53 2.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.408 1.483 . . . . 0.0 109.624 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.59 -6.16 40.82 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 120.882 -1.136 . . . . 0.0 114.307 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.24 164.13 20.31 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.75 -39.75 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.705 1.202 . . . . 0.0 110.796 -168.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.93 74.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.571 0.748 . . . . 0.0 111.547 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -86.18 -22.11 27.16 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.056 -1.027 . . . . 0.0 110.66 173.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -59.0 -43.58 91.5 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 120.76 -1.213 . . . . 0.0 110.733 170.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.06 -22.47 55.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.732 0.696 . . . . 0.0 111.869 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -60.25 -24.07 64.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.917 1.235 . . . . 0.0 109.714 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.7 tpp -54.44 -26.66 32.23 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.922 0.783 . . . . 0.0 112.372 173.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -74.38 -40.92 49.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -77.55 -31.36 53.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.443 -0.785 . . . . 0.0 112.208 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -74.9 -38.5 61.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 112.665 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.8 p -133.27 -12.31 2.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -168.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.21 -8.47 70.72 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.945 -168.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -127.54 -161.93 1.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.703 1.752 . . . . 0.0 111.337 -168.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.3 m -155.68 -23.79 0.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.708 2.403 . . . . 0.0 109.948 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.6 p -74.08 163.01 28.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.93 1.692 . . . . 0.0 110.857 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.65 161.97 53.65 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 0.0 109.135 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.98 153.8 84.29 Favored 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.242 1.122 . . . . 0.0 112.116 2.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -130.63 103.37 6.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 105.761 -1.941 . . . . 0.0 105.761 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.65 146.87 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 168.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.91 119.25 27.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 168.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -125.28 129.41 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.697 1.59 . . . . 0.0 107.53 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 48.0 32.82 3.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.639 1.975 . . . . 0.0 110.102 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.26 4.68 4.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 131.107 3.763 . . . . 0.0 115.793 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.84 123.45 24.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -65.13 113.97 4.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.88 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.183 0.993 . . . . 0.0 109.546 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.08 -136.83 8.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -168.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.02 -175.93 43.86 Favored Glycine 0 CA--C 1.521 0.456 0 O-C-N 124.231 0.607 . . . . 0.0 112.483 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.432 ' CE2' ' HD3' ' A' ' 16' ' ' ARG . 2.9 t80 -52.02 -49.71 62.84 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.603 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.3 -25.15 65.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.357 0.663 . . . . 0.0 110.627 -170.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -71.39 -51.88 21.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.528 1.131 . . . . 0.0 110.426 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -51.22 69.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.892 1.277 . . . . 0.0 110.012 176.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -51.05 -38.97 54.73 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.138 1.375 . . . . 0.0 111.413 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.0 91.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 117.882 -1.056 . . . . 0.0 111.746 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.75 -51.02 70.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.467 1.03 . . . . 0.0 109.131 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.79 -42.79 80.09 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.373 1.069 . . . . 0.0 110.433 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -22.81 61.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.175 0.99 . . . . 0.0 112.566 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -88.58 4.47 46.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.188 0.995 . . . . 0.0 112.26 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.85 71.59 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.592 0.633 . . . . 0.0 112.243 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.79 -17.1 80.19 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.477 1.138 . . . . 0.0 112.056 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.3 tp -77.95 -39.73 41.74 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.004 0.902 . . . . 0.0 110.68 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.26 -56.22 22.1 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.269 1.428 . . . . 0.0 109.921 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.56 -0.75 8.72 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.5 2.133 . . . . 0.0 113.508 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.56 -9.9 15.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 112.26 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.5 mt -133.09 7.29 3.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.258 1.823 . . . . 0.0 112.623 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 117.271 -1.347 . . . . 0.0 108.572 -169.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.4 96.49 4.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.916 -0.49 . . . . 0.0 109.703 -166.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.7 t -125.43 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.3 135.91 52.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 tt -135.0 107.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.282 0.563 . . . . 0.0 110.49 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -73.57 136.14 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.401 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 73.2 p -141.29 179.07 6.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.135 1.374 . . . . 0.0 109.106 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.37 -179.62 7.84 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -48.62 -29.96 4.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.773 3.229 . . . . 0.0 113.924 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -138.41 86.55 2.17 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.203 1.001 . . . . 0.0 111.044 -173.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -156.75 91.23 2.51 Favored Pre-proline 0 CA--C 1.539 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 110.354 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.18 -27.55 72.85 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.361 2.041 . . . . 0.0 112.067 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -73.46 -29.47 62.55 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 7' ' ' THR . 74.1 m -66.75 -47.74 71.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.178 0.899 . . . . 0.0 108.902 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.19 -53.68 26.17 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.784 168.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -53.61 55.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.6 1.091 . . . . 0.0 111.174 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.34 76.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.936 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -60.61 -39.8 89.5 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.672 1.124 . . . . 0.0 110.935 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.3 68.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.208 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp -66.2 -54.34 26.38 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.61 -35.37 80.29 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -68.97 -35.31 76.59 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 109.66 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -74.04 -11.6 60.37 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.14 -0.975 . . . . 0.0 112.167 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -92.28 -27.4 17.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.519 1.054 . . . . 0.0 108.59 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.33 54.03 7.17 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.93 167.47 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.295 0.638 . . . . 0.0 112.088 -172.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.7 m -82.55 120.18 25.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.375 . . . . 0.0 107.308 169.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.87 169.7 17.55 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 109.286 169.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.45 147.29 44.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.77 155.08 28.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.641 0.655 . . . . 0.0 110.557 170.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.49 93.86 27.81 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 124.651 1.181 . . . . 0.0 108.848 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.84 145.98 91.18 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.221 1.948 . . . . 0.0 109.063 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mt -87.72 -32.73 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.761 0.709 . . . . 0.0 109.1 168.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -62.42 102.71 0.34 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.594 1.558 . . . . 0.0 109.084 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.7 -20.73 7.71 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.273 1.892 . . . . 0.0 111.929 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.07 -179.45 7.24 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.027 1.731 . . . . 0.0 110.815 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.31 -64.7 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.357 2.663 . . . . 0.0 105.223 169.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.77 83.39 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.004 0.82 . . . . 0.0 110.872 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -77.87 -17.4 57.38 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 118.927 0.785 . . . . 0.0 112.835 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -67.11 -52.07 46.38 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -32.37 73.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.964 0.802 . . . . 0.0 109.41 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -23.42 66.33 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.291 -0.88 . . . . 0.0 111.917 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.44 -26.38 19.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.002 0.819 . . . . 0.0 112.308 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.39 -56.7 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -61.67 7.51 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.437 2.295 . . . . 0.0 116.125 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.12 -32.2 0.47 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.057 1.299 . . . . 0.0 110.517 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.3 p -129.29 -10.35 4.67 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.476 1.489 . . . . 0.0 113.108 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.84 -14.86 34.85 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.657 1.599 . . . . 0.0 114.322 -171.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.57 ' NH1' ' HG1' ' A' ' 51' ' ' THR . 43.6 mtp180 -131.99 162.44 30.71 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 126.211 1.804 . . . . 0.0 109.01 -169.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -105.45 4.46 30.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 112.645 170.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.57 ' HG1' ' NH1' ' A' ' 49' ' ' ARG . 12.2 p -73.69 175.26 7.33 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.877 1.271 . . . . 0.0 109.8 172.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.98 164.49 29.34 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.976 1.31 . . . . 0.0 110.509 176.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.51 162.12 80.81 Favored 'Cis proline' 0 N--CA 1.454 -0.807 0 CA-C-N 119.151 0.732 . . . . 0.0 110.503 -7.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -127.36 99.6 5.71 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.85 139.82 16.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.22 129.29 47.52 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 128.988 2.915 . . . . 0.0 104.935 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.63 123.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 53.75 30.14 10.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.452 1.024 . . . . 0.0 111.476 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.3 -1.11 2.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.722 3.209 . . . . 0.0 114.691 -172.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -73.95 114.39 12.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.316 1.846 . . . . 0.0 108.055 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -69.85 106.64 3.22 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.667 -0.645 . . . . 0.0 110.045 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.4 mm -73.96 -63.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.786 0.835 . . . . 0.0 109.04 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.87 -142.13 9.84 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.23 -173.31 38.78 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.472 1.51 . . . . 0.0 111.384 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.83 -38.83 76.3 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.598 -0.942 . . . . 0.0 110.625 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.54 -41.82 95.25 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.433 0.693 . . . . 0.0 110.276 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.58 -48.56 66.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.437 1.095 . . . . 0.0 110.052 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -49.86 71.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.861 1.264 . . . . 0.0 110.3 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -67.91 -27.78 66.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.83 69.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.188 0.995 . . . . 0.0 111.674 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.7 tp -56.34 -41.43 76.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.052 1.296 . . . . 0.0 109.94 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.62 -35.48 77.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.274 1.03 . . . . 0.0 112.845 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.95 -29.06 68.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.375 0.534 . . . . 0.0 110.809 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 -74.59 -10.76 59.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.177 0.991 . . . . 0.0 110.784 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.56 3.65 54.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.094 -0.837 . . . . 0.0 111.427 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.9 -6.08 89.25 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.916 1.246 . . . . 0.0 112.368 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 tp -73.5 -44.36 58.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.56 -46.99 99.77 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-O 116.7 -1.619 . . . . 0.0 113.494 -169.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 -12.63 35.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.541 1.943 . . . . 0.0 113.087 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -99.67 0.05 41.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.168 0.894 . . . . 0.0 111.506 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mt -141.73 -28.16 0.64 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.57 139.31 45.5 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 167.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.5 t -139.47 118.84 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -113.88 147.22 38.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.319 1.047 . . . . 0.0 108.324 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.65 110.45 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.279 0.491 . . . . 0.0 111.284 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -79.94 140.02 36.83 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.654 -0.654 . . . . 0.0 110.713 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -152.81 178.58 9.49 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.311 2.645 . . . . 0.0 109.223 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.24 -173.56 4.28 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 119.608 -1.933 . . . . 0.0 110.322 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.03 -35.31 24.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.949 1.7 . . . . 0.0 111.578 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -138.27 160.44 39.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.678 2.391 . . . . 0.0 105.651 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 t 163.61 105.9 0.02 OUTLIER Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 127.733 2.413 . . . . 0.0 106.603 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.53 -40.38 30.91 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.846 2.364 . . . . 0.0 110.628 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -73.38 -26.83 61.16 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.99 -1.069 . . . . 0.0 110.306 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.2 m -64.87 -45.14 87.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.24 -0.913 . . . . 0.0 109.805 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -56.11 -47.62 77.72 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.827 -1.083 . . . . 0.0 110.124 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -54.24 -52.64 60.72 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.05 1.295 . . . . 0.0 111.199 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.38 -49.83 75.32 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.686 -0.634 . . . . 0.0 112.037 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -64.43 -32.63 74.33 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.035 0.834 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.52 -28.24 69.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.006 0.821 . . . . 0.0 110.951 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -60.3 2.65 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.02 -41.63 83.56 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.589 0.755 . . . . 0.0 111.356 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -67.77 -26.77 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.047 0.539 . . . . 0.0 110.702 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m -75.98 -29.29 58.18 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.551 -0.718 . . . . 0.0 111.183 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -77.42 -17.3 58.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.852 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.73 43.45 94.14 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.77 156.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.467 0.651 . . . . 0.0 111.575 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.06 117.63 22.98 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -134.13 163.66 29.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 168.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -103.62 144.05 31.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.33 146.86 42.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.88 134.48 26.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -95.38 162.83 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.559 2.172 . . . . 0.0 113.012 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.288 1.2 mt -132.19 37.93 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.623 1.969 . . . . 0.0 108.196 167.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.06 60.73 0.11 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.405 2.682 . . . . 0.0 110.71 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.68 52.87 5.69 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.078 1.323 . . . . 0.0 112.308 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -83.92 179.95 7.42 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.94 0.87 . . . . 0.0 111.627 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.93 -52.72 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.368 2.267 . . . . 0.0 106.797 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.12 -57.2 13.91 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 168.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -83.8 13.7 4.59 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 120.838 -1.163 . . . . 0.0 110.424 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -86.07 -60.82 1.9 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.76 -32.76 72.05 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 124.054 0.846 . . . . 0.0 111.339 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.01 -40.01 79.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.105 -0.372 . . . . 0.0 110.988 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -70.33 -17.88 63.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 121.136 -0.977 . . . . 0.0 112.597 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.32 -56.52 13.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 168.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.6 -25.52 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.615 0.766 . . . . 0.0 112.271 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -95.33 -33.62 12.47 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.625 -1.655 . . . . 0.0 113.107 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.5 p -124.07 -24.95 4.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.564 1.984 . . . . 0.0 114.876 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.73 -10.08 20.11 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.073 2.273 . . . . 0.0 114.486 -169.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -94.54 -63.94 1.13 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -168.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 86.71 0.42 0.56 Allowed 'General case' 0 CA--C 1.54 0.567 1 C-N-CA 131.844 4.058 . . . . 0.0 111.718 -168.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.4 p -111.4 161.52 16.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.465 1.506 . . . . 0.0 108.225 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.71 166.8 23.4 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 125.531 1.532 . . . . 0.0 113.833 -168.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.52 163.55 77.73 Favored 'Cis proline' 0 C--N 1.354 0.864 0 CA-C-N 120.847 1.338 . . . . 0.0 110.638 -2.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -146.03 84.48 1.65 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -168.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.61 142.1 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -137.1 85.16 2.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.021 2.128 . . . . 0.0 105.913 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.7 mt -92.93 132.41 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.42 24.61 2.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.408 1.083 . . . . 0.0 110.882 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.65 12.88 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.762 2.025 . . . . 0.0 115.562 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.49 128.0 33.08 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 168.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -69.48 114.05 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mm -76.13 -58.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.524 1.13 . . . . 0.0 110.461 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -157.72 27.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -169.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.34 -168.63 43.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.819 1.676 . . . . 0.0 110.96 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -62.63 -43.98 97.43 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.271 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.63 -34.48 77.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.598 1.09 . . . . 0.0 110.307 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -70.19 -46.32 64.85 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.115 0.966 . . . . 0.0 109.996 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.28 -50.13 74.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 127.543 2.337 . . . . 0.0 111.528 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -67.54 -29.27 68.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -40.3 71.82 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.54 169.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 tp -56.31 -41.43 75.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.956 1.253 . . . . 0.0 109.762 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.43 -32.39 73.99 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.69 -30.68 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.308 -0.87 . . . . 0.0 111.427 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -80.14 -5.15 55.5 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.821 0.737 . . . . 0.0 110.944 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.48 19.12 79.59 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.372 -0.682 . . . . 0.0 111.436 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.34 -3.5 65.0 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.306 1.053 . . . . 0.0 112.646 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.48 -50.92 7.31 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.637 1.219 . . . . 0.0 110.283 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -44.46 99.64 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.247 -176.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.14 7.43 3.31 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 123.311 2.218 . . . . 0.0 113.003 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.18 -2.13 13.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.535 1.534 . . . . 0.0 110.428 168.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.0 mt -125.99 8.01 7.36 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.185 1.794 . . . . 0.0 110.903 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.3 tttt . . . . . 0 C--O 1.256 1.396 0 C-N-CA 125.712 1.605 . . . . 0.0 108.042 -169.045 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.37 108.43 7.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.15 1.78 . . . . 0.0 107.848 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.18 89.72 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.55 135.18 37.24 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.875 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -136.64 113.14 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 124.462 1.105 . . . . 0.0 109.128 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.88 142.23 46.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.887 0.875 . . . . 0.0 108.779 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -150.01 166.1 30.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.056 1.342 . . . . 0.0 110.669 -169.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 176.55 12.54 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.891 -1.13 . . . . 0.0 108.715 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -56.37 -30.13 62.31 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.763 2.425 . . . . 0.0 113.853 -170.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 109.66 9.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -164.89 84.94 1.11 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -63.67 -26.1 68.89 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.836 1.691 . . . . 0.0 111.986 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -73.43 -30.48 63.24 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.074 -1.016 . . . . 0.0 109.419 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -66.33 -43.96 84.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 119.23 0.923 . . . . 0.0 108.968 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -53.25 -47.8 68.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.94 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -54.8 -59.3 4.91 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.598 1.545 . . . . 0.0 112.076 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.16 89.71 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.069 0.395 . . . . 0.0 110.27 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.771 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.26 99.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -59.66 -49.69 76.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.707 0.685 . . . . 0.0 110.229 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.99 -43.51 95.47 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.265 1.026 . . . . 0.0 111.048 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -59.03 -42.73 90.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.717 0.807 . . . . 0.0 109.167 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 t -69.69 -30.93 68.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.113 0.965 . . . . 0.0 110.416 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -78.18 -15.48 58.79 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.154 0.888 . . . . 0.0 111.453 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 47.95 23.58 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 124.991 1.282 . . . . 0.0 110.043 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 m -104.43 171.5 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.038 0.535 . . . . 0.0 112.271 -170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.4 p -94.35 126.99 39.95 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.32 170.4 16.38 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.433 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -128.92 124.43 35.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.617 1.567 . . . . 0.0 108.105 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -116.68 113.58 40.22 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.33 146.94 20.02 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.159 1.906 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mm -124.78 -5.64 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 125.495 1.518 . . . . 0.0 109.743 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 9' ' ' GLU . 5.9 p-10 -66.31 113.19 4.42 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.805 2.042 . . . . 0.0 107.441 168.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.3 -32.38 0.96 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.136 1.351 . . . . 0.0 113.173 -173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.515 HD22 ' CB ' ' A' ' 39' ' ' LYS . 9.1 t30 -83.51 73.29 10.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 123.233 1.492 . . . . 0.0 108.955 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.67 -19.05 65.68 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.831 168.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.73 -57.63 11.17 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 120.203 1.365 . . . . 0.0 109.725 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.515 ' CB ' HD22 ' A' ' 36' ' ' ASN . 9.4 ttmm -74.75 -15.83 60.75 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.998 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -56.99 -50.74 71.78 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.118 0.872 . . . . 0.0 109.191 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.54 -30.28 68.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.299 0.499 . . . . 0.0 110.888 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.79 -37.77 88.61 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.868 -0.52 . . . . 0.0 110.507 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.2 ttm -61.94 -18.95 62.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.681 1.592 . . . . 0.0 112.36 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.59 -57.94 9.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -59.17 -44.29 92.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.101 -0.374 . . . . 0.0 111.15 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.55 -34.39 72.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.828 -171.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -121.16 -21.68 6.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.8 1.182 . . . . 0.0 114.029 -171.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.52 8.79 57.0 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.703 -168.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -129.89 -52.4 1.14 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.255 1.528 . . . . 0.0 112.708 -170.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m 76.72 6.97 3.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.297 1.439 . . . . 0.0 111.492 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.6 p -86.13 173.2 10.0 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 110.076 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.1 154.01 64.21 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 122.793 0.437 . . . . 0.0 110.856 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.68 157.67 81.47 Favored 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 106.574 -2.125 . . . . 0.0 106.574 -11.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -136.3 118.64 15.67 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 169.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.42 145.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 O-C-N 125.118 1.511 . . . . 0.0 107.499 -174.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -137.1 111.59 8.62 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.396 2.678 . . . . 0.0 105.903 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -103.46 111.6 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.34 56.02 8.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.327 1.451 . . . . 0.0 107.809 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.27 -14.09 0.41 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.152 3.381 . . . . 0.0 114.24 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -77.83 112.58 14.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.693 0.797 . . . . 0.0 109.565 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.53 105.73 3.2 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.281 1.032 . . . . 0.0 110.394 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -74.42 -53.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.103 0.961 . . . . 0.0 108.659 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.54 -139.84 14.4 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -170.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.28 -173.29 47.31 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.011 1.767 . . . . 0.0 114.207 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -54.68 -50.89 67.16 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 122.225 -0.574 . . . . 0.0 110.238 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -73.77 -17.98 61.03 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.055 0.388 . . . . 0.0 110.717 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.39 -48.51 55.87 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 109.385 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -60.29 -49.77 76.29 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.814 1.646 . . . . 0.0 111.108 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.34 -37.68 81.4 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.606 1.562 . . . . 0.0 110.806 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.67 -44.22 78.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.678 0.791 . . . . 0.0 111.223 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.3 tp -56.58 -43.99 80.6 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 110.396 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.08 -35.58 81.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.021 0.528 . . . . 0.0 111.577 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.02 -26.47 66.79 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.905 0.482 . . . . 0.0 111.946 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -4.85 47.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.296 -0.877 . . . . 0.0 112.437 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.4 29.08 70.59 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.15 -28.3 13.76 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 118.339 1.07 . . . . 0.0 111.446 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -73.6 -52.5 13.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.045 0.923 . . . . 0.0 109.045 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.49 -55.92 22.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.23 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -9.27 25.4 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 122.135 1.798 . . . . 0.0 114.056 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 mt -83.41 -46.85 12.06 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 120.031 1.287 . . . . 0.0 108.813 169.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.8 mt -83.15 -0.28 48.53 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.462 1.105 . . . . 0.0 113.921 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 C-N-CA 125.089 1.356 . . . . 0.0 110.972 -171.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.0 125.58 28.59 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.178 -0.951 . . . . 0.0 110.383 -175.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.9 t -130.36 130.29 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -130.17 144.29 51.27 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.86 1.264 . . . . 0.0 108.67 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 tt -141.49 113.21 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.116 0.484 . . . . 0.0 110.058 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -73.8 129.28 37.59 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -141.18 174.52 10.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.41 1.484 . . . . 0.0 110.75 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 173.47 11.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.76 -20.72 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.672 0.789 . . . . 0.0 112.128 -174.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 t -133.49 77.85 1.74 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.815 1.646 . . . . 0.0 107.411 -168.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.6 87.34 4.83 Favored Pre-proline 0 N--CA 1.443 -0.78 0 C-N-CA 124.764 1.226 . . . . 0.0 108.289 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.17 -31.0 92.57 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.65 1.567 . . . . 0.0 111.362 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.46 -36.49 65.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.56 1.527 . . . . 0.0 110.806 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.7 m -58.0 -46.42 85.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -60.23 -43.8 95.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.09 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.85 -51.81 64.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.163 1.801 . . . . 0.0 110.89 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 -55.98 27.15 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.923 0.889 . . . . 0.0 110.129 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -63.29 -29.75 71.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.28 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.55 -46.08 87.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.345 0.975 . . . . 0.0 109.228 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.0 -40.57 95.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.058 0.845 . . . . 0.0 110.235 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.44 -40.43 97.13 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.374 -0.828 . . . . 0.0 111.07 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -67.74 -30.43 69.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 110.678 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -71.23 -34.41 70.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.962 0.905 . . . . 0.0 111.238 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -73.79 -17.93 61.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.516 0.598 . . . . 0.0 109.474 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.92 23.11 67.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.137 1.351 . . . . 0.0 111.751 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 m -89.92 157.13 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 118.068 0.934 . . . . 0.0 112.751 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -85.22 136.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 168.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.45 165.81 28.28 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.48 1.912 . . . . 0.0 106.012 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -107.02 140.18 40.23 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.7 145.22 30.39 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -128.3 118.49 20.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 151.93 54.2 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.451 1.434 . . . . 0.0 108.984 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.44 25.4 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.463 1.505 . . . . 0.0 110.034 170.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.61 64.0 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.845 2.058 . . . . 0.0 113.243 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.47 9.7 86.81 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.842 1.687 . . . . 0.0 113.699 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.52 103.76 13.12 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -168.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.48 -25.7 68.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.351 -0.843 . . . . 0.0 112.4 -172.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.16 -54.48 29.08 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.022 0.828 . . . . 0.0 109.872 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -71.53 -23.77 61.83 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 121.239 -0.913 . . . . 0.0 111.303 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -58.93 -53.23 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.793 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.03 -28.12 64.17 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.676 1.125 . . . . 0.0 112.424 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.6 -39.39 76.73 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.019 0.827 . . . . 0.0 108.94 169.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -65.32 -26.0 67.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.443 -0.785 . . . . 0.0 110.996 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.0 mt -74.27 -46.41 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.13 -63.79 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.332 0.969 . . . . 0.0 109.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -64.62 -42.56 95.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.704 2.402 . . . . 0.0 112.806 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -1.2 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -168.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.45 46.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.284 0.947 . . . . 0.0 113.251 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -136.72 -167.5 2.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.433 1.493 . . . . 0.0 109.6 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 p -155.9 3.46 0.17 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 129.565 3.146 . . . . 0.0 109.911 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.6 p -101.0 175.94 5.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.133 2.573 . . . . 0.0 110.343 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.93 158.21 62.59 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.6 163.09 82.3 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.776 -1.344 . . . . 0.0 108.639 -11.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.92 98.84 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 171.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.13 145.07 8.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -131.91 132.18 43.37 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 126.861 2.064 . . . . 0.0 106.04 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.54 122.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 169.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 41.66 47.22 3.37 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.554 1.542 . . . . 0.0 112.486 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.96 3.46 4.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.543 2.337 . . . . 0.0 114.539 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -75.88 105.78 7.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -62.41 122.79 16.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -92.24 -75.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.74 -138.78 5.77 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 -162.25 19.61 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 126.504 2.002 . . . . 0.0 111.027 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -61.34 -42.07 98.08 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.089 0.945 . . . . 0.0 110.666 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.16 -38.52 91.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.392 0.433 . . . . 0.0 110.341 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.07 -48.86 64.42 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.411 1.084 . . . . 0.0 109.968 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -54.29 -52.21 62.17 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 126.581 1.953 . . . . 0.0 110.571 172.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -68.75 -37.95 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.3 99.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.686 -0.673 . . . . 0.0 111.213 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.82 -42.43 79.59 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.057 1.298 . . . . 0.0 110.399 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.57 -37.51 87.81 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.274 1.03 . . . . 0.0 110.957 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.0 -21.82 65.03 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.425 -0.797 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -82.58 -7.23 59.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.876 1.271 . . . . 0.0 111.168 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.03 19.96 68.4 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.41 8.49 66.72 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.429 1.115 . . . . 0.0 112.014 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -110.3 -52.8 2.75 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.986 1.314 . . . . 0.0 109.192 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.33 -55.63 9.53 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.517 1.527 . . . . 0.0 113.782 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.53 -12.54 31.61 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.67 1.58 . . . . 0.0 113.216 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.98 -10.55 18.88 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.038 0.935 . . . . 0.0 111.34 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.5 mt -94.49 10.17 35.61 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.415 1.007 . . . . 0.0 112.319 174.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mttp . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.054 1.341 . . . . 0.0 108.281 174.912 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.31 126.46 30.17 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 165.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.9 t -123.88 128.96 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -122.87 121.91 37.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -168.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.25 18.6 tt -133.17 102.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 121.823 0.82 . . . . 0.0 110.935 -169.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.08 136.2 43.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -143.67 175.71 9.77 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.833 1.653 . . . . 0.0 110.793 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 173.52 11.52 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.872 1.669 . . . . 0.0 107.343 168.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -29.46 68.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.655 0.782 . . . . 0.0 111.915 -174.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -87.79 -129.08 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 168.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.9 t 74.73 88.05 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.563 2.345 . . . . 0.0 111.058 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.73 -36.74 83.27 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.198 1.932 . . . . 0.0 110.992 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -73.55 -27.08 61.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.482 -0.761 . . . . 0.0 111.151 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -63.13 -49.83 72.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -55.5 -46.87 76.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.313 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -54.84 -52.87 61.39 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 119.261 0.937 . . . . 0.0 111.374 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.56 -51.84 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.275 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -60.61 -34.96 75.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.714 1.143 . . . . 0.0 111.551 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.89 82.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.658 0.663 . . . . 0.0 110.068 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.38 -46.59 86.06 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.044 0.938 . . . . 0.0 110.077 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.26 -45.32 73.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.453 1.101 . . . . 0.0 111.329 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -69.5 -27.69 65.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.083 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -63.6 -41.95 98.29 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.049 0.84 . . . . 0.0 109.696 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -74.65 -6.63 49.77 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.627 0.649 . . . . 0.0 111.596 175.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.57 27.28 72.78 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.68 171.69 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 117.501 0.65 . . . . 0.0 110.476 -172.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 m -102.04 131.26 48.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -140.96 173.1 11.8 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.691 0.796 . . . . 0.0 108.883 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -125.24 126.65 45.49 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 128.101 2.56 . . . . 0.0 105.69 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.23 140.0 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -124.88 116.4 26.2 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.092 . . . . 0.0 110.799 -168.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -68.55 146.01 66.24 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.016 1.81 . . . . 0.0 109.115 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -125.15 -11.77 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 124.33 1.052 . . . . 0.0 110.864 169.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.05 129.49 39.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.89 -42.67 1.35 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.09 0.853 . . . . 0.0 112.842 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.419 HD22 ' HB2' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -83.1 91.03 7.13 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 125.197 1.399 . . . . 0.0 107.493 -171.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.84 -36.18 81.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.049 -1.032 . . . . 0.0 113.268 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.04 -55.4 23.99 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.982 0.913 . . . . 0.0 111.787 -168.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.419 ' HB2' HD22 ' A' ' 36' ' ' ASN . 20.7 mtpt -86.63 -10.79 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -74.03 -32.64 63.44 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.633 1.106 . . . . 0.0 110.47 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.17 -43.39 67.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.695 169.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -62.21 -31.51 72.05 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.696 -0.628 . . . . 0.0 110.435 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.2 -19.86 63.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.605 -1.31 . . . . 0.0 112.484 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -64.1 -58.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.33 -31.8 72.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.917 1.687 . . . . 0.0 111.016 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -95.33 -40.89 9.3 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.381 1.473 . . . . 0.0 112.83 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -103.34 -26.71 12.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.285 1.402 . . . . 0.0 112.526 -173.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.7 33.2 76.53 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.47 -1.183 . . . . 0.0 112.063 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -143.66 -52.6 0.35 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.23 1.515 . . . . 0.0 113.335 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.406 62.5 p 68.29 4.99 4.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.483 2.713 . . . . 0.0 115.51 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -81.44 176.08 10.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.97 160.72 54.53 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.328 168.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.1 160.35 86.18 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.65 0.911 . . . . 0.0 112.078 -0.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.75 99.64 5.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 168.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.59 141.5 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 171.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.69 136.31 49.55 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 129.228 3.011 . . . . 0.0 105.248 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.3 mt -128.89 110.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 46.0 48.8 12.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.866 0.866 . . . . 0.0 111.814 -169.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.71 -6.74 1.86 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 129.531 3.132 . . . . 0.0 114.8 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.06 105.65 5.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -70.14 105.71 3.02 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.85 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.67 -144.03 13.09 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 -169.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.04 -161.04 24.59 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.986 1.755 . . . . 0.0 111.177 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -61.52 -45.58 93.61 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 121.808 -0.819 . . . . 0.0 110.496 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.44 -27.19 65.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.842 0.746 . . . . 0.0 109.2 -169.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.99 -55.32 11.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.288 2.235 . . . . 0.0 110.229 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.08 -47.33 86.32 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.302 1.841 . . . . 0.0 111.061 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.76 -41.22 90.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.219 1.408 . . . . 0.0 108.831 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.79 -34.96 76.43 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.004 0.82 . . . . 0.0 112.494 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.68 -51.96 66.75 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.992 1.269 . . . . 0.0 110.662 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -66.15 -28.01 68.46 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.146 0.978 . . . . 0.0 111.267 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.17 -8.58 56.41 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.481 -1.387 . . . . 0.0 112.328 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.37 -3.53 28.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.715 170.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.07 18.71 79.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.143 0.883 . . . . 0.0 110.913 -171.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.38 -1.32 69.19 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.546 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.3 -46.07 7.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.035 1.417 . . . . 0.0 111.044 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER -47.64 -49.24 57.05 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 174.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.72 -5.62 14.78 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 CA-C-N 121.905 1.716 . . . . 0.0 113.234 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.77 -55.82 2.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.723 1.209 . . . . 0.0 109.519 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mt -89.98 19.69 4.73 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.82 1.648 . . . . 0.0 114.764 -169.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.4 tttm . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.297 1.039 . . . . 0.0 110.064 -176.549 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.475 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.256 0.074 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.32 104.31 7.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 128.111 2.565 . . . . 0.0 109.255 -177.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.68 160.95 5.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -154.42 112.91 3.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.81 110.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 118.512 0.596 . . . . 0.0 112.561 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -89.62 124.49 34.61 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -141.36 173.2 11.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.808 0.843 . . . . 0.0 111.336 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 -178.19 5.51 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.973 -1.079 . . . . 0.0 111.145 -172.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -31.55 68.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.958 1.303 . . . . 0.0 112.065 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -134.17 148.5 50.94 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t 163.8 89.87 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 129.288 3.035 . . . . 0.0 106.125 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.92 -30.7 90.49 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 111.533 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.32 -31.97 64.32 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.264 -0.897 . . . . 0.0 110.02 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -65.09 -46.72 79.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -51.85 -52.3 50.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.404 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -54.26 -50.33 67.48 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.194 1.361 . . . . 0.0 111.751 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.25 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.721 0.692 . . . . 0.0 111.472 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -62.46 -37.21 85.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.489 1.041 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.81 98.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.516 0.726 . . . . 0.0 109.604 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.5 -48.53 80.51 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.59 0.632 . . . . 0.0 109.529 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.63 -38.23 90.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.164 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.6 m -69.92 -30.64 68.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.5 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.6 m -66.22 -36.28 82.62 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 120.262 1.392 . . . . 0.0 110.202 172.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -77.15 -12.93 60.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.848 -0.533 . . . . 0.0 111.673 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.75 26.65 71.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.73 168.31 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.326 1.063 . . . . 0.0 109.779 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -91.62 124.13 35.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 170.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -150.13 168.46 23.89 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 122.638 0.375 . . . . 0.0 111.37 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -132.47 132.57 42.85 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.06 148.37 38.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.157 0.911 . . . . 0.0 109.646 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.27 92.65 31.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 125.272 1.429 . . . . 0.0 109.221 -168.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.11 129.38 21.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.181 2.588 . . . . 0.0 109.692 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.37 5.09 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.008 1.323 . . . . 0.0 109.474 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -76.03 135.71 39.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.477 1.111 . . . . 0.0 109.742 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.43 34.68 76.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.33 169.74 17.01 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.647 1.979 . . . . 0.0 109.477 -168.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.74 -33.0 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.581 1.152 . . . . 0.0 110.723 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.83 -55.62 25.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.262 1.392 . . . . 0.0 111.067 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.61 -10.0 59.26 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.507 -1.37 . . . . 0.0 111.927 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 ttt-85 -78.78 -50.42 11.36 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.8 -26.41 68.34 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.771 0.714 . . . . 0.0 110.897 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.17 -51.76 68.22 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.2 ttp -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -65.08 -51.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.643 -1.286 . . . . 0.0 108.908 169.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -57.57 -36.49 71.75 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.308 0.958 . . . . 0.0 112.282 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -92.32 -28.84 16.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.623 -169.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -124.17 -18.49 5.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.833 1.197 . . . . 0.0 112.855 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.98 -16.08 1.64 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.843 1.687 . . . . 0.0 112.734 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -91.57 -71.02 0.66 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 126.45 1.9 . . . . 0.0 112.453 -168.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.385 0.6 OUTLIER 71.72 1.73 4.0 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 129.984 3.314 . . . . 0.0 113.903 -168.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.4 p -74.28 176.32 6.78 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.607 1.563 . . . . 0.0 107.716 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.09 158.95 74.53 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.8 161.42 79.51 Favored 'Cis proline' 0 C--N 1.348 0.519 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 -11.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.14 97.37 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 170.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mp -89.94 146.42 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -131.56 148.55 52.63 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.284 3.034 . . . . 0.0 106.11 170.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.88 116.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 168.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 6.9 m-20 62.31 40.7 11.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 110.279 176.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 75.0 -8.64 1.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.666 3.187 . . . . 0.0 114.246 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -74.35 101.12 3.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.63 1.972 . . . . 0.0 105.872 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -60.98 106.34 0.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.3 mm -74.36 -56.61 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.263 1.025 . . . . 0.0 108.847 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.61 -141.9 12.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.14 -169.67 26.02 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.053 1.787 . . . . 0.0 111.334 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -57.17 -42.51 81.28 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.526 -0.985 . . . . 0.0 111.437 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.45 -37.85 88.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.248 0.476 . . . . 0.0 109.786 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.0 -47.35 74.79 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.652 1.181 . . . . 0.0 109.901 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -55.19 29.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.337 1.855 . . . . 0.0 110.31 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.75 -34.5 77.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.79 88.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.189 0.904 . . . . 0.0 111.912 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.84 -46.35 81.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.875 1.216 . . . . 0.0 110.28 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.67 -41.03 98.86 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.16 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.92 71.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.71 1.204 . . . . 0.0 110.94 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -17.1 61.1 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.119 0.968 . . . . 0.0 110.439 176.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 25.62 41.28 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -169.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.86 -7.19 48.09 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.62 -1.1 . . . . 0.0 113.322 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.19 -48.77 8.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.985 1.392 . . . . 0.0 108.442 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.48 96.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.204 1.402 . . . . 0.0 112.111 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 -12.06 34.45 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 123.266 2.202 . . . . 0.0 113.238 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.43 -48.82 4.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.814 0.846 . . . . 0.0 110.181 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -115.84 7.78 14.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.669 1.588 . . . . 0.0 114.58 -168.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 C--O 1.25 1.104 0 C-N-CA 126.948 2.099 . . . . 0.0 112.722 178.917 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.26 134.49 44.27 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 152.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.43 90.15 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -104.64 124.67 49.75 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.531 -1.668 . . . . 0.0 108.328 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -126.82 101.85 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 0.0 111.389 -171.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.467 ' HH ' ' NH1' ' A' ' 46' ' ' ARG . 62.5 m-85 -73.82 142.38 46.14 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.433 -0.792 . . . . 0.0 109.14 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.9 p -151.6 171.09 18.15 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.53 1.132 . . . . 0.0 111.199 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 174.04 11.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.499 1.52 . . . . 0.0 107.138 168.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -38.4 68.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.084 1.354 . . . . 0.0 113.057 -168.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.64 145.11 48.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t 172.69 103.45 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.561 2.344 . . . . 0.0 104.793 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -65.93 -30.11 48.88 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.148 1.899 . . . . 0.0 110.853 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -73.63 -37.23 65.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.021 0.929 . . . . 0.0 110.43 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -61.65 -47.36 85.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.855 0.752 . . . . 0.0 109.043 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -53.48 -53.42 51.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.02 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.48 -50.75 70.85 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.867 1.212 . . . . 0.0 112.068 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.02 -49.83 66.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.77 0.714 . . . . 0.0 110.9 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -61.71 -37.2 83.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.495 1.043 . . . . 0.0 110.787 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.68 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.043 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.81 -48.61 81.01 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.36 -42.15 79.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.438 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.5 m -70.91 -30.64 67.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.957 0.798 . . . . 0.0 111.056 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -70.31 -35.44 73.67 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.313 0.961 . . . . 0.0 110.824 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -75.08 -15.09 60.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.234 0.925 . . . . 0.0 110.704 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.38 24.43 75.16 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.334 1.445 . . . . 0.0 112.206 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.9 m -83.14 154.78 3.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.22 1.01 . . . . 0.0 110.35 -172.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 m -81.2 115.51 20.64 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.249 1.82 . . . . 0.0 107.931 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -137.49 175.91 9.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 109.157 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -124.85 144.51 50.27 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.019 2.527 . . . . 0.0 106.561 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -116.14 152.44 33.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.633 0.652 . . . . 0.0 110.363 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.32 81.28 61.2 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.29 1.036 . . . . 0.0 109.735 -172.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.14 148.26 84.94 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.362 2.041 . . . . 0.0 112.074 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 pt -124.98 15.75 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.412 1.885 . . . . 0.0 110.636 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.39 128.17 35.11 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 168.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.16 29.43 29.01 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.658 0.646 . . . . 0.0 114.027 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.455 HD22 ' HB3' ' A' ' 39' ' ' LYS . 4.5 t30 -146.97 80.87 1.54 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.545 1.172 . . . . 0.0 110.786 -168.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.85 -28.5 68.4 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 120.812 -1.18 . . . . 0.0 111.549 168.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.54 -55.32 35.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.379 0.672 . . . . 0.0 111.242 -169.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.455 ' HB3' HD22 ' A' ' 36' ' ' ASN 0.259 0.1 OUTLIER -86.44 -7.31 58.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.49 0.716 . . . . 0.0 111.62 176.364 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.48 -45.98 88.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.259 -1.526 . . . . 0.0 110.898 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -29.91 70.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.902 -177.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -55.76 -37.48 68.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.819 0.848 . . . . 0.0 110.465 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.1 ttm -61.89 -18.39 60.01 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.333 1.053 . . . . 0.0 112.782 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.49 -65.53 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -59.74 -28.16 67.12 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 121.476 1.944 . . . . 0.0 112.295 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' NH1' ' HH ' ' A' ' 6' ' ' TYR . 11.8 mmt85 -68.45 -45.08 73.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.604 176.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.3 p -121.72 -22.69 5.74 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.94 5.22 79.45 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.702 1.62 . . . . 0.0 112.376 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -124.85 -55.37 1.61 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.779 2.289 . . . . 0.0 114.951 -168.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.378 0.7 OUTLIER 69.15 13.67 8.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.676 2.79 . . . . 0.0 114.707 -173.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.9 p -75.99 175.59 8.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.113 1.765 . . . . 0.0 109.109 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.94 164.43 32.12 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.857 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.85 159.92 78.84 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.377 1.17 . . . . 0.0 109.639 -9.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -136.43 103.11 5.16 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 172.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 143.74 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 171.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -133.53 119.31 19.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.125 1.77 . . . . 0.0 106.369 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.16 97.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 49.44 65.71 1.32 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.193 0.997 . . . . 0.0 111.054 -168.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 73.23 -13.99 0.66 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 128.444 2.698 . . . . 0.0 114.488 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -74.81 96.8 3.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.736 2.414 . . . . 0.0 108.457 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -64.03 110.55 2.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.94 -64.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.31 -145.14 14.07 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.21 -163.96 38.85 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.232 1.396 . . . . 0.0 111.798 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -65.15 -41.5 94.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.095 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.27 -45.26 80.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.033 0.833 . . . . 0.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -63.93 -48.33 77.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.666 1.186 . . . . 0.0 110.097 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.51 -48.58 78.93 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.85 1.26 . . . . 0.0 111.893 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.24 -33.82 75.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 123.589 0.756 . . . . 0.0 109.313 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -43.18 83.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.931 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.5 -44.91 81.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.18 1.355 . . . . 0.0 110.543 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.7 -42.08 91.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.048 0.539 . . . . 0.0 111.22 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.14 70.52 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.769 -0.582 . . . . 0.0 110.373 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -73.85 -19.77 60.63 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.898 1.279 . . . . 0.0 109.291 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 23.7 68.81 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.7 -13.53 40.39 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.769 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.4 -49.2 12.72 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.665 1.233 . . . . 0.0 109.8 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.96 -54.34 20.9 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 112.502 -173.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.0 3.09 5.35 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.898 2.398 . . . . 0.0 113.275 -175.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.2 mt -110.67 -3.86 15.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.958 -1.089 . . . . 0.0 110.571 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.07 5.42 26.03 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.943 0.897 . . . . 0.0 112.391 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? . . . . . 0 C--O 1.245 0.836 0 C-N-CA 124.995 1.318 . . . . 0.0 108.441 -175.582 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.669 HG21 HD21 ' A' ' 81' ' ' LEU . 73.3 t -127.62 128.02 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 118.854 0.752 . . . . 0.0 109.79 -171.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.13 145.34 45.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 124.095 0.872 . . . . 0.0 109.599 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -139.47 115.59 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -75.4 144.68 42.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -147.23 172.14 14.29 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.279 1.032 . . . . 0.0 113.2 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -146.15 173.97 11.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.637 169.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -49.68 -39.54 36.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.125 2.57 . . . . 0.0 111.331 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.7 p -133.62 88.25 2.46 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -168.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.1 t -148.81 86.66 5.69 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.05 -37.16 78.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.291 1.994 . . . . 0.0 110.394 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -73.45 -24.78 60.27 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.143 -0.973 . . . . 0.0 111.549 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 75.1 m -63.14 -51.96 64.4 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 120.264 1.393 . . . . 0.0 108.968 169.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.75 -41.93 74.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.912 -1.042 . . . . 0.0 111.053 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -54.45 -56.04 22.82 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.345 1.429 . . . . 0.0 110.924 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.98 -49.34 76.49 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.393 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.786 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.16 90.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.003 0.82 . . . . 0.0 110.19 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 tt -64.99 -47.68 76.66 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.551 0.614 . . . . 0.0 109.468 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.9 -35.01 79.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.386 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 m -75.18 -28.94 60.25 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.65 0.78 . . . . 0.0 111.631 174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -40.15 92.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.359 0.982 . . . . 0.0 109.328 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -73.35 -25.57 60.66 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.766 -1.209 . . . . 0.0 108.921 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.5 32.32 59.84 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.889 1.709 . . . . 0.0 111.03 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.69 171.37 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.281 0.562 . . . . 0.0 110.117 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.08 121.64 42.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -141.73 165.02 28.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.578 1.151 . . . . 0.0 110.131 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.53 144.62 35.94 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.181 1.392 . . . . 0.0 108.385 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.57 143.72 44.92 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.444 1.498 . . . . 0.0 108.068 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.44 103.56 16.4 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.912 1.285 . . . . 0.0 110.0 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.92 144.35 27.25 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.854 1.703 . . . . 0.0 110.26 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 122.131 0.967 . . . . 0.0 109.994 172.883 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.341 0.115 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -67.64 -39.12 84.64 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.296 -1.502 . . . . 0.0 108.751 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -63.07 -40.78 98.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.506 0.723 . . . . 0.0 109.962 171.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -52.77 -45.7 67.24 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.425 0.557 . . . . 0.0 109.934 172.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.51 -24.96 66.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 113.366 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mt -65.0 -54.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.51 -36.98 85.57 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 119.605 -0.236 . . . . 0.0 110.843 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -75.66 -56.28 4.84 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.541 0.736 . . . . 0.0 111.282 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -91.09 -38.73 12.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.596 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.84 38.55 89.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -148.05 -58.09 0.24 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.359 1.464 . . . . 0.0 110.696 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.259 3.6 m 83.16 10.87 0.52 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.729 1.612 . . . . 0.0 111.909 171.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 81.1 p -109.35 171.89 7.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.454 2.702 . . . . 0.0 108.129 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.454 HG21 ' HG2' ' A' ' 8' ' ' LYS . 1.1 m -140.19 166.02 26.49 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.56 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.417 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 73.2 Cg_endo -63.28 148.7 64.84 Favored 'Cis proline' 0 CA--C 1.509 -0.738 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 -6.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -138.02 108.17 6.41 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.0 mp -94.28 145.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 125.271 1.607 . . . . 0.0 107.083 -176.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -128.36 124.15 35.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.806 2.842 . . . . 0.0 103.793 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 HG13 ' A' ' 3' ' ' VAL . 29.0 mm -120.96 117.99 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.255 0.6 OUTLIER 49.32 52.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.335 1.454 . . . . 0.0 110.659 -172.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.03 0.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.62 2.768 . . . . 0.0 114.329 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -86.59 108.17 18.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.253 1.421 . . . . 0.0 107.244 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -63.1 109.3 1.46 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.943 0.897 . . . . 0.0 109.071 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.38 -56.44 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.79 0.836 . . . . 0.0 109.292 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.1 -141.72 12.94 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.04 -165.8 30.16 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 118.885 1.343 . . . . 0.0 113.343 -168.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.0 -43.21 91.46 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.241 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.84 -35.84 82.41 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.733 0.697 . . . . 0.0 109.823 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -45.86 70.25 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.734 1.613 . . . . 0.0 111.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.45 -48.51 79.32 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 127.471 2.309 . . . . 0.0 111.363 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -69.51 -29.4 67.01 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -44.17 81.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.156 0.582 . . . . 0.0 110.941 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.77 -37.74 71.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.403 1.001 . . . . 0.0 110.801 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.38 -40.82 89.92 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.185 -0.947 . . . . 0.0 111.97 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.19 68.12 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.742 1.217 . . . . 0.0 112.171 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -89.22 3.84 50.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.814 1.246 . . . . 0.0 112.445 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 18.3 69.33 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.424 0.557 . . . . 0.0 112.154 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.86 -12.4 43.54 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.643 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.5 tp -73.65 -49.17 27.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.262 1.031 . . . . 0.0 109.511 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.87 -51.77 73.81 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.424 1.49 . . . . 0.0 112.33 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.36 -8.5 23.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.803 2.335 . . . . 0.0 114.707 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 mt -91.07 -49.52 6.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.669 HD21 HG21 ' A' ' 3' ' ' VAL . 4.9 mt . . . . . 0 N--CA 1.464 0.229 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.468 ' N ' HD21 ' A' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.608 HG21 HD21 ' A' ' 81' ' ' LEU . 93.8 t -126.84 132.88 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -136.59 127.37 27.32 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -168.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 tt -128.73 110.77 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.01 143.52 45.52 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -147.54 179.9 7.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.433 1.093 . . . . 0.0 111.725 -171.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.492 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -150.15 -172.56 4.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.245 -1.534 . . . . 0.0 107.929 168.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 10' ' ' THR . 1.1 pt-20 -35.76 -64.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.664 3.586 . . . . 0.0 111.259 170.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.438 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 14.7 t -134.13 124.21 25.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.0 t -169.6 101.11 0.47 Allowed Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.44 -35.73 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.971 1.781 . . . . 0.0 109.872 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -73.27 -32.8 64.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.778 -0.576 . . . . 0.0 109.811 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -61.59 -51.14 69.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.043 0.838 . . . . 0.0 109.15 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -54.54 -45.75 73.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.562 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -59.71 -49.77 76.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.525 1.511 . . . . 0.0 111.688 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.51 94.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.61 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -57.26 -51.52 69.03 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.495 1.043 . . . . 0.0 109.819 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.83 -22.58 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.655 0.782 . . . . 0.0 111.599 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -75.98 -50.61 14.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.101 1.36 . . . . 0.0 110.011 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.03 -42.52 98.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.25 1.02 . . . . 0.0 111.021 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.3 m -67.52 -28.14 67.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.809 1.644 . . . . 0.0 110.995 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -42.56 99.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HE3' ' OD1' ' A' ' 72' ' ' ASP . 66.2 mmtt -84.25 -6.55 59.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.004 0.82 . . . . 0.0 112.081 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.46 34.73 80.05 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 124.659 1.123 . . . . 0.0 111.901 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 81' ' ' LEU . 18.0 m -90.65 157.44 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 123.331 0.653 . . . . 0.0 110.912 -169.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -95.4 98.99 10.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' HD1' HG23 ' A' ' 26' ' ' VAL . 36.9 p90 -106.51 165.92 10.93 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.822 0.849 . . . . 0.0 108.781 169.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.22 144.19 31.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.178 1.791 . . . . 0.0 106.407 168.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.71 144.84 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mt -129.94 69.77 81.83 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.937 1.295 . . . . 0.0 108.495 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.58 140.3 47.03 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 N-CA-C 108.59 -1.35 . . . . 0.0 108.59 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 pt . . . . . 0 N--CA 1.468 0.45 0 C-N-CA 124.478 1.111 . . . . 0.0 111.324 170.867 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.225 -0.204 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -54.27 -44.59 72.0 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 168.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -73.01 -42.33 63.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.163 0.585 . . . . 0.0 109.965 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.67 -32.1 72.26 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.659 -0.65 . . . . 0.0 110.956 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.4 ttp -55.75 -16.01 3.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.873 1.269 . . . . 0.0 113.235 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.73 -70.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 170.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -66.91 -27.6 67.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 120.194 1.361 . . . . 0.0 112.314 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HD2' ' CE2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -66.2 -50.87 62.37 Favored 'General case' 0 CA--C 1.524 -0.047 0 CA-C-N 119.17 0.895 . . . . 0.0 109.735 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 p -105.31 -31.89 8.86 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.671 1.123 . . . . 0.0 112.875 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.93 24.29 75.77 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 121.452 -0.78 . . . . 0.0 112.196 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -136.36 -53.13 0.73 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.99 1.316 . . . . 0.0 110.573 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m 75.72 2.66 3.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.448 1.099 . . . . 0.0 110.927 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 p -84.22 177.15 8.31 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.99 3.316 . . . . 0.0 107.873 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.1 m -129.5 161.12 60.84 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.129 169.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.26 166.51 79.75 Favored 'Cis proline' 0 N--CA 1.456 -0.698 0 CA-C-N 119.396 0.82 . . . . 0.0 110.675 -10.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -132.94 104.29 6.49 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 168.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.22 142.78 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CE2' ' HD2' ' A' ' 46' ' ' ARG . 96.7 m-85 -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.338 2.255 . . . . 0.0 106.871 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 3' ' ' VAL . 68.1 mt -132.83 119.66 38.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.281 14.8 m-20 45.6 45.51 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.805 0.812 . . . . 0.0 112.566 -169.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.37 -0.16 2.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.557 2.743 . . . . 0.0 114.249 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.24 109.58 7.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.9 113.48 3.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.9 mm -77.38 -55.02 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 108.872 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.68 -144.91 13.02 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.28 -163.67 26.5 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.421 2.438 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -57.17 -47.62 80.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.107 0.953 . . . . 0.0 112.022 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -64.77 -33.46 76.03 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.181 0.446 . . . . 0.0 109.939 -170.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.0 -44.57 72.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.924 1.69 . . . . 0.0 110.914 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.72 -51.13 70.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.889 1.276 . . . . 0.0 109.806 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.41 -30.33 70.06 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -40.97 85.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.138 1.375 . . . . 0.0 112.327 169.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.0 tp -56.25 -45.71 79.91 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.8 1.637 . . . . 0.0 110.322 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.411 ' OD1' ' HE3' ' A' ' 24' ' ' LYS . 27.5 t70 -62.83 -34.68 77.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.965 0.506 . . . . 0.0 112.106 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.15 -15.58 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.772 1.229 . . . . 0.0 112.135 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -5.25 59.23 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.368 1.067 . . . . 0.0 111.224 168.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.07 15.83 70.05 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -168.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.57 -9.34 55.07 Favored Glycine 0 C--N 1.341 0.843 0 C-N-CA 124.697 1.142 . . . . 0.0 112.868 -170.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.431 HD11 HD12 ' A' ' 81' ' ' LEU . 57.4 tp -73.94 -47.93 34.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.329 1.065 . . . . 0.0 109.844 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -54.78 35.84 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.892 1.277 . . . . 0.0 112.156 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.21 -1.91 8.86 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.396 2.064 . . . . 0.0 113.889 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.38 -3.13 19.9 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.806 1.243 . . . . 0.0 111.428 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.608 HD21 HG21 ' A' ' 3' ' ' VAL . 26.6 mt . . . . . 0 C--O 1.237 0.421 0 C-N-CA 124.971 1.308 . . . . 0.0 111.303 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.639 HG21 HD21 ' A' ' 81' ' ' LEU . 70.1 t -133.72 120.07 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 119.355 0.98 . . . . 0.0 108.844 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -129.52 146.97 51.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.14 0.976 . . . . 0.0 109.462 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 tt -140.72 118.37 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 124.509 1.124 . . . . 0.0 108.226 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.782 ' HB3' HD11 ' A' ' 33' ' ' ILE . 34.6 m-85 -78.94 135.58 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.25 1.02 . . . . 0.0 108.812 171.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -144.11 -177.18 5.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.456 1.502 . . . . 0.0 111.501 -168.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -157.5 177.67 11.16 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 119.661 -1.899 . . . . 0.0 107.889 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.66 -25.23 38.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.836 1.654 . . . . 0.0 112.325 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.89 120.6 20.6 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 172.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.0 t -167.77 93.68 0.65 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.022 0.929 . . . . 0.0 111.342 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.11 -39.63 30.45 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.509 2.14 . . . . 0.0 112.033 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -73.58 -29.21 62.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.316 1.871 . . . . 0.0 110.084 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -59.3 -52.71 64.47 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 119.924 1.238 . . . . 0.0 108.239 169.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -54.56 -40.14 68.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.254 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -59.84 -54.01 51.21 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.004 1.274 . . . . 0.0 111.777 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.19 93.12 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.862 -0.523 . . . . 0.0 110.233 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -63.48 -36.51 84.0 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.202 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -26.77 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 120.268 1.394 . . . . 0.0 110.906 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.05 -55.14 11.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 26' ' ' VAL . 90.9 mt -64.87 -43.27 93.49 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.001 1.32 . . . . 0.0 112.081 -173.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -69.94 -30.81 68.29 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.496 1.118 . . . . 0.0 109.674 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -66.05 -39.87 90.47 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.474 1.033 . . . . 0.0 109.593 169.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -73.72 -9.35 58.57 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.222 0.919 . . . . 0.0 110.763 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.0 81.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 125.603 1.573 . . . . 0.0 110.446 172.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 81' ' ' LEU . 20.0 m -90.55 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.596 0.713 . . . . 0.0 112.838 -168.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.3 p -105.75 116.92 32.75 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.69 1.996 . . . . 0.0 105.792 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.467 ' HD2' HG23 ' A' ' 26' ' ' VAL . 50.8 p90 -134.78 167.75 20.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -112.73 133.36 54.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.24 111.53 20.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.438 1.895 . . . . 0.0 107.424 -168.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.85 102.37 50.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.328 1.451 . . . . 0.0 111.381 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.85 137.0 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.01 2.474 . . . . 0.0 113.892 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 6' ' ' TYR . 15.5 mt . . . . . 0 N--CA 1.452 -0.356 0 C-N-CA 127.322 2.249 . . . . 0.0 107.365 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.224 -0.28 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.996 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -60.63 -59.34 5.55 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.54 1.064 . . . . 0.0 108.581 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.07 -41.88 89.05 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.393 0.433 . . . . 0.0 110.908 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.61 -56.19 15.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.386 1.474 . . . . 0.0 109.558 173.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.719 ' CE ' HD13 ' A' ' 33' ' ' ILE . 1.3 ttm -67.12 -26.35 66.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.837 -0.54 . . . . 0.0 112.184 -174.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.38 -54.28 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -60.83 -46.46 90.47 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.93 1.241 . . . . 0.0 112.245 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -79.88 -30.75 40.24 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 117.431 -1.271 . . . . 0.0 112.508 -169.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.2 p -116.15 -27.79 6.78 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.078 1.308 . . . . 0.0 113.458 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.03 23.88 53.04 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.482 1.037 . . . . 0.0 113.497 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -130.52 -57.9 1.05 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.271 1.035 . . . . 0.0 110.186 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.263 3.4 m 74.23 37.78 0.58 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 123.237 1.494 . . . . 0.0 110.989 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.1 p -142.09 176.91 8.59 Favored 'General case' 0 C--N 1.329 -0.325 1 C-N-CA 132.27 4.228 . . . . 0.0 105.902 -176.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.527 ' CG1' HD12 ' A' ' 33' ' ' ILE . 1.1 m -132.71 160.17 69.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.35 167.87 78.59 Favored 'Cis proline' 0 CA--C 1.534 0.514 0 N-CA-C 110.233 -0.718 . . . . 0.0 110.233 -10.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -130.47 96.21 4.07 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 168.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.555 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -81.15 144.26 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -133.04 125.1 28.92 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.561 2.744 . . . . 0.0 104.964 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.7 mm -125.28 120.99 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.92 40.89 26.17 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.722 1.249 . . . . 0.0 111.789 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.31 0.28 0.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.874 2.87 . . . . 0.0 114.45 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.7 121.07 20.18 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -75.01 98.86 3.71 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.41 -49.21 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 -132.19 6.8 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.51 -178.16 45.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.474 1.035 . . . . 0.0 111.264 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -54.23 -42.95 70.43 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.437 -1.037 . . . . 0.0 110.721 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -34.77 71.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.856 0.862 . . . . 0.0 111.87 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -71.69 -44.22 64.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.194 0.598 . . . . 0.0 110.993 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -62.13 -48.6 79.42 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.309 1.044 . . . . 0.0 110.619 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -59.77 -39.26 84.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.125 1.77 . . . . 0.0 109.197 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.1 81.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.189 0.596 . . . . 0.0 110.976 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 tp -56.66 -45.32 81.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.969 0.804 . . . . 0.0 110.121 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.58 -38.78 91.45 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.984 0.914 . . . . 0.0 112.181 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.32 69.77 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.429 0.559 . . . . 0.0 110.716 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -5.44 56.47 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.083 -1.011 . . . . 0.0 110.58 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.94 21.28 79.09 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.275 -0.89 . . . . 0.0 111.081 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.24 -28.19 28.59 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.12 0.96 . . . . 0.0 111.662 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.4 tp -74.21 -50.87 17.29 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.324 1.062 . . . . 0.0 110.81 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.46 -55.77 20.36 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.791 0.836 . . . . 0.0 113.133 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.7 11.86 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.825 2.35 . . . . 0.0 113.427 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.7 mt -112.35 -2.87 14.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.15 1.38 . . . . 0.0 110.396 168.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.639 HD21 HG21 ' A' ' 3' ' ' VAL . 54.5 mt . . . . . 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 110.088 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 81' ' ' LEU . 92.5 t -106.02 133.92 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.71 144.27 33.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 123.854 0.721 . . . . 0.0 109.56 -169.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.73 117.44 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.468 0.707 . . . . 0.0 110.142 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -78.04 140.3 39.13 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -146.99 177.46 9.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.045 0.938 . . . . 0.0 112.487 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.411 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -157.73 -177.06 6.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.942 1.297 . . . . 0.0 110.899 169.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.57 -24.27 3.12 Favored 'General case' 0 CA--C 1.52 -0.187 1 C-N-CA 132.555 4.342 . . . . 0.0 114.538 -168.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -133.32 -83.47 0.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.9 t 33.99 75.99 0.43 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.752 2.021 . . . . 0.0 112.173 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.66 -24.28 74.83 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.362 2.041 . . . . 0.0 111.34 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -73.1 -37.46 66.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.957 1.253 . . . . 0.0 109.71 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -60.7 -46.86 88.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -54.39 -50.6 67.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.173 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 49.9 mtp180 -54.47 -49.73 69.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.14 1.336 . . . . 0.0 110.919 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.07 39.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.173 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -60.09 -32.05 70.6 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.617 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.91 75.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.736 1.153 . . . . 0.0 109.271 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.75 -44.66 93.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 26' ' ' VAL . 95.6 mt -69.4 -40.77 77.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.633 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -71.57 -31.93 67.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.966 0.803 . . . . 0.0 110.745 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -62.64 -44.92 95.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 3.8 mmpt? -73.7 -15.71 61.22 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.52 0.6 . . . . 0.0 110.416 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.34 18.85 78.92 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.768 1.652 . . . . 0.0 112.546 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 21' ' ' LEU . 3.2 m -73.59 160.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 118.278 1.039 . . . . 0.0 111.746 -168.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.7 m -94.56 120.98 35.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -134.16 -172.66 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.531 1.933 . . . . 0.0 107.693 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.45 137.0 48.42 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -109.62 135.57 50.37 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.498 0.719 . . . . 0.0 109.092 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.11 77.27 75.56 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.632 1.173 . . . . 0.0 108.962 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.53 152.4 80.39 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.794 2.33 . . . . 0.0 110.868 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 CA--C 1.541 0.63 0 C-N-CA 124.794 1.238 . . . . 0.0 112.507 177.582 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -82.85 -43.31 16.76 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -60.61 -33.48 72.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.07 -38.1 72.79 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.493 -0.755 . . . . 0.0 110.296 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -20.61 62.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.942 0.897 . . . . 0.0 111.643 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.1 mt -73.58 -42.65 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.26 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -30.74 37.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.982 1.719 . . . . 0.0 112.258 173.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -70.62 -44.97 66.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.387 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.51 -11.77 3.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -168.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.01 -20.22 47.21 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.613 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -138.56 148.03 43.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.29 1.545 . . . . 0.0 111.811 -169.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -88.17 -5.9 58.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 131.37 3.868 . . . . 0.0 113.189 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -76.56 168.52 19.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.22 1.408 . . . . 0.0 111.35 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.411 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -143.62 166.17 21.08 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.615 0.766 . . . . 0.0 110.15 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.14 155.42 73.42 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.224 1.116 . . . . 0.0 109.589 -8.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -134.1 91.92 2.88 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -86.17 150.49 3.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 46' ' ' ARG . 58.9 m-85 -141.75 145.51 34.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.369 2.668 . . . . 0.0 108.523 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.71 116.49 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 43.55 51.64 6.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.741 1.616 . . . . 0.0 112.133 -172.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.3 -0.07 2.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.87 2.468 . . . . 0.0 114.234 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -75.5 108.86 8.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -65.82 110.19 2.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.79 -58.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.33 -143.69 11.6 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -173.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.62 -172.49 41.14 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.635 2.064 . . . . 0.0 111.327 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 17.9 t80 -56.38 -46.2 80.21 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.93 -0.747 . . . . 0.0 111.154 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.74 -32.0 73.36 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.959 0.345 . . . . 0.0 110.436 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.56 -46.0 64.35 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.692 0.758 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.2 -50.21 74.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.852 1.261 . . . . 0.0 111.004 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -68.31 -28.65 67.36 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.61 82.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 110.447 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.7 tp -56.7 -46.05 81.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.735 1.152 . . . . 0.0 109.926 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.51 -43.29 89.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.635 0.774 . . . . 0.0 111.259 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.15 63.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.943 0.897 . . . . 0.0 112.123 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.87 6.84 26.5 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.232 1.413 . . . . 0.0 111.713 169.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.93 17.92 68.1 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.043 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.08 -8.53 41.53 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.862 1.331 . . . . 0.0 113.008 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -75.24 -55.48 5.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.877 1.338 . . . . 0.0 109.5 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -50.99 74.53 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.68 -17.69 30.01 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.928 2.419 . . . . 0.0 114.806 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -104.8 -1.52 25.99 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.996 1.318 . . . . 0.0 111.115 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.405 HD21 HG21 ' A' ' 3' ' ' VAL . 11.7 mt . . . . . 0 N--CA 1.465 0.278 0 O-C-N 120.322 -1.486 . . . . 0.0 112.005 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 81' ' ' LEU . 58.7 t -101.03 99.41 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.45 148.06 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.583 0.552 . . . . 0.0 111.58 -168.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.97 114.94 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -74.31 140.37 44.84 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -150.82 172.65 15.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.905 1.682 . . . . 0.0 110.832 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.488 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -149.41 174.81 12.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.782 1.233 . . . . 0.0 107.862 168.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -18.87 61.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.1 1.36 . . . . 0.0 113.842 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 106.75 7.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -167.0 85.63 0.83 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.664 0.786 . . . . 0.0 108.932 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.78 -33.91 96.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.633 1.555 . . . . 0.0 111.424 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -73.46 -27.57 61.48 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.769 -1.207 . . . . 0.0 109.832 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.47 -49.32 74.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.023 -1.048 . . . . 0.0 108.93 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.75 -46.55 74.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.946 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -54.56 -52.77 61.05 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 120.225 1.375 . . . . 0.0 111.335 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.23 71.35 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.527 0.603 . . . . 0.0 110.39 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -58.54 -38.1 77.08 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.39 0.996 . . . . 0.0 111.474 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.98 95.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.112 0.565 . . . . 0.0 109.706 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 tp -62.55 -48.28 80.18 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.139 0.576 . . . . 0.0 109.875 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.1 mt -65.09 -42.14 94.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 110.734 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 t -65.12 -36.34 83.95 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.512 1.125 . . . . 0.0 110.226 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.3 t -70.22 -34.4 72.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.219 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -80.92 -5.29 57.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.462 1.028 . . . . 0.0 111.424 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 23.32 77.11 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 124.609 1.1 . . . . 0.0 111.686 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.86 162.93 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 118.181 0.991 . . . . 0.0 110.283 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -100.53 113.54 26.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 172.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.76 170.18 16.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.124 1.77 . . . . 0.0 109.207 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -123.44 140.81 52.63 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.61 143.0 39.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.18 113.83 23.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.09 158.76 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.927 2.418 . . . . 0.0 110.393 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mm . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.849 1.26 . . . . 0.0 110.778 170.472 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.3 -45.21 94.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.959 1.254 . . . . 0.0 110.339 168.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.7 -39.55 93.84 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.779 0.718 . . . . 0.0 110.098 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -58.01 -36.96 73.43 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.605 -0.684 . . . . 0.0 110.377 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.8 ttm -64.4 -16.05 61.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.922 1.689 . . . . 0.0 112.513 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.28 -58.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -55.08 -50.13 69.93 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.403 0.62 . . . . 0.0 110.567 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.74 -39.99 73.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.426 -168.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.8 p -112.03 -25.37 9.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 112.865 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.0 21.73 63.97 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.353 -168.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -136.54 -57.03 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.307 1.554 . . . . 0.0 113.011 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 79.3 -6.34 1.86 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 129.755 3.222 . . . . 0.0 113.612 -172.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.4 p -73.79 176.4 6.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.772 2.029 . . . . 0.0 107.92 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.488 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -140.3 159.42 63.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 O-C-N 121.849 -0.532 . . . . 0.0 110.033 176.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.36 165.79 81.94 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 125.591 -0.587 . . . . 0.0 111.395 -5.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -132.89 104.44 6.58 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 168.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.487 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.8 mp -81.12 141.79 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 171.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -127.69 128.76 45.98 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 128.332 2.653 . . . . 0.0 104.953 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.527 HG21 ' HB3' ' A' ' 80' ' ' LEU . 68.3 mt -119.44 104.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 52.22 52.14 14.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.295 1.038 . . . . 0.0 109.175 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.19 -13.49 0.9 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 130.565 3.546 . . . . 0.0 114.428 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -74.7 108.75 7.65 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -67.55 110.24 3.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -74.25 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.14 -145.9 13.82 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -168.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.78 -168.74 36.67 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.169 1.366 . . . . 0.0 112.016 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -61.51 -39.98 92.96 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.682 -0.893 . . . . 0.0 110.214 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.54 -35.92 82.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -65.7 -45.78 81.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.941 1.296 . . . . 0.0 110.701 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.26 -48.32 70.85 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 126.188 1.795 . . . . 0.0 111.087 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -64.96 -34.68 79.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.705 1.202 . . . . 0.0 109.541 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.17 77.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.233 0.613 . . . . 0.0 110.824 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.62 -39.33 73.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.858 0.863 . . . . 0.0 109.839 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.24 -34.18 70.54 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.527 -0.733 . . . . 0.0 112.722 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.28 -34.05 75.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.224 1.009 . . . . 0.0 110.781 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -90.53 6.77 42.18 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 124.799 1.24 . . . . 0.0 112.888 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.95 3.86 52.95 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.273 0.939 . . . . 0.0 112.463 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.12 -17.62 80.22 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.376 0.988 . . . . 0.0 112.047 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.54 -40.39 61.75 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.242 1.017 . . . . 0.0 111.61 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -56.21 24.83 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.154 0.982 . . . . 0.0 112.398 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.49 16.32 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.197 3.264 . . . . 0.0 112.227 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB3' HG21 ' A' ' 57' ' ' ILE . 67.3 mt -115.96 -17.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.038 -1.039 . . . . 0.0 111.967 171.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 3' ' ' VAL . 6.5 mt . . . . . 0 N--CA 1.468 0.427 0 CA-C-N 119.534 1.061 . . . . 0.0 112.527 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -133.48 142.96 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 119.866 1.212 . . . . 0.0 108.159 170.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -140.87 120.57 13.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.27 14.2 tt -134.72 101.75 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.609 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -77.58 141.97 39.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.984 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 14' ' ' CYS . 41.7 p -147.5 -176.97 5.45 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.261 1.425 . . . . 0.0 112.442 -169.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.19 -170.01 2.62 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.393 -1.442 . . . . 0.0 108.241 169.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.32 -5.98 12.49 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -140.9 -119.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.423 1.489 . . . . 0.0 107.911 -168.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t 58.52 85.68 0.18 Allowed Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 127.451 2.3 . . . . 0.0 111.284 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.94 -38.88 86.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.174 2.583 . . . . 0.0 112.941 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -74.22 -34.19 63.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.205 1.366 . . . . 0.0 110.925 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.473 ' HB3' HG22 ' A' ' 7' ' ' THR . 68.7 m -58.57 -48.14 81.92 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.61 1.095 . . . . 0.0 109.108 169.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -60.79 -39.65 89.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.073 -1.442 . . . . 0.0 110.97 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 23.9 mmt85 -54.3 -53.0 59.71 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.831 1.65 . . . . 0.0 109.699 173.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.95 79.57 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.354 0.525 . . . . 0.0 110.968 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -62.51 -40.2 95.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.248 0.931 . . . . 0.0 111.051 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.06 99.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.826 0.851 . . . . 0.0 109.75 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.54 -52.43 65.42 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.97 -36.5 83.5 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.373 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 m -69.46 -34.6 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.211 0.605 . . . . 0.0 110.773 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -64.7 -38.08 89.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.428 0.691 . . . . 0.0 109.337 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -86.06 0.14 54.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.932 -0.48 . . . . 0.0 111.453 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.02 21.4 69.72 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.721 2.105 . . . . 0.0 111.416 169.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -74.5 163.2 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -169.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -99.07 118.1 35.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -143.73 166.68 24.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.471 1.908 . . . . 0.0 109.512 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -113.57 140.15 48.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -109.08 145.23 36.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.451 1.9 . . . . 0.0 106.674 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.415 ' CD2' ' HE2' ' A' ' 39' ' ' LYS . 1.8 mp -128.19 83.26 66.63 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 108.669 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.52 142.03 98.27 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.321 2.014 . . . . 0.0 109.193 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.466 0.37 0 CA-C-N 120.222 1.374 . . . . 0.0 107.855 168.372 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HE2' ' CD2' ' A' ' 31' ' ' LEU . 25.5 mtpp . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -59.45 -48.93 79.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -56.67 -46.76 80.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.352 1.061 . . . . 0.0 110.258 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -55.98 -33.03 64.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.112 0.565 . . . . 0.0 110.926 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ttp -62.79 -12.92 27.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.848 1.259 . . . . 0.0 113.967 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mt -63.91 -55.21 23.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -71.97 -36.24 69.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.2 -0.937 . . . . 0.0 111.776 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -35.16 80.17 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.259 -1.353 . . . . 0.0 112.289 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -129.04 -16.14 4.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.086 1.312 . . . . 0.0 114.355 -170.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.7 -5.65 11.09 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.044 -1.42 . . . . 0.0 113.458 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.68 -54.59 2.5 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.89 1.845 . . . . 0.0 111.69 -169.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m 86.1 -9.91 0.71 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.867 3.267 . . . . 0.0 111.823 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.9 p -74.06 176.66 6.31 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 130.486 3.515 . . . . 0.0 109.441 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.02 158.84 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.642 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.73 156.95 98.91 Favored 'Cis proline' 0 C--N 1.349 0.559 0 CA-C-N 120.248 1.124 . . . . 0.0 111.482 0.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -130.0 99.42 5.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.462 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.1 mp -87.84 142.15 13.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -129.3 141.66 51.04 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 128.339 2.655 . . . . 0.0 105.575 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.86 136.49 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.09 35.97 26.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.028 0.931 . . . . 0.0 111.052 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.78 -0.21 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.659 2.384 . . . . 0.0 114.476 -173.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -80.83 121.33 25.82 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -63.76 119.38 9.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 mm -82.77 -66.73 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.7 -125.2 1.87 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.24 -172.18 14.06 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.858 2.171 . . . . 0.0 110.771 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 36.4 t80 -56.02 -46.0 78.93 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.081 -173.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.48 -36.9 81.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.847 1.203 . . . . 0.0 110.447 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.8 -51.08 64.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.185 0.994 . . . . 0.0 109.727 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.73 -48.86 75.35 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.401 2.281 . . . . 0.0 111.393 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -61.29 -42.09 98.06 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.12 0.968 . . . . 0.0 109.018 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.27 96.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.955 0.798 . . . . 0.0 110.884 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.7 tp -56.68 -41.21 76.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.232 0.924 . . . . 0.0 110.58 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.69 -37.93 79.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.687 -0.633 . . . . 0.0 112.282 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.49 -25.23 66.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.605 1.162 . . . . 0.0 111.363 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -73.8 -20.72 60.38 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.377 1.071 . . . . 0.0 110.148 172.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.77 27.01 59.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -168.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.86 -9.11 23.28 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.192 1.377 . . . . 0.0 112.753 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -74.77 -42.59 57.88 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.854 1.327 . . . . 0.0 109.4 170.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -56.35 29.59 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.632 1.573 . . . . 0.0 109.543 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.64 -8.24 23.15 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.525 2.15 . . . . 0.0 113.957 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.5 -58.48 2.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.235 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 111.737 -172.767 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.234 0.284 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.513 HG21 HD21 ' A' ' 81' ' ' LEU . 59.9 t -96.41 97.52 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -102.62 122.11 43.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.259 19.7 tt -129.75 107.96 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.527 0.679 . . . . 0.0 112.208 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -74.04 149.74 41.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.664 1.186 . . . . 0.0 110.926 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -155.42 -177.66 6.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.036 1.335 . . . . 0.0 113.3 -169.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -173.77 4.55 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 168.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.26 -25.9 25.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.43 2.692 . . . . 0.0 114.711 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -138.82 -82.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.4 t 45.43 88.35 0.1 Allowed Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.349 1.86 . . . . 0.0 110.841 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 43.67 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 125.062 3.841 . . . . 0.0 113.415 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.21 -50.23 0.38 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 131.164 3.786 . . . . 0.0 105.243 171.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.08 -50.54 66.56 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.657 1.183 . . . . 0.0 110.69 170.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -51.49 -55.24 19.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.342 1.027 . . . . 0.0 109.801 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -54.04 -47.24 71.79 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.858 0.863 . . . . 0.0 111.456 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.2 66.44 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.553 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -30.8 70.58 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.534 1.516 . . . . 0.0 115.058 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.35 93.27 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 119.911 1.232 . . . . 0.0 108.867 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.38 -53.83 52.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.764 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.2 -37.65 87.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.398 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -73.73 -28.45 61.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.615 0.643 . . . . 0.0 110.193 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -68.61 -28.84 67.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.197 0.908 . . . . 0.0 110.501 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -89.97 -8.32 51.97 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.853 1.206 . . . . 0.0 111.567 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.36 25.59 72.53 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.804 1.669 . . . . 0.0 111.963 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.451 HG21 HD13 ' A' ' 81' ' ' LEU . 13.2 m -73.94 158.63 5.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 121.876 -0.779 . . . . 0.0 112.963 -168.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 107.63 8.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.161 1.784 . . . . 0.0 108.824 168.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -135.07 170.25 16.19 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.428 1.091 . . . . 0.0 108.147 172.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -118.32 135.57 54.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.02 135.98 41.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.67 117.84 33.87 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -84.17 155.06 12.78 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.392 2.062 . . . . 0.0 111.184 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt . . . . . 0 CA--C 1.54 0.585 0 C-N-CA 125.297 1.439 . . . . 0.0 108.832 168.19 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.09 -45.42 67.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.209 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.66 -28.87 67.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.465 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.89 -41.56 87.47 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.783 0.72 . . . . 0.0 109.248 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -60.76 -22.33 63.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.127 -0.983 . . . . 0.0 113.414 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.48 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -68.82 -27.09 65.54 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.366 0.984 . . . . 0.0 112.588 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -74.21 -40.18 62.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.326 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.3 p -124.32 -21.52 4.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -3.54 10.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.156 1.836 . . . . 0.0 113.791 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -90.92 -70.64 0.67 Allowed 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 119.413 1.607 . . . . 0.0 114.004 -168.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 p 83.0 -8.55 1.14 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.877 3.271 . . . . 0.0 110.719 -168.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 p -74.13 171.02 14.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.873 1.269 . . . . 0.0 107.9 169.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 161.19 40.97 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.165 0.986 . . . . 0.0 110.072 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 159.2 88.82 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.687 0.567 . . . . 0.0 110.937 -4.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.42 99.99 5.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 174.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -84.1 142.5 13.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -128.38 135.73 49.95 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.996 2.518 . . . . 0.0 104.577 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -130.67 110.24 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 14.0 m-20 43.04 63.74 1.41 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.803 1.241 . . . . 0.0 111.981 -168.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.78 -10.54 0.48 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.605 2.762 . . . . 0.0 113.636 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -84.94 108.18 17.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -62.78 114.53 3.67 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.947 0.899 . . . . 0.0 109.059 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.0 -65.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.396 1.078 . . . . 0.0 110.267 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' HD12 ' A' ' 55' ' ' ILE . . . 155.85 -138.03 5.83 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -169.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.46 -166.28 12.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.752 1.644 . . . . 0.0 111.595 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.61 -39.6 77.23 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 118.35 1.075 . . . . 0.0 112.706 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -61.08 -44.13 97.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.652 0.66 . . . . 0.0 109.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.18 -38.72 91.39 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.678 -0.639 . . . . 0.0 111.296 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.62 -43.5 76.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.637 1.175 . . . . 0.0 111.131 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.65 -32.59 62.31 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.04 87.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.948 0.499 . . . . 0.0 109.719 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 tp -56.52 -44.06 80.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.817 0.735 . . . . 0.0 110.308 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -37.79 88.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.992 0.517 . . . . 0.0 111.884 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.51 -35.03 79.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.659 -0.65 . . . . 0.0 111.026 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -78.58 -1.0 31.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 21.21 75.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.672 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.65 -7.1 56.99 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.058 -0.857 . . . . 0.0 112.094 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.93 -50.03 12.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.317 1.059 . . . . 0.0 108.972 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.94 -53.52 20.91 Favored Pre-proline 0 N--CA 1.464 0.263 0 C-N-CA 125.872 1.669 . . . . 0.0 113.993 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.94 -16.83 36.96 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 121.255 1.484 . . . . 0.0 113.037 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.29 -1.87 55.58 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.573 1.149 . . . . 0.0 110.921 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 3' ' ' VAL . 26.1 mt . . . . . 0 C--O 1.232 0.172 0 C-N-CA 125.314 1.446 . . . . 0.0 108.737 170.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.553 HG21 HD21 ' A' ' 81' ' ' LEU . 49.4 t -136.16 88.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -91.27 143.6 26.48 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.38 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt -140.44 113.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.115 0.483 . . . . 0.0 110.651 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.69 124.21 26.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.763 0.825 . . . . 0.0 109.1 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -142.22 169.05 18.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.6 0.76 . . . . 0.0 111.236 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.86 174.4 15.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.961 1.304 . . . . 0.0 109.483 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.69 -68.63 0.3 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.599 1.56 . . . . 0.0 109.856 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.7 m -86.22 90.63 8.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.8 t -155.52 91.15 2.82 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.43 -44.74 30.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.579 2.186 . . . . 0.0 110.959 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -73.3 -27.13 61.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.631 -0.668 . . . . 0.0 110.501 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -60.81 -57.0 14.5 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.676 1.126 . . . . 0.0 109.368 170.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -54.47 -42.4 70.64 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.828 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -56.71 -51.64 68.02 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.126 1.33 . . . . 0.0 111.624 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.22 77.88 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.452 0.569 . . . . 0.0 110.887 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -58.33 -41.4 84.52 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.939 0.791 . . . . 0.0 110.562 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.96 77.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.611 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.07 -48.75 77.31 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.201 0.91 . . . . 0.0 108.859 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.93 -44.39 85.28 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 122.002 -0.436 . . . . 0.0 111.314 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.2 m -64.12 -35.64 81.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.937 0.495 . . . . 0.0 110.487 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -68.13 -34.16 75.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.601 0.761 . . . . 0.0 110.371 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -76.27 -13.39 60.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.93 0.786 . . . . 0.0 111.17 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.79 42.4 70.53 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 81' ' ' LEU . 15.7 m -99.63 161.85 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.456 0.703 . . . . 0.0 110.447 -175.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 p -87.7 137.07 32.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -150.22 168.41 24.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.433 1.493 . . . . 0.0 108.187 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -114.89 147.62 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -115.66 142.93 46.07 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.06 92.9 47.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.81 147.65 44.85 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.974 2.449 . . . . 0.0 110.455 -169.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 mt . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 125.404 1.482 . . . . 0.0 109.725 174.672 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 120.363 0.125 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -74.37 -56.91 4.33 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -22.82 63.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.834 0.743 . . . . 0.0 111.818 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -55.78 -27.63 52.0 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.805 -1.184 . . . . 0.0 111.586 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.2 ttm -52.52 -22.76 5.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 113.325 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.91 -45.52 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.882 0.873 . . . . 0.0 109.217 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -75.07 -35.38 61.83 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 121.05 1.75 . . . . 0.0 111.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -66.8 -42.28 86.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.79 -10.53 1.81 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.793 1.237 . . . . 0.0 113.232 -168.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.99 1.25 84.84 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.998 -168.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -130.9 -161.71 1.15 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.977 2.388 . . . . 0.0 110.376 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.76 8.35 0.3 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.844 2.458 . . . . 0.0 110.55 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.04 158.34 18.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.759 2.823 . . . . 0.0 110.314 -173.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.31 166.58 24.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -167.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.52 168.95 68.73 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 119.898 0.999 . . . . 0.0 110.043 -7.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.76 102.81 5.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.0 136.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.51 95.58 4.73 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 168.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.1 mm -90.08 111.86 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 52.0 60.84 3.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.929 1.292 . . . . 0.0 113.011 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.47 15.54 6.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.301 1.441 . . . . 0.0 113.282 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.26 109.72 14.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -60.32 112.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 108.909 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.9 mm -76.67 -73.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.51 -138.44 6.82 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.2 -171.09 47.2 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.899 1.714 . . . . 0.0 111.677 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -62.3 -36.97 83.77 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.489 -1.243 . . . . 0.0 110.944 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.76 -43.94 94.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.721 1.146 . . . . 0.0 109.14 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.3 -46.72 79.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.987 1.315 . . . . 0.0 109.701 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.51 -47.97 76.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 126.444 1.898 . . . . 0.0 111.869 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -67.01 -33.3 75.25 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.016 0.926 . . . . 0.0 108.599 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.07 82.33 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.493 1.042 . . . . 0.0 111.217 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -56.52 -44.08 80.43 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.931 0.787 . . . . 0.0 110.317 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.5 -36.14 80.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.689 1.196 . . . . 0.0 111.812 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.84 -26.29 65.08 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.584 1.154 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -20.52 60.5 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.129 0.572 . . . . 0.0 111.201 170.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.95 7.03 88.65 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -168.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.4 -9.42 84.93 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 117.967 0.884 . . . . 0.0 111.685 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.3 tp -74.51 -39.16 62.57 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.243 1.021 . . . . 0.0 110.302 170.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.74 -53.14 27.38 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 -4.96 13.89 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.509 2.139 . . . . 0.0 113.527 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.5 mt -114.47 3.1 14.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.997 1.719 . . . . 0.0 110.982 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 3' ' ' VAL . 11.3 mt . . . . . 0 C--O 1.235 0.33 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.716 HG21 HD21 ' A' ' 81' ' ' LEU . 99.0 t -130.49 120.67 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -135.57 128.37 31.12 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -131.33 109.39 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -73.92 138.07 44.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -149.19 -179.44 7.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.222 1.409 . . . . 0.0 110.818 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.14 173.94 12.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -66.72 -16.36 64.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -136.97 127.42 26.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 168.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 t -168.5 95.45 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.67 -39.61 90.15 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.669 2.246 . . . . 0.0 112.618 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.79 -30.04 56.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.819 0.736 . . . . 0.0 111.09 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.37 -51.37 70.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.73 1.15 . . . . 0.0 108.672 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -57.73 -40.57 79.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.966 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -54.54 -54.48 40.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.577 1.535 . . . . 0.0 110.833 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.57 68.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.336 0.516 . . . . 0.0 110.702 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -61.67 -34.05 75.05 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.388 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.72 69.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.36 -49.35 76.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.477 0.711 . . . . 0.0 109.462 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -66.89 -41.78 86.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.261 0.625 . . . . 0.0 111.032 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -69.28 -31.94 70.78 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.6 m -68.47 -33.49 74.26 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.322 0.965 . . . . 0.0 111.271 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -74.97 -11.27 60.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.613 0.642 . . . . 0.0 110.757 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.21 16.22 76.92 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.274 1.416 . . . . 0.0 112.158 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.518 ' HB ' HD22 ' A' ' 81' ' ' LEU . 4.0 m -74.18 162.9 4.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 117.796 0.798 . . . . 0.0 110.99 -168.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.45 106.74 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.081 1.752 . . . . 0.0 108.136 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -134.25 169.33 17.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.224 1.41 . . . . 0.0 110.357 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -117.39 145.18 44.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.621 1.568 . . . . 0.0 107.435 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -114.01 150.15 34.33 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -134.2 88.02 32.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.609 1.564 . . . . 0.0 108.767 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.07 152.73 46.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.907 1.738 . . . . 0.0 111.855 -168.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 ' CE ' ' A' ' 43' ' ' MET . 7.2 pt . . . . . 0 C--N 1.332 -0.183 0 C-N-CA 126.131 1.772 . . . . 0.0 109.421 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.275 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -48.14 33.73 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.252 0.933 . . . . 0.0 109.012 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.23 -40.88 87.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.146 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.23 -44.31 83.69 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.671 0.788 . . . . 0.0 109.704 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.416 ' CE ' HG21 ' A' ' 33' ' ' ILE . 3.6 ttm -60.29 -18.32 48.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.868 1.267 . . . . 0.0 111.956 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -68.65 -58.58 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -61.25 -40.82 95.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.554 1.524 . . . . 0.0 111.886 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -67.03 -44.29 80.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.879 0.872 . . . . 0.0 111.565 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -126.39 -27.03 3.23 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.25 -21.36 5.13 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.692 2.568 . . . . 0.0 113.168 -168.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -87.68 -60.59 1.93 Allowed 'General case' 0 C--O 1.231 0.089 0 C-N-CA 124.45 1.1 . . . . 0.0 113.25 -168.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.3 p 75.38 15.86 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.954 2.102 . . . . 0.0 113.324 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.0 p -96.64 176.23 6.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.911 1.284 . . . . 0.0 108.484 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -136.65 154.11 76.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.139 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.11 156.02 91.2 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.604 -0.998 . . . . 0.0 110.18 -11.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.35 93.79 4.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.583 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.3 mp -81.51 143.39 12.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -130.09 127.0 38.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 129.635 3.174 . . . . 0.0 105.037 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.4 mt -130.67 126.5 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.38 55.73 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.527 2.331 . . . . 0.0 110.492 -168.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 67.04 -7.96 0.46 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 129.692 3.197 . . . . 0.0 114.175 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -81.08 117.6 21.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -172.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -63.66 101.58 0.36 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -74.07 -59.32 3.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.709 1.203 . . . . 0.0 109.49 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.48 -141.13 10.8 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.98 -170.44 32.43 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.032 1.301 . . . . 0.0 111.174 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -62.1 -40.03 94.49 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.758 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.5 -40.09 85.92 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.772 0.714 . . . . 0.0 110.015 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.77 -48.71 73.54 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.306 1.443 . . . . 0.0 110.085 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.31 -47.63 85.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.117 1.767 . . . . 0.0 111.374 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -66.13 -35.31 80.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.062 0.945 . . . . 0.0 109.228 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.34 -47.17 85.41 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.787 0.722 . . . . 0.0 110.512 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.61 -45.75 81.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.717 0.807 . . . . 0.0 110.649 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.59 -43.63 97.14 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.819 1.248 . . . . 0.0 111.394 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -25.0 67.84 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.491 0.717 . . . . 0.0 110.661 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.25 3.2 55.45 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.529 1.132 . . . . 0.0 110.669 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.7 20.89 53.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.349 0.976 . . . . 0.0 111.941 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.0 63.14 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 118.527 1.163 . . . . 0.0 111.451 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.424 HD11 HD12 ' A' ' 81' ' ' LEU . 54.6 tp -78.33 -53.18 7.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.657 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -53.25 32.24 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 127.165 2.186 . . . . 0.0 113.88 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -69.25 -1.49 8.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.846 1.697 . . . . 0.0 112.968 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 99.0 mt -112.36 -3.34 14.54 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.051 1.74 . . . . 0.0 111.727 170.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.716 HD21 HG21 ' A' ' 3' ' ' VAL . 8.1 mt . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 125.509 1.523 . . . . 0.0 114.245 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.371 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.17 132.05 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -133.02 141.86 48.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.49 1.516 . . . . 0.0 107.179 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 tt -136.99 125.42 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -103.04 127.62 50.22 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.675 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 14' ' ' CYS . 29.8 p -141.08 177.62 7.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.822 1.249 . . . . 0.0 109.747 -173.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.55 -173.47 3.97 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.895 -1.128 . . . . 0.0 108.631 173.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -56.77 9.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.938 1.695 . . . . 0.0 109.299 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -85.33 -173.58 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.638 1.175 . . . . 0.0 109.698 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t 96.34 81.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 129.664 3.186 . . . . 0.0 108.266 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.33 -27.69 71.69 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.341 2.028 . . . . 0.0 112.062 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -73.31 -31.21 63.88 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.4 -0.813 . . . . 0.0 109.185 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.426 ' HB3' HG22 ' A' ' 7' ' ' THR . 97.7 m -61.65 -48.03 82.7 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.029 -1.044 . . . . 0.0 110.245 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -53.35 -51.79 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.713 -0.66 . . . . 0.0 109.809 170.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -54.47 -43.94 72.14 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.126 0.876 . . . . 0.0 112.753 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.72 68.1 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.361 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.46 -37.17 74.92 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.425 1.466 . . . . 0.0 110.809 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.76 -39.23 90.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.116 0.566 . . . . 0.0 110.852 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tt -65.35 -45.92 82.24 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -41.09 96.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.796 0.725 . . . . 0.0 111.282 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 -36.92 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 m -72.46 -29.53 63.74 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.961 0.801 . . . . 0.0 112.68 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mmmp? -75.29 -15.2 60.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.198 0.908 . . . . 0.0 110.377 169.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.07 47.18 61.0 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HB ' HD22 ' A' ' 81' ' ' LEU . 3.1 m -103.24 170.72 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.231 0.613 . . . . 0.0 110.641 -176.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -104.44 117.12 33.38 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.061 1.744 . . . . 0.0 108.104 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -134.35 163.39 29.76 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.606 0.763 . . . . 0.0 110.182 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -95.61 139.54 31.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.48 133.74 55.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.77 106.96 31.55 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.88 1.272 . . . . 0.0 107.931 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.02 153.21 41.49 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.92 1.746 . . . . 0.0 108.828 173.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 40' ' ' ARG . 16.9 mm . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 123.55 0.74 . . . . 0.0 110.799 174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 tptt . . . . . 0 CA--C 1.516 -0.363 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HB2' HG23 ' A' ' 33' ' ' ILE . 5.9 tmm_? -55.45 -49.93 71.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 110.057 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -68.55 -31.71 71.12 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.103 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -61.03 -39.13 88.6 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.247 1.385 . . . . 0.0 110.476 169.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 ttm -56.04 -12.59 1.52 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.841 1.657 . . . . 0.0 112.303 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mt -63.98 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -69.47 -20.05 63.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.835 1.652 . . . . 0.0 112.168 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -21.55 61.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.312 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.1 p -134.76 -15.65 2.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.012 1.733 . . . . 0.0 114.982 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.85 69.12 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.023 1.297 . . . . 0.0 112.167 -168.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.42 ' HB2' HE22 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -116.55 -72.94 0.66 Allowed 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 125.346 1.459 . . . . 0.0 110.084 -169.249 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 86.63 -4.78 0.71 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 130.797 3.639 . . . . 0.0 111.616 -168.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.5 p -106.2 162.85 13.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.566 1.547 . . . . 0.0 108.073 -172.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.99 163.05 42.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.226 0.61 . . . . 0.0 109.95 -168.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -65.43 161.67 70.05 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.082 1.065 . . . . 0.0 112.387 -4.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.42 HE22 ' HB2' ' A' ' 49' ' ' ARG . 2.7 mt-30 -139.57 140.66 37.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.564 168.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.478 HD11 ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -125.24 146.98 30.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 168.064 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -122.16 133.74 54.74 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.6 mt -136.99 120.94 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 51.09 43.5 29.04 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.521 1.128 . . . . 0.0 109.192 -168.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.21 -3.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.866 2.466 . . . . 0.0 114.797 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -83.03 114.89 21.59 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.402 1.881 . . . . 0.0 108.416 -173.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -64.95 113.39 3.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.461 1.028 . . . . 0.0 108.589 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -82.93 -74.45 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.486 1.114 . . . . 0.0 109.03 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.16 -145.83 14.1 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 119.169 0.895 . . . . 0.0 113.683 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.6 -171.71 47.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.72 2.105 . . . . 0.0 113.474 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.9 -40.28 68.97 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.462 -1.611 . . . . 0.0 110.039 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -34.29 74.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.283 175.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -67.54 -49.13 64.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.569 0.699 . . . . 0.0 110.59 171.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 55' ' ' ILE . 2.8 tm? -60.49 -42.71 96.87 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.926 1.29 . . . . 0.0 111.757 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.59 -37.22 68.2 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.01 85.71 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.295 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -56.22 -47.74 77.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.531 1.059 . . . . 0.0 110.894 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.43 -33.68 76.09 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.594 -0.691 . . . . 0.0 111.738 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.04 60.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.472 1.109 . . . . 0.0 112.516 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 1.51 44.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.897 1.226 . . . . 0.0 110.982 168.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.37 23.17 77.83 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -171.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.35 -3.78 29.1 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.04 -1.422 . . . . 0.0 113.403 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 tp -80.5 -48.25 13.07 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.441 1.621 . . . . 0.0 108.342 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -49.78 85.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.717 1.207 . . . . 0.0 113.158 -174.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 -28.59 53.62 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 CA-C-N 122.22 1.829 . . . . 0.0 112.636 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.85 -14.34 58.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.008 0.822 . . . . 0.0 111.837 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 26' ' ' VAL . 5.3 mt . . . . . 0 C--O 1.236 0.388 0 C-N-CA 126.779 2.032 . . . . 0.0 109.395 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.41 HG21 ' CG ' ' A' ' 81' ' ' LEU . 93.7 t -94.71 135.4 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -129.15 139.9 51.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 tt -139.54 120.04 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.846 0.355 . . . . 0.0 110.256 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -92.33 132.29 36.84 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.0 p -140.72 168.72 19.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.156 0.982 . . . . 0.0 111.521 -169.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.11 -179.45 7.33 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.785 -1.197 . . . . 0.0 110.521 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -53.59 -39.56 64.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 128.175 2.59 . . . . 0.0 113.52 -168.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -134.25 105.83 6.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -155.93 80.09 4.04 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.754 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -57.71 -33.94 97.47 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.242 1.961 . . . . 0.0 112.139 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -73.54 -28.89 62.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.393 1.451 . . . . 0.0 110.175 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.19 -53.16 61.06 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -53.21 -44.74 68.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.345 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 38.3 mmt180 -54.39 -62.2 1.81 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.779 1.172 . . . . 0.0 110.712 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -46.16 91.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -63.08 -34.97 78.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.292 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.36 77.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.341 0.973 . . . . 0.0 110.407 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.24 -52.84 63.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.796 0.725 . . . . 0.0 109.149 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.91 -43.33 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.027 0.531 . . . . 0.0 111.191 -170.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -64.9 -35.05 79.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.304 0.642 . . . . 0.0 110.131 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.7 m -73.08 -30.72 63.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.629 0.649 . . . . 0.0 112.492 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -74.29 -10.73 59.88 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.508 1.123 . . . . 0.0 109.767 172.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.03 46.05 60.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.82 175.99 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.426 1.09 . . . . 0.0 110.227 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.5 m -133.49 99.29 4.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.593 1.187 . . . . 0.0 108.08 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -92.03 165.64 13.09 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 128.382 2.673 . . . . 0.0 107.911 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -97.3 138.44 34.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -115.92 136.29 53.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.547 0.739 . . . . 0.0 109.419 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.64 106.17 20.92 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.761 1.625 . . . . 0.0 110.439 -168.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.97 144.79 19.15 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.577 1.518 . . . . 0.0 111.992 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.4 mm . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 168.002 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.571 0.224 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -54.09 -62.78 1.43 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.065 1.746 . . . . 0.0 109.218 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.08 -21.48 56.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.165 0.439 . . . . 0.0 111.149 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.98 -32.28 70.69 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.461 -0.774 . . . . 0.0 109.842 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ttp -59.95 -20.89 60.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.06 -1.025 . . . . 0.0 112.681 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.27 -58.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -19.42 64.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.015 . . . . 0.0 112.165 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -91.42 -56.02 3.29 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.77 -1.206 . . . . 0.0 110.931 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.0 p -90.32 -21.91 21.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.926 1.239 . . . . 0.0 113.834 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.66 22.22 63.77 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.963 -0.909 . . . . 0.0 112.204 -168.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -136.17 -57.72 0.76 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.155 1.477 . . . . 0.0 112.723 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.283 0.0 OUTLIER 67.88 -0.15 2.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.912 2.085 . . . . 0.0 113.872 -171.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.9 p -76.87 176.28 8.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.282 1.833 . . . . 0.0 107.507 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.58 158.99 73.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.99 -0.444 . . . . 0.0 111.786 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.07 167.4 78.84 Favored 'Cis proline' 0 C--N 1.347 0.454 0 N-CA-C 109.605 -0.96 . . . . 0.0 109.605 -11.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -128.83 112.08 13.76 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -99.7 143.15 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -134.84 142.31 46.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 128.693 2.797 . . . . 0.0 105.536 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.407 HG12 HG22 ' A' ' 3' ' ' VAL . 49.7 mt -138.5 119.09 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.256 1.2 m-20 52.71 37.53 23.9 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.956 0.884 . . . . 0.0 111.306 -168.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 62.98 2.84 1.08 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.719 2.408 . . . . 0.0 114.382 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -73.79 119.31 17.84 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -69.08 107.74 3.29 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 108.978 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.5 mm -73.94 -63.79 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.41 -138.13 5.7 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.77 -165.06 30.38 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.592 2.044 . . . . 0.0 111.14 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 5.0 t80 -57.66 -46.15 84.6 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.885 -0.773 . . . . 0.0 110.541 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.03 -32.38 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.679 0.792 . . . . 0.0 109.604 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -73.16 -45.02 59.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.87 1.268 . . . . 0.0 111.957 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.33 -53.69 55.31 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.93 -39.23 80.98 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.68 -46.44 89.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.894 0.878 . . . . 0.0 112.55 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 tp -56.82 -46.71 81.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.762 1.164 . . . . 0.0 110.919 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.26 -38.9 92.68 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.636 1.174 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.895 0.878 . . . . 0.0 111.659 172.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.09 -0.68 57.72 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.909 1.284 . . . . 0.0 112.084 170.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.88 4.12 13.28 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.194 0.907 . . . . 0.0 112.985 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.79 -3.78 89.2 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 119.306 1.553 . . . . 0.0 112.265 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.5 tp -74.25 -51.47 15.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.988 1.315 . . . . 0.0 109.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -56.08 22.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.457 1.503 . . . . 0.0 112.235 -170.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.85 -4.82 15.84 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.205 1.937 . . . . 0.0 113.375 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -100.71 -0.54 37.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.352 0.978 . . . . 0.0 111.107 172.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.41 ' CG ' HG21 ' A' ' 3' ' ' VAL . 6.5 mt . . . . . 0 C--O 1.23 0.074 0 C-N-CA 125.648 1.579 . . . . 0.0 113.726 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.155 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 57' ' ' ILE . 94.8 t -91.92 134.35 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.42 150.78 46.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.3 tt -144.27 110.71 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.233 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.52 124.53 28.58 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 107.614 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -144.25 169.16 18.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.39 1.076 . . . . 0.0 112.347 -171.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.467 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -133.76 173.94 10.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.036 1.335 . . . . 0.0 109.138 176.184 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.38 -28.81 68.51 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.106 1.762 . . . . 0.0 111.695 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -133.33 110.18 9.87 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.8 91.43 0.67 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 124.946 1.298 . . . . 0.0 108.578 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.12 -40.21 62.61 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.661 2.241 . . . . 0.0 111.049 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.51 -31.93 63.97 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.921 -1.112 . . . . 0.0 110.672 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m -61.98 -46.18 90.38 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 119.185 0.902 . . . . 0.0 109.507 170.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -55.48 -47.71 75.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.335 -0.84 . . . . 0.0 109.997 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -56.08 -50.09 71.98 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.659 1.118 . . . . 0.0 111.158 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.1 -53.95 50.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.634 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -61.75 -36.03 79.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.795 0.725 . . . . 0.0 110.856 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -47.68 82.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.64 -49.5 77.28 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.58 -39.84 84.86 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.051 -0.406 . . . . 0.0 111.217 -174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -67.97 -34.04 75.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.879 0.763 . . . . 0.0 110.276 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -69.72 -27.97 65.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.499 1.045 . . . . 0.0 111.657 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -80.94 -11.53 59.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.215 1.006 . . . . 0.0 110.547 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.94 43.56 49.11 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.762 1.172 . . . . 0.0 110.779 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -98.91 169.04 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.966 0.888 . . . . 0.0 112.066 -170.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.41 128.39 35.92 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.839 2.056 . . . . 0.0 105.819 169.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -155.14 164.51 38.73 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -112.69 139.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.359 1.864 . . . . 0.0 106.875 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.08 146.99 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.66 125.29 19.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.14 138.42 18.08 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.192 1.261 . . . . 0.0 109.578 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 169.329 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -61.84 -50.9 70.42 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.146 0.978 . . . . 0.0 108.669 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -41.53 90.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.288 1.435 . . . . 0.0 111.536 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.46 -33.31 75.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.392 0.677 . . . . 0.0 110.839 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.8 ttp -63.98 -26.28 68.51 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.569 -0.707 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -67.05 -53.44 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 6.89 0.09 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.551 1.94 . . . . 0.0 114.675 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.34 -28.72 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 120.643 1.565 . . . . 0.0 112.703 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -116.02 -22.1 9.15 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.157 1.344 . . . . 0.0 112.898 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -9.64 0.88 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.083 1.802 . . . . 0.0 113.465 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -91.24 -56.12 3.27 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.512 1.156 . . . . 0.0 111.378 -169.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 80.99 -1.53 1.78 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.005 1.322 . . . . 0.0 111.605 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.2 p -80.18 177.09 9.19 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 131.262 3.825 . . . . 0.0 108.58 168.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.467 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -136.84 159.23 71.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 169.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.5 166.9 80.66 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-O 121.718 0.632 . . . . 0.0 111.391 -8.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -126.34 100.28 6.21 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 102.098 -3.297 . . . . 0.0 102.098 168.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -87.37 146.67 6.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 170.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -137.01 150.88 48.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.334 2.254 . . . . 0.0 107.453 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 3' ' ' VAL . 69.9 mt -135.86 109.04 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 51.57 43.69 29.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.636 -1.29 . . . . 0.0 110.764 -169.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.04 -1.78 2.88 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.013 2.925 . . . . 0.0 114.665 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -73.93 103.09 4.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.995 1.718 . . . . 0.0 106.826 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -66.62 109.04 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.11 -59.24 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.95 -133.28 6.81 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.71 -175.13 38.38 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.372 1.463 . . . . 0.0 111.601 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.45 -41.69 81.03 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.557 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.98 -34.83 78.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.565 0.62 . . . . 0.0 110.799 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -66.33 -48.29 70.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 109.773 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.28 -43.75 97.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.351 1.061 . . . . 0.0 111.161 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.73 -37.7 73.51 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.41 94.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.793 0.724 . . . . 0.0 110.711 170.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.79 -49.13 76.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.395 0.998 . . . . 0.0 110.573 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -36.92 78.11 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 111.51 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.55 -22.44 63.55 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.39 -3.58 56.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.55 1.14 . . . . 0.0 110.018 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.53 37.95 92.9 Favored Glycine 0 C--O 1.225 -0.406 0 O-C-N 120.634 -1.291 . . . . 0.0 110.192 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.07 -1.57 58.31 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.845 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.21 -67.77 0.77 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.935 1.294 . . . . 0.0 108.847 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.296 0.0 OUTLIER -45.07 -51.25 24.45 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-O 116.564 -1.684 . . . . 0.0 114.263 177.284 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.65 3.67 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 CA-C-N 123.526 2.295 . . . . 0.0 113.612 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -109.83 -38.61 5.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.36 0.982 . . . . 0.0 110.258 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 CA--C 1.535 0.392 0 O-C-N 121.201 -0.937 . . . . 0.0 113.124 178.957 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.214 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 81' ' ' LEU . 95.1 t -131.51 107.01 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 173.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.19 128.77 44.03 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -169.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -130.22 104.89 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.153 0.502 . . . . 0.0 109.908 -171.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -74.95 131.21 40.5 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -143.39 -179.42 6.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.402 0.681 . . . . 0.0 112.146 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.47 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -133.72 175.94 9.0 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.93 1.692 . . . . 0.0 108.815 168.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -18.68 4.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.271 3.028 . . . . 0.0 115.168 -169.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -137.02 -83.92 0.34 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 168.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 t 56.73 97.5 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.687 1.595 . . . . 0.0 112.463 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.91 42.85 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.777 2.985 . . . . 0.0 113.907 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -150.6 -42.83 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.771 2.828 . . . . 0.0 106.046 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -53.83 -50.52 66.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 109.548 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -52.73 -51.46 60.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.562 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.449 ' HD3' ' CE2' ' A' ' 65' ' ' TYR . 18.0 mtt-85 -56.69 -50.22 72.79 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.563 0.62 . . . . 0.0 110.786 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.19 -43.55 94.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.982 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.33 -47.12 84.76 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.081 1.309 . . . . 0.0 110.261 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.95 79.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.67 0.388 . . . . 0.0 110.46 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.28 -46.71 82.47 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.606 0.763 . . . . 0.0 110.17 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.53 -38.43 89.62 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.204 0.602 . . . . 0.0 110.005 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -64.35 -35.43 80.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.401 0.68 . . . . 0.0 110.793 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 t -67.3 -35.35 79.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.734 0.814 . . . . 0.0 109.65 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -80.58 -6.77 58.76 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.588 0.631 . . . . 0.0 111.937 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.01 28.59 66.34 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.148 0.885 . . . . 0.0 111.462 170.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG21 HD13 ' A' ' 81' ' ' LEU . 5.8 m -93.15 167.7 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 121.907 -0.76 . . . . 0.0 112.241 -168.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.3 p -98.49 130.12 45.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -145.91 164.27 32.52 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.434 1.094 . . . . 0.0 108.176 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -104.94 136.52 44.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.189 2.195 . . . . 0.0 107.17 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -116.39 139.14 50.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.644 1.178 . . . . 0.0 109.337 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.26 87.81 49.72 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 125.045 1.338 . . . . 0.0 110.702 -169.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.79 141.85 67.31 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.185 1.923 . . . . 0.0 111.701 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 124.938 1.295 . . . . 0.0 112.214 170.826 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.627 0.251 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -59.0 -43.58 91.5 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 120.76 -1.213 . . . . 0.0 110.733 170.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.06 -22.47 55.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.732 0.696 . . . . 0.0 111.869 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -60.25 -24.07 64.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.917 1.235 . . . . 0.0 109.714 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.7 tpp -54.44 -26.66 32.23 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.922 0.783 . . . . 0.0 112.372 173.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -74.38 -40.92 49.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -77.55 -31.36 53.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.443 -0.785 . . . . 0.0 112.208 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -74.9 -38.5 61.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 112.665 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.8 p -133.27 -12.31 2.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -168.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.21 -8.47 70.72 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.945 -168.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -127.54 -161.93 1.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.703 1.752 . . . . 0.0 111.337 -168.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 51' ' ' THR . 2.3 m -155.68 -23.79 0.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.708 2.403 . . . . 0.0 109.948 -170.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 50' ' ' THR . 13.6 p -74.08 163.01 28.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.93 1.692 . . . . 0.0 110.857 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG21 ' HG2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -139.65 161.97 53.65 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 0.0 109.135 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 59.4 Cg_endo -66.98 153.8 84.29 Favored 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.242 1.122 . . . . 0.0 112.116 2.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -130.63 103.37 6.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 105.761 -1.941 . . . . 0.0 105.761 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.672 HD12 ' H ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -84.65 146.87 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 168.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.91 119.25 27.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 168.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -125.28 129.41 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.697 1.59 . . . . 0.0 107.53 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 48.0 32.82 3.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.639 1.975 . . . . 0.0 110.102 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.26 4.68 4.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 131.107 3.763 . . . . 0.0 115.793 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.84 123.45 24.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -65.13 113.97 4.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.88 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.183 0.993 . . . . 0.0 109.546 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.08 -136.83 8.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -168.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.02 -175.93 43.86 Favored Glycine 0 CA--C 1.521 0.456 0 O-C-N 124.231 0.607 . . . . 0.0 112.483 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 16' ' ' ARG . 2.9 t80 -52.02 -49.71 62.84 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.603 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.3 -25.15 65.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.357 0.663 . . . . 0.0 110.627 -170.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -71.39 -51.88 21.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.528 1.131 . . . . 0.0 110.426 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -61.55 -51.22 69.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.892 1.277 . . . . 0.0 110.012 176.115 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -51.05 -38.97 54.73 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.138 1.375 . . . . 0.0 111.413 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.0 91.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 117.882 -1.056 . . . . 0.0 111.746 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.75 -51.02 70.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.467 1.03 . . . . 0.0 109.131 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.79 -42.79 80.09 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.373 1.069 . . . . 0.0 110.433 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -22.81 61.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.175 0.99 . . . . 0.0 112.566 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -88.58 4.47 46.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.188 0.995 . . . . 0.0 112.26 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.85 71.59 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.592 0.633 . . . . 0.0 112.243 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.79 -17.1 80.19 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.477 1.138 . . . . 0.0 112.056 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 81' ' ' LEU . 41.3 tp -77.95 -39.73 41.74 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.004 0.902 . . . . 0.0 110.68 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.26 -56.22 22.1 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.269 1.428 . . . . 0.0 109.921 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.56 -0.75 8.72 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.5 2.133 . . . . 0.0 113.508 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.56 -9.9 15.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 112.26 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 3' ' ' VAL . 11.5 mt . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 126.258 1.823 . . . . 0.0 112.623 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.632 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.651 HG21 HD21 ' A' ' 81' ' ' LEU . 94.7 t -125.43 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.3 135.91 52.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 tt -135.0 107.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.282 0.563 . . . . 0.0 110.49 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -73.57 136.14 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.438 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 73.2 p -141.29 179.07 6.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.135 1.374 . . . . 0.0 109.106 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -160.37 -179.62 7.84 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -48.62 -29.96 4.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.773 3.229 . . . . 0.0 113.924 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -138.41 86.55 2.17 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.203 1.001 . . . . 0.0 111.044 -173.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -156.75 91.23 2.51 Favored Pre-proline 0 CA--C 1.539 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 110.354 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.18 -27.55 72.85 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.361 2.041 . . . . 0.0 112.067 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -73.46 -29.47 62.55 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 7' ' ' THR . 74.1 m -66.75 -47.74 71.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.178 0.899 . . . . 0.0 108.902 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.19 -53.68 26.17 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.784 168.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -53.61 55.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.6 1.091 . . . . 0.0 111.174 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.34 76.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.936 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -60.61 -39.8 89.5 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.672 1.124 . . . . 0.0 110.935 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.3 68.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.208 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp -66.2 -54.34 26.38 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.61 -35.37 80.29 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -68.97 -35.31 76.59 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 109.66 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -74.04 -11.6 60.37 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.14 -0.975 . . . . 0.0 112.167 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -92.28 -27.4 17.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.519 1.054 . . . . 0.0 108.59 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.33 54.03 7.17 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 HD22 ' A' ' 81' ' ' LEU . 15.9 m -112.93 167.47 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.295 0.638 . . . . 0.0 112.088 -172.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.7 m -82.55 120.18 25.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.375 . . . . 0.0 107.308 169.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.87 169.7 17.55 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 109.286 169.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.45 147.29 44.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.77 155.08 28.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.641 0.655 . . . . 0.0 110.557 170.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.49 93.86 27.81 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 124.651 1.181 . . . . 0.0 108.848 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.84 145.98 91.18 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.221 1.948 . . . . 0.0 109.063 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 118.761 0.709 . . . . 0.0 109.1 168.677 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt . . . . . 0 C--O 1.231 0.115 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -67.11 -52.07 46.38 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -32.37 73.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.964 0.802 . . . . 0.0 109.41 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -23.42 66.33 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.291 -0.88 . . . . 0.0 111.917 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.44 -26.38 19.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.002 0.819 . . . . 0.0 112.308 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.39 -56.7 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -61.67 7.51 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.437 2.295 . . . . 0.0 116.125 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.12 -32.2 0.47 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.057 1.299 . . . . 0.0 110.517 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.3 p -129.29 -10.35 4.67 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.476 1.489 . . . . 0.0 113.108 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.84 -14.86 34.85 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.657 1.599 . . . . 0.0 114.322 -171.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -131.99 162.44 30.71 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 126.211 1.804 . . . . 0.0 109.01 -169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -105.45 4.46 30.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 112.645 170.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.2 p -73.69 175.26 7.33 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.877 1.271 . . . . 0.0 109.8 172.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.456 HG21 ' CG ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -143.98 164.49 29.34 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.976 1.31 . . . . 0.0 110.509 176.375 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.51 162.12 80.81 Favored 'Cis proline' 0 N--CA 1.454 -0.807 0 CA-C-N 119.151 0.732 . . . . 0.0 110.503 -7.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -127.36 99.6 5.71 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.1 mp -88.85 139.82 16.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.22 129.29 47.52 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 128.988 2.915 . . . . 0.0 104.935 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.63 123.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 53.75 30.14 10.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.452 1.024 . . . . 0.0 111.476 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.3 -1.11 2.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.722 3.209 . . . . 0.0 114.691 -172.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -73.95 114.39 12.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.316 1.846 . . . . 0.0 108.055 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -69.85 106.64 3.22 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.667 -0.645 . . . . 0.0 110.045 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.4 mm -73.96 -63.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.786 0.835 . . . . 0.0 109.04 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.87 -142.13 9.84 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.23 -173.31 38.78 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.472 1.51 . . . . 0.0 111.384 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.83 -38.83 76.3 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.598 -0.942 . . . . 0.0 110.625 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.54 -41.82 95.25 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.433 0.693 . . . . 0.0 110.276 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.58 -48.56 66.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.437 1.095 . . . . 0.0 110.052 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -49.86 71.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.861 1.264 . . . . 0.0 110.3 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -67.91 -27.78 66.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.83 69.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.188 0.995 . . . . 0.0 111.674 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.7 tp -56.34 -41.43 76.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.052 1.296 . . . . 0.0 109.94 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.62 -35.48 77.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.274 1.03 . . . . 0.0 112.845 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.95 -29.06 68.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.375 0.534 . . . . 0.0 110.809 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 -74.59 -10.76 59.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.177 0.991 . . . . 0.0 110.784 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.56 3.65 54.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.094 -0.837 . . . . 0.0 111.427 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.9 -6.08 89.25 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.916 1.246 . . . . 0.0 112.368 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 tp -73.5 -44.36 58.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.56 -46.99 99.77 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-O 116.7 -1.619 . . . . 0.0 113.494 -169.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 -12.63 35.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.541 1.943 . . . . 0.0 113.087 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -99.67 0.05 41.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.168 0.894 . . . . 0.0 111.506 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 3' ' ' VAL . 8.1 mt . . . . . 0 C--O 1.234 0.239 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.511 ' N ' HD21 ' A' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.527 HG21 HD21 ' A' ' 81' ' ' LEU . 96.5 t -139.47 118.84 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -113.88 147.22 38.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.319 1.047 . . . . 0.0 108.324 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.65 110.45 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.279 0.491 . . . . 0.0 111.284 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 4.1 m-85 -79.94 140.02 36.83 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.654 -0.654 . . . . 0.0 110.713 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -152.81 178.58 9.49 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.311 2.645 . . . . 0.0 109.223 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.24 -173.56 4.28 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 119.608 -1.933 . . . . 0.0 110.322 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.03 -35.31 24.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.949 1.7 . . . . 0.0 111.578 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -138.27 160.44 39.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.678 2.391 . . . . 0.0 105.651 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 t 163.61 105.9 0.02 OUTLIER Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 127.733 2.413 . . . . 0.0 106.603 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.53 -40.38 30.91 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.846 2.364 . . . . 0.0 110.628 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -73.38 -26.83 61.16 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.99 -1.069 . . . . 0.0 110.306 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.2 m -64.87 -45.14 87.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.24 -0.913 . . . . 0.0 109.805 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -56.11 -47.62 77.72 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.827 -1.083 . . . . 0.0 110.124 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -54.24 -52.64 60.72 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.05 1.295 . . . . 0.0 111.199 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.38 -49.83 75.32 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.686 -0.634 . . . . 0.0 112.037 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -64.43 -32.63 74.33 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.035 0.834 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.52 -28.24 69.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.006 0.821 . . . . 0.0 110.951 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -60.3 2.65 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.02 -41.63 83.56 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.589 0.755 . . . . 0.0 111.356 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -67.77 -26.77 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.047 0.539 . . . . 0.0 110.702 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m -75.98 -29.29 58.18 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.551 -0.718 . . . . 0.0 111.183 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -77.42 -17.3 58.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.852 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.73 43.45 94.14 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.77 156.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.467 0.651 . . . . 0.0 111.575 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.06 117.63 22.98 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -134.13 163.66 29.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 168.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -103.62 144.05 31.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.33 146.86 42.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.88 134.48 26.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -95.38 162.83 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.559 2.172 . . . . 0.0 113.012 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.288 1.2 mt . . . . . 0 C--O 1.236 0.374 0 C-N-CA 126.623 1.969 . . . . 0.0 108.196 167.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -86.07 -60.82 1.9 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.76 -32.76 72.05 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 124.054 0.846 . . . . 0.0 111.339 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.01 -40.01 79.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.105 -0.372 . . . . 0.0 110.988 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -70.33 -17.88 63.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 121.136 -0.977 . . . . 0.0 112.597 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.32 -56.52 13.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 168.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.6 -25.52 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.615 0.766 . . . . 0.0 112.271 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -95.33 -33.62 12.47 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.625 -1.655 . . . . 0.0 113.107 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.5 p -124.07 -24.95 4.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.564 1.984 . . . . 0.0 114.876 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.73 -10.08 20.11 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.073 2.273 . . . . 0.0 114.486 -169.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -94.54 -63.94 1.13 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -168.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 86.71 0.42 0.56 Allowed 'General case' 0 CA--C 1.54 0.567 1 C-N-CA 131.844 4.058 . . . . 0.0 111.718 -168.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.4 p -111.4 161.52 16.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.465 1.506 . . . . 0.0 108.225 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.71 166.8 23.4 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 125.531 1.532 . . . . 0.0 113.833 -168.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.52 163.55 77.73 Favored 'Cis proline' 0 C--N 1.354 0.864 0 CA-C-N 120.847 1.338 . . . . 0.0 110.638 -2.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 15.3 mm-40 -146.03 84.48 1.65 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -168.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.61 142.1 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -137.1 85.16 2.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.021 2.128 . . . . 0.0 105.913 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.7 mt -92.93 132.41 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.42 24.61 2.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.408 1.083 . . . . 0.0 110.882 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.65 12.88 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.762 2.025 . . . . 0.0 115.562 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.49 128.0 33.08 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 168.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -69.48 114.05 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mm -76.13 -58.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.524 1.13 . . . . 0.0 110.461 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -157.72 27.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -169.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.34 -168.63 43.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.819 1.676 . . . . 0.0 110.96 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -62.63 -43.98 97.43 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.271 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.63 -34.48 77.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.598 1.09 . . . . 0.0 110.307 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -70.19 -46.32 64.85 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.115 0.966 . . . . 0.0 109.996 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.28 -50.13 74.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 127.543 2.337 . . . . 0.0 111.528 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -67.54 -29.27 68.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -40.3 71.82 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.54 169.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 tp -56.31 -41.43 75.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.956 1.253 . . . . 0.0 109.762 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.43 -32.39 73.99 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.69 -30.68 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.308 -0.87 . . . . 0.0 111.427 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -80.14 -5.15 55.5 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.821 0.737 . . . . 0.0 110.944 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.48 19.12 79.59 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.372 -0.682 . . . . 0.0 111.436 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.34 -3.5 65.0 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.306 1.053 . . . . 0.0 112.646 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.48 -50.92 7.31 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.637 1.219 . . . . 0.0 110.283 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -44.46 99.64 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.247 -176.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.14 7.43 3.31 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 123.311 2.218 . . . . 0.0 113.003 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.18 -2.13 13.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.535 1.534 . . . . 0.0 110.428 168.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 3' ' ' VAL . 12.0 mt . . . . . 0 C--N 1.331 -0.229 0 C-N-CA 126.185 1.794 . . . . 0.0 110.903 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 81' ' ' LEU . 99.4 t -112.18 89.72 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.55 135.18 37.24 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.875 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -136.64 113.14 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 124.462 1.105 . . . . 0.0 109.128 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.88 142.23 46.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.887 0.875 . . . . 0.0 108.779 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -150.01 166.1 30.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.056 1.342 . . . . 0.0 110.669 -169.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 176.55 12.54 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.891 -1.13 . . . . 0.0 108.715 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -56.37 -30.13 62.31 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.763 2.425 . . . . 0.0 113.853 -170.196 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 109.66 9.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -164.89 84.94 1.11 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -63.67 -26.1 68.89 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.836 1.691 . . . . 0.0 111.986 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -73.43 -30.48 63.24 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.074 -1.016 . . . . 0.0 109.419 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -66.33 -43.96 84.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 119.23 0.923 . . . . 0.0 108.968 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -53.25 -47.8 68.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.94 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -54.8 -59.3 4.91 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.598 1.545 . . . . 0.0 112.076 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.16 89.71 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.069 0.395 . . . . 0.0 110.27 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.771 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.26 99.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -59.66 -49.69 76.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.707 0.685 . . . . 0.0 110.229 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.99 -43.51 95.47 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.265 1.026 . . . . 0.0 111.048 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -59.03 -42.73 90.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.717 0.807 . . . . 0.0 109.167 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 t -69.69 -30.93 68.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.113 0.965 . . . . 0.0 110.416 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -78.18 -15.48 58.79 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.154 0.888 . . . . 0.0 111.453 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 47.95 23.58 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 124.991 1.282 . . . . 0.0 110.043 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 81' ' ' LEU . 13.8 m -104.43 171.5 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.038 0.535 . . . . 0.0 112.271 -170.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.4 p -94.35 126.99 39.95 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.32 170.4 16.38 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.433 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -128.92 124.43 35.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.617 1.567 . . . . 0.0 108.105 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.402 HD23 ' HE3' ' A' ' 39' ' ' LYS . 1.8 mp -116.68 113.58 40.22 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.33 146.94 20.02 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.159 1.906 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 125.495 1.518 . . . . 0.0 109.743 175.71 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HE3' HD23 ' A' ' 31' ' ' LEU . 9.4 ttmm . . . . . 0 C--O 1.222 -0.383 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -56.99 -50.74 71.78 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.118 0.872 . . . . 0.0 109.191 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.54 -30.28 68.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.299 0.499 . . . . 0.0 110.888 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.79 -37.77 88.61 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.868 -0.52 . . . . 0.0 110.507 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.2 ttm -61.94 -18.95 62.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.681 1.592 . . . . 0.0 112.36 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.59 -57.94 9.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -59.17 -44.29 92.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.101 -0.374 . . . . 0.0 111.15 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.55 -34.39 72.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.828 -171.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -121.16 -21.68 6.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.8 1.182 . . . . 0.0 114.029 -171.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.52 8.79 57.0 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.703 -168.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -129.89 -52.4 1.14 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.255 1.528 . . . . 0.0 112.708 -170.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m 76.72 6.97 3.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.297 1.439 . . . . 0.0 111.492 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.6 p -86.13 173.2 10.0 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 110.076 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.1 154.01 64.21 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 122.793 0.437 . . . . 0.0 110.856 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.68 157.67 81.47 Favored 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 106.574 -2.125 . . . . 0.0 106.574 -11.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -136.3 118.64 15.67 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 169.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.0 OUTLIER -97.42 145.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 O-C-N 125.118 1.511 . . . . 0.0 107.499 -174.069 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -137.1 111.59 8.62 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.396 2.678 . . . . 0.0 105.903 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -103.46 111.6 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.34 56.02 8.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.327 1.451 . . . . 0.0 107.809 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.27 -14.09 0.41 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.152 3.381 . . . . 0.0 114.24 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -77.83 112.58 14.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.693 0.797 . . . . 0.0 109.565 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.53 105.73 3.2 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.281 1.032 . . . . 0.0 110.394 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -74.42 -53.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.103 0.961 . . . . 0.0 108.659 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.54 -139.84 14.4 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -170.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.28 -173.29 47.31 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.011 1.767 . . . . 0.0 114.207 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -54.68 -50.89 67.16 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 122.225 -0.574 . . . . 0.0 110.238 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -73.77 -17.98 61.03 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.055 0.388 . . . . 0.0 110.717 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.39 -48.51 55.87 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 109.385 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -60.29 -49.77 76.29 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.814 1.646 . . . . 0.0 111.108 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.34 -37.68 81.4 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.606 1.562 . . . . 0.0 110.806 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.67 -44.22 78.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.678 0.791 . . . . 0.0 111.223 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.3 tp -56.58 -43.99 80.6 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 110.396 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.08 -35.58 81.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.021 0.528 . . . . 0.0 111.577 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.02 -26.47 66.79 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.905 0.482 . . . . 0.0 111.946 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -4.85 47.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.296 -0.877 . . . . 0.0 112.437 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.4 29.08 70.59 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.15 -28.3 13.76 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 118.339 1.07 . . . . 0.0 111.446 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -73.6 -52.5 13.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.045 0.923 . . . . 0.0 109.045 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.49 -55.92 22.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.23 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -9.27 25.4 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 122.135 1.798 . . . . 0.0 114.056 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 mt -83.41 -46.85 12.06 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 120.031 1.287 . . . . 0.0 108.813 169.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 3' ' ' VAL . 13.8 mt . . . . . 0 C--O 1.239 0.531 0 C-N-CA 124.462 1.105 . . . . 0.0 113.921 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.368 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 81' ' ' LEU . 80.9 t -130.36 130.29 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -130.17 144.29 51.27 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.86 1.264 . . . . 0.0 108.67 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 tt -141.49 113.21 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.116 0.484 . . . . 0.0 110.058 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -73.8 129.28 37.59 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -141.18 174.52 10.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.41 1.484 . . . . 0.0 110.75 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 173.47 11.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.76 -20.72 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.672 0.789 . . . . 0.0 112.128 -174.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 t -133.49 77.85 1.74 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.815 1.646 . . . . 0.0 107.411 -168.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.6 87.34 4.83 Favored Pre-proline 0 N--CA 1.443 -0.78 0 C-N-CA 124.764 1.226 . . . . 0.0 108.289 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.17 -31.0 92.57 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.65 1.567 . . . . 0.0 111.362 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.46 -36.49 65.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.56 1.527 . . . . 0.0 110.806 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.7 m -58.0 -46.42 85.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -60.23 -43.8 95.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.09 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.85 -51.81 64.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.163 1.801 . . . . 0.0 110.89 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -60.19 -55.98 27.15 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.923 0.889 . . . . 0.0 110.129 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -63.29 -29.75 71.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.28 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.55 -46.08 87.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.345 0.975 . . . . 0.0 109.228 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.0 -40.57 95.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.058 0.845 . . . . 0.0 110.235 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.44 -40.43 97.13 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.374 -0.828 . . . . 0.0 111.07 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -67.74 -30.43 69.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 110.678 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -71.23 -34.41 70.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.962 0.905 . . . . 0.0 111.238 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -73.79 -17.93 61.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.516 0.598 . . . . 0.0 109.474 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.92 23.11 67.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.137 1.351 . . . . 0.0 111.751 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 m -89.92 157.13 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 118.068 0.934 . . . . 0.0 112.751 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -85.22 136.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 168.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.45 165.81 28.28 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.48 1.912 . . . . 0.0 106.012 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -107.02 140.18 40.23 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.7 145.22 30.39 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -128.3 118.49 20.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 151.93 54.2 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.451 1.434 . . . . 0.0 108.984 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 125.463 1.505 . . . . 0.0 110.034 170.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp . . . . . 0 C--O 1.227 -0.129 0 N-CA-C 111.303 0.112 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -58.93 -53.23 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.793 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.03 -28.12 64.17 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.676 1.125 . . . . 0.0 112.424 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.6 -39.39 76.73 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.019 0.827 . . . . 0.0 108.94 169.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -65.32 -26.0 67.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.443 -0.785 . . . . 0.0 110.996 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.0 mt -74.27 -46.41 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.13 -63.79 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.332 0.969 . . . . 0.0 109.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -64.62 -42.56 95.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.704 2.402 . . . . 0.0 112.806 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -1.2 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -168.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.45 46.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.284 0.947 . . . . 0.0 113.251 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -136.72 -167.5 2.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.433 1.493 . . . . 0.0 109.6 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 p -155.9 3.46 0.17 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 129.565 3.146 . . . . 0.0 109.911 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.6 p -101.0 175.94 5.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.133 2.573 . . . . 0.0 110.343 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.93 158.21 62.59 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.6 163.09 82.3 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.776 -1.344 . . . . 0.0 108.639 -11.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.92 98.84 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 171.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.13 145.07 8.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -131.91 132.18 43.37 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 126.861 2.064 . . . . 0.0 106.04 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 HG22 ' A' ' 3' ' ' VAL . 3.2 mp -125.54 122.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 41.66 47.22 3.37 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.554 1.542 . . . . 0.0 112.486 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.96 3.46 4.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.543 2.337 . . . . 0.0 114.539 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -75.88 105.78 7.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -62.41 122.79 16.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -92.24 -75.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.74 -138.78 5.77 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 -162.25 19.61 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 126.504 2.002 . . . . 0.0 111.027 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -61.34 -42.07 98.08 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.089 0.945 . . . . 0.0 110.666 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.16 -38.52 91.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.392 0.433 . . . . 0.0 110.341 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.07 -48.86 64.42 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.411 1.084 . . . . 0.0 109.968 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.46 HD13 ' HB1' ' A' ' 17' ' ' ALA . 4.5 tt -54.29 -52.21 62.17 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 126.581 1.953 . . . . 0.0 110.571 172.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -68.75 -37.95 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.3 99.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.686 -0.673 . . . . 0.0 111.213 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.82 -42.43 79.59 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.057 1.298 . . . . 0.0 110.399 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.57 -37.51 87.81 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.274 1.03 . . . . 0.0 110.957 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.0 -21.82 65.03 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.425 -0.797 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -82.58 -7.23 59.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.876 1.271 . . . . 0.0 111.168 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.03 19.96 68.4 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.41 8.49 66.72 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.429 1.115 . . . . 0.0 112.014 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -110.3 -52.8 2.75 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.986 1.314 . . . . 0.0 109.192 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.33 -55.63 9.53 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.517 1.527 . . . . 0.0 113.782 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.53 -12.54 31.61 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.67 1.58 . . . . 0.0 113.216 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.98 -10.55 18.88 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.038 0.935 . . . . 0.0 111.34 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.564 ' CD2' HG21 ' A' ' 3' ' ' VAL . 13.5 mt . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 119.415 1.007 . . . . 0.0 112.319 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.52 ' CG2' HD21 ' A' ' 81' ' ' LEU . 70.9 t -123.88 128.96 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -122.87 121.91 37.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -168.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.25 18.6 tt -133.17 102.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 121.823 0.82 . . . . 0.0 110.935 -169.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.08 136.2 43.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -143.67 175.71 9.77 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.833 1.653 . . . . 0.0 110.793 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.507 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -134.25 173.52 11.52 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.872 1.669 . . . . 0.0 107.343 168.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -29.46 68.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.655 0.782 . . . . 0.0 111.915 -174.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -87.79 -129.08 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 168.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.9 t 74.73 88.05 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.563 2.345 . . . . 0.0 111.058 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.73 -36.74 83.27 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.198 1.932 . . . . 0.0 110.992 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -73.55 -27.08 61.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.482 -0.761 . . . . 0.0 111.151 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -63.13 -49.83 72.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -55.5 -46.87 76.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.313 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -54.84 -52.87 61.39 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 119.261 0.937 . . . . 0.0 111.374 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.56 -51.84 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.275 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -60.61 -34.96 75.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.714 1.143 . . . . 0.0 111.551 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.89 82.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.658 0.663 . . . . 0.0 110.068 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.38 -46.59 86.06 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.044 0.938 . . . . 0.0 110.077 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.26 -45.32 73.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.453 1.101 . . . . 0.0 111.329 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -69.5 -27.69 65.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.083 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -63.6 -41.95 98.29 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.049 0.84 . . . . 0.0 109.696 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -74.65 -6.63 49.77 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.627 0.649 . . . . 0.0 111.596 175.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.57 27.28 72.78 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.68 171.69 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 117.501 0.65 . . . . 0.0 110.476 -172.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 m -102.04 131.26 48.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -140.96 173.1 11.8 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.691 0.796 . . . . 0.0 108.883 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -125.24 126.65 45.49 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 128.101 2.56 . . . . 0.0 105.69 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.23 140.0 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -124.88 116.4 26.2 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.092 . . . . 0.0 110.799 -168.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -68.55 146.01 66.24 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.016 1.81 . . . . 0.0 109.115 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.465 0.304 0 C-N-CA 124.33 1.052 . . . . 0.0 110.864 169.997 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt . . . . . 0 C--O 1.224 -0.254 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -74.03 -32.64 63.44 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.633 1.106 . . . . 0.0 110.47 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.17 -43.39 67.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.695 169.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -62.21 -31.51 72.05 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.696 -0.628 . . . . 0.0 110.435 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.2 -19.86 63.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.605 -1.31 . . . . 0.0 112.484 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -64.1 -58.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.33 -31.8 72.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.917 1.687 . . . . 0.0 111.016 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -95.33 -40.89 9.3 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.381 1.473 . . . . 0.0 112.83 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -103.34 -26.71 12.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.285 1.402 . . . . 0.0 112.526 -173.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.7 33.2 76.53 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.47 -1.183 . . . . 0.0 112.063 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -143.66 -52.6 0.35 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.23 1.515 . . . . 0.0 113.335 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.406 62.5 p 68.29 4.99 4.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.483 2.713 . . . . 0.0 115.51 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -81.44 176.08 10.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -141.97 160.72 54.53 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.328 168.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 72.6 Cg_endo -69.1 160.35 86.18 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.65 0.911 . . . . 0.0 112.078 -0.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.75 99.64 5.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 168.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.51 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.6 mp -86.59 141.5 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 171.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.69 136.31 49.55 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 129.228 3.011 . . . . 0.0 105.248 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.439 HG12 HG22 ' A' ' 3' ' ' VAL . 56.3 mt -128.89 110.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 46.0 48.8 12.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.866 0.866 . . . . 0.0 111.814 -169.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.71 -6.74 1.86 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 129.531 3.132 . . . . 0.0 114.8 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.06 105.65 5.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -70.14 105.71 3.02 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.85 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.67 -144.03 13.09 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 -169.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.04 -161.04 24.59 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.986 1.755 . . . . 0.0 111.177 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -61.52 -45.58 93.61 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 121.808 -0.819 . . . . 0.0 110.496 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.44 -27.19 65.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.842 0.746 . . . . 0.0 109.2 -169.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.99 -55.32 11.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.288 2.235 . . . . 0.0 110.229 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.08 -47.33 86.32 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.302 1.841 . . . . 0.0 111.061 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.76 -41.22 90.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.219 1.408 . . . . 0.0 108.831 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.79 -34.96 76.43 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.004 0.82 . . . . 0.0 112.494 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.68 -51.96 66.75 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.992 1.269 . . . . 0.0 110.662 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -66.15 -28.01 68.46 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.146 0.978 . . . . 0.0 111.267 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.17 -8.58 56.41 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.481 -1.387 . . . . 0.0 112.328 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.37 -3.53 28.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.715 170.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.07 18.71 79.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.143 0.883 . . . . 0.0 110.913 -171.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.38 -1.32 69.19 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.546 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.3 -46.07 7.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.035 1.417 . . . . 0.0 111.044 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER -47.64 -49.24 57.05 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 174.19 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.72 -5.62 14.78 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 CA-C-N 121.905 1.716 . . . . 0.0 113.234 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.77 -55.82 2.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.723 1.209 . . . . 0.0 109.519 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.52 HD21 ' CG2' ' A' ' 3' ' ' VAL . 8.1 mt . . . . . 0 C--O 1.236 0.362 0 C-N-CA 125.82 1.648 . . . . 0.0 114.764 -169.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.68 160.95 5.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -154.42 112.91 3.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.81 110.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 118.512 0.596 . . . . 0.0 112.561 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -89.62 124.49 34.61 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -141.36 173.2 11.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.808 0.843 . . . . 0.0 111.336 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 -178.19 5.51 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.973 -1.079 . . . . 0.0 111.145 -172.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -31.55 68.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.958 1.303 . . . . 0.0 112.065 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -134.17 148.5 50.94 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t 163.8 89.87 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 129.288 3.035 . . . . 0.0 106.125 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.92 -30.7 90.49 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 111.533 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.32 -31.97 64.32 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.264 -0.897 . . . . 0.0 110.02 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -65.09 -46.72 79.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -51.85 -52.3 50.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.404 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -54.26 -50.33 67.48 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.194 1.361 . . . . 0.0 111.751 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.25 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.721 0.692 . . . . 0.0 111.472 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -62.46 -37.21 85.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.489 1.041 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.81 98.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.516 0.726 . . . . 0.0 109.604 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.5 -48.53 80.51 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.59 0.632 . . . . 0.0 109.529 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.63 -38.23 90.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.164 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.6 m -69.92 -30.64 68.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.5 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.6 m -66.22 -36.28 82.62 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 120.262 1.392 . . . . 0.0 110.202 172.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -77.15 -12.93 60.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.848 -0.533 . . . . 0.0 111.673 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.75 26.65 71.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.73 168.31 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.326 1.063 . . . . 0.0 109.779 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -91.62 124.13 35.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 170.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -150.13 168.46 23.89 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 122.638 0.375 . . . . 0.0 111.37 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -132.47 132.57 42.85 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.06 148.37 38.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.157 0.911 . . . . 0.0 109.646 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.27 92.65 31.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 125.272 1.429 . . . . 0.0 109.221 -168.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.11 129.38 21.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.181 2.588 . . . . 0.0 109.692 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.705 0 C-N-CA 125.008 1.323 . . . . 0.0 109.474 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 ttt-85 -78.78 -50.42 11.36 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.8 -26.41 68.34 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.771 0.714 . . . . 0.0 110.897 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.17 -51.76 68.22 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.2 ttp -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -65.08 -51.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.643 -1.286 . . . . 0.0 108.908 169.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -57.57 -36.49 71.75 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.308 0.958 . . . . 0.0 112.282 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -92.32 -28.84 16.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.623 -169.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -124.17 -18.49 5.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.833 1.197 . . . . 0.0 112.855 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.98 -16.08 1.64 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.843 1.687 . . . . 0.0 112.734 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -91.57 -71.02 0.66 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 126.45 1.9 . . . . 0.0 112.453 -168.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.385 0.6 OUTLIER 71.72 1.73 4.0 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 129.984 3.314 . . . . 0.0 113.903 -168.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.4 p -74.28 176.32 6.78 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.607 1.563 . . . . 0.0 107.716 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.09 158.95 74.53 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.8 161.42 79.51 Favored 'Cis proline' 0 C--N 1.348 0.519 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 -11.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.14 97.37 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 170.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -89.94 146.42 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -131.56 148.55 52.63 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.284 3.034 . . . . 0.0 106.11 170.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.88 116.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 168.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 62.31 40.7 11.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 110.279 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 75.0 -8.64 1.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.666 3.187 . . . . 0.0 114.246 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -74.35 101.12 3.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.63 1.972 . . . . 0.0 105.872 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -60.98 106.34 0.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.3 mm -74.36 -56.61 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.263 1.025 . . . . 0.0 108.847 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.61 -141.9 12.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.14 -169.67 26.02 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.053 1.787 . . . . 0.0 111.334 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -57.17 -42.51 81.28 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.526 -0.985 . . . . 0.0 111.437 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.45 -37.85 88.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.248 0.476 . . . . 0.0 109.786 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.0 -47.35 74.79 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.652 1.181 . . . . 0.0 109.901 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -55.19 29.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.337 1.855 . . . . 0.0 110.31 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.75 -34.5 77.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.79 88.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.189 0.904 . . . . 0.0 111.912 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.84 -46.35 81.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.875 1.216 . . . . 0.0 110.28 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.67 -41.03 98.86 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.16 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.92 71.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.71 1.204 . . . . 0.0 110.94 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -17.1 61.1 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.119 0.968 . . . . 0.0 110.439 176.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 25.62 41.28 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -169.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.86 -7.19 48.09 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.62 -1.1 . . . . 0.0 113.322 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.19 -48.77 8.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.985 1.392 . . . . 0.0 108.442 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.48 96.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.204 1.402 . . . . 0.0 112.111 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 -12.06 34.45 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 123.266 2.202 . . . . 0.0 113.238 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.43 -48.82 4.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.814 0.846 . . . . 0.0 110.181 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 N--CA 1.463 0.193 0 C-N-CA 125.669 1.588 . . . . 0.0 114.58 -168.197 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.43 90.15 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -104.64 124.67 49.75 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.531 -1.668 . . . . 0.0 108.328 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -126.82 101.85 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 0.0 111.389 -171.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -73.82 142.38 46.14 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.433 -0.792 . . . . 0.0 109.14 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.9 p -151.6 171.09 18.15 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.53 1.132 . . . . 0.0 111.199 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.545 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -135.67 174.04 11.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.499 1.52 . . . . 0.0 107.138 168.384 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -38.4 68.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.084 1.354 . . . . 0.0 113.057 -168.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.64 145.11 48.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t 172.69 103.45 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.561 2.344 . . . . 0.0 104.793 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -65.93 -30.11 48.88 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.148 1.899 . . . . 0.0 110.853 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -73.63 -37.23 65.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.021 0.929 . . . . 0.0 110.43 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -61.65 -47.36 85.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.855 0.752 . . . . 0.0 109.043 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -53.48 -53.42 51.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.02 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.48 -50.75 70.85 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.867 1.212 . . . . 0.0 112.068 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.02 -49.83 66.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.77 0.714 . . . . 0.0 110.9 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -61.71 -37.2 83.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.495 1.043 . . . . 0.0 110.787 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.68 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.043 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.81 -48.61 81.01 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.36 -42.15 79.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.438 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.5 m -70.91 -30.64 67.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.957 0.798 . . . . 0.0 111.056 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -70.31 -35.44 73.67 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.313 0.961 . . . . 0.0 110.824 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -75.08 -15.09 60.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.234 0.925 . . . . 0.0 110.704 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.38 24.43 75.16 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.334 1.445 . . . . 0.0 112.206 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 81' ' ' LEU . 7.9 m -83.14 154.78 3.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.22 1.01 . . . . 0.0 110.35 -172.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 m -81.2 115.51 20.64 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.249 1.82 . . . . 0.0 107.931 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -137.49 175.91 9.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 109.157 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -124.85 144.51 50.27 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.019 2.527 . . . . 0.0 106.561 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -116.14 152.44 33.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.633 0.652 . . . . 0.0 110.363 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.32 81.28 61.2 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.29 1.036 . . . . 0.0 109.735 -172.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.14 148.26 84.94 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.362 2.041 . . . . 0.0 112.074 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 pt . . . . . 0 CA--C 1.533 0.296 0 C-N-CA 126.412 1.885 . . . . 0.0 110.636 169.585 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . 0.259 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.48 -45.98 88.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.259 -1.526 . . . . 0.0 110.898 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -29.91 70.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.902 -177.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -55.76 -37.48 68.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.819 0.848 . . . . 0.0 110.465 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.1 ttm -61.89 -18.39 60.01 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.333 1.053 . . . . 0.0 112.782 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.49 -65.53 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -59.74 -28.16 67.12 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 121.476 1.944 . . . . 0.0 112.295 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -68.45 -45.08 73.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.604 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.3 p -121.72 -22.69 5.74 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.94 5.22 79.45 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.702 1.62 . . . . 0.0 112.376 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.438 ' HB2' HE22 ' A' ' 54' ' ' GLN . 11.2 mtp180 -124.85 -55.37 1.61 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.779 2.289 . . . . 0.0 114.951 -168.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.378 0.7 OUTLIER 69.15 13.67 8.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.676 2.79 . . . . 0.0 114.707 -173.352 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.9 p -75.99 175.59 8.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.113 1.765 . . . . 0.0 109.109 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.545 HG21 ' HG2' ' A' ' 8' ' ' LYS . 1.2 m -142.94 164.43 32.12 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.857 172.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.85 159.92 78.84 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.377 1.17 . . . . 0.0 109.639 -9.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.438 HE22 ' HB2' ' A' ' 49' ' ' ARG . 8.2 mt-30 -136.43 103.11 5.16 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 172.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 143.74 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 171.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -133.53 119.31 19.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.125 1.77 . . . . 0.0 106.369 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.438 HG21 HD13 ' A' ' 80' ' ' LEU . 26.4 mm -113.16 97.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 49.44 65.71 1.32 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.193 0.997 . . . . 0.0 111.054 -168.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 73.23 -13.99 0.66 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 128.444 2.698 . . . . 0.0 114.488 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -74.81 96.8 3.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.736 2.414 . . . . 0.0 108.457 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -64.03 110.55 2.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.94 -64.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.31 -145.14 14.07 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.21 -163.96 38.85 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.232 1.396 . . . . 0.0 111.798 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -65.15 -41.5 94.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.095 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.27 -45.26 80.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.033 0.833 . . . . 0.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -63.93 -48.33 77.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.666 1.186 . . . . 0.0 110.097 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.51 -48.58 78.93 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.85 1.26 . . . . 0.0 111.893 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.24 -33.82 75.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 123.589 0.756 . . . . 0.0 109.313 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -43.18 83.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.931 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.5 -44.91 81.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.18 1.355 . . . . 0.0 110.543 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.7 -42.08 91.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.048 0.539 . . . . 0.0 111.22 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.14 70.52 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.769 -0.582 . . . . 0.0 110.373 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -73.85 -19.77 60.63 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.898 1.279 . . . . 0.0 109.291 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 23.7 68.81 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.7 -13.53 40.39 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.769 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.4 -49.2 12.72 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.665 1.233 . . . . 0.0 109.8 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.96 -54.34 20.9 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 112.502 -173.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.0 3.09 5.35 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.898 2.398 . . . . 0.0 113.275 -175.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 HG21 ' A' ' 57' ' ' ILE . 96.2 mt -110.67 -3.86 15.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.958 -1.089 . . . . 0.0 110.571 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.414 HD12 ' HB ' ' A' ' 26' ' ' VAL . 3.8 mm? . . . . . 0 C--O 1.233 0.197 0 C-N-CA 123.943 0.897 . . . . 0.0 112.391 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.35 93.54 9.56 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.897 0.879 . . . . 0.0 110.513 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.669 HG21 HD21 ' A' ' 81' ' ' LEU . 73.3 t -127.62 128.02 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 118.854 0.752 . . . . 0.0 109.79 -171.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.13 145.34 45.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 124.095 0.872 . . . . 0.0 109.599 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -139.47 115.59 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -75.4 144.68 42.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -147.23 172.14 14.29 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.279 1.032 . . . . 0.0 113.2 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -146.15 173.97 11.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.637 169.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -49.68 -39.54 36.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.125 2.57 . . . . 0.0 111.331 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.7 p -133.62 88.25 2.46 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -168.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.1 t -148.81 86.66 5.69 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.05 -37.16 78.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.291 1.994 . . . . 0.0 110.394 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -73.45 -24.78 60.27 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.143 -0.973 . . . . 0.0 111.549 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 75.1 m -63.14 -51.96 64.4 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 120.264 1.393 . . . . 0.0 108.968 169.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.75 -41.93 74.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.912 -1.042 . . . . 0.0 111.053 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -54.45 -56.04 22.82 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.345 1.429 . . . . 0.0 110.924 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.98 -49.34 76.49 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.393 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.786 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.16 90.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.003 0.82 . . . . 0.0 110.19 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 tt -64.99 -47.68 76.66 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.551 0.614 . . . . 0.0 109.468 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.9 -35.01 79.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.386 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 m -75.18 -28.94 60.25 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.65 0.78 . . . . 0.0 111.631 174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -40.15 92.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.359 0.982 . . . . 0.0 109.328 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -73.35 -25.57 60.66 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.766 -1.209 . . . . 0.0 108.921 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.5 32.32 59.84 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.889 1.709 . . . . 0.0 111.03 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.69 171.37 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.281 0.562 . . . . 0.0 110.117 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.08 121.64 42.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -141.73 165.02 28.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.578 1.151 . . . . 0.0 110.131 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.53 144.62 35.94 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.181 1.392 . . . . 0.0 108.385 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.57 143.72 44.92 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.444 1.498 . . . . 0.0 108.068 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.44 103.56 16.4 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.912 1.285 . . . . 0.0 110.0 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.92 144.35 27.25 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.854 1.703 . . . . 0.0 110.26 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.441 ' HA ' ' HB3' ' A' ' 36' ' ' ASN . 6.7 mt -104.72 6.73 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 122.131 0.967 . . . . 0.0 109.994 172.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.66 95.67 2.88 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.369 2.267 . . . . 0.0 108.903 -171.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.14 -1.87 84.97 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.875 0.75 . . . . 0.0 113.243 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 33' ' ' ILE . 13.6 t-20 -83.4 168.47 16.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.623 1.569 . . . . 0.0 107.299 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.1 -47.31 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.37 2.268 . . . . 0.0 108.267 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.9 83.61 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.784 1.174 . . . . 0.0 111.039 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -81.09 -17.64 49.34 Favored 'General case' 0 N--CA 1.462 0.152 0 O-C-N 120.708 -1.245 . . . . 0.0 111.079 174.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -67.64 -39.12 84.64 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.296 -1.502 . . . . 0.0 108.751 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -63.07 -40.78 98.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.506 0.723 . . . . 0.0 109.962 171.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -52.77 -45.7 67.24 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.425 0.557 . . . . 0.0 109.934 172.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.51 -24.96 66.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 113.366 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mt -65.0 -54.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.51 -36.98 85.57 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 119.605 -0.236 . . . . 0.0 110.843 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -75.66 -56.28 4.84 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.541 0.736 . . . . 0.0 111.282 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -91.09 -38.73 12.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.596 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.84 38.55 89.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -148.05 -58.09 0.24 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.359 1.464 . . . . 0.0 110.696 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.259 3.6 m 83.16 10.87 0.52 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.729 1.612 . . . . 0.0 111.909 171.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 81.1 p -109.35 171.89 7.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.454 2.702 . . . . 0.0 108.129 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.454 HG21 ' HG2' ' A' ' 8' ' ' LYS . 1.1 m -140.19 166.02 26.49 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.56 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.417 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 73.2 Cg_endo -63.28 148.7 64.84 Favored 'Cis proline' 0 CA--C 1.509 -0.738 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 -6.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -138.02 108.17 6.41 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.0 mp -94.28 145.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 125.271 1.607 . . . . 0.0 107.083 -176.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -128.36 124.15 35.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.806 2.842 . . . . 0.0 103.793 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 HG13 ' A' ' 3' ' ' VAL . 29.0 mm -120.96 117.99 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.255 0.6 OUTLIER 49.32 52.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.335 1.454 . . . . 0.0 110.659 -172.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.03 0.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.62 2.768 . . . . 0.0 114.329 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -86.59 108.17 18.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.253 1.421 . . . . 0.0 107.244 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -63.1 109.3 1.46 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.943 0.897 . . . . 0.0 109.071 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.38 -56.44 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.79 0.836 . . . . 0.0 109.292 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.1 -141.72 12.94 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.04 -165.8 30.16 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 118.885 1.343 . . . . 0.0 113.343 -168.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.0 -43.21 91.46 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.241 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.84 -35.84 82.41 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.733 0.697 . . . . 0.0 109.823 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -45.86 70.25 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.734 1.613 . . . . 0.0 111.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.45 -48.51 79.32 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 127.471 2.309 . . . . 0.0 111.363 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -69.51 -29.4 67.01 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -44.17 81.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.156 0.582 . . . . 0.0 110.941 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.77 -37.74 71.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.403 1.001 . . . . 0.0 110.801 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.38 -40.82 89.92 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.185 -0.947 . . . . 0.0 111.97 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.19 68.12 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.742 1.217 . . . . 0.0 112.171 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -89.22 3.84 50.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.814 1.246 . . . . 0.0 112.445 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 18.3 69.33 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.424 0.557 . . . . 0.0 112.154 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.86 -12.4 43.54 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.643 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.5 tp -73.65 -49.17 27.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.262 1.031 . . . . 0.0 109.511 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.87 -51.77 73.81 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.424 1.49 . . . . 0.0 112.33 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.36 -8.5 23.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.803 2.335 . . . . 0.0 114.707 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 mt -91.07 -49.52 6.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.669 HD21 HG21 ' A' ' 3' ' ' VAL . 4.9 mt -82.59 -22.31 34.86 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -173.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-N 120.07 1.304 . . . . 0.0 109.209 -168.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 121.0 19.76 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 169.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.608 HG21 HD21 ' A' ' 81' ' ' LEU . 93.8 t -126.84 132.88 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -136.59 127.37 27.32 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -168.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 tt -128.73 110.77 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.01 143.52 45.52 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -147.54 179.9 7.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.433 1.093 . . . . 0.0 111.725 -171.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.492 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -150.15 -172.56 4.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.245 -1.534 . . . . 0.0 107.929 168.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 10' ' ' THR . 1.1 pt-20 -35.76 -64.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.664 3.586 . . . . 0.0 111.259 170.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.438 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 14.7 t -134.13 124.21 25.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.0 t -169.6 101.11 0.47 Allowed Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.44 -35.73 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.971 1.781 . . . . 0.0 109.872 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -73.27 -32.8 64.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.778 -0.576 . . . . 0.0 109.811 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -61.59 -51.14 69.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.043 0.838 . . . . 0.0 109.15 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -54.54 -45.75 73.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.562 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -59.71 -49.77 76.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.525 1.511 . . . . 0.0 111.688 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.51 94.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.61 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -57.26 -51.52 69.03 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.495 1.043 . . . . 0.0 109.819 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.83 -22.58 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.655 0.782 . . . . 0.0 111.599 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -75.98 -50.61 14.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.101 1.36 . . . . 0.0 110.011 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.03 -42.52 98.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.25 1.02 . . . . 0.0 111.021 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.3 m -67.52 -28.14 67.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.809 1.644 . . . . 0.0 110.995 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -42.56 99.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HE3' ' OD1' ' A' ' 72' ' ' ASP . 66.2 mmtt -84.25 -6.55 59.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.004 0.82 . . . . 0.0 112.081 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.46 34.73 80.05 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 124.659 1.123 . . . . 0.0 111.901 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 81' ' ' LEU . 18.0 m -90.65 157.44 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 123.331 0.653 . . . . 0.0 110.912 -169.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -95.4 98.99 10.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' HD1' HG23 ' A' ' 26' ' ' VAL . 36.9 p90 -106.51 165.92 10.93 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.822 0.849 . . . . 0.0 108.781 169.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.22 144.19 31.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.178 1.791 . . . . 0.0 106.407 168.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.71 144.84 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mt -129.94 69.77 81.83 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.937 1.295 . . . . 0.0 108.495 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.58 140.3 47.03 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 N-CA-C 108.59 -1.35 . . . . 0.0 108.59 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 pt -98.98 -2.71 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.478 1.111 . . . . 0.0 111.324 170.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.3 -24.83 66.7 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.467 1.507 . . . . 0.0 114.104 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.88 34.94 2.15 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.12 1.819 . . . . 0.0 110.738 169.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.409 HD21 ' HB3' ' A' ' 39' ' ' LYS . 1.3 t30 -144.71 74.86 1.43 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.999 1.32 . . . . 0.0 108.886 -172.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.52 -17.28 64.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.72 -62.28 1.6 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.343 0.974 . . . . 0.0 109.877 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 36' ' ' ASN . 0.7 OUTLIER -77.84 -13.5 59.87 Favored 'General case' 0 C--O 1.225 -0.204 0 O-C-N 121.816 -0.552 . . . . 0.0 110.798 -174.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -54.27 -44.59 72.0 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 168.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -73.01 -42.33 63.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.163 0.585 . . . . 0.0 109.965 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.67 -32.1 72.26 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.659 -0.65 . . . . 0.0 110.956 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.4 ttp -55.75 -16.01 3.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.873 1.269 . . . . 0.0 113.235 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.73 -70.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 170.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -66.91 -27.6 67.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 120.194 1.361 . . . . 0.0 112.314 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HD2' ' CE2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -66.2 -50.87 62.37 Favored 'General case' 0 CA--C 1.524 -0.047 0 CA-C-N 119.17 0.895 . . . . 0.0 109.735 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 p -105.31 -31.89 8.86 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.671 1.123 . . . . 0.0 112.875 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.93 24.29 75.77 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 121.452 -0.78 . . . . 0.0 112.196 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -136.36 -53.13 0.73 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.99 1.316 . . . . 0.0 110.573 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m 75.72 2.66 3.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.448 1.099 . . . . 0.0 110.927 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 p -84.22 177.15 8.31 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.99 3.316 . . . . 0.0 107.873 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.1 m -129.5 161.12 60.84 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.129 169.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.26 166.51 79.75 Favored 'Cis proline' 0 N--CA 1.456 -0.698 0 CA-C-N 119.396 0.82 . . . . 0.0 110.675 -10.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -132.94 104.29 6.49 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 168.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.22 142.78 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CE2' ' HD2' ' A' ' 46' ' ' ARG . 96.7 m-85 -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.338 2.255 . . . . 0.0 106.871 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 3' ' ' VAL . 68.1 mt -132.83 119.66 38.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.281 14.8 m-20 45.6 45.51 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.805 0.812 . . . . 0.0 112.566 -169.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.37 -0.16 2.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.557 2.743 . . . . 0.0 114.249 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.24 109.58 7.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.9 113.48 3.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.9 mm -77.38 -55.02 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 108.872 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.68 -144.91 13.02 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.28 -163.67 26.5 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.421 2.438 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -57.17 -47.62 80.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.107 0.953 . . . . 0.0 112.022 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -64.77 -33.46 76.03 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.181 0.446 . . . . 0.0 109.939 -170.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.0 -44.57 72.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.924 1.69 . . . . 0.0 110.914 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.72 -51.13 70.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.889 1.276 . . . . 0.0 109.806 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.41 -30.33 70.06 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -40.97 85.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.138 1.375 . . . . 0.0 112.327 169.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.0 tp -56.25 -45.71 79.91 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.8 1.637 . . . . 0.0 110.322 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.411 ' OD1' ' HE3' ' A' ' 24' ' ' LYS . 27.5 t70 -62.83 -34.68 77.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.965 0.506 . . . . 0.0 112.106 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.15 -15.58 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.772 1.229 . . . . 0.0 112.135 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -5.25 59.23 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.368 1.067 . . . . 0.0 111.224 168.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.07 15.83 70.05 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -168.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.57 -9.34 55.07 Favored Glycine 0 C--N 1.341 0.843 0 C-N-CA 124.697 1.142 . . . . 0.0 112.868 -170.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.431 HD11 HD12 ' A' ' 81' ' ' LEU . 57.4 tp -73.94 -47.93 34.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.329 1.065 . . . . 0.0 109.844 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -54.78 35.84 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.892 1.277 . . . . 0.0 112.156 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.21 -1.91 8.86 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.396 2.064 . . . . 0.0 113.889 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.38 -3.13 19.9 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.806 1.243 . . . . 0.0 111.428 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.608 HD21 HG21 ' A' ' 3' ' ' VAL . 26.6 mt -137.65 18.25 2.88 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.971 1.308 . . . . 0.0 111.303 -178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp . . . . . 0 C--O 1.246 0.902 0 CA-C-O 116.686 -1.626 . . . . 0.0 108.412 174.253 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.508 ' HB1' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.62 123.11 26.21 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.197 0.908 . . . . 0.0 109.031 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.639 HG21 HD21 ' A' ' 81' ' ' LEU . 70.1 t -133.72 120.07 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 119.355 0.98 . . . . 0.0 108.844 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -129.52 146.97 51.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.14 0.976 . . . . 0.0 109.462 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 tt -140.72 118.37 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 124.509 1.124 . . . . 0.0 108.226 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.782 ' HB3' HD11 ' A' ' 33' ' ' ILE . 34.6 m-85 -78.94 135.58 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.25 1.02 . . . . 0.0 108.812 171.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -144.11 -177.18 5.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.456 1.502 . . . . 0.0 111.501 -168.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -157.5 177.67 11.16 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 119.661 -1.899 . . . . 0.0 107.889 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.66 -25.23 38.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.836 1.654 . . . . 0.0 112.325 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.89 120.6 20.6 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 172.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.0 t -167.77 93.68 0.65 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.022 0.929 . . . . 0.0 111.342 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.11 -39.63 30.45 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.509 2.14 . . . . 0.0 112.033 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -73.58 -29.21 62.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.316 1.871 . . . . 0.0 110.084 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -59.3 -52.71 64.47 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 119.924 1.238 . . . . 0.0 108.239 169.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -54.56 -40.14 68.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.254 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -59.84 -54.01 51.21 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.004 1.274 . . . . 0.0 111.777 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.19 93.12 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.862 -0.523 . . . . 0.0 110.233 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -63.48 -36.51 84.0 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.202 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -26.77 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 120.268 1.394 . . . . 0.0 110.906 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.05 -55.14 11.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 26' ' ' VAL . 90.9 mt -64.87 -43.27 93.49 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.001 1.32 . . . . 0.0 112.081 -173.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -69.94 -30.81 68.29 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.496 1.118 . . . . 0.0 109.674 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -66.05 -39.87 90.47 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.474 1.033 . . . . 0.0 109.593 169.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -73.72 -9.35 58.57 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.222 0.919 . . . . 0.0 110.763 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.0 81.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 125.603 1.573 . . . . 0.0 110.446 172.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 81' ' ' LEU . 20.0 m -90.55 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.596 0.713 . . . . 0.0 112.838 -168.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.3 p -105.75 116.92 32.75 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.69 1.996 . . . . 0.0 105.792 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.467 ' HD2' HG23 ' A' ' 26' ' ' VAL . 50.8 p90 -134.78 167.75 20.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -112.73 133.36 54.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.24 111.53 20.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.438 1.895 . . . . 0.0 107.424 -168.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.85 102.37 50.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.328 1.451 . . . . 0.0 111.381 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.85 137.0 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.01 2.474 . . . . 0.0 113.892 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 6' ' ' TYR . 15.5 mt -117.86 49.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 127.322 2.249 . . . . 0.0 107.365 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.81 53.55 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.39 1.876 . . . . 0.0 111.63 174.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.73 22.29 39.68 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 119.44 -2.038 . . . . 0.0 113.851 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.4 125.54 31.79 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 -168.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.02 -29.07 68.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.081 0.855 . . . . 0.0 112.049 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.14 -50.04 71.99 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.671 1.188 . . . . 0.0 110.081 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -18.53 50.39 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.996 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -60.63 -59.34 5.55 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.54 1.064 . . . . 0.0 108.581 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.07 -41.88 89.05 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.393 0.433 . . . . 0.0 110.908 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.61 -56.19 15.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.386 1.474 . . . . 0.0 109.558 173.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.719 ' CE ' HD13 ' A' ' 33' ' ' ILE . 1.3 ttm -67.12 -26.35 66.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.837 -0.54 . . . . 0.0 112.184 -174.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.38 -54.28 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -60.83 -46.46 90.47 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.93 1.241 . . . . 0.0 112.245 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -79.88 -30.75 40.24 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 117.431 -1.271 . . . . 0.0 112.508 -169.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.2 p -116.15 -27.79 6.78 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.078 1.308 . . . . 0.0 113.458 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.03 23.88 53.04 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.482 1.037 . . . . 0.0 113.497 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -130.52 -57.9 1.05 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.271 1.035 . . . . 0.0 110.186 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.263 3.4 m 74.23 37.78 0.58 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 123.237 1.494 . . . . 0.0 110.989 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.1 p -142.09 176.91 8.59 Favored 'General case' 0 C--N 1.329 -0.325 1 C-N-CA 132.27 4.228 . . . . 0.0 105.902 -176.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.527 ' CG1' HD12 ' A' ' 33' ' ' ILE . 1.1 m -132.71 160.17 69.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.35 167.87 78.59 Favored 'Cis proline' 0 CA--C 1.534 0.514 0 N-CA-C 110.233 -0.718 . . . . 0.0 110.233 -10.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -130.47 96.21 4.07 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 168.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.555 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -81.15 144.26 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -133.04 125.1 28.92 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.561 2.744 . . . . 0.0 104.964 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.7 mm -125.28 120.99 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER 50.92 40.89 26.17 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.722 1.249 . . . . 0.0 111.789 -174.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.31 0.28 0.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.874 2.87 . . . . 0.0 114.45 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.7 121.07 20.18 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -75.01 98.86 3.71 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.41 -49.21 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 -132.19 6.8 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.51 -178.16 45.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.474 1.035 . . . . 0.0 111.264 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -54.23 -42.95 70.43 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.437 -1.037 . . . . 0.0 110.721 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -34.77 71.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.856 0.862 . . . . 0.0 111.87 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -71.69 -44.22 64.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.194 0.598 . . . . 0.0 110.993 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -62.13 -48.6 79.42 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.309 1.044 . . . . 0.0 110.619 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -59.77 -39.26 84.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.125 1.77 . . . . 0.0 109.197 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.1 81.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.189 0.596 . . . . 0.0 110.976 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 tp -56.66 -45.32 81.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.969 0.804 . . . . 0.0 110.121 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.58 -38.78 91.45 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.984 0.914 . . . . 0.0 112.181 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.32 69.77 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.429 0.559 . . . . 0.0 110.716 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -5.44 56.47 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.083 -1.011 . . . . 0.0 110.58 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.94 21.28 79.09 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.275 -0.89 . . . . 0.0 111.081 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.24 -28.19 28.59 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.12 0.96 . . . . 0.0 111.662 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.4 tp -74.21 -50.87 17.29 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.324 1.062 . . . . 0.0 110.81 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.46 -55.77 20.36 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.791 0.836 . . . . 0.0 113.133 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.7 11.86 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.825 2.35 . . . . 0.0 113.427 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.7 mt -112.35 -2.87 14.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.15 1.38 . . . . 0.0 110.396 168.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.639 HD21 HG21 ' A' ' 3' ' ' VAL . 54.5 mt -126.06 10.37 7.54 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 110.088 170.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.913 0 C-N-CA 127.745 2.418 . . . . 0.0 107.126 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.47 94.03 2.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 164.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 81' ' ' LEU . 92.5 t -106.02 133.92 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.71 144.27 33.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 123.854 0.721 . . . . 0.0 109.56 -169.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.73 117.44 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.468 0.707 . . . . 0.0 110.142 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -78.04 140.3 39.13 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -146.99 177.46 9.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.045 0.938 . . . . 0.0 112.487 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.411 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -157.73 -177.06 6.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.942 1.297 . . . . 0.0 110.899 169.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.57 -24.27 3.12 Favored 'General case' 0 CA--C 1.52 -0.187 1 C-N-CA 132.555 4.342 . . . . 0.0 114.538 -168.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -133.32 -83.47 0.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.9 t 33.99 75.99 0.43 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.752 2.021 . . . . 0.0 112.173 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.66 -24.28 74.83 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.362 2.041 . . . . 0.0 111.34 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -73.1 -37.46 66.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.957 1.253 . . . . 0.0 109.71 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -60.7 -46.86 88.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -54.39 -50.6 67.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.173 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 49.9 mtp180 -54.47 -49.73 69.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.14 1.336 . . . . 0.0 110.919 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.07 39.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.173 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -60.09 -32.05 70.6 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.617 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.91 75.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.736 1.153 . . . . 0.0 109.271 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.75 -44.66 93.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 26' ' ' VAL . 95.6 mt -69.4 -40.77 77.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.633 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -71.57 -31.93 67.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.966 0.803 . . . . 0.0 110.745 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -62.64 -44.92 95.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 3.8 mmpt? -73.7 -15.71 61.22 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.52 0.6 . . . . 0.0 110.416 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.34 18.85 78.92 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.768 1.652 . . . . 0.0 112.546 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 21' ' ' LEU . 3.2 m -73.59 160.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 118.278 1.039 . . . . 0.0 111.746 -168.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.7 m -94.56 120.98 35.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -134.16 -172.66 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.531 1.933 . . . . 0.0 107.693 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.45 137.0 48.42 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -109.62 135.57 50.37 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.498 0.719 . . . . 0.0 109.092 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.11 77.27 75.56 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.632 1.173 . . . . 0.0 108.962 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.53 152.4 80.39 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.794 2.33 . . . . 0.0 110.868 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pt -133.52 22.72 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.794 1.238 . . . . 0.0 112.507 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -70.07 138.65 52.24 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.03 -13.81 0.9 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.612 1.101 . . . . 0.0 114.707 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.419 HD21 ' N ' ' A' ' 40' ' ' ARG . 5.4 t30 -83.88 177.49 8.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 128.513 2.725 . . . . 0.0 109.485 -171.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.26 -45.23 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.167 1.787 . . . . 0.0 108.4 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.75 57.78 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.069 0.85 . . . . 0.0 110.971 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -78.13 -6.77 55.76 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.449 -0.782 . . . . 0.0 112.426 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.419 ' N ' HD21 ' A' ' 36' ' ' ASN . 31.0 ttp180 -82.85 -43.31 16.76 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -60.61 -33.48 72.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.07 -38.1 72.79 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.493 -0.755 . . . . 0.0 110.296 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -20.61 62.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.942 0.897 . . . . 0.0 111.643 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.1 mt -73.58 -42.65 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.26 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -30.74 37.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.982 1.719 . . . . 0.0 112.258 173.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -70.62 -44.97 66.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.387 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.51 -11.77 3.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -168.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.01 -20.22 47.21 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.613 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -138.56 148.03 43.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.29 1.545 . . . . 0.0 111.811 -169.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -88.17 -5.9 58.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 131.37 3.868 . . . . 0.0 113.189 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -76.56 168.52 19.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.22 1.408 . . . . 0.0 111.35 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.411 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -143.62 166.17 21.08 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.615 0.766 . . . . 0.0 110.15 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.14 155.42 73.42 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.224 1.116 . . . . 0.0 109.589 -8.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -134.1 91.92 2.88 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -86.17 150.49 3.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 46' ' ' ARG . 58.9 m-85 -141.75 145.51 34.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.369 2.668 . . . . 0.0 108.523 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.71 116.49 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 43.55 51.64 6.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.741 1.616 . . . . 0.0 112.133 -172.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.3 -0.07 2.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.87 2.468 . . . . 0.0 114.234 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -75.5 108.86 8.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -65.82 110.19 2.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.79 -58.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.33 -143.69 11.6 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -173.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.62 -172.49 41.14 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.635 2.064 . . . . 0.0 111.327 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 17.9 t80 -56.38 -46.2 80.21 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.93 -0.747 . . . . 0.0 111.154 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.74 -32.0 73.36 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.959 0.345 . . . . 0.0 110.436 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.56 -46.0 64.35 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.692 0.758 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.2 -50.21 74.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.852 1.261 . . . . 0.0 111.004 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -68.31 -28.65 67.36 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.61 82.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 110.447 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.7 tp -56.7 -46.05 81.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.735 1.152 . . . . 0.0 109.926 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.51 -43.29 89.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.635 0.774 . . . . 0.0 111.259 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.15 63.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.943 0.897 . . . . 0.0 112.123 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.87 6.84 26.5 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.232 1.413 . . . . 0.0 111.713 169.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.93 17.92 68.1 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.043 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.08 -8.53 41.53 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.862 1.331 . . . . 0.0 113.008 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -75.24 -55.48 5.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.877 1.338 . . . . 0.0 109.5 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -50.99 74.53 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.68 -17.69 30.01 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.928 2.419 . . . . 0.0 114.806 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -104.8 -1.52 25.99 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.996 1.318 . . . . 0.0 111.115 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.405 HD21 HG21 ' A' ' 3' ' ' VAL . 11.7 mt -117.83 16.85 14.35 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.322 -1.486 . . . . 0.0 112.005 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.25 2.22 . . . . 0.0 112.859 -168.086 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.57 93.98 3.93 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 81' ' ' LEU . 58.7 t -101.03 99.41 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.45 148.06 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.583 0.552 . . . . 0.0 111.58 -168.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.97 114.94 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -74.31 140.37 44.84 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -150.82 172.65 15.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.905 1.682 . . . . 0.0 110.832 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.488 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -149.41 174.81 12.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.782 1.233 . . . . 0.0 107.862 168.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -18.87 61.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.1 1.36 . . . . 0.0 113.842 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 106.75 7.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -167.0 85.63 0.83 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.664 0.786 . . . . 0.0 108.932 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.78 -33.91 96.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.633 1.555 . . . . 0.0 111.424 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -73.46 -27.57 61.48 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.769 -1.207 . . . . 0.0 109.832 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.47 -49.32 74.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.023 -1.048 . . . . 0.0 108.93 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.75 -46.55 74.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.946 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -54.56 -52.77 61.05 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 120.225 1.375 . . . . 0.0 111.335 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.23 71.35 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.527 0.603 . . . . 0.0 110.39 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -58.54 -38.1 77.08 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.39 0.996 . . . . 0.0 111.474 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.98 95.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.112 0.565 . . . . 0.0 109.706 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 tp -62.55 -48.28 80.18 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.139 0.576 . . . . 0.0 109.875 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.1 mt -65.09 -42.14 94.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 110.734 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 t -65.12 -36.34 83.95 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.512 1.125 . . . . 0.0 110.226 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.3 t -70.22 -34.4 72.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.219 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -80.92 -5.29 57.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.462 1.028 . . . . 0.0 111.424 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 23.32 77.11 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 124.609 1.1 . . . . 0.0 111.686 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.86 162.93 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 118.181 0.991 . . . . 0.0 110.283 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -100.53 113.54 26.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 172.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.76 170.18 16.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.124 1.77 . . . . 0.0 109.207 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -123.44 140.81 52.63 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.61 143.0 39.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.18 113.83 23.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.09 158.76 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.927 2.418 . . . . 0.0 110.393 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mm -125.97 -9.69 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.849 1.26 . . . . 0.0 110.778 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.04 119.76 11.95 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 168.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.9 -34.3 1.9 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.247 0.927 . . . . 0.0 112.729 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 39' ' ' LYS . 10.1 t30 -87.45 53.98 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 123.336 1.541 . . . . 0.0 107.831 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 -18.74 63.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.154 -1.591 . . . . 0.0 110.973 168.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.03 -69.69 0.1 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.991 1.716 . . . . 0.0 109.657 169.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' HB3' HD21 ' A' ' 36' ' ' ASN . 6.2 ttmm -74.79 -12.24 60.35 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.407 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.3 -45.21 94.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.959 1.254 . . . . 0.0 110.339 168.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.7 -39.55 93.84 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.779 0.718 . . . . 0.0 110.098 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -58.01 -36.96 73.43 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.605 -0.684 . . . . 0.0 110.377 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.8 ttm -64.4 -16.05 61.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.922 1.689 . . . . 0.0 112.513 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.28 -58.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -55.08 -50.13 69.93 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.403 0.62 . . . . 0.0 110.567 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.74 -39.99 73.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.426 -168.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.8 p -112.03 -25.37 9.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 112.865 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.0 21.73 63.97 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.353 -168.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -136.54 -57.03 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.307 1.554 . . . . 0.0 113.011 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 79.3 -6.34 1.86 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 129.755 3.222 . . . . 0.0 113.612 -172.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.4 p -73.79 176.4 6.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.772 2.029 . . . . 0.0 107.92 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.488 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -140.3 159.42 63.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 O-C-N 121.849 -0.532 . . . . 0.0 110.033 176.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.36 165.79 81.94 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 125.591 -0.587 . . . . 0.0 111.395 -5.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -132.89 104.44 6.58 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 168.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.487 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.8 mp -81.12 141.79 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 171.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -127.69 128.76 45.98 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 128.332 2.653 . . . . 0.0 104.953 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.527 HG21 ' HB3' ' A' ' 80' ' ' LEU . 68.3 mt -119.44 104.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 52.22 52.14 14.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.295 1.038 . . . . 0.0 109.175 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.19 -13.49 0.9 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 130.565 3.546 . . . . 0.0 114.428 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -74.7 108.75 7.65 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -67.55 110.24 3.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -74.25 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.14 -145.9 13.82 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -168.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.78 -168.74 36.67 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.169 1.366 . . . . 0.0 112.016 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -61.51 -39.98 92.96 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.682 -0.893 . . . . 0.0 110.214 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.54 -35.92 82.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -65.7 -45.78 81.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.941 1.296 . . . . 0.0 110.701 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.26 -48.32 70.85 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 126.188 1.795 . . . . 0.0 111.087 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -64.96 -34.68 79.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.705 1.202 . . . . 0.0 109.541 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.17 77.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.233 0.613 . . . . 0.0 110.824 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.62 -39.33 73.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.858 0.863 . . . . 0.0 109.839 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.24 -34.18 70.54 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.527 -0.733 . . . . 0.0 112.722 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.28 -34.05 75.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.224 1.009 . . . . 0.0 110.781 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -90.53 6.77 42.18 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 124.799 1.24 . . . . 0.0 112.888 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.95 3.86 52.95 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.273 0.939 . . . . 0.0 112.463 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.12 -17.62 80.22 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.376 0.988 . . . . 0.0 112.047 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.54 -40.39 61.75 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.242 1.017 . . . . 0.0 111.61 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -56.21 24.83 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.154 0.982 . . . . 0.0 112.398 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.49 16.32 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.197 3.264 . . . . 0.0 112.227 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB3' HG21 ' A' ' 57' ' ' ILE . 67.3 mt -115.96 -17.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.038 -1.039 . . . . 0.0 111.967 171.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 3' ' ' VAL . 6.5 mt -111.79 23.04 14.29 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.534 1.061 . . . . 0.0 112.527 -175.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.255 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 C-N-CA 127.282 2.233 . . . . 0.0 115.73 -168.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.44 0.638 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.46 142.75 46.83 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 164.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -133.48 142.96 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 119.866 1.212 . . . . 0.0 108.159 170.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -140.87 120.57 13.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.27 14.2 tt -134.72 101.75 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.609 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -77.58 141.97 39.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.984 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 14' ' ' CYS . 41.7 p -147.5 -176.97 5.45 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.261 1.425 . . . . 0.0 112.442 -169.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.19 -170.01 2.62 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.393 -1.442 . . . . 0.0 108.241 169.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.32 -5.98 12.49 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -140.9 -119.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.423 1.489 . . . . 0.0 107.911 -168.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t 58.52 85.68 0.18 Allowed Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 127.451 2.3 . . . . 0.0 111.284 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.94 -38.88 86.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.174 2.583 . . . . 0.0 112.941 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -74.22 -34.19 63.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.205 1.366 . . . . 0.0 110.925 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.473 ' HB3' HG22 ' A' ' 7' ' ' THR . 68.7 m -58.57 -48.14 81.92 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.61 1.095 . . . . 0.0 109.108 169.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -60.79 -39.65 89.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.073 -1.442 . . . . 0.0 110.97 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 23.9 mmt85 -54.3 -53.0 59.71 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.831 1.65 . . . . 0.0 109.699 173.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.95 79.57 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.354 0.525 . . . . 0.0 110.968 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -62.51 -40.2 95.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.248 0.931 . . . . 0.0 111.051 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.06 99.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.826 0.851 . . . . 0.0 109.75 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.54 -52.43 65.42 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.97 -36.5 83.5 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.373 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 m -69.46 -34.6 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.211 0.605 . . . . 0.0 110.773 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -64.7 -38.08 89.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.428 0.691 . . . . 0.0 109.337 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -86.06 0.14 54.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.932 -0.48 . . . . 0.0 111.453 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.02 21.4 69.72 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.721 2.105 . . . . 0.0 111.416 169.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -74.5 163.2 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -169.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -99.07 118.1 35.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -143.73 166.68 24.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.471 1.908 . . . . 0.0 109.512 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -113.57 140.15 48.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -109.08 145.23 36.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.451 1.9 . . . . 0.0 106.674 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.415 ' CD2' ' HE2' ' A' ' 39' ' ' LYS . 1.8 mp -128.19 83.26 66.63 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 108.669 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.52 142.03 98.27 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.321 2.014 . . . . 0.0 109.193 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.1 mt -84.72 -28.3 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 120.222 1.374 . . . . 0.0 107.855 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -56.3 113.0 1.39 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 169.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.11 -0.53 81.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.847 1.689 . . . . 0.0 113.856 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.417 HD21 ' HB2' ' A' ' 39' ' ' LYS . 9.1 t30 -144.47 38.45 1.25 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.624 1.57 . . . . 0.0 110.266 -168.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.63 63.99 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.85 1.66 . . . . 0.0 108.541 168.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.87 -59.82 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 128.001 2.52 . . . . 0.0 107.153 -169.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HB2' HD21 ' A' ' 36' ' ' ASN . 25.5 mtpp -69.46 -15.03 63.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 118.476 -1.29 . . . . 0.0 109.615 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -59.45 -48.93 79.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -56.67 -46.76 80.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.352 1.061 . . . . 0.0 110.258 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -55.98 -33.03 64.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.112 0.565 . . . . 0.0 110.926 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ttp -62.79 -12.92 27.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.848 1.259 . . . . 0.0 113.967 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mt -63.91 -55.21 23.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -71.97 -36.24 69.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.2 -0.937 . . . . 0.0 111.776 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -35.16 80.17 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.259 -1.353 . . . . 0.0 112.289 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -129.04 -16.14 4.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.086 1.312 . . . . 0.0 114.355 -170.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.7 -5.65 11.09 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.044 -1.42 . . . . 0.0 113.458 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.68 -54.59 2.5 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.89 1.845 . . . . 0.0 111.69 -169.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m 86.1 -9.91 0.71 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.867 3.267 . . . . 0.0 111.823 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.9 p -74.06 176.66 6.31 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 130.486 3.515 . . . . 0.0 109.441 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.02 158.84 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.642 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.73 156.95 98.91 Favored 'Cis proline' 0 C--N 1.349 0.559 0 CA-C-N 120.248 1.124 . . . . 0.0 111.482 0.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -130.0 99.42 5.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.462 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.1 mp -87.84 142.15 13.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -129.3 141.66 51.04 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 128.339 2.655 . . . . 0.0 105.575 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.86 136.49 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.09 35.97 26.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.028 0.931 . . . . 0.0 111.052 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.78 -0.21 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.659 2.384 . . . . 0.0 114.476 -173.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -80.83 121.33 25.82 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -63.76 119.38 9.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 mm -82.77 -66.73 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.7 -125.2 1.87 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.24 -172.18 14.06 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.858 2.171 . . . . 0.0 110.771 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 36.4 t80 -56.02 -46.0 78.93 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.081 -173.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.48 -36.9 81.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.847 1.203 . . . . 0.0 110.447 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.8 -51.08 64.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.185 0.994 . . . . 0.0 109.727 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.73 -48.86 75.35 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.401 2.281 . . . . 0.0 111.393 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -61.29 -42.09 98.06 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.12 0.968 . . . . 0.0 109.018 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.27 96.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.955 0.798 . . . . 0.0 110.884 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.7 tp -56.68 -41.21 76.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.232 0.924 . . . . 0.0 110.58 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.69 -37.93 79.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.687 -0.633 . . . . 0.0 112.282 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.49 -25.23 66.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.605 1.162 . . . . 0.0 111.363 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -73.8 -20.72 60.38 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.377 1.071 . . . . 0.0 110.148 172.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.77 27.01 59.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -168.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.86 -9.11 23.28 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.192 1.377 . . . . 0.0 112.753 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -74.77 -42.59 57.88 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.854 1.327 . . . . 0.0 109.4 170.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -56.35 29.59 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.632 1.573 . . . . 0.0 109.543 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.64 -8.24 23.15 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.525 2.15 . . . . 0.0 113.957 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.5 -58.48 2.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mt -63.68 -54.38 36.57 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 111.737 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.5 mttt . . . . . 0 C--O 1.246 0.909 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.56 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.481 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.778 -0.082 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.63 98.75 2.92 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 158.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.513 HG21 HD21 ' A' ' 81' ' ' LEU . 59.9 t -96.41 97.52 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -102.62 122.11 43.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.259 19.7 tt -129.75 107.96 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.527 0.679 . . . . 0.0 112.208 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -74.04 149.74 41.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.664 1.186 . . . . 0.0 110.926 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -155.42 -177.66 6.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.036 1.335 . . . . 0.0 113.3 -169.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -173.77 4.55 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 168.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.26 -25.9 25.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.43 2.692 . . . . 0.0 114.711 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -138.82 -82.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.4 t 45.43 88.35 0.1 Allowed Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.349 1.86 . . . . 0.0 110.841 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 43.67 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 125.062 3.841 . . . . 0.0 113.415 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.21 -50.23 0.38 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 131.164 3.786 . . . . 0.0 105.243 171.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.08 -50.54 66.56 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.657 1.183 . . . . 0.0 110.69 170.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -51.49 -55.24 19.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.342 1.027 . . . . 0.0 109.801 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -54.04 -47.24 71.79 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.858 0.863 . . . . 0.0 111.456 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.2 66.44 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.553 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -30.8 70.58 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.534 1.516 . . . . 0.0 115.058 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.35 93.27 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 119.911 1.232 . . . . 0.0 108.867 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.38 -53.83 52.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.764 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.2 -37.65 87.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.398 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -73.73 -28.45 61.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.615 0.643 . . . . 0.0 110.193 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -68.61 -28.84 67.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.197 0.908 . . . . 0.0 110.501 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -89.97 -8.32 51.97 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.853 1.206 . . . . 0.0 111.567 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.36 25.59 72.53 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.804 1.669 . . . . 0.0 111.963 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.451 HG21 HD13 ' A' ' 81' ' ' LEU . 13.2 m -73.94 158.63 5.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 121.876 -0.779 . . . . 0.0 112.963 -168.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 107.63 8.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.161 1.784 . . . . 0.0 108.824 168.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -135.07 170.25 16.19 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.428 1.091 . . . . 0.0 108.147 172.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -118.32 135.57 54.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.02 135.98 41.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.67 117.84 33.87 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -84.17 155.06 12.78 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.392 2.062 . . . . 0.0 111.184 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt -134.4 0.55 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.297 1.439 . . . . 0.0 108.832 168.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.95 105.8 4.0 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 168.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.66 20.65 68.33 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.216 0.912 . . . . 0.0 114.247 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -113.78 153.75 28.55 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 118.758 1.279 . . . . 0.0 108.39 169.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.95 -28.35 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.753 1.621 . . . . 0.0 109.79 -172.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.43 -49.23 78.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.784 0.72 . . . . 0.0 110.299 169.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -85.62 -8.39 58.28 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.318 -0.864 . . . . 0.0 112.376 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.09 -45.42 67.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.209 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.66 -28.87 67.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.465 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.89 -41.56 87.47 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.783 0.72 . . . . 0.0 109.248 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -60.76 -22.33 63.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.127 -0.983 . . . . 0.0 113.414 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.48 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -68.82 -27.09 65.54 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.366 0.984 . . . . 0.0 112.588 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -74.21 -40.18 62.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.326 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.3 p -124.32 -21.52 4.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -3.54 10.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.156 1.836 . . . . 0.0 113.791 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -90.92 -70.64 0.67 Allowed 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 119.413 1.607 . . . . 0.0 114.004 -168.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 p 83.0 -8.55 1.14 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.877 3.271 . . . . 0.0 110.719 -168.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 p -74.13 171.02 14.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.873 1.269 . . . . 0.0 107.9 169.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 161.19 40.97 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.165 0.986 . . . . 0.0 110.072 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 159.2 88.82 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.687 0.567 . . . . 0.0 110.937 -4.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.42 99.99 5.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 174.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -84.1 142.5 13.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -128.38 135.73 49.95 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.996 2.518 . . . . 0.0 104.577 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -130.67 110.24 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 1' ' ' ALA 0.27 14.0 m-20 43.04 63.74 1.41 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.803 1.241 . . . . 0.0 111.981 -168.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.78 -10.54 0.48 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.605 2.762 . . . . 0.0 113.636 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -84.94 108.18 17.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -62.78 114.53 3.67 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.947 0.899 . . . . 0.0 109.059 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.0 -65.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.396 1.078 . . . . 0.0 110.267 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' HD12 ' A' ' 55' ' ' ILE . . . 155.85 -138.03 5.83 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -169.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.46 -166.28 12.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.752 1.644 . . . . 0.0 111.595 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.61 -39.6 77.23 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 118.35 1.075 . . . . 0.0 112.706 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -61.08 -44.13 97.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.652 0.66 . . . . 0.0 109.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.18 -38.72 91.39 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.678 -0.639 . . . . 0.0 111.296 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.62 -43.5 76.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.637 1.175 . . . . 0.0 111.131 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.65 -32.59 62.31 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.04 87.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.948 0.499 . . . . 0.0 109.719 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 tp -56.52 -44.06 80.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.817 0.735 . . . . 0.0 110.308 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -37.79 88.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.992 0.517 . . . . 0.0 111.884 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.51 -35.03 79.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.659 -0.65 . . . . 0.0 111.026 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -78.58 -1.0 31.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 21.21 75.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.672 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.65 -7.1 56.99 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.058 -0.857 . . . . 0.0 112.094 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.93 -50.03 12.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.317 1.059 . . . . 0.0 108.972 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.94 -53.52 20.91 Favored Pre-proline 0 N--CA 1.464 0.263 0 C-N-CA 125.872 1.669 . . . . 0.0 113.993 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.94 -16.83 36.96 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 121.255 1.484 . . . . 0.0 113.037 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.29 -1.87 55.58 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.573 1.149 . . . . 0.0 110.921 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 3' ' ' VAL . 26.1 mt -122.18 44.0 2.72 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.314 1.446 . . . . 0.0 108.737 170.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 tttt . . . . . 0 C--O 1.248 1.014 0 C-N-CA 125.908 1.683 . . . . 0.0 107.465 169.442 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.462 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.71 135.35 33.96 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 158.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.553 HG21 HD21 ' A' ' 81' ' ' LEU . 49.4 t -136.16 88.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -91.27 143.6 26.48 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.38 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt -140.44 113.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.115 0.483 . . . . 0.0 110.651 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.69 124.21 26.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.763 0.825 . . . . 0.0 109.1 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -142.22 169.05 18.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.6 0.76 . . . . 0.0 111.236 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.86 174.4 15.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.961 1.304 . . . . 0.0 109.483 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.69 -68.63 0.3 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.599 1.56 . . . . 0.0 109.856 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.7 m -86.22 90.63 8.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.8 t -155.52 91.15 2.82 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.43 -44.74 30.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.579 2.186 . . . . 0.0 110.959 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -73.3 -27.13 61.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.631 -0.668 . . . . 0.0 110.501 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -60.81 -57.0 14.5 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.676 1.126 . . . . 0.0 109.368 170.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -54.47 -42.4 70.64 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.828 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -56.71 -51.64 68.02 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.126 1.33 . . . . 0.0 111.624 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.22 77.88 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.452 0.569 . . . . 0.0 110.887 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -58.33 -41.4 84.52 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.939 0.791 . . . . 0.0 110.562 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.96 77.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.611 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.07 -48.75 77.31 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.201 0.91 . . . . 0.0 108.859 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.93 -44.39 85.28 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 122.002 -0.436 . . . . 0.0 111.314 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.2 m -64.12 -35.64 81.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.937 0.495 . . . . 0.0 110.487 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -68.13 -34.16 75.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.601 0.761 . . . . 0.0 110.371 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -76.27 -13.39 60.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.93 0.786 . . . . 0.0 111.17 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.79 42.4 70.53 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 81' ' ' LEU . 15.7 m -99.63 161.85 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.456 0.703 . . . . 0.0 110.447 -175.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 p -87.7 137.07 32.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -150.22 168.41 24.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.433 1.493 . . . . 0.0 108.187 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -114.89 147.62 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -115.66 142.93 46.07 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.06 92.9 47.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.81 147.65 44.85 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.974 2.449 . . . . 0.0 110.455 -169.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.496 ' HA ' HD22 ' A' ' 36' ' ' ASN . 21.2 mt -121.5 -2.08 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.404 1.482 . . . . 0.0 109.725 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -63.8 122.19 15.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.959 -1.088 . . . . 0.0 108.573 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 21.48 79.71 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 119.447 -0.641 . . . . 0.0 112.546 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.496 HD22 ' HA ' ' A' ' 33' ' ' ILE . 2.9 t30 -128.78 165.62 20.59 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.933 1.293 . . . . 0.0 110.216 -171.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.01 -49.79 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.148 2.179 . . . . 0.0 108.404 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.21 -50.88 68.27 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.331 0.514 . . . . 0.0 111.363 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -78.03 -8.74 58.58 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.841 -1.162 . . . . 0.0 110.925 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -74.37 -56.91 4.33 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -22.82 63.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.834 0.743 . . . . 0.0 111.818 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -55.78 -27.63 52.0 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.805 -1.184 . . . . 0.0 111.586 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.2 ttm -52.52 -22.76 5.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 113.325 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.91 -45.52 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.882 0.873 . . . . 0.0 109.217 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -75.07 -35.38 61.83 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 121.05 1.75 . . . . 0.0 111.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -66.8 -42.28 86.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.79 -10.53 1.81 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.793 1.237 . . . . 0.0 113.232 -168.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.99 1.25 84.84 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.998 -168.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -130.9 -161.71 1.15 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.977 2.388 . . . . 0.0 110.376 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.76 8.35 0.3 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.844 2.458 . . . . 0.0 110.55 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.04 158.34 18.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.759 2.823 . . . . 0.0 110.314 -173.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.31 166.58 24.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -167.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.52 168.95 68.73 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 119.898 0.999 . . . . 0.0 110.043 -7.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.76 102.81 5.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.0 136.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.51 95.58 4.73 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 168.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.1 mm -90.08 111.86 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER 52.0 60.84 3.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.929 1.292 . . . . 0.0 113.011 -179.216 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.47 15.54 6.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.301 1.441 . . . . 0.0 113.282 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.26 109.72 14.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -60.32 112.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 108.909 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.9 mm -76.67 -73.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.51 -138.44 6.82 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.2 -171.09 47.2 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.899 1.714 . . . . 0.0 111.677 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -62.3 -36.97 83.77 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.489 -1.243 . . . . 0.0 110.944 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.76 -43.94 94.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.721 1.146 . . . . 0.0 109.14 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.3 -46.72 79.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.987 1.315 . . . . 0.0 109.701 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.51 -47.97 76.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 126.444 1.898 . . . . 0.0 111.869 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -67.01 -33.3 75.25 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.016 0.926 . . . . 0.0 108.599 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.07 82.33 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.493 1.042 . . . . 0.0 111.217 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -56.52 -44.08 80.43 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.931 0.787 . . . . 0.0 110.317 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.5 -36.14 80.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.689 1.196 . . . . 0.0 111.812 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.84 -26.29 65.08 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.584 1.154 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -20.52 60.5 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.129 0.572 . . . . 0.0 111.201 170.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.95 7.03 88.65 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -168.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.4 -9.42 84.93 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 117.967 0.884 . . . . 0.0 111.685 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.3 tp -74.51 -39.16 62.57 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.243 1.021 . . . . 0.0 110.302 170.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.74 -53.14 27.38 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 -4.96 13.89 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.509 2.139 . . . . 0.0 113.527 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.5 mt -114.47 3.1 14.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.997 1.719 . . . . 0.0 110.982 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 3' ' ' VAL . 11.3 mt -137.71 7.55 2.77 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.6 tttt . . . . . 0 C--O 1.247 0.941 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -177.724 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 121.443 0.64 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.2 134.34 38.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.406 2.683 . . . . 0.0 105.54 163.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.716 HG21 HD21 ' A' ' 81' ' ' LEU . 99.0 t -130.49 120.67 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -135.57 128.37 31.12 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -131.33 109.39 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -73.92 138.07 44.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -149.19 -179.44 7.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.222 1.409 . . . . 0.0 110.818 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.14 173.94 12.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -66.72 -16.36 64.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -136.97 127.42 26.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 168.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 t -168.5 95.45 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.67 -39.61 90.15 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.669 2.246 . . . . 0.0 112.618 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.79 -30.04 56.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.819 0.736 . . . . 0.0 111.09 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.37 -51.37 70.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.73 1.15 . . . . 0.0 108.672 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -57.73 -40.57 79.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.966 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -54.54 -54.48 40.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.577 1.535 . . . . 0.0 110.833 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.57 68.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.336 0.516 . . . . 0.0 110.702 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -61.67 -34.05 75.05 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.388 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.72 69.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.36 -49.35 76.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.477 0.711 . . . . 0.0 109.462 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -66.89 -41.78 86.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.261 0.625 . . . . 0.0 111.032 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -69.28 -31.94 70.78 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.6 m -68.47 -33.49 74.26 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.322 0.965 . . . . 0.0 111.271 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -74.97 -11.27 60.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.613 0.642 . . . . 0.0 110.757 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.21 16.22 76.92 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.274 1.416 . . . . 0.0 112.158 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.518 ' HB ' HD22 ' A' ' 81' ' ' LEU . 4.0 m -74.18 162.9 4.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 117.796 0.798 . . . . 0.0 110.99 -168.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.45 106.74 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.081 1.752 . . . . 0.0 108.136 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -134.25 169.33 17.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.224 1.41 . . . . 0.0 110.357 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -117.39 145.18 44.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.621 1.568 . . . . 0.0 107.435 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -114.01 150.15 34.33 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -134.2 88.02 32.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.609 1.564 . . . . 0.0 108.767 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.07 152.73 46.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.907 1.738 . . . . 0.0 111.855 -168.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 ' CE ' ' A' ' 43' ' ' MET . 7.2 pt -126.65 47.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 126.131 1.772 . . . . 0.0 109.421 168.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -58.26 -143.36 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.779 3.232 . . . . 0.0 109.141 168.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.6 64.09 0.63 Allowed Glycine 0 CA--C 1.531 1.065 0 O-C-N 119.024 -2.298 . . . . 0.0 109.833 169.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.496 HD21 ' CG ' ' A' ' 39' ' ' LYS . 4.5 t30 -153.76 91.41 1.47 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.753 2.021 . . . . 0.0 108.783 -168.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.61 -22.39 66.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.75 -1.119 . . . . 0.0 113.877 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.2 -54.04 43.68 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 120.568 1.531 . . . . 0.0 109.822 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' CG ' HD21 ' A' ' 36' ' ' ASN . 0.0 OUTLIER -67.89 -23.56 65.13 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.017 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -48.14 33.73 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.252 0.933 . . . . 0.0 109.012 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.23 -40.88 87.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.146 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.23 -44.31 83.69 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.671 0.788 . . . . 0.0 109.704 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.416 ' CE ' HG21 ' A' ' 33' ' ' ILE . 3.6 ttm -60.29 -18.32 48.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.868 1.267 . . . . 0.0 111.956 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -68.65 -58.58 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -61.25 -40.82 95.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.554 1.524 . . . . 0.0 111.886 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -67.03 -44.29 80.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.879 0.872 . . . . 0.0 111.565 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -126.39 -27.03 3.23 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.25 -21.36 5.13 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.692 2.568 . . . . 0.0 113.168 -168.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -87.68 -60.59 1.93 Allowed 'General case' 0 C--O 1.231 0.089 0 C-N-CA 124.45 1.1 . . . . 0.0 113.25 -168.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.3 p 75.38 15.86 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.954 2.102 . . . . 0.0 113.324 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.0 p -96.64 176.23 6.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.911 1.284 . . . . 0.0 108.484 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -136.65 154.11 76.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.139 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.11 156.02 91.2 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.604 -0.998 . . . . 0.0 110.18 -11.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.35 93.79 4.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.583 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.3 mp -81.51 143.39 12.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -130.09 127.0 38.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 129.635 3.174 . . . . 0.0 105.037 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.4 mt -130.67 126.5 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.38 55.73 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.527 2.331 . . . . 0.0 110.492 -168.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 67.04 -7.96 0.46 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 129.692 3.197 . . . . 0.0 114.175 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -81.08 117.6 21.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -172.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -63.66 101.58 0.36 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -74.07 -59.32 3.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.709 1.203 . . . . 0.0 109.49 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.48 -141.13 10.8 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.98 -170.44 32.43 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.032 1.301 . . . . 0.0 111.174 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -62.1 -40.03 94.49 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.758 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.5 -40.09 85.92 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.772 0.714 . . . . 0.0 110.015 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.77 -48.71 73.54 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.306 1.443 . . . . 0.0 110.085 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.31 -47.63 85.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.117 1.767 . . . . 0.0 111.374 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -66.13 -35.31 80.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.062 0.945 . . . . 0.0 109.228 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.34 -47.17 85.41 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.787 0.722 . . . . 0.0 110.512 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.61 -45.75 81.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.717 0.807 . . . . 0.0 110.649 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.59 -43.63 97.14 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.819 1.248 . . . . 0.0 111.394 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -25.0 67.84 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.491 0.717 . . . . 0.0 110.661 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.25 3.2 55.45 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.529 1.132 . . . . 0.0 110.669 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.7 20.89 53.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.349 0.976 . . . . 0.0 111.941 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.0 63.14 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 118.527 1.163 . . . . 0.0 111.451 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.424 HD11 HD12 ' A' ' 81' ' ' LEU . 54.6 tp -78.33 -53.18 7.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.657 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -53.25 32.24 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 127.165 2.186 . . . . 0.0 113.88 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -69.25 -1.49 8.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.846 1.697 . . . . 0.0 112.968 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 99.0 mt -112.36 -3.34 14.54 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.051 1.74 . . . . 0.0 111.727 170.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.716 HD21 HG21 ' A' ' 3' ' ' VAL . 8.1 mt -123.07 4.7 9.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.509 1.523 . . . . 0.0 114.245 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.185 0 C-N-CA 125.341 1.456 . . . . 0.0 108.429 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.41 93.58 7.24 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.17 132.05 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -133.02 141.86 48.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.49 1.516 . . . . 0.0 107.179 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 tt -136.99 125.42 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -103.04 127.62 50.22 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.675 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 14' ' ' CYS . 29.8 p -141.08 177.62 7.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.822 1.249 . . . . 0.0 109.747 -173.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.55 -173.47 3.97 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.895 -1.128 . . . . 0.0 108.631 173.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -56.77 9.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.938 1.695 . . . . 0.0 109.299 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -85.33 -173.58 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.638 1.175 . . . . 0.0 109.698 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t 96.34 81.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 129.664 3.186 . . . . 0.0 108.266 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.33 -27.69 71.69 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.341 2.028 . . . . 0.0 112.062 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -73.31 -31.21 63.88 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.4 -0.813 . . . . 0.0 109.185 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.426 ' HB3' HG22 ' A' ' 7' ' ' THR . 97.7 m -61.65 -48.03 82.7 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.029 -1.044 . . . . 0.0 110.245 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -53.35 -51.79 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.713 -0.66 . . . . 0.0 109.809 170.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -54.47 -43.94 72.14 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.126 0.876 . . . . 0.0 112.753 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.72 68.1 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.361 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.46 -37.17 74.92 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.425 1.466 . . . . 0.0 110.809 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.76 -39.23 90.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.116 0.566 . . . . 0.0 110.852 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tt -65.35 -45.92 82.24 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -41.09 96.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.796 0.725 . . . . 0.0 111.282 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 -36.92 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 m -72.46 -29.53 63.74 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.961 0.801 . . . . 0.0 112.68 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mmmp? -75.29 -15.2 60.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.198 0.908 . . . . 0.0 110.377 169.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.07 47.18 61.0 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HB ' HD22 ' A' ' 81' ' ' LEU . 3.1 m -103.24 170.72 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.231 0.613 . . . . 0.0 110.641 -176.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -104.44 117.12 33.38 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.061 1.744 . . . . 0.0 108.104 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -134.35 163.39 29.76 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.606 0.763 . . . . 0.0 110.182 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -95.61 139.54 31.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.48 133.74 55.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.77 106.96 31.55 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.88 1.272 . . . . 0.0 107.931 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.02 153.21 41.49 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.92 1.746 . . . . 0.0 108.828 173.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 40' ' ' ARG . 16.9 mm -116.5 -12.76 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.55 0.74 . . . . 0.0 110.799 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -69.34 116.03 9.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.05 18.34 74.54 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.751 -1.027 . . . . 0.0 112.628 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -135.45 39.7 2.85 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 123.509 1.623 . . . . 0.0 106.67 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.17 -16.41 63.96 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 119.982 -1.699 . . . . 0.0 113.696 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.66 81.65 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.835 1.198 . . . . 0.0 109.508 169.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -66.43 -34.55 78.19 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.729 -0.607 . . . . 0.0 111.345 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HB2' HG23 ' A' ' 33' ' ' ILE . 5.9 tmm_? -55.45 -49.93 71.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 110.057 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -68.55 -31.71 71.12 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.103 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -61.03 -39.13 88.6 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.247 1.385 . . . . 0.0 110.476 169.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 ttm -56.04 -12.59 1.52 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.841 1.657 . . . . 0.0 112.303 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mt -63.98 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -69.47 -20.05 63.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.835 1.652 . . . . 0.0 112.168 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -21.55 61.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.312 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.1 p -134.76 -15.65 2.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.012 1.733 . . . . 0.0 114.982 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.85 69.12 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.023 1.297 . . . . 0.0 112.167 -168.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.42 ' HB2' HE22 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -116.55 -72.94 0.66 Allowed 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 125.346 1.459 . . . . 0.0 110.084 -169.249 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 86.63 -4.78 0.71 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 130.797 3.639 . . . . 0.0 111.616 -168.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.5 p -106.2 162.85 13.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.566 1.547 . . . . 0.0 108.073 -172.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.99 163.05 42.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.226 0.61 . . . . 0.0 109.95 -168.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -65.43 161.67 70.05 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.082 1.065 . . . . 0.0 112.387 -4.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.42 HE22 ' HB2' ' A' ' 49' ' ' ARG . 2.7 mt-30 -139.57 140.66 37.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.564 168.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.478 HD11 ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -125.24 146.98 30.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 168.064 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -122.16 133.74 54.74 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.6 mt -136.99 120.94 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 51.09 43.5 29.04 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.521 1.128 . . . . 0.0 109.192 -168.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.21 -3.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.866 2.466 . . . . 0.0 114.797 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -83.03 114.89 21.59 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.402 1.881 . . . . 0.0 108.416 -173.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -64.95 113.39 3.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.461 1.028 . . . . 0.0 108.589 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -82.93 -74.45 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.486 1.114 . . . . 0.0 109.03 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.16 -145.83 14.1 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 119.169 0.895 . . . . 0.0 113.683 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.6 -171.71 47.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.72 2.105 . . . . 0.0 113.474 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.9 -40.28 68.97 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.462 -1.611 . . . . 0.0 110.039 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -34.29 74.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.283 175.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -67.54 -49.13 64.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.569 0.699 . . . . 0.0 110.59 171.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 55' ' ' ILE . 2.8 tm? -60.49 -42.71 96.87 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.926 1.29 . . . . 0.0 111.757 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.59 -37.22 68.2 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.01 85.71 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.295 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -56.22 -47.74 77.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.531 1.059 . . . . 0.0 110.894 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.43 -33.68 76.09 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.594 -0.691 . . . . 0.0 111.738 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.04 60.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.472 1.109 . . . . 0.0 112.516 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 1.51 44.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.897 1.226 . . . . 0.0 110.982 168.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.37 23.17 77.83 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -171.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.35 -3.78 29.1 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.04 -1.422 . . . . 0.0 113.403 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 tp -80.5 -48.25 13.07 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.441 1.621 . . . . 0.0 108.342 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -49.78 85.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.717 1.207 . . . . 0.0 113.158 -174.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 -28.59 53.62 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 CA-C-N 122.22 1.829 . . . . 0.0 112.636 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.85 -14.34 58.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.008 0.822 . . . . 0.0 111.837 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 26' ' ' VAL . 5.3 mt -139.2 -97.27 0.17 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.779 2.032 . . . . 0.0 109.395 -174.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.3 mttt . . . . . 0 C--O 1.25 1.118 0 C-N-CA 129.248 3.019 . . . . 0.0 107.141 -176.644 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.99 93.86 2.29 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.158 0.89 . . . . 0.0 113.02 -171.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.41 HG21 ' CG ' ' A' ' 81' ' ' LEU . 93.7 t -94.71 135.4 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -129.15 139.9 51.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 tt -139.54 120.04 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.846 0.355 . . . . 0.0 110.256 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -92.33 132.29 36.84 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.0 p -140.72 168.72 19.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.156 0.982 . . . . 0.0 111.521 -169.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.11 -179.45 7.33 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.785 -1.197 . . . . 0.0 110.521 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -53.59 -39.56 64.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 128.175 2.59 . . . . 0.0 113.52 -168.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -134.25 105.83 6.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -155.93 80.09 4.04 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.754 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -57.71 -33.94 97.47 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.242 1.961 . . . . 0.0 112.139 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -73.54 -28.89 62.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.393 1.451 . . . . 0.0 110.175 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.19 -53.16 61.06 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -53.21 -44.74 68.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.345 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 38.3 mmt180 -54.39 -62.2 1.81 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.779 1.172 . . . . 0.0 110.712 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -46.16 91.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -63.08 -34.97 78.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.292 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.36 77.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.341 0.973 . . . . 0.0 110.407 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.24 -52.84 63.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.796 0.725 . . . . 0.0 109.149 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.91 -43.33 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.027 0.531 . . . . 0.0 111.191 -170.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -64.9 -35.05 79.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.304 0.642 . . . . 0.0 110.131 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.7 m -73.08 -30.72 63.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.629 0.649 . . . . 0.0 112.492 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -74.29 -10.73 59.88 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.508 1.123 . . . . 0.0 109.767 172.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.03 46.05 60.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.82 175.99 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.426 1.09 . . . . 0.0 110.227 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.5 m -133.49 99.29 4.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.593 1.187 . . . . 0.0 108.08 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -92.03 165.64 13.09 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 128.382 2.673 . . . . 0.0 107.911 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -97.3 138.44 34.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -115.92 136.29 53.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.547 0.739 . . . . 0.0 109.419 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.64 106.17 20.92 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.761 1.625 . . . . 0.0 110.439 -168.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.97 144.79 19.15 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.577 1.518 . . . . 0.0 111.992 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.4 mm -101.05 -15.8 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -66.99 132.61 48.28 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.12 12.03 59.74 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.699 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -125.83 138.24 53.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.473 1.636 . . . . 0.0 108.405 -174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.95 55.44 0.19 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.724 2.01 . . . . 0.0 105.735 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.12 -51.89 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.092 2.157 . . . . 0.0 108.906 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -86.21 -7.87 58.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.779 1.172 . . . . 0.0 110.614 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -54.09 -62.78 1.43 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.065 1.746 . . . . 0.0 109.218 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.08 -21.48 56.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.165 0.439 . . . . 0.0 111.149 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.98 -32.28 70.69 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.461 -0.774 . . . . 0.0 109.842 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ttp -59.95 -20.89 60.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.06 -1.025 . . . . 0.0 112.681 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.27 -58.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -19.42 64.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.015 . . . . 0.0 112.165 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -91.42 -56.02 3.29 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.77 -1.206 . . . . 0.0 110.931 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.0 p -90.32 -21.91 21.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.926 1.239 . . . . 0.0 113.834 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.66 22.22 63.77 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.963 -0.909 . . . . 0.0 112.204 -168.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -136.17 -57.72 0.76 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.155 1.477 . . . . 0.0 112.723 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.283 0.0 OUTLIER 67.88 -0.15 2.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.912 2.085 . . . . 0.0 113.872 -171.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.9 p -76.87 176.28 8.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.282 1.833 . . . . 0.0 107.507 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.58 158.99 73.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.99 -0.444 . . . . 0.0 111.786 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.07 167.4 78.84 Favored 'Cis proline' 0 C--N 1.347 0.454 0 N-CA-C 109.605 -0.96 . . . . 0.0 109.605 -11.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -128.83 112.08 13.76 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -99.7 143.15 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -134.84 142.31 46.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 128.693 2.797 . . . . 0.0 105.536 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.407 HG12 HG22 ' A' ' 3' ' ' VAL . 49.7 mt -138.5 119.09 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.256 1.2 m-20 52.71 37.53 23.9 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.956 0.884 . . . . 0.0 111.306 -168.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 62.98 2.84 1.08 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.719 2.408 . . . . 0.0 114.382 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -73.79 119.31 17.84 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -69.08 107.74 3.29 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 108.978 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.5 mm -73.94 -63.79 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.41 -138.13 5.7 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.77 -165.06 30.38 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.592 2.044 . . . . 0.0 111.14 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 5.0 t80 -57.66 -46.15 84.6 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.885 -0.773 . . . . 0.0 110.541 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.03 -32.38 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.679 0.792 . . . . 0.0 109.604 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -73.16 -45.02 59.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.87 1.268 . . . . 0.0 111.957 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.33 -53.69 55.31 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.93 -39.23 80.98 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.68 -46.44 89.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.894 0.878 . . . . 0.0 112.55 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 tp -56.82 -46.71 81.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.762 1.164 . . . . 0.0 110.919 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.26 -38.9 92.68 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.636 1.174 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.895 0.878 . . . . 0.0 111.659 172.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.09 -0.68 57.72 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.909 1.284 . . . . 0.0 112.084 170.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.88 4.12 13.28 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.194 0.907 . . . . 0.0 112.985 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.79 -3.78 89.2 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 119.306 1.553 . . . . 0.0 112.265 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.5 tp -74.25 -51.47 15.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.988 1.315 . . . . 0.0 109.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -56.08 22.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.457 1.503 . . . . 0.0 112.235 -170.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.85 -4.82 15.84 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.205 1.937 . . . . 0.0 113.375 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -100.71 -0.54 37.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.352 0.978 . . . . 0.0 111.107 172.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.41 ' CG ' HG21 ' A' ' 3' ' ' VAL . 6.5 mt -134.55 3.02 3.27 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 125.648 1.579 . . . . 0.0 113.726 -174.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.8 mttp . . . . . 0 C--O 1.248 0.982 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.906 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 118.272 -0.871 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.85 93.57 2.18 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 172.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 57' ' ' ILE . 94.8 t -91.92 134.35 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.42 150.78 46.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.3 tt -144.27 110.71 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.233 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.52 124.53 28.58 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 107.614 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -144.25 169.16 18.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.39 1.076 . . . . 0.0 112.347 -171.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -133.76 173.94 10.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.036 1.335 . . . . 0.0 109.138 176.184 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.38 -28.81 68.51 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.106 1.762 . . . . 0.0 111.695 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -133.33 110.18 9.87 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.8 91.43 0.67 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 124.946 1.298 . . . . 0.0 108.578 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.12 -40.21 62.61 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.661 2.241 . . . . 0.0 111.049 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.51 -31.93 63.97 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.921 -1.112 . . . . 0.0 110.672 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m -61.98 -46.18 90.38 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 119.185 0.902 . . . . 0.0 109.507 170.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -55.48 -47.71 75.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.335 -0.84 . . . . 0.0 109.997 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -56.08 -50.09 71.98 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.659 1.118 . . . . 0.0 111.158 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.1 -53.95 50.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.634 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -61.75 -36.03 79.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.795 0.725 . . . . 0.0 110.856 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -47.68 82.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.64 -49.5 77.28 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.58 -39.84 84.86 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.051 -0.406 . . . . 0.0 111.217 -174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -67.97 -34.04 75.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.879 0.763 . . . . 0.0 110.276 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -69.72 -27.97 65.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.499 1.045 . . . . 0.0 111.657 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -80.94 -11.53 59.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.215 1.006 . . . . 0.0 110.547 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.94 43.56 49.11 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.762 1.172 . . . . 0.0 110.779 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -98.91 169.04 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.966 0.888 . . . . 0.0 112.066 -170.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.41 128.39 35.92 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.839 2.056 . . . . 0.0 105.819 169.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -155.14 164.51 38.73 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -112.69 139.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.359 1.864 . . . . 0.0 106.875 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.08 146.99 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.66 125.29 19.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.14 138.42 18.08 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.192 1.261 . . . . 0.0 109.578 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -121.24 6.33 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.42 73.78 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.781 2.033 . . . . 0.0 111.09 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.43 11.17 67.75 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.163 1.84 . . . . 0.0 114.725 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . 0.282 0.0 OUTLIER -83.59 102.82 12.44 Favored 'General case' 0 C--O 1.241 0.648 1 N-CA-C 96.389 -5.412 . . . . 0.0 96.389 -177.654 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.59 -33.95 64.39 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -168.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.43 -55.06 38.12 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 119.374 0.988 . . . . 0.0 110.221 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -71.86 -25.74 62.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.48 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -61.84 -50.9 70.42 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.146 0.978 . . . . 0.0 108.669 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -41.53 90.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.288 1.435 . . . . 0.0 111.536 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.46 -33.31 75.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.392 0.677 . . . . 0.0 110.839 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.8 ttp -63.98 -26.28 68.51 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.569 -0.707 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -67.05 -53.44 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 6.89 0.09 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.551 1.94 . . . . 0.0 114.675 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.34 -28.72 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 120.643 1.565 . . . . 0.0 112.703 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -116.02 -22.1 9.15 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.157 1.344 . . . . 0.0 112.898 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -9.64 0.88 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.083 1.802 . . . . 0.0 113.465 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -91.24 -56.12 3.27 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.512 1.156 . . . . 0.0 111.378 -169.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 80.99 -1.53 1.78 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.005 1.322 . . . . 0.0 111.605 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.2 p -80.18 177.09 9.19 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 131.262 3.825 . . . . 0.0 108.58 168.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.467 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -136.84 159.23 71.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 169.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.5 166.9 80.66 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-O 121.718 0.632 . . . . 0.0 111.391 -8.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -126.34 100.28 6.21 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 102.098 -3.297 . . . . 0.0 102.098 168.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -87.37 146.67 6.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 170.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -137.01 150.88 48.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.334 2.254 . . . . 0.0 107.453 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 3' ' ' VAL . 69.9 mt -135.86 109.04 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 51.57 43.69 29.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.636 -1.29 . . . . 0.0 110.764 -169.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.04 -1.78 2.88 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.013 2.925 . . . . 0.0 114.665 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -73.93 103.09 4.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.995 1.718 . . . . 0.0 106.826 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -66.62 109.04 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.11 -59.24 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.95 -133.28 6.81 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.71 -175.13 38.38 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.372 1.463 . . . . 0.0 111.601 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.45 -41.69 81.03 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.557 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.98 -34.83 78.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.565 0.62 . . . . 0.0 110.799 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -66.33 -48.29 70.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 109.773 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.28 -43.75 97.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.351 1.061 . . . . 0.0 111.161 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.73 -37.7 73.51 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.41 94.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.793 0.724 . . . . 0.0 110.711 170.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.79 -49.13 76.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.395 0.998 . . . . 0.0 110.573 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -36.92 78.11 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 111.51 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.55 -22.44 63.55 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.39 -3.58 56.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.55 1.14 . . . . 0.0 110.018 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.53 37.95 92.9 Favored Glycine 0 C--O 1.225 -0.406 0 O-C-N 120.634 -1.291 . . . . 0.0 110.192 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.07 -1.57 58.31 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.845 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.21 -67.77 0.77 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.935 1.294 . . . . 0.0 108.847 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.296 0.0 OUTLIER -45.07 -51.25 24.45 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-O 116.564 -1.684 . . . . 0.0 114.263 177.284 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.65 3.67 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 CA-C-N 123.526 2.295 . . . . 0.0 113.612 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -109.83 -38.61 5.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.36 0.982 . . . . 0.0 110.258 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.79 -16.1 56.17 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.201 -0.937 . . . . 0.0 113.124 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp . . . . . 0 C--O 1.25 1.079 0 C-N-CA 124.992 1.317 . . . . 0.0 107.889 171.662 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.62 93.6 6.15 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 81' ' ' LEU . 95.1 t -131.51 107.01 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 173.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.19 128.77 44.03 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -169.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -130.22 104.89 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.153 0.502 . . . . 0.0 109.908 -171.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -74.95 131.21 40.5 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -143.39 -179.42 6.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.402 0.681 . . . . 0.0 112.146 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.47 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -133.72 175.94 9.0 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.93 1.692 . . . . 0.0 108.815 168.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -18.68 4.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.271 3.028 . . . . 0.0 115.168 -169.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -137.02 -83.92 0.34 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 168.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 t 56.73 97.5 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.687 1.595 . . . . 0.0 112.463 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.91 42.85 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.777 2.985 . . . . 0.0 113.907 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -150.6 -42.83 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.771 2.828 . . . . 0.0 106.046 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -53.83 -50.52 66.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 109.548 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -52.73 -51.46 60.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.562 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.449 ' HD3' ' CE2' ' A' ' 65' ' ' TYR . 18.0 mtt-85 -56.69 -50.22 72.79 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.563 0.62 . . . . 0.0 110.786 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.19 -43.55 94.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.982 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.33 -47.12 84.76 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.081 1.309 . . . . 0.0 110.261 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.95 79.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.67 0.388 . . . . 0.0 110.46 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.28 -46.71 82.47 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.606 0.763 . . . . 0.0 110.17 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.53 -38.43 89.62 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.204 0.602 . . . . 0.0 110.005 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -64.35 -35.43 80.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.401 0.68 . . . . 0.0 110.793 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 t -67.3 -35.35 79.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.734 0.814 . . . . 0.0 109.65 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -80.58 -6.77 58.76 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.588 0.631 . . . . 0.0 111.937 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.01 28.59 66.34 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.148 0.885 . . . . 0.0 111.462 170.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG21 HD13 ' A' ' 81' ' ' LEU . 5.8 m -93.15 167.7 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 121.907 -0.76 . . . . 0.0 112.241 -168.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.3 p -98.49 130.12 45.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -145.91 164.27 32.52 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.434 1.094 . . . . 0.0 108.176 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -104.94 136.52 44.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.189 2.195 . . . . 0.0 107.17 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -116.39 139.14 50.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.644 1.178 . . . . 0.0 109.337 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.26 87.81 49.72 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 125.045 1.338 . . . . 0.0 110.702 -169.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.79 141.85 67.31 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.185 1.923 . . . . 0.0 111.701 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt -121.18 8.92 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.938 1.295 . . . . 0.0 112.214 170.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -66.38 107.53 2.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.408 1.483 . . . . 0.0 109.624 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.59 -6.16 40.82 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 120.882 -1.136 . . . . 0.0 114.307 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.24 164.13 20.31 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 40' ' ' ARG . . . -162.75 -39.75 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.705 1.202 . . . . 0.0 110.796 -168.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.93 74.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.571 0.748 . . . . 0.0 111.547 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -86.18 -22.11 27.16 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.056 -1.027 . . . . 0.0 110.66 173.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 70.9 ttt-85 -59.0 -43.58 91.5 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 120.76 -1.213 . . . . 0.0 110.733 170.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.06 -22.47 55.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.732 0.696 . . . . 0.0 111.869 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -60.25 -24.07 64.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.917 1.235 . . . . 0.0 109.714 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.7 tpp -54.44 -26.66 32.23 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.922 0.783 . . . . 0.0 112.372 173.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -74.38 -40.92 49.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -77.55 -31.36 53.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.443 -0.785 . . . . 0.0 112.208 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -74.9 -38.5 61.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 112.665 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.8 p -133.27 -12.31 2.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -168.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.21 -8.47 70.72 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.945 -168.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -127.54 -161.93 1.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.703 1.752 . . . . 0.0 111.337 -168.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 51' ' ' THR . 2.3 m -155.68 -23.79 0.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.708 2.403 . . . . 0.0 109.948 -170.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 50' ' ' THR . 13.6 p -74.08 163.01 28.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.93 1.692 . . . . 0.0 110.857 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG21 ' HG2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -139.65 161.97 53.65 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 0.0 109.135 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 59.4 Cg_endo -66.98 153.8 84.29 Favored 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.242 1.122 . . . . 0.0 112.116 2.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -130.63 103.37 6.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 105.761 -1.941 . . . . 0.0 105.761 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.672 HD12 ' H ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -84.65 146.87 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 168.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.91 119.25 27.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 168.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -125.28 129.41 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.697 1.59 . . . . 0.0 107.53 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 48.0 32.82 3.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.639 1.975 . . . . 0.0 110.102 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.26 4.68 4.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 131.107 3.763 . . . . 0.0 115.793 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.84 123.45 24.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -65.13 113.97 4.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.88 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.183 0.993 . . . . 0.0 109.546 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.08 -136.83 8.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -168.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.02 -175.93 43.86 Favored Glycine 0 CA--C 1.521 0.456 0 O-C-N 124.231 0.607 . . . . 0.0 112.483 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 16' ' ' ARG . 2.9 t80 -52.02 -49.71 62.84 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.603 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.3 -25.15 65.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.357 0.663 . . . . 0.0 110.627 -170.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -71.39 -51.88 21.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.528 1.131 . . . . 0.0 110.426 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -61.55 -51.22 69.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.892 1.277 . . . . 0.0 110.012 176.115 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -51.05 -38.97 54.73 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.138 1.375 . . . . 0.0 111.413 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.0 91.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 117.882 -1.056 . . . . 0.0 111.746 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.75 -51.02 70.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.467 1.03 . . . . 0.0 109.131 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.79 -42.79 80.09 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.373 1.069 . . . . 0.0 110.433 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -22.81 61.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.175 0.99 . . . . 0.0 112.566 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -88.58 4.47 46.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.188 0.995 . . . . 0.0 112.26 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.85 71.59 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.592 0.633 . . . . 0.0 112.243 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.79 -17.1 80.19 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.477 1.138 . . . . 0.0 112.056 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 81' ' ' LEU . 41.3 tp -77.95 -39.73 41.74 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.004 0.902 . . . . 0.0 110.68 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.26 -56.22 22.1 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.269 1.428 . . . . 0.0 109.921 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.56 -0.75 8.72 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.5 2.133 . . . . 0.0 113.508 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.56 -9.9 15.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 112.26 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 3' ' ' VAL . 11.5 mt -133.09 7.29 3.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.258 1.823 . . . . 0.0 112.623 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 117.271 -1.347 . . . . 0.0 108.572 -169.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.4 96.49 4.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.916 -0.49 . . . . 0.0 109.703 -166.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.651 HG21 HD21 ' A' ' 81' ' ' LEU . 94.7 t -125.43 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.3 135.91 52.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 tt -135.0 107.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.282 0.563 . . . . 0.0 110.49 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -73.57 136.14 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.438 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 73.2 p -141.29 179.07 6.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.135 1.374 . . . . 0.0 109.106 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -160.37 -179.62 7.84 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -48.62 -29.96 4.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.773 3.229 . . . . 0.0 113.924 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -138.41 86.55 2.17 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.203 1.001 . . . . 0.0 111.044 -173.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -156.75 91.23 2.51 Favored Pre-proline 0 CA--C 1.539 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 110.354 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.18 -27.55 72.85 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.361 2.041 . . . . 0.0 112.067 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -73.46 -29.47 62.55 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 7' ' ' THR . 74.1 m -66.75 -47.74 71.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.178 0.899 . . . . 0.0 108.902 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.19 -53.68 26.17 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.784 168.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -53.61 55.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.6 1.091 . . . . 0.0 111.174 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.34 76.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.936 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -60.61 -39.8 89.5 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.672 1.124 . . . . 0.0 110.935 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.3 68.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.208 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp -66.2 -54.34 26.38 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.61 -35.37 80.29 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -68.97 -35.31 76.59 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 109.66 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -74.04 -11.6 60.37 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.14 -0.975 . . . . 0.0 112.167 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -92.28 -27.4 17.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.519 1.054 . . . . 0.0 108.59 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.33 54.03 7.17 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 HD22 ' A' ' 81' ' ' LEU . 15.9 m -112.93 167.47 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.295 0.638 . . . . 0.0 112.088 -172.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.7 m -82.55 120.18 25.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.375 . . . . 0.0 107.308 169.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.87 169.7 17.55 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 109.286 169.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.45 147.29 44.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.77 155.08 28.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.641 0.655 . . . . 0.0 110.557 170.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.49 93.86 27.81 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 124.651 1.181 . . . . 0.0 108.848 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.84 145.98 91.18 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.221 1.948 . . . . 0.0 109.063 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mt -87.72 -32.73 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.761 0.709 . . . . 0.0 109.1 168.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -62.42 102.71 0.34 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.594 1.558 . . . . 0.0 109.084 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.7 -20.73 7.71 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.273 1.892 . . . . 0.0 111.929 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.07 -179.45 7.24 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.027 1.731 . . . . 0.0 110.815 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.31 -64.7 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.357 2.663 . . . . 0.0 105.223 169.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.77 83.39 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.004 0.82 . . . . 0.0 110.872 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -77.87 -17.4 57.38 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 118.927 0.785 . . . . 0.0 112.835 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -67.11 -52.07 46.38 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -32.37 73.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.964 0.802 . . . . 0.0 109.41 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -23.42 66.33 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.291 -0.88 . . . . 0.0 111.917 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.44 -26.38 19.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.002 0.819 . . . . 0.0 112.308 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.39 -56.7 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -61.67 7.51 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.437 2.295 . . . . 0.0 116.125 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.12 -32.2 0.47 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.057 1.299 . . . . 0.0 110.517 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.3 p -129.29 -10.35 4.67 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.476 1.489 . . . . 0.0 113.108 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.84 -14.86 34.85 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.657 1.599 . . . . 0.0 114.322 -171.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -131.99 162.44 30.71 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 126.211 1.804 . . . . 0.0 109.01 -169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -105.45 4.46 30.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 112.645 170.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.2 p -73.69 175.26 7.33 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.877 1.271 . . . . 0.0 109.8 172.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.456 HG21 ' CG ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -143.98 164.49 29.34 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.976 1.31 . . . . 0.0 110.509 176.375 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.51 162.12 80.81 Favored 'Cis proline' 0 N--CA 1.454 -0.807 0 CA-C-N 119.151 0.732 . . . . 0.0 110.503 -7.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -127.36 99.6 5.71 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.1 mp -88.85 139.82 16.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.22 129.29 47.52 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 128.988 2.915 . . . . 0.0 104.935 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.63 123.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 53.75 30.14 10.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.452 1.024 . . . . 0.0 111.476 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.3 -1.11 2.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.722 3.209 . . . . 0.0 114.691 -172.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -73.95 114.39 12.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.316 1.846 . . . . 0.0 108.055 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -69.85 106.64 3.22 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.667 -0.645 . . . . 0.0 110.045 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.4 mm -73.96 -63.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.786 0.835 . . . . 0.0 109.04 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.87 -142.13 9.84 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.23 -173.31 38.78 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.472 1.51 . . . . 0.0 111.384 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.83 -38.83 76.3 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.598 -0.942 . . . . 0.0 110.625 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.54 -41.82 95.25 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.433 0.693 . . . . 0.0 110.276 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.58 -48.56 66.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.437 1.095 . . . . 0.0 110.052 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -49.86 71.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.861 1.264 . . . . 0.0 110.3 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -67.91 -27.78 66.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.83 69.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.188 0.995 . . . . 0.0 111.674 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.7 tp -56.34 -41.43 76.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.052 1.296 . . . . 0.0 109.94 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.62 -35.48 77.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.274 1.03 . . . . 0.0 112.845 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.95 -29.06 68.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.375 0.534 . . . . 0.0 110.809 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 -74.59 -10.76 59.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.177 0.991 . . . . 0.0 110.784 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.56 3.65 54.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.094 -0.837 . . . . 0.0 111.427 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.9 -6.08 89.25 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.916 1.246 . . . . 0.0 112.368 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 tp -73.5 -44.36 58.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.56 -46.99 99.77 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-O 116.7 -1.619 . . . . 0.0 113.494 -169.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 -12.63 35.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.541 1.943 . . . . 0.0 113.087 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -99.67 0.05 41.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.168 0.894 . . . . 0.0 111.506 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 3' ' ' VAL . 8.1 mt -141.73 -28.16 0.64 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -173.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 80' ' ' LEU . . . . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.57 139.31 45.5 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 167.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.527 HG21 HD21 ' A' ' 81' ' ' LEU . 96.5 t -139.47 118.84 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -113.88 147.22 38.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.319 1.047 . . . . 0.0 108.324 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.65 110.45 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.279 0.491 . . . . 0.0 111.284 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 4.1 m-85 -79.94 140.02 36.83 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.654 -0.654 . . . . 0.0 110.713 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -152.81 178.58 9.49 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.311 2.645 . . . . 0.0 109.223 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.24 -173.56 4.28 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 119.608 -1.933 . . . . 0.0 110.322 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.03 -35.31 24.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.949 1.7 . . . . 0.0 111.578 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -138.27 160.44 39.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.678 2.391 . . . . 0.0 105.651 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 t 163.61 105.9 0.02 OUTLIER Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 127.733 2.413 . . . . 0.0 106.603 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.53 -40.38 30.91 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.846 2.364 . . . . 0.0 110.628 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -73.38 -26.83 61.16 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.99 -1.069 . . . . 0.0 110.306 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.2 m -64.87 -45.14 87.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.24 -0.913 . . . . 0.0 109.805 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -56.11 -47.62 77.72 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.827 -1.083 . . . . 0.0 110.124 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -54.24 -52.64 60.72 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.05 1.295 . . . . 0.0 111.199 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.38 -49.83 75.32 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.686 -0.634 . . . . 0.0 112.037 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -64.43 -32.63 74.33 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.035 0.834 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.52 -28.24 69.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.006 0.821 . . . . 0.0 110.951 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -60.3 2.65 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.02 -41.63 83.56 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.589 0.755 . . . . 0.0 111.356 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -67.77 -26.77 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.047 0.539 . . . . 0.0 110.702 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m -75.98 -29.29 58.18 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.551 -0.718 . . . . 0.0 111.183 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -77.42 -17.3 58.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.852 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.73 43.45 94.14 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.77 156.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.467 0.651 . . . . 0.0 111.575 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.06 117.63 22.98 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -134.13 163.66 29.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 168.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -103.62 144.05 31.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.33 146.86 42.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.88 134.48 26.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -95.38 162.83 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.559 2.172 . . . . 0.0 113.012 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.288 1.2 mt -132.19 37.93 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.623 1.969 . . . . 0.0 108.196 167.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.06 60.73 0.11 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.405 2.682 . . . . 0.0 110.71 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.68 52.87 5.69 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.078 1.323 . . . . 0.0 112.308 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -83.92 179.95 7.42 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.94 0.87 . . . . 0.0 111.627 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.93 -52.72 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.368 2.267 . . . . 0.0 106.797 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.12 -57.2 13.91 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 168.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -83.8 13.7 4.59 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 120.838 -1.163 . . . . 0.0 110.424 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -86.07 -60.82 1.9 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.76 -32.76 72.05 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 124.054 0.846 . . . . 0.0 111.339 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.01 -40.01 79.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.105 -0.372 . . . . 0.0 110.988 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -70.33 -17.88 63.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 121.136 -0.977 . . . . 0.0 112.597 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.32 -56.52 13.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 168.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.6 -25.52 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.615 0.766 . . . . 0.0 112.271 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -95.33 -33.62 12.47 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.625 -1.655 . . . . 0.0 113.107 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.5 p -124.07 -24.95 4.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.564 1.984 . . . . 0.0 114.876 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.73 -10.08 20.11 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.073 2.273 . . . . 0.0 114.486 -169.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -94.54 -63.94 1.13 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -168.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 86.71 0.42 0.56 Allowed 'General case' 0 CA--C 1.54 0.567 1 C-N-CA 131.844 4.058 . . . . 0.0 111.718 -168.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.4 p -111.4 161.52 16.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.465 1.506 . . . . 0.0 108.225 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.71 166.8 23.4 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 125.531 1.532 . . . . 0.0 113.833 -168.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.52 163.55 77.73 Favored 'Cis proline' 0 C--N 1.354 0.864 0 CA-C-N 120.847 1.338 . . . . 0.0 110.638 -2.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 15.3 mm-40 -146.03 84.48 1.65 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -168.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.61 142.1 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -137.1 85.16 2.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.021 2.128 . . . . 0.0 105.913 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.7 mt -92.93 132.41 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.42 24.61 2.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.408 1.083 . . . . 0.0 110.882 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.65 12.88 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.762 2.025 . . . . 0.0 115.562 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.49 128.0 33.08 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 168.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -69.48 114.05 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mm -76.13 -58.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.524 1.13 . . . . 0.0 110.461 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -157.72 27.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -169.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.34 -168.63 43.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.819 1.676 . . . . 0.0 110.96 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -62.63 -43.98 97.43 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.271 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.63 -34.48 77.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.598 1.09 . . . . 0.0 110.307 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -70.19 -46.32 64.85 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.115 0.966 . . . . 0.0 109.996 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.28 -50.13 74.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 127.543 2.337 . . . . 0.0 111.528 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -67.54 -29.27 68.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -40.3 71.82 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.54 169.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 tp -56.31 -41.43 75.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.956 1.253 . . . . 0.0 109.762 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.43 -32.39 73.99 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.69 -30.68 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.308 -0.87 . . . . 0.0 111.427 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -80.14 -5.15 55.5 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.821 0.737 . . . . 0.0 110.944 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.48 19.12 79.59 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.372 -0.682 . . . . 0.0 111.436 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.34 -3.5 65.0 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.306 1.053 . . . . 0.0 112.646 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.48 -50.92 7.31 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.637 1.219 . . . . 0.0 110.283 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -44.46 99.64 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.247 -176.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.14 7.43 3.31 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 123.311 2.218 . . . . 0.0 113.003 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 1' ' ' ALA . 92.8 mt -114.18 -2.13 13.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.535 1.534 . . . . 0.0 110.428 168.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 3' ' ' VAL . 12.0 mt -125.99 8.01 7.36 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.185 1.794 . . . . 0.0 110.903 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.3 tttt . . . . . 0 C--O 1.256 1.396 0 C-N-CA 125.712 1.605 . . . . 0.0 108.042 -169.045 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.37 108.43 7.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.15 1.78 . . . . 0.0 107.848 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 81' ' ' LEU . 99.4 t -112.18 89.72 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.55 135.18 37.24 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.875 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -136.64 113.14 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 124.462 1.105 . . . . 0.0 109.128 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.88 142.23 46.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.887 0.875 . . . . 0.0 108.779 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -150.01 166.1 30.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.056 1.342 . . . . 0.0 110.669 -169.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 176.55 12.54 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.891 -1.13 . . . . 0.0 108.715 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -56.37 -30.13 62.31 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.763 2.425 . . . . 0.0 113.853 -170.196 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 109.66 9.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -164.89 84.94 1.11 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -63.67 -26.1 68.89 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.836 1.691 . . . . 0.0 111.986 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -73.43 -30.48 63.24 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.074 -1.016 . . . . 0.0 109.419 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -66.33 -43.96 84.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 119.23 0.923 . . . . 0.0 108.968 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -53.25 -47.8 68.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.94 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -54.8 -59.3 4.91 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.598 1.545 . . . . 0.0 112.076 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.16 89.71 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.069 0.395 . . . . 0.0 110.27 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.771 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.26 99.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -59.66 -49.69 76.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.707 0.685 . . . . 0.0 110.229 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.99 -43.51 95.47 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.265 1.026 . . . . 0.0 111.048 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -59.03 -42.73 90.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.717 0.807 . . . . 0.0 109.167 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 t -69.69 -30.93 68.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.113 0.965 . . . . 0.0 110.416 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -78.18 -15.48 58.79 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.154 0.888 . . . . 0.0 111.453 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 47.95 23.58 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 124.991 1.282 . . . . 0.0 110.043 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 81' ' ' LEU . 13.8 m -104.43 171.5 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.038 0.535 . . . . 0.0 112.271 -170.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.4 p -94.35 126.99 39.95 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.32 170.4 16.38 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.433 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -128.92 124.43 35.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.617 1.567 . . . . 0.0 108.105 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.402 HD23 ' HE3' ' A' ' 39' ' ' LYS . 1.8 mp -116.68 113.58 40.22 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.33 146.94 20.02 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.159 1.906 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mm -124.78 -5.64 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 125.495 1.518 . . . . 0.0 109.743 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 9' ' ' GLU . 5.9 p-10 -66.31 113.19 4.42 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.805 2.042 . . . . 0.0 107.441 168.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.3 -32.38 0.96 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.136 1.351 . . . . 0.0 113.173 -173.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.533 HD21 ' CB ' ' A' ' 39' ' ' LYS . 9.1 t30 -83.51 73.29 10.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 123.233 1.492 . . . . 0.0 108.955 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.67 -19.05 65.68 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.831 168.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.73 -57.63 11.17 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 120.203 1.365 . . . . 0.0 109.725 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.533 ' CB ' HD21 ' A' ' 36' ' ' ASN . 9.4 ttmm -74.75 -15.83 60.75 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.998 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -56.99 -50.74 71.78 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.118 0.872 . . . . 0.0 109.191 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.54 -30.28 68.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.299 0.499 . . . . 0.0 110.888 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.79 -37.77 88.61 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.868 -0.52 . . . . 0.0 110.507 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.2 ttm -61.94 -18.95 62.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.681 1.592 . . . . 0.0 112.36 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.59 -57.94 9.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -59.17 -44.29 92.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.101 -0.374 . . . . 0.0 111.15 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.55 -34.39 72.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.828 -171.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -121.16 -21.68 6.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.8 1.182 . . . . 0.0 114.029 -171.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.52 8.79 57.0 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.703 -168.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -129.89 -52.4 1.14 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.255 1.528 . . . . 0.0 112.708 -170.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m 76.72 6.97 3.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.297 1.439 . . . . 0.0 111.492 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.6 p -86.13 173.2 10.0 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 110.076 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.1 154.01 64.21 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 122.793 0.437 . . . . 0.0 110.856 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.68 157.67 81.47 Favored 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 106.574 -2.125 . . . . 0.0 106.574 -11.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -136.3 118.64 15.67 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 169.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.0 OUTLIER -97.42 145.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 O-C-N 125.118 1.511 . . . . 0.0 107.499 -174.069 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -137.1 111.59 8.62 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.396 2.678 . . . . 0.0 105.903 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -103.46 111.6 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.34 56.02 8.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.327 1.451 . . . . 0.0 107.809 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.27 -14.09 0.41 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.152 3.381 . . . . 0.0 114.24 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -77.83 112.58 14.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.693 0.797 . . . . 0.0 109.565 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.53 105.73 3.2 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.281 1.032 . . . . 0.0 110.394 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -74.42 -53.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.103 0.961 . . . . 0.0 108.659 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.54 -139.84 14.4 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -170.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.28 -173.29 47.31 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.011 1.767 . . . . 0.0 114.207 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -54.68 -50.89 67.16 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 122.225 -0.574 . . . . 0.0 110.238 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -73.77 -17.98 61.03 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.055 0.388 . . . . 0.0 110.717 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.39 -48.51 55.87 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 109.385 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -60.29 -49.77 76.29 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.814 1.646 . . . . 0.0 111.108 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.34 -37.68 81.4 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.606 1.562 . . . . 0.0 110.806 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.67 -44.22 78.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.678 0.791 . . . . 0.0 111.223 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.3 tp -56.58 -43.99 80.6 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 110.396 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.08 -35.58 81.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.021 0.528 . . . . 0.0 111.577 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.02 -26.47 66.79 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.905 0.482 . . . . 0.0 111.946 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -4.85 47.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.296 -0.877 . . . . 0.0 112.437 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.4 29.08 70.59 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.15 -28.3 13.76 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 118.339 1.07 . . . . 0.0 111.446 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -73.6 -52.5 13.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.045 0.923 . . . . 0.0 109.045 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.49 -55.92 22.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.23 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -9.27 25.4 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 122.135 1.798 . . . . 0.0 114.056 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 mt -83.41 -46.85 12.06 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 120.031 1.287 . . . . 0.0 108.813 169.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 3' ' ' VAL . 13.8 mt -83.15 -0.28 48.53 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.462 1.105 . . . . 0.0 113.921 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 C-N-CA 125.089 1.356 . . . . 0.0 110.972 -171.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.46 ' HB1' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.0 125.58 28.59 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.178 -0.951 . . . . 0.0 110.383 -175.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 81' ' ' LEU . 80.9 t -130.36 130.29 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -130.17 144.29 51.27 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.86 1.264 . . . . 0.0 108.67 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 tt -141.49 113.21 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.116 0.484 . . . . 0.0 110.058 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -73.8 129.28 37.59 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -141.18 174.52 10.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.41 1.484 . . . . 0.0 110.75 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 173.47 11.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.76 -20.72 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.672 0.789 . . . . 0.0 112.128 -174.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 t -133.49 77.85 1.74 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.815 1.646 . . . . 0.0 107.411 -168.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.6 87.34 4.83 Favored Pre-proline 0 N--CA 1.443 -0.78 0 C-N-CA 124.764 1.226 . . . . 0.0 108.289 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.17 -31.0 92.57 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.65 1.567 . . . . 0.0 111.362 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.46 -36.49 65.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.56 1.527 . . . . 0.0 110.806 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.7 m -58.0 -46.42 85.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -60.23 -43.8 95.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.09 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.85 -51.81 64.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.163 1.801 . . . . 0.0 110.89 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -60.19 -55.98 27.15 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.923 0.889 . . . . 0.0 110.129 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -63.29 -29.75 71.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.28 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.55 -46.08 87.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.345 0.975 . . . . 0.0 109.228 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.0 -40.57 95.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.058 0.845 . . . . 0.0 110.235 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.44 -40.43 97.13 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.374 -0.828 . . . . 0.0 111.07 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -67.74 -30.43 69.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 110.678 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -71.23 -34.41 70.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.962 0.905 . . . . 0.0 111.238 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -73.79 -17.93 61.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.516 0.598 . . . . 0.0 109.474 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.92 23.11 67.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.137 1.351 . . . . 0.0 111.751 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 m -89.92 157.13 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 118.068 0.934 . . . . 0.0 112.751 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -85.22 136.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 168.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.45 165.81 28.28 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.48 1.912 . . . . 0.0 106.012 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -107.02 140.18 40.23 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.7 145.22 30.39 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -128.3 118.49 20.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 151.93 54.2 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.451 1.434 . . . . 0.0 108.984 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.44 25.4 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.463 1.505 . . . . 0.0 110.034 170.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.61 64.0 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.845 2.058 . . . . 0.0 113.243 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.47 9.7 86.81 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.842 1.687 . . . . 0.0 113.699 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.52 103.76 13.12 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -168.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.48 -25.7 68.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.351 -0.843 . . . . 0.0 112.4 -172.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.16 -54.48 29.08 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.022 0.828 . . . . 0.0 109.872 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -71.53 -23.77 61.83 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 121.239 -0.913 . . . . 0.0 111.303 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -58.93 -53.23 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.793 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.03 -28.12 64.17 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.676 1.125 . . . . 0.0 112.424 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.6 -39.39 76.73 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.019 0.827 . . . . 0.0 108.94 169.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -65.32 -26.0 67.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.443 -0.785 . . . . 0.0 110.996 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.0 mt -74.27 -46.41 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.13 -63.79 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.332 0.969 . . . . 0.0 109.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -64.62 -42.56 95.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.704 2.402 . . . . 0.0 112.806 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -1.2 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -168.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.45 46.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.284 0.947 . . . . 0.0 113.251 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -136.72 -167.5 2.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.433 1.493 . . . . 0.0 109.6 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 p -155.9 3.46 0.17 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 129.565 3.146 . . . . 0.0 109.911 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.6 p -101.0 175.94 5.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.133 2.573 . . . . 0.0 110.343 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.93 158.21 62.59 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.6 163.09 82.3 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.776 -1.344 . . . . 0.0 108.639 -11.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.92 98.84 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 171.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.13 145.07 8.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -131.91 132.18 43.37 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 126.861 2.064 . . . . 0.0 106.04 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 HG22 ' A' ' 3' ' ' VAL . 3.2 mp -125.54 122.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.46 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 15.9 m-20 41.66 47.22 3.37 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.554 1.542 . . . . 0.0 112.486 -172.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.96 3.46 4.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.543 2.337 . . . . 0.0 114.539 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -75.88 105.78 7.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -62.41 122.79 16.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -92.24 -75.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.74 -138.78 5.77 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 -162.25 19.61 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 126.504 2.002 . . . . 0.0 111.027 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -61.34 -42.07 98.08 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.089 0.945 . . . . 0.0 110.666 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.16 -38.52 91.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.392 0.433 . . . . 0.0 110.341 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.07 -48.86 64.42 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.411 1.084 . . . . 0.0 109.968 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.46 HD13 ' HB1' ' A' ' 17' ' ' ALA . 4.5 tt -54.29 -52.21 62.17 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 126.581 1.953 . . . . 0.0 110.571 172.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -68.75 -37.95 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.3 99.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.686 -0.673 . . . . 0.0 111.213 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.82 -42.43 79.59 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.057 1.298 . . . . 0.0 110.399 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.57 -37.51 87.81 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.274 1.03 . . . . 0.0 110.957 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.0 -21.82 65.03 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.425 -0.797 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -82.58 -7.23 59.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.876 1.271 . . . . 0.0 111.168 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.03 19.96 68.4 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.41 8.49 66.72 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.429 1.115 . . . . 0.0 112.014 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -110.3 -52.8 2.75 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.986 1.314 . . . . 0.0 109.192 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.33 -55.63 9.53 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.517 1.527 . . . . 0.0 113.782 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.53 -12.54 31.61 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.67 1.58 . . . . 0.0 113.216 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.98 -10.55 18.88 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.038 0.935 . . . . 0.0 111.34 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.564 ' CD2' HG21 ' A' ' 3' ' ' VAL . 13.5 mt -94.49 10.17 35.61 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.415 1.007 . . . . 0.0 112.319 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mttp . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.054 1.341 . . . . 0.0 108.281 174.912 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.31 126.46 30.17 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 165.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.52 ' CG2' HD21 ' A' ' 81' ' ' LEU . 70.9 t -123.88 128.96 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -122.87 121.91 37.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -168.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.25 18.6 tt -133.17 102.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 121.823 0.82 . . . . 0.0 110.935 -169.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.08 136.2 43.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -143.67 175.71 9.77 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.833 1.653 . . . . 0.0 110.793 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.507 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -134.25 173.52 11.52 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.872 1.669 . . . . 0.0 107.343 168.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -29.46 68.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.655 0.782 . . . . 0.0 111.915 -174.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -87.79 -129.08 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 168.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.9 t 74.73 88.05 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.563 2.345 . . . . 0.0 111.058 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.73 -36.74 83.27 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.198 1.932 . . . . 0.0 110.992 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -73.55 -27.08 61.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.482 -0.761 . . . . 0.0 111.151 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -63.13 -49.83 72.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -55.5 -46.87 76.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.313 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -54.84 -52.87 61.39 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 119.261 0.937 . . . . 0.0 111.374 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.56 -51.84 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.275 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -60.61 -34.96 75.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.714 1.143 . . . . 0.0 111.551 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.89 82.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.658 0.663 . . . . 0.0 110.068 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.38 -46.59 86.06 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.044 0.938 . . . . 0.0 110.077 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.26 -45.32 73.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.453 1.101 . . . . 0.0 111.329 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -69.5 -27.69 65.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.083 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -63.6 -41.95 98.29 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.049 0.84 . . . . 0.0 109.696 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -74.65 -6.63 49.77 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.627 0.649 . . . . 0.0 111.596 175.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.57 27.28 72.78 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.68 171.69 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 117.501 0.65 . . . . 0.0 110.476 -172.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 m -102.04 131.26 48.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -140.96 173.1 11.8 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.691 0.796 . . . . 0.0 108.883 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -125.24 126.65 45.49 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 128.101 2.56 . . . . 0.0 105.69 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.23 140.0 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -124.88 116.4 26.2 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.092 . . . . 0.0 110.799 -168.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -68.55 146.01 66.24 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.016 1.81 . . . . 0.0 109.115 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -125.15 -11.77 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 124.33 1.052 . . . . 0.0 110.864 169.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.05 129.49 39.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.89 -42.67 1.35 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.09 0.853 . . . . 0.0 112.842 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.405 HD21 ' HB2' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -83.1 91.03 7.13 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 125.197 1.399 . . . . 0.0 107.493 -171.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.84 -36.18 81.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.049 -1.032 . . . . 0.0 113.268 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.04 -55.4 23.99 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.982 0.913 . . . . 0.0 111.787 -168.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 36' ' ' ASN . 20.7 mtpt -86.63 -10.79 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -74.03 -32.64 63.44 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.633 1.106 . . . . 0.0 110.47 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.17 -43.39 67.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.695 169.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -62.21 -31.51 72.05 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.696 -0.628 . . . . 0.0 110.435 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.2 -19.86 63.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.605 -1.31 . . . . 0.0 112.484 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -64.1 -58.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.33 -31.8 72.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.917 1.687 . . . . 0.0 111.016 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -95.33 -40.89 9.3 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.381 1.473 . . . . 0.0 112.83 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -103.34 -26.71 12.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.285 1.402 . . . . 0.0 112.526 -173.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.7 33.2 76.53 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.47 -1.183 . . . . 0.0 112.063 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -143.66 -52.6 0.35 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.23 1.515 . . . . 0.0 113.335 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.406 62.5 p 68.29 4.99 4.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.483 2.713 . . . . 0.0 115.51 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -81.44 176.08 10.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -141.97 160.72 54.53 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.328 168.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 72.6 Cg_endo -69.1 160.35 86.18 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.65 0.911 . . . . 0.0 112.078 -0.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.75 99.64 5.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 168.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.51 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.6 mp -86.59 141.5 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 171.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.69 136.31 49.55 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 129.228 3.011 . . . . 0.0 105.248 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.439 HG12 HG22 ' A' ' 3' ' ' VAL . 56.3 mt -128.89 110.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 46.0 48.8 12.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.866 0.866 . . . . 0.0 111.814 -169.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.71 -6.74 1.86 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 129.531 3.132 . . . . 0.0 114.8 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.06 105.65 5.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -70.14 105.71 3.02 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.85 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.67 -144.03 13.09 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 -169.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.04 -161.04 24.59 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.986 1.755 . . . . 0.0 111.177 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -61.52 -45.58 93.61 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 121.808 -0.819 . . . . 0.0 110.496 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.44 -27.19 65.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.842 0.746 . . . . 0.0 109.2 -169.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.99 -55.32 11.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.288 2.235 . . . . 0.0 110.229 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.08 -47.33 86.32 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.302 1.841 . . . . 0.0 111.061 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.76 -41.22 90.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.219 1.408 . . . . 0.0 108.831 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.79 -34.96 76.43 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.004 0.82 . . . . 0.0 112.494 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.68 -51.96 66.75 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.992 1.269 . . . . 0.0 110.662 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -66.15 -28.01 68.46 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.146 0.978 . . . . 0.0 111.267 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.17 -8.58 56.41 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.481 -1.387 . . . . 0.0 112.328 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.37 -3.53 28.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.715 170.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.07 18.71 79.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.143 0.883 . . . . 0.0 110.913 -171.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.38 -1.32 69.19 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.546 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.3 -46.07 7.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.035 1.417 . . . . 0.0 111.044 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER -47.64 -49.24 57.05 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 174.19 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.72 -5.62 14.78 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 CA-C-N 121.905 1.716 . . . . 0.0 113.234 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.77 -55.82 2.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.723 1.209 . . . . 0.0 109.519 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.52 HD21 ' CG2' ' A' ' 3' ' ' VAL . 8.1 mt -89.98 19.69 4.73 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.82 1.648 . . . . 0.0 114.764 -169.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.4 tttm . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.297 1.039 . . . . 0.0 110.064 -176.549 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.48 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.256 0.074 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.32 104.31 7.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 128.111 2.565 . . . . 0.0 109.255 -177.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.68 160.95 5.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -154.42 112.91 3.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.81 110.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 118.512 0.596 . . . . 0.0 112.561 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -89.62 124.49 34.61 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -141.36 173.2 11.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.808 0.843 . . . . 0.0 111.336 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 -178.19 5.51 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.973 -1.079 . . . . 0.0 111.145 -172.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -31.55 68.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.958 1.303 . . . . 0.0 112.065 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -134.17 148.5 50.94 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t 163.8 89.87 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 129.288 3.035 . . . . 0.0 106.125 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.92 -30.7 90.49 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 111.533 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.32 -31.97 64.32 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.264 -0.897 . . . . 0.0 110.02 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -65.09 -46.72 79.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -51.85 -52.3 50.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.404 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -54.26 -50.33 67.48 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.194 1.361 . . . . 0.0 111.751 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.25 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.721 0.692 . . . . 0.0 111.472 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -62.46 -37.21 85.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.489 1.041 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.81 98.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.516 0.726 . . . . 0.0 109.604 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.5 -48.53 80.51 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.59 0.632 . . . . 0.0 109.529 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.63 -38.23 90.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.164 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.6 m -69.92 -30.64 68.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.5 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.6 m -66.22 -36.28 82.62 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 120.262 1.392 . . . . 0.0 110.202 172.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -77.15 -12.93 60.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.848 -0.533 . . . . 0.0 111.673 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.75 26.65 71.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.73 168.31 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.326 1.063 . . . . 0.0 109.779 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -91.62 124.13 35.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 170.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -150.13 168.46 23.89 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 122.638 0.375 . . . . 0.0 111.37 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -132.47 132.57 42.85 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.06 148.37 38.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.157 0.911 . . . . 0.0 109.646 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.27 92.65 31.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 125.272 1.429 . . . . 0.0 109.221 -168.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.11 129.38 21.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.181 2.588 . . . . 0.0 109.692 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.37 5.09 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.008 1.323 . . . . 0.0 109.474 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -76.03 135.71 39.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.477 1.111 . . . . 0.0 109.742 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.43 34.68 76.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.33 169.74 17.01 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.647 1.979 . . . . 0.0 109.477 -168.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.74 -33.0 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.581 1.152 . . . . 0.0 110.723 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.83 -55.62 25.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.262 1.392 . . . . 0.0 111.067 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.61 -10.0 59.26 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.507 -1.37 . . . . 0.0 111.927 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 ttt-85 -78.78 -50.42 11.36 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.8 -26.41 68.34 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.771 0.714 . . . . 0.0 110.897 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.17 -51.76 68.22 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.2 ttp -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -65.08 -51.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.643 -1.286 . . . . 0.0 108.908 169.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -57.57 -36.49 71.75 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.308 0.958 . . . . 0.0 112.282 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -92.32 -28.84 16.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.623 -169.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -124.17 -18.49 5.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.833 1.197 . . . . 0.0 112.855 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.98 -16.08 1.64 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.843 1.687 . . . . 0.0 112.734 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -91.57 -71.02 0.66 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 126.45 1.9 . . . . 0.0 112.453 -168.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.385 0.6 OUTLIER 71.72 1.73 4.0 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 129.984 3.314 . . . . 0.0 113.903 -168.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.4 p -74.28 176.32 6.78 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.607 1.563 . . . . 0.0 107.716 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.09 158.95 74.53 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.8 161.42 79.51 Favored 'Cis proline' 0 C--N 1.348 0.519 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 -11.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.14 97.37 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 170.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -89.94 146.42 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -131.56 148.55 52.63 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.284 3.034 . . . . 0.0 106.11 170.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.88 116.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 168.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 6.9 m-20 62.31 40.7 11.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 110.279 176.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 75.0 -8.64 1.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.666 3.187 . . . . 0.0 114.246 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -74.35 101.12 3.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.63 1.972 . . . . 0.0 105.872 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -60.98 106.34 0.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.3 mm -74.36 -56.61 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.263 1.025 . . . . 0.0 108.847 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.61 -141.9 12.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.14 -169.67 26.02 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.053 1.787 . . . . 0.0 111.334 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -57.17 -42.51 81.28 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.526 -0.985 . . . . 0.0 111.437 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.45 -37.85 88.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.248 0.476 . . . . 0.0 109.786 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.0 -47.35 74.79 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.652 1.181 . . . . 0.0 109.901 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -55.19 29.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.337 1.855 . . . . 0.0 110.31 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.75 -34.5 77.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.79 88.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.189 0.904 . . . . 0.0 111.912 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.84 -46.35 81.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.875 1.216 . . . . 0.0 110.28 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.67 -41.03 98.86 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.16 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.92 71.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.71 1.204 . . . . 0.0 110.94 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -17.1 61.1 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.119 0.968 . . . . 0.0 110.439 176.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 25.62 41.28 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -169.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.86 -7.19 48.09 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.62 -1.1 . . . . 0.0 113.322 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.19 -48.77 8.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.985 1.392 . . . . 0.0 108.442 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.48 96.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.204 1.402 . . . . 0.0 112.111 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 -12.06 34.45 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 123.266 2.202 . . . . 0.0 113.238 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.43 -48.82 4.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.814 0.846 . . . . 0.0 110.181 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -115.84 7.78 14.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.669 1.588 . . . . 0.0 114.58 -168.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 C--O 1.25 1.104 0 C-N-CA 126.948 2.099 . . . . 0.0 112.722 178.917 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.26 134.49 44.27 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 152.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.43 90.15 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -104.64 124.67 49.75 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.531 -1.668 . . . . 0.0 108.328 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -126.82 101.85 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 0.0 111.389 -171.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -73.82 142.38 46.14 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.433 -0.792 . . . . 0.0 109.14 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.9 p -151.6 171.09 18.15 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.53 1.132 . . . . 0.0 111.199 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.545 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -135.67 174.04 11.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.499 1.52 . . . . 0.0 107.138 168.384 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -38.4 68.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.084 1.354 . . . . 0.0 113.057 -168.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.64 145.11 48.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t 172.69 103.45 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.561 2.344 . . . . 0.0 104.793 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -65.93 -30.11 48.88 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.148 1.899 . . . . 0.0 110.853 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -73.63 -37.23 65.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.021 0.929 . . . . 0.0 110.43 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -61.65 -47.36 85.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.855 0.752 . . . . 0.0 109.043 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -53.48 -53.42 51.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.02 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.48 -50.75 70.85 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.867 1.212 . . . . 0.0 112.068 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.02 -49.83 66.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.77 0.714 . . . . 0.0 110.9 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -61.71 -37.2 83.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.495 1.043 . . . . 0.0 110.787 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.68 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.043 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.81 -48.61 81.01 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.36 -42.15 79.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.438 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.5 m -70.91 -30.64 67.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.957 0.798 . . . . 0.0 111.056 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -70.31 -35.44 73.67 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.313 0.961 . . . . 0.0 110.824 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -75.08 -15.09 60.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.234 0.925 . . . . 0.0 110.704 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.38 24.43 75.16 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.334 1.445 . . . . 0.0 112.206 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 81' ' ' LEU . 7.9 m -83.14 154.78 3.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.22 1.01 . . . . 0.0 110.35 -172.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 m -81.2 115.51 20.64 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.249 1.82 . . . . 0.0 107.931 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -137.49 175.91 9.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 109.157 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -124.85 144.51 50.27 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.019 2.527 . . . . 0.0 106.561 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -116.14 152.44 33.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.633 0.652 . . . . 0.0 110.363 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.32 81.28 61.2 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.29 1.036 . . . . 0.0 109.735 -172.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.14 148.26 84.94 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.362 2.041 . . . . 0.0 112.074 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 pt -124.98 15.75 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.412 1.885 . . . . 0.0 110.636 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.39 128.17 35.11 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 168.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.16 29.43 29.01 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.658 0.646 . . . . 0.0 114.027 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.541 HD21 ' HB3' ' A' ' 39' ' ' LYS . 4.5 t30 -146.97 80.87 1.54 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.545 1.172 . . . . 0.0 110.786 -168.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.85 -28.5 68.4 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 120.812 -1.18 . . . . 0.0 111.549 168.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.54 -55.32 35.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.379 0.672 . . . . 0.0 111.242 -169.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' HB3' HD21 ' A' ' 36' ' ' ASN 0.259 0.1 OUTLIER -86.44 -7.31 58.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.49 0.716 . . . . 0.0 111.62 176.364 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.48 -45.98 88.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.259 -1.526 . . . . 0.0 110.898 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -29.91 70.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.902 -177.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -55.76 -37.48 68.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.819 0.848 . . . . 0.0 110.465 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.1 ttm -61.89 -18.39 60.01 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.333 1.053 . . . . 0.0 112.782 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.49 -65.53 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -59.74 -28.16 67.12 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 121.476 1.944 . . . . 0.0 112.295 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -68.45 -45.08 73.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.604 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.3 p -121.72 -22.69 5.74 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.94 5.22 79.45 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.702 1.62 . . . . 0.0 112.376 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.438 ' HB2' HE22 ' A' ' 54' ' ' GLN . 11.2 mtp180 -124.85 -55.37 1.61 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.779 2.289 . . . . 0.0 114.951 -168.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.378 0.7 OUTLIER 69.15 13.67 8.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.676 2.79 . . . . 0.0 114.707 -173.352 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.9 p -75.99 175.59 8.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.113 1.765 . . . . 0.0 109.109 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.545 HG21 ' HG2' ' A' ' 8' ' ' LYS . 1.2 m -142.94 164.43 32.12 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.857 172.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.85 159.92 78.84 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.377 1.17 . . . . 0.0 109.639 -9.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.438 HE22 ' HB2' ' A' ' 49' ' ' ARG . 8.2 mt-30 -136.43 103.11 5.16 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 172.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 143.74 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 171.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -133.53 119.31 19.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.125 1.77 . . . . 0.0 106.369 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.438 HG21 HD13 ' A' ' 80' ' ' LEU . 26.4 mm -113.16 97.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 49.44 65.71 1.32 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.193 0.997 . . . . 0.0 111.054 -168.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 73.23 -13.99 0.66 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 128.444 2.698 . . . . 0.0 114.488 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -74.81 96.8 3.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.736 2.414 . . . . 0.0 108.457 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -64.03 110.55 2.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.94 -64.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.31 -145.14 14.07 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.21 -163.96 38.85 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.232 1.396 . . . . 0.0 111.798 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -65.15 -41.5 94.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.095 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.27 -45.26 80.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.033 0.833 . . . . 0.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -63.93 -48.33 77.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.666 1.186 . . . . 0.0 110.097 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.51 -48.58 78.93 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.85 1.26 . . . . 0.0 111.893 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.24 -33.82 75.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 123.589 0.756 . . . . 0.0 109.313 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -43.18 83.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.931 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.5 -44.91 81.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.18 1.355 . . . . 0.0 110.543 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.7 -42.08 91.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.048 0.539 . . . . 0.0 111.22 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.14 70.52 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.769 -0.582 . . . . 0.0 110.373 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -73.85 -19.77 60.63 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.898 1.279 . . . . 0.0 109.291 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 23.7 68.81 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.7 -13.53 40.39 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.769 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.4 -49.2 12.72 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.665 1.233 . . . . 0.0 109.8 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.96 -54.34 20.9 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 112.502 -173.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.0 3.09 5.35 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.898 2.398 . . . . 0.0 113.275 -175.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 HG21 ' A' ' 57' ' ' ILE . 96.2 mt -110.67 -3.86 15.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.958 -1.089 . . . . 0.0 110.571 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD12 ' HB ' ' A' ' 26' ' ' VAL . 3.8 mm? -108.07 5.42 26.03 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.943 0.897 . . . . 0.0 112.391 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? . . . . . 0 C--O 1.245 0.836 0 C-N-CA 124.995 1.318 . . . . 0.0 108.441 -175.582 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.669 HG21 HD21 ' A' ' 81' ' ' LEU . 73.3 t -127.62 128.02 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 118.854 0.752 . . . . 0.0 109.79 -171.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.13 145.34 45.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 124.095 0.872 . . . . 0.0 109.599 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -139.47 115.59 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -75.4 144.68 42.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -147.23 172.14 14.29 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.279 1.032 . . . . 0.0 113.2 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -146.15 173.97 11.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.637 169.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -49.68 -39.54 36.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.125 2.57 . . . . 0.0 111.331 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.7 p -133.62 88.25 2.46 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -168.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.1 t -148.81 86.66 5.69 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.05 -37.16 78.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.291 1.994 . . . . 0.0 110.394 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -73.45 -24.78 60.27 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.143 -0.973 . . . . 0.0 111.549 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 75.1 m -63.14 -51.96 64.4 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 120.264 1.393 . . . . 0.0 108.968 169.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.75 -41.93 74.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.912 -1.042 . . . . 0.0 111.053 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -54.45 -56.04 22.82 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.345 1.429 . . . . 0.0 110.924 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.98 -49.34 76.49 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.393 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.786 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.16 90.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.003 0.82 . . . . 0.0 110.19 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 tt -64.99 -47.68 76.66 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.551 0.614 . . . . 0.0 109.468 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.9 -35.01 79.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.386 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 m -75.18 -28.94 60.25 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.65 0.78 . . . . 0.0 111.631 174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -40.15 92.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.359 0.982 . . . . 0.0 109.328 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -73.35 -25.57 60.66 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.766 -1.209 . . . . 0.0 108.921 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.5 32.32 59.84 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.889 1.709 . . . . 0.0 111.03 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.69 171.37 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.281 0.562 . . . . 0.0 110.117 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.08 121.64 42.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -141.73 165.02 28.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.578 1.151 . . . . 0.0 110.131 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.53 144.62 35.94 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.181 1.392 . . . . 0.0 108.385 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.57 143.72 44.92 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.444 1.498 . . . . 0.0 108.068 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.44 103.56 16.4 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.912 1.285 . . . . 0.0 110.0 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.92 144.35 27.25 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.854 1.703 . . . . 0.0 110.26 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 122.131 0.967 . . . . 0.0 109.994 172.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.341 0.115 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -67.64 -39.12 84.64 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.296 -1.502 . . . . 0.0 108.751 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -63.07 -40.78 98.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.506 0.723 . . . . 0.0 109.962 171.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -52.77 -45.7 67.24 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.425 0.557 . . . . 0.0 109.934 172.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.51 -24.96 66.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 113.366 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mt -65.0 -54.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.51 -36.98 85.57 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 119.605 -0.236 . . . . 0.0 110.843 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -75.66 -56.28 4.84 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.541 0.736 . . . . 0.0 111.282 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -91.09 -38.73 12.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.596 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.84 38.55 89.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -148.05 -58.09 0.24 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.359 1.464 . . . . 0.0 110.696 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.259 3.6 m 83.16 10.87 0.52 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.729 1.612 . . . . 0.0 111.909 171.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 81.1 p -109.35 171.89 7.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.454 2.702 . . . . 0.0 108.129 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.454 HG21 ' HG2' ' A' ' 8' ' ' LYS . 1.1 m -140.19 166.02 26.49 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.56 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.417 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 73.2 Cg_endo -63.28 148.7 64.84 Favored 'Cis proline' 0 CA--C 1.509 -0.738 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 -6.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -138.02 108.17 6.41 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.0 mp -94.28 145.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 125.271 1.607 . . . . 0.0 107.083 -176.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -128.36 124.15 35.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.806 2.842 . . . . 0.0 103.793 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 HG13 ' A' ' 3' ' ' VAL . 29.0 mm -120.96 117.99 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.255 0.6 OUTLIER 49.32 52.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.335 1.454 . . . . 0.0 110.659 -172.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.03 0.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.62 2.768 . . . . 0.0 114.329 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -86.59 108.17 18.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.253 1.421 . . . . 0.0 107.244 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -63.1 109.3 1.46 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.943 0.897 . . . . 0.0 109.071 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.38 -56.44 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.79 0.836 . . . . 0.0 109.292 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.1 -141.72 12.94 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.04 -165.8 30.16 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 118.885 1.343 . . . . 0.0 113.343 -168.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.0 -43.21 91.46 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.241 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.84 -35.84 82.41 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.733 0.697 . . . . 0.0 109.823 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -45.86 70.25 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.734 1.613 . . . . 0.0 111.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.45 -48.51 79.32 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 127.471 2.309 . . . . 0.0 111.363 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -69.51 -29.4 67.01 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -44.17 81.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.156 0.582 . . . . 0.0 110.941 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.77 -37.74 71.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.403 1.001 . . . . 0.0 110.801 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.38 -40.82 89.92 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.185 -0.947 . . . . 0.0 111.97 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.19 68.12 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.742 1.217 . . . . 0.0 112.171 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -89.22 3.84 50.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.814 1.246 . . . . 0.0 112.445 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 18.3 69.33 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.424 0.557 . . . . 0.0 112.154 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.86 -12.4 43.54 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.643 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.5 tp -73.65 -49.17 27.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.262 1.031 . . . . 0.0 109.511 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.87 -51.77 73.81 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.424 1.49 . . . . 0.0 112.33 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.36 -8.5 23.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.803 2.335 . . . . 0.0 114.707 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 mt -91.07 -49.52 6.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.669 HD21 HG21 ' A' ' 3' ' ' VAL . 4.9 mt . . . . . 0 N--CA 1.464 0.229 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.608 HG21 HD21 ' A' ' 81' ' ' LEU . 93.8 t -126.84 132.88 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -136.59 127.37 27.32 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -168.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 tt -128.73 110.77 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.01 143.52 45.52 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -147.54 179.9 7.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.433 1.093 . . . . 0.0 111.725 -171.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.492 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -150.15 -172.56 4.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.245 -1.534 . . . . 0.0 107.929 168.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 10' ' ' THR . 1.1 pt-20 -35.76 -64.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.664 3.586 . . . . 0.0 111.259 170.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.438 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 14.7 t -134.13 124.21 25.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.0 t -169.6 101.11 0.47 Allowed Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.44 -35.73 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.971 1.781 . . . . 0.0 109.872 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -73.27 -32.8 64.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.778 -0.576 . . . . 0.0 109.811 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -61.59 -51.14 69.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.043 0.838 . . . . 0.0 109.15 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -54.54 -45.75 73.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.562 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -59.71 -49.77 76.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.525 1.511 . . . . 0.0 111.688 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.51 94.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.61 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -57.26 -51.52 69.03 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.495 1.043 . . . . 0.0 109.819 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.83 -22.58 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.655 0.782 . . . . 0.0 111.599 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -75.98 -50.61 14.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.101 1.36 . . . . 0.0 110.011 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.03 -42.52 98.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.25 1.02 . . . . 0.0 111.021 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.3 m -67.52 -28.14 67.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.809 1.644 . . . . 0.0 110.995 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -42.56 99.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HE3' ' OD1' ' A' ' 72' ' ' ASP . 66.2 mmtt -84.25 -6.55 59.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.004 0.82 . . . . 0.0 112.081 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.46 34.73 80.05 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 124.659 1.123 . . . . 0.0 111.901 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 81' ' ' LEU . 18.0 m -90.65 157.44 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 123.331 0.653 . . . . 0.0 110.912 -169.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -95.4 98.99 10.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' HD1' HG23 ' A' ' 26' ' ' VAL . 36.9 p90 -106.51 165.92 10.93 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.822 0.849 . . . . 0.0 108.781 169.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.22 144.19 31.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.178 1.791 . . . . 0.0 106.407 168.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.71 144.84 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mt -129.94 69.77 81.83 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.937 1.295 . . . . 0.0 108.495 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.58 140.3 47.03 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 N-CA-C 108.59 -1.35 . . . . 0.0 108.59 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 pt . . . . . 0 N--CA 1.468 0.45 0 C-N-CA 124.478 1.111 . . . . 0.0 111.324 170.867 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.225 -0.204 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -54.27 -44.59 72.0 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 168.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -73.01 -42.33 63.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.163 0.585 . . . . 0.0 109.965 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.67 -32.1 72.26 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.659 -0.65 . . . . 0.0 110.956 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.4 ttp -55.75 -16.01 3.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.873 1.269 . . . . 0.0 113.235 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.73 -70.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 170.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -66.91 -27.6 67.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 120.194 1.361 . . . . 0.0 112.314 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HD2' ' CE2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -66.2 -50.87 62.37 Favored 'General case' 0 CA--C 1.524 -0.047 0 CA-C-N 119.17 0.895 . . . . 0.0 109.735 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 p -105.31 -31.89 8.86 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.671 1.123 . . . . 0.0 112.875 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.93 24.29 75.77 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 121.452 -0.78 . . . . 0.0 112.196 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -136.36 -53.13 0.73 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.99 1.316 . . . . 0.0 110.573 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m 75.72 2.66 3.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.448 1.099 . . . . 0.0 110.927 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 p -84.22 177.15 8.31 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.99 3.316 . . . . 0.0 107.873 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.1 m -129.5 161.12 60.84 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.129 169.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.26 166.51 79.75 Favored 'Cis proline' 0 N--CA 1.456 -0.698 0 CA-C-N 119.396 0.82 . . . . 0.0 110.675 -10.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -132.94 104.29 6.49 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 168.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.22 142.78 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CE2' ' HD2' ' A' ' 46' ' ' ARG . 96.7 m-85 -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.338 2.255 . . . . 0.0 106.871 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 3' ' ' VAL . 68.1 mt -132.83 119.66 38.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.281 14.8 m-20 45.6 45.51 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.805 0.812 . . . . 0.0 112.566 -169.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.37 -0.16 2.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.557 2.743 . . . . 0.0 114.249 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.24 109.58 7.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.9 113.48 3.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.9 mm -77.38 -55.02 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 108.872 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.68 -144.91 13.02 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.28 -163.67 26.5 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.421 2.438 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -57.17 -47.62 80.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.107 0.953 . . . . 0.0 112.022 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -64.77 -33.46 76.03 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.181 0.446 . . . . 0.0 109.939 -170.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.0 -44.57 72.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.924 1.69 . . . . 0.0 110.914 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.72 -51.13 70.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.889 1.276 . . . . 0.0 109.806 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.41 -30.33 70.06 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -40.97 85.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.138 1.375 . . . . 0.0 112.327 169.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.0 tp -56.25 -45.71 79.91 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.8 1.637 . . . . 0.0 110.322 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.411 ' OD1' ' HE3' ' A' ' 24' ' ' LYS . 27.5 t70 -62.83 -34.68 77.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.965 0.506 . . . . 0.0 112.106 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.15 -15.58 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.772 1.229 . . . . 0.0 112.135 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -5.25 59.23 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.368 1.067 . . . . 0.0 111.224 168.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.07 15.83 70.05 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -168.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.57 -9.34 55.07 Favored Glycine 0 C--N 1.341 0.843 0 C-N-CA 124.697 1.142 . . . . 0.0 112.868 -170.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.431 HD11 HD12 ' A' ' 81' ' ' LEU . 57.4 tp -73.94 -47.93 34.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.329 1.065 . . . . 0.0 109.844 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -54.78 35.84 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.892 1.277 . . . . 0.0 112.156 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.21 -1.91 8.86 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.396 2.064 . . . . 0.0 113.889 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.38 -3.13 19.9 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.806 1.243 . . . . 0.0 111.428 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.608 HD21 HG21 ' A' ' 3' ' ' VAL . 26.6 mt . . . . . 0 C--O 1.237 0.421 0 C-N-CA 124.971 1.308 . . . . 0.0 111.303 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.639 HG21 HD21 ' A' ' 81' ' ' LEU . 70.1 t -133.72 120.07 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 119.355 0.98 . . . . 0.0 108.844 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -129.52 146.97 51.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.14 0.976 . . . . 0.0 109.462 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 tt -140.72 118.37 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 124.509 1.124 . . . . 0.0 108.226 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.782 ' HB3' HD11 ' A' ' 33' ' ' ILE . 34.6 m-85 -78.94 135.58 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.25 1.02 . . . . 0.0 108.812 171.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -144.11 -177.18 5.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.456 1.502 . . . . 0.0 111.501 -168.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -157.5 177.67 11.16 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 119.661 -1.899 . . . . 0.0 107.889 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.66 -25.23 38.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.836 1.654 . . . . 0.0 112.325 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.89 120.6 20.6 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 172.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.0 t -167.77 93.68 0.65 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.022 0.929 . . . . 0.0 111.342 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.11 -39.63 30.45 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.509 2.14 . . . . 0.0 112.033 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -73.58 -29.21 62.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.316 1.871 . . . . 0.0 110.084 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -59.3 -52.71 64.47 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 119.924 1.238 . . . . 0.0 108.239 169.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -54.56 -40.14 68.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.254 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -59.84 -54.01 51.21 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.004 1.274 . . . . 0.0 111.777 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.19 93.12 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.862 -0.523 . . . . 0.0 110.233 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -63.48 -36.51 84.0 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.202 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -26.77 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 120.268 1.394 . . . . 0.0 110.906 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.05 -55.14 11.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 26' ' ' VAL . 90.9 mt -64.87 -43.27 93.49 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.001 1.32 . . . . 0.0 112.081 -173.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -69.94 -30.81 68.29 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.496 1.118 . . . . 0.0 109.674 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -66.05 -39.87 90.47 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.474 1.033 . . . . 0.0 109.593 169.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -73.72 -9.35 58.57 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.222 0.919 . . . . 0.0 110.763 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.0 81.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 125.603 1.573 . . . . 0.0 110.446 172.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 81' ' ' LEU . 20.0 m -90.55 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.596 0.713 . . . . 0.0 112.838 -168.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.3 p -105.75 116.92 32.75 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.69 1.996 . . . . 0.0 105.792 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.467 ' HD2' HG23 ' A' ' 26' ' ' VAL . 50.8 p90 -134.78 167.75 20.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -112.73 133.36 54.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.24 111.53 20.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.438 1.895 . . . . 0.0 107.424 -168.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.85 102.37 50.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.328 1.451 . . . . 0.0 111.381 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.85 137.0 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.01 2.474 . . . . 0.0 113.892 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 6' ' ' TYR . 15.5 mt . . . . . 0 N--CA 1.452 -0.356 0 C-N-CA 127.322 2.249 . . . . 0.0 107.365 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.224 -0.28 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.996 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -60.63 -59.34 5.55 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.54 1.064 . . . . 0.0 108.581 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.07 -41.88 89.05 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.393 0.433 . . . . 0.0 110.908 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.61 -56.19 15.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.386 1.474 . . . . 0.0 109.558 173.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.719 ' CE ' HD13 ' A' ' 33' ' ' ILE . 1.3 ttm -67.12 -26.35 66.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.837 -0.54 . . . . 0.0 112.184 -174.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.38 -54.28 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -60.83 -46.46 90.47 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.93 1.241 . . . . 0.0 112.245 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -79.88 -30.75 40.24 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 117.431 -1.271 . . . . 0.0 112.508 -169.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.2 p -116.15 -27.79 6.78 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.078 1.308 . . . . 0.0 113.458 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.03 23.88 53.04 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.482 1.037 . . . . 0.0 113.497 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -130.52 -57.9 1.05 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.271 1.035 . . . . 0.0 110.186 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.263 3.4 m 74.23 37.78 0.58 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 123.237 1.494 . . . . 0.0 110.989 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.1 p -142.09 176.91 8.59 Favored 'General case' 0 C--N 1.329 -0.325 1 C-N-CA 132.27 4.228 . . . . 0.0 105.902 -176.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.527 ' CG1' HD12 ' A' ' 33' ' ' ILE . 1.1 m -132.71 160.17 69.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.35 167.87 78.59 Favored 'Cis proline' 0 CA--C 1.534 0.514 0 N-CA-C 110.233 -0.718 . . . . 0.0 110.233 -10.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -130.47 96.21 4.07 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 168.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.555 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -81.15 144.26 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -133.04 125.1 28.92 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.561 2.744 . . . . 0.0 104.964 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.7 mm -125.28 120.99 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.92 40.89 26.17 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.722 1.249 . . . . 0.0 111.789 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.31 0.28 0.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.874 2.87 . . . . 0.0 114.45 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.7 121.07 20.18 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -75.01 98.86 3.71 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.41 -49.21 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 -132.19 6.8 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.51 -178.16 45.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.474 1.035 . . . . 0.0 111.264 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -54.23 -42.95 70.43 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.437 -1.037 . . . . 0.0 110.721 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -34.77 71.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.856 0.862 . . . . 0.0 111.87 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -71.69 -44.22 64.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.194 0.598 . . . . 0.0 110.993 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -62.13 -48.6 79.42 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.309 1.044 . . . . 0.0 110.619 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -59.77 -39.26 84.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.125 1.77 . . . . 0.0 109.197 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.1 81.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.189 0.596 . . . . 0.0 110.976 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 tp -56.66 -45.32 81.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.969 0.804 . . . . 0.0 110.121 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.58 -38.78 91.45 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.984 0.914 . . . . 0.0 112.181 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.32 69.77 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.429 0.559 . . . . 0.0 110.716 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -5.44 56.47 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.083 -1.011 . . . . 0.0 110.58 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.94 21.28 79.09 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.275 -0.89 . . . . 0.0 111.081 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.24 -28.19 28.59 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.12 0.96 . . . . 0.0 111.662 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.4 tp -74.21 -50.87 17.29 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.324 1.062 . . . . 0.0 110.81 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.46 -55.77 20.36 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.791 0.836 . . . . 0.0 113.133 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.7 11.86 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.825 2.35 . . . . 0.0 113.427 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.7 mt -112.35 -2.87 14.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.15 1.38 . . . . 0.0 110.396 168.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.639 HD21 HG21 ' A' ' 3' ' ' VAL . 54.5 mt . . . . . 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 110.088 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 81' ' ' LEU . 92.5 t -106.02 133.92 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.71 144.27 33.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 123.854 0.721 . . . . 0.0 109.56 -169.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.73 117.44 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.468 0.707 . . . . 0.0 110.142 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -78.04 140.3 39.13 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -146.99 177.46 9.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.045 0.938 . . . . 0.0 112.487 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.411 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -157.73 -177.06 6.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.942 1.297 . . . . 0.0 110.899 169.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.57 -24.27 3.12 Favored 'General case' 0 CA--C 1.52 -0.187 1 C-N-CA 132.555 4.342 . . . . 0.0 114.538 -168.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -133.32 -83.47 0.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.9 t 33.99 75.99 0.43 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.752 2.021 . . . . 0.0 112.173 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.66 -24.28 74.83 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.362 2.041 . . . . 0.0 111.34 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -73.1 -37.46 66.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.957 1.253 . . . . 0.0 109.71 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -60.7 -46.86 88.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -54.39 -50.6 67.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.173 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 49.9 mtp180 -54.47 -49.73 69.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.14 1.336 . . . . 0.0 110.919 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.07 39.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.173 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -60.09 -32.05 70.6 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.617 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.91 75.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.736 1.153 . . . . 0.0 109.271 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.75 -44.66 93.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 26' ' ' VAL . 95.6 mt -69.4 -40.77 77.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.633 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -71.57 -31.93 67.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.966 0.803 . . . . 0.0 110.745 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -62.64 -44.92 95.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 3.8 mmpt? -73.7 -15.71 61.22 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.52 0.6 . . . . 0.0 110.416 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.34 18.85 78.92 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.768 1.652 . . . . 0.0 112.546 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 21' ' ' LEU . 3.2 m -73.59 160.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 118.278 1.039 . . . . 0.0 111.746 -168.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.7 m -94.56 120.98 35.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -134.16 -172.66 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.531 1.933 . . . . 0.0 107.693 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.45 137.0 48.42 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -109.62 135.57 50.37 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.498 0.719 . . . . 0.0 109.092 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.11 77.27 75.56 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.632 1.173 . . . . 0.0 108.962 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.53 152.4 80.39 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.794 2.33 . . . . 0.0 110.868 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 CA--C 1.541 0.63 0 C-N-CA 124.794 1.238 . . . . 0.0 112.507 177.582 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -82.85 -43.31 16.76 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -60.61 -33.48 72.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.07 -38.1 72.79 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.493 -0.755 . . . . 0.0 110.296 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -20.61 62.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.942 0.897 . . . . 0.0 111.643 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.1 mt -73.58 -42.65 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.26 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -30.74 37.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.982 1.719 . . . . 0.0 112.258 173.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -70.62 -44.97 66.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.387 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.51 -11.77 3.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -168.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.01 -20.22 47.21 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.613 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -138.56 148.03 43.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.29 1.545 . . . . 0.0 111.811 -169.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -88.17 -5.9 58.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 131.37 3.868 . . . . 0.0 113.189 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -76.56 168.52 19.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.22 1.408 . . . . 0.0 111.35 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.411 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -143.62 166.17 21.08 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.615 0.766 . . . . 0.0 110.15 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.14 155.42 73.42 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.224 1.116 . . . . 0.0 109.589 -8.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -134.1 91.92 2.88 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -86.17 150.49 3.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 46' ' ' ARG . 58.9 m-85 -141.75 145.51 34.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.369 2.668 . . . . 0.0 108.523 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.71 116.49 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 43.55 51.64 6.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.741 1.616 . . . . 0.0 112.133 -172.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.3 -0.07 2.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.87 2.468 . . . . 0.0 114.234 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -75.5 108.86 8.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -65.82 110.19 2.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.79 -58.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.33 -143.69 11.6 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -173.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.62 -172.49 41.14 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.635 2.064 . . . . 0.0 111.327 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 17.9 t80 -56.38 -46.2 80.21 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.93 -0.747 . . . . 0.0 111.154 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.74 -32.0 73.36 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.959 0.345 . . . . 0.0 110.436 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.56 -46.0 64.35 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.692 0.758 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.2 -50.21 74.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.852 1.261 . . . . 0.0 111.004 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -68.31 -28.65 67.36 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.61 82.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 110.447 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.7 tp -56.7 -46.05 81.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.735 1.152 . . . . 0.0 109.926 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.51 -43.29 89.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.635 0.774 . . . . 0.0 111.259 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.15 63.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.943 0.897 . . . . 0.0 112.123 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.87 6.84 26.5 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.232 1.413 . . . . 0.0 111.713 169.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.93 17.92 68.1 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.043 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.08 -8.53 41.53 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.862 1.331 . . . . 0.0 113.008 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -75.24 -55.48 5.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.877 1.338 . . . . 0.0 109.5 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -50.99 74.53 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.68 -17.69 30.01 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.928 2.419 . . . . 0.0 114.806 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -104.8 -1.52 25.99 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.996 1.318 . . . . 0.0 111.115 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.405 HD21 HG21 ' A' ' 3' ' ' VAL . 11.7 mt . . . . . 0 N--CA 1.465 0.278 0 O-C-N 120.322 -1.486 . . . . 0.0 112.005 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 81' ' ' LEU . 58.7 t -101.03 99.41 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.45 148.06 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.583 0.552 . . . . 0.0 111.58 -168.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.97 114.94 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -74.31 140.37 44.84 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -150.82 172.65 15.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.905 1.682 . . . . 0.0 110.832 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.488 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -149.41 174.81 12.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.782 1.233 . . . . 0.0 107.862 168.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -18.87 61.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.1 1.36 . . . . 0.0 113.842 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 106.75 7.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -167.0 85.63 0.83 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.664 0.786 . . . . 0.0 108.932 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.78 -33.91 96.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.633 1.555 . . . . 0.0 111.424 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -73.46 -27.57 61.48 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.769 -1.207 . . . . 0.0 109.832 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.47 -49.32 74.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.023 -1.048 . . . . 0.0 108.93 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.75 -46.55 74.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.946 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -54.56 -52.77 61.05 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 120.225 1.375 . . . . 0.0 111.335 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.23 71.35 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.527 0.603 . . . . 0.0 110.39 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -58.54 -38.1 77.08 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.39 0.996 . . . . 0.0 111.474 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.98 95.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.112 0.565 . . . . 0.0 109.706 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 tp -62.55 -48.28 80.18 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.139 0.576 . . . . 0.0 109.875 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.1 mt -65.09 -42.14 94.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 110.734 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 t -65.12 -36.34 83.95 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.512 1.125 . . . . 0.0 110.226 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.3 t -70.22 -34.4 72.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.219 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -80.92 -5.29 57.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.462 1.028 . . . . 0.0 111.424 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 23.32 77.11 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 124.609 1.1 . . . . 0.0 111.686 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.86 162.93 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 118.181 0.991 . . . . 0.0 110.283 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -100.53 113.54 26.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 172.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.76 170.18 16.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.124 1.77 . . . . 0.0 109.207 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -123.44 140.81 52.63 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.61 143.0 39.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.18 113.83 23.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.09 158.76 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.927 2.418 . . . . 0.0 110.393 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mm . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.849 1.26 . . . . 0.0 110.778 170.472 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.3 -45.21 94.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.959 1.254 . . . . 0.0 110.339 168.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.7 -39.55 93.84 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.779 0.718 . . . . 0.0 110.098 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -58.01 -36.96 73.43 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.605 -0.684 . . . . 0.0 110.377 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.8 ttm -64.4 -16.05 61.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.922 1.689 . . . . 0.0 112.513 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.28 -58.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -55.08 -50.13 69.93 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.403 0.62 . . . . 0.0 110.567 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.74 -39.99 73.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.426 -168.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.8 p -112.03 -25.37 9.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 112.865 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.0 21.73 63.97 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.353 -168.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -136.54 -57.03 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.307 1.554 . . . . 0.0 113.011 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 79.3 -6.34 1.86 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 129.755 3.222 . . . . 0.0 113.612 -172.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.4 p -73.79 176.4 6.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.772 2.029 . . . . 0.0 107.92 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.488 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -140.3 159.42 63.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 O-C-N 121.849 -0.532 . . . . 0.0 110.033 176.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.36 165.79 81.94 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 125.591 -0.587 . . . . 0.0 111.395 -5.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -132.89 104.44 6.58 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 168.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.487 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.8 mp -81.12 141.79 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 171.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -127.69 128.76 45.98 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 128.332 2.653 . . . . 0.0 104.953 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.527 HG21 ' HB3' ' A' ' 80' ' ' LEU . 68.3 mt -119.44 104.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 52.22 52.14 14.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.295 1.038 . . . . 0.0 109.175 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.19 -13.49 0.9 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 130.565 3.546 . . . . 0.0 114.428 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -74.7 108.75 7.65 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -67.55 110.24 3.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -74.25 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.14 -145.9 13.82 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -168.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.78 -168.74 36.67 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.169 1.366 . . . . 0.0 112.016 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -61.51 -39.98 92.96 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.682 -0.893 . . . . 0.0 110.214 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.54 -35.92 82.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -65.7 -45.78 81.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.941 1.296 . . . . 0.0 110.701 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.26 -48.32 70.85 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 126.188 1.795 . . . . 0.0 111.087 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -64.96 -34.68 79.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.705 1.202 . . . . 0.0 109.541 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.17 77.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.233 0.613 . . . . 0.0 110.824 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.62 -39.33 73.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.858 0.863 . . . . 0.0 109.839 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.24 -34.18 70.54 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.527 -0.733 . . . . 0.0 112.722 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.28 -34.05 75.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.224 1.009 . . . . 0.0 110.781 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -90.53 6.77 42.18 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 124.799 1.24 . . . . 0.0 112.888 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.95 3.86 52.95 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.273 0.939 . . . . 0.0 112.463 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.12 -17.62 80.22 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.376 0.988 . . . . 0.0 112.047 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.54 -40.39 61.75 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.242 1.017 . . . . 0.0 111.61 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -56.21 24.83 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.154 0.982 . . . . 0.0 112.398 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.49 16.32 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.197 3.264 . . . . 0.0 112.227 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB3' HG21 ' A' ' 57' ' ' ILE . 67.3 mt -115.96 -17.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.038 -1.039 . . . . 0.0 111.967 171.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 3' ' ' VAL . 6.5 mt . . . . . 0 N--CA 1.468 0.427 0 CA-C-N 119.534 1.061 . . . . 0.0 112.527 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -133.48 142.96 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 119.866 1.212 . . . . 0.0 108.159 170.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -140.87 120.57 13.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.27 14.2 tt -134.72 101.75 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.609 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -77.58 141.97 39.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.984 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 14' ' ' CYS . 41.7 p -147.5 -176.97 5.45 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.261 1.425 . . . . 0.0 112.442 -169.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.19 -170.01 2.62 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.393 -1.442 . . . . 0.0 108.241 169.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.32 -5.98 12.49 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -140.9 -119.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.423 1.489 . . . . 0.0 107.911 -168.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t 58.52 85.68 0.18 Allowed Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 127.451 2.3 . . . . 0.0 111.284 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.94 -38.88 86.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.174 2.583 . . . . 0.0 112.941 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -74.22 -34.19 63.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.205 1.366 . . . . 0.0 110.925 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.473 ' HB3' HG22 ' A' ' 7' ' ' THR . 68.7 m -58.57 -48.14 81.92 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.61 1.095 . . . . 0.0 109.108 169.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -60.79 -39.65 89.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.073 -1.442 . . . . 0.0 110.97 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 23.9 mmt85 -54.3 -53.0 59.71 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.831 1.65 . . . . 0.0 109.699 173.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.95 79.57 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.354 0.525 . . . . 0.0 110.968 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -62.51 -40.2 95.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.248 0.931 . . . . 0.0 111.051 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.06 99.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.826 0.851 . . . . 0.0 109.75 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.54 -52.43 65.42 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.97 -36.5 83.5 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.373 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 m -69.46 -34.6 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.211 0.605 . . . . 0.0 110.773 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -64.7 -38.08 89.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.428 0.691 . . . . 0.0 109.337 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -86.06 0.14 54.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.932 -0.48 . . . . 0.0 111.453 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.02 21.4 69.72 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.721 2.105 . . . . 0.0 111.416 169.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -74.5 163.2 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -169.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -99.07 118.1 35.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -143.73 166.68 24.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.471 1.908 . . . . 0.0 109.512 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -113.57 140.15 48.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -109.08 145.23 36.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.451 1.9 . . . . 0.0 106.674 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.415 ' CD2' ' HE2' ' A' ' 39' ' ' LYS . 1.8 mp -128.19 83.26 66.63 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 108.669 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.52 142.03 98.27 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.321 2.014 . . . . 0.0 109.193 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.466 0.37 0 CA-C-N 120.222 1.374 . . . . 0.0 107.855 168.372 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HE2' ' CD2' ' A' ' 31' ' ' LEU . 25.5 mtpp . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -59.45 -48.93 79.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -56.67 -46.76 80.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.352 1.061 . . . . 0.0 110.258 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -55.98 -33.03 64.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.112 0.565 . . . . 0.0 110.926 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ttp -62.79 -12.92 27.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.848 1.259 . . . . 0.0 113.967 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mt -63.91 -55.21 23.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -71.97 -36.24 69.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.2 -0.937 . . . . 0.0 111.776 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -35.16 80.17 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.259 -1.353 . . . . 0.0 112.289 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -129.04 -16.14 4.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.086 1.312 . . . . 0.0 114.355 -170.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.7 -5.65 11.09 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.044 -1.42 . . . . 0.0 113.458 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.68 -54.59 2.5 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.89 1.845 . . . . 0.0 111.69 -169.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m 86.1 -9.91 0.71 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.867 3.267 . . . . 0.0 111.823 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.9 p -74.06 176.66 6.31 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 130.486 3.515 . . . . 0.0 109.441 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.02 158.84 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.642 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.73 156.95 98.91 Favored 'Cis proline' 0 C--N 1.349 0.559 0 CA-C-N 120.248 1.124 . . . . 0.0 111.482 0.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -130.0 99.42 5.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.462 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.1 mp -87.84 142.15 13.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -129.3 141.66 51.04 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 128.339 2.655 . . . . 0.0 105.575 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.86 136.49 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.09 35.97 26.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.028 0.931 . . . . 0.0 111.052 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.78 -0.21 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.659 2.384 . . . . 0.0 114.476 -173.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -80.83 121.33 25.82 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -63.76 119.38 9.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 mm -82.77 -66.73 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.7 -125.2 1.87 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.24 -172.18 14.06 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.858 2.171 . . . . 0.0 110.771 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 36.4 t80 -56.02 -46.0 78.93 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.081 -173.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.48 -36.9 81.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.847 1.203 . . . . 0.0 110.447 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.8 -51.08 64.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.185 0.994 . . . . 0.0 109.727 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.73 -48.86 75.35 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.401 2.281 . . . . 0.0 111.393 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -61.29 -42.09 98.06 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.12 0.968 . . . . 0.0 109.018 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.27 96.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.955 0.798 . . . . 0.0 110.884 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.7 tp -56.68 -41.21 76.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.232 0.924 . . . . 0.0 110.58 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.69 -37.93 79.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.687 -0.633 . . . . 0.0 112.282 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.49 -25.23 66.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.605 1.162 . . . . 0.0 111.363 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -73.8 -20.72 60.38 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.377 1.071 . . . . 0.0 110.148 172.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.77 27.01 59.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -168.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.86 -9.11 23.28 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.192 1.377 . . . . 0.0 112.753 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -74.77 -42.59 57.88 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.854 1.327 . . . . 0.0 109.4 170.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -56.35 29.59 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.632 1.573 . . . . 0.0 109.543 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.64 -8.24 23.15 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.525 2.15 . . . . 0.0 113.957 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.5 -58.48 2.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.235 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 111.737 -172.767 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.234 0.284 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.513 HG21 HD21 ' A' ' 81' ' ' LEU . 59.9 t -96.41 97.52 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -102.62 122.11 43.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.259 19.7 tt -129.75 107.96 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.527 0.679 . . . . 0.0 112.208 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -74.04 149.74 41.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.664 1.186 . . . . 0.0 110.926 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -155.42 -177.66 6.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.036 1.335 . . . . 0.0 113.3 -169.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -173.77 4.55 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 168.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.26 -25.9 25.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.43 2.692 . . . . 0.0 114.711 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -138.82 -82.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.4 t 45.43 88.35 0.1 Allowed Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.349 1.86 . . . . 0.0 110.841 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 43.67 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 125.062 3.841 . . . . 0.0 113.415 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.21 -50.23 0.38 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 131.164 3.786 . . . . 0.0 105.243 171.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.08 -50.54 66.56 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.657 1.183 . . . . 0.0 110.69 170.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -51.49 -55.24 19.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.342 1.027 . . . . 0.0 109.801 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -54.04 -47.24 71.79 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.858 0.863 . . . . 0.0 111.456 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.2 66.44 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.553 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -30.8 70.58 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.534 1.516 . . . . 0.0 115.058 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.35 93.27 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 119.911 1.232 . . . . 0.0 108.867 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.38 -53.83 52.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.764 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.2 -37.65 87.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.398 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -73.73 -28.45 61.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.615 0.643 . . . . 0.0 110.193 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -68.61 -28.84 67.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.197 0.908 . . . . 0.0 110.501 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -89.97 -8.32 51.97 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.853 1.206 . . . . 0.0 111.567 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.36 25.59 72.53 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.804 1.669 . . . . 0.0 111.963 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.451 HG21 HD13 ' A' ' 81' ' ' LEU . 13.2 m -73.94 158.63 5.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 121.876 -0.779 . . . . 0.0 112.963 -168.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 107.63 8.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.161 1.784 . . . . 0.0 108.824 168.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -135.07 170.25 16.19 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.428 1.091 . . . . 0.0 108.147 172.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -118.32 135.57 54.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.02 135.98 41.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.67 117.84 33.87 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -84.17 155.06 12.78 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.392 2.062 . . . . 0.0 111.184 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt . . . . . 0 CA--C 1.54 0.585 0 C-N-CA 125.297 1.439 . . . . 0.0 108.832 168.19 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.09 -45.42 67.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.209 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.66 -28.87 67.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.465 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.89 -41.56 87.47 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.783 0.72 . . . . 0.0 109.248 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -60.76 -22.33 63.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.127 -0.983 . . . . 0.0 113.414 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.48 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -68.82 -27.09 65.54 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.366 0.984 . . . . 0.0 112.588 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -74.21 -40.18 62.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.326 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.3 p -124.32 -21.52 4.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -3.54 10.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.156 1.836 . . . . 0.0 113.791 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -90.92 -70.64 0.67 Allowed 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 119.413 1.607 . . . . 0.0 114.004 -168.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 p 83.0 -8.55 1.14 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.877 3.271 . . . . 0.0 110.719 -168.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 p -74.13 171.02 14.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.873 1.269 . . . . 0.0 107.9 169.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 161.19 40.97 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.165 0.986 . . . . 0.0 110.072 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 159.2 88.82 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.687 0.567 . . . . 0.0 110.937 -4.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.42 99.99 5.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 174.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -84.1 142.5 13.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -128.38 135.73 49.95 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.996 2.518 . . . . 0.0 104.577 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -130.67 110.24 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 14.0 m-20 43.04 63.74 1.41 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.803 1.241 . . . . 0.0 111.981 -168.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.78 -10.54 0.48 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.605 2.762 . . . . 0.0 113.636 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -84.94 108.18 17.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -62.78 114.53 3.67 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.947 0.899 . . . . 0.0 109.059 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.0 -65.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.396 1.078 . . . . 0.0 110.267 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' HD12 ' A' ' 55' ' ' ILE . . . 155.85 -138.03 5.83 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -169.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.46 -166.28 12.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.752 1.644 . . . . 0.0 111.595 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.61 -39.6 77.23 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 118.35 1.075 . . . . 0.0 112.706 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -61.08 -44.13 97.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.652 0.66 . . . . 0.0 109.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.18 -38.72 91.39 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.678 -0.639 . . . . 0.0 111.296 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.62 -43.5 76.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.637 1.175 . . . . 0.0 111.131 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.65 -32.59 62.31 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.04 87.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.948 0.499 . . . . 0.0 109.719 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 tp -56.52 -44.06 80.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.817 0.735 . . . . 0.0 110.308 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -37.79 88.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.992 0.517 . . . . 0.0 111.884 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.51 -35.03 79.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.659 -0.65 . . . . 0.0 111.026 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -78.58 -1.0 31.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 21.21 75.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.672 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.65 -7.1 56.99 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.058 -0.857 . . . . 0.0 112.094 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.93 -50.03 12.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.317 1.059 . . . . 0.0 108.972 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.94 -53.52 20.91 Favored Pre-proline 0 N--CA 1.464 0.263 0 C-N-CA 125.872 1.669 . . . . 0.0 113.993 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.94 -16.83 36.96 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 121.255 1.484 . . . . 0.0 113.037 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.29 -1.87 55.58 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.573 1.149 . . . . 0.0 110.921 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 3' ' ' VAL . 26.1 mt . . . . . 0 C--O 1.232 0.172 0 C-N-CA 125.314 1.446 . . . . 0.0 108.737 170.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.553 HG21 HD21 ' A' ' 81' ' ' LEU . 49.4 t -136.16 88.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -91.27 143.6 26.48 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.38 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt -140.44 113.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.115 0.483 . . . . 0.0 110.651 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.69 124.21 26.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.763 0.825 . . . . 0.0 109.1 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -142.22 169.05 18.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.6 0.76 . . . . 0.0 111.236 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.86 174.4 15.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.961 1.304 . . . . 0.0 109.483 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.69 -68.63 0.3 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.599 1.56 . . . . 0.0 109.856 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.7 m -86.22 90.63 8.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.8 t -155.52 91.15 2.82 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.43 -44.74 30.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.579 2.186 . . . . 0.0 110.959 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -73.3 -27.13 61.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.631 -0.668 . . . . 0.0 110.501 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -60.81 -57.0 14.5 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.676 1.126 . . . . 0.0 109.368 170.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -54.47 -42.4 70.64 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.828 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -56.71 -51.64 68.02 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.126 1.33 . . . . 0.0 111.624 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.22 77.88 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.452 0.569 . . . . 0.0 110.887 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -58.33 -41.4 84.52 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.939 0.791 . . . . 0.0 110.562 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.96 77.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.611 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.07 -48.75 77.31 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.201 0.91 . . . . 0.0 108.859 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.93 -44.39 85.28 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 122.002 -0.436 . . . . 0.0 111.314 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.2 m -64.12 -35.64 81.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.937 0.495 . . . . 0.0 110.487 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -68.13 -34.16 75.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.601 0.761 . . . . 0.0 110.371 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -76.27 -13.39 60.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.93 0.786 . . . . 0.0 111.17 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.79 42.4 70.53 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 81' ' ' LEU . 15.7 m -99.63 161.85 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.456 0.703 . . . . 0.0 110.447 -175.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 p -87.7 137.07 32.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -150.22 168.41 24.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.433 1.493 . . . . 0.0 108.187 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -114.89 147.62 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -115.66 142.93 46.07 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.06 92.9 47.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.81 147.65 44.85 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.974 2.449 . . . . 0.0 110.455 -169.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 mt . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 125.404 1.482 . . . . 0.0 109.725 174.672 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 120.363 0.125 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -74.37 -56.91 4.33 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -22.82 63.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.834 0.743 . . . . 0.0 111.818 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -55.78 -27.63 52.0 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.805 -1.184 . . . . 0.0 111.586 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.2 ttm -52.52 -22.76 5.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 113.325 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.91 -45.52 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.882 0.873 . . . . 0.0 109.217 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -75.07 -35.38 61.83 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 121.05 1.75 . . . . 0.0 111.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -66.8 -42.28 86.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.79 -10.53 1.81 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.793 1.237 . . . . 0.0 113.232 -168.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.99 1.25 84.84 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.998 -168.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -130.9 -161.71 1.15 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.977 2.388 . . . . 0.0 110.376 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.76 8.35 0.3 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.844 2.458 . . . . 0.0 110.55 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.04 158.34 18.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.759 2.823 . . . . 0.0 110.314 -173.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.31 166.58 24.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -167.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.52 168.95 68.73 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 119.898 0.999 . . . . 0.0 110.043 -7.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.76 102.81 5.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.0 136.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.51 95.58 4.73 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 168.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.1 mm -90.08 111.86 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 52.0 60.84 3.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.929 1.292 . . . . 0.0 113.011 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.47 15.54 6.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.301 1.441 . . . . 0.0 113.282 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.26 109.72 14.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -60.32 112.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 108.909 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.9 mm -76.67 -73.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.51 -138.44 6.82 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.2 -171.09 47.2 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.899 1.714 . . . . 0.0 111.677 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -62.3 -36.97 83.77 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.489 -1.243 . . . . 0.0 110.944 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.76 -43.94 94.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.721 1.146 . . . . 0.0 109.14 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.3 -46.72 79.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.987 1.315 . . . . 0.0 109.701 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.51 -47.97 76.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 126.444 1.898 . . . . 0.0 111.869 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -67.01 -33.3 75.25 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.016 0.926 . . . . 0.0 108.599 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.07 82.33 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.493 1.042 . . . . 0.0 111.217 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -56.52 -44.08 80.43 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.931 0.787 . . . . 0.0 110.317 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.5 -36.14 80.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.689 1.196 . . . . 0.0 111.812 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.84 -26.29 65.08 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.584 1.154 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -20.52 60.5 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.129 0.572 . . . . 0.0 111.201 170.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.95 7.03 88.65 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -168.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.4 -9.42 84.93 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 117.967 0.884 . . . . 0.0 111.685 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.3 tp -74.51 -39.16 62.57 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.243 1.021 . . . . 0.0 110.302 170.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.74 -53.14 27.38 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 -4.96 13.89 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.509 2.139 . . . . 0.0 113.527 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.5 mt -114.47 3.1 14.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.997 1.719 . . . . 0.0 110.982 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 3' ' ' VAL . 11.3 mt . . . . . 0 C--O 1.235 0.33 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.716 HG21 HD21 ' A' ' 81' ' ' LEU . 99.0 t -130.49 120.67 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -135.57 128.37 31.12 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -131.33 109.39 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -73.92 138.07 44.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -149.19 -179.44 7.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.222 1.409 . . . . 0.0 110.818 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.14 173.94 12.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -66.72 -16.36 64.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -136.97 127.42 26.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 168.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 t -168.5 95.45 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.67 -39.61 90.15 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.669 2.246 . . . . 0.0 112.618 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.79 -30.04 56.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.819 0.736 . . . . 0.0 111.09 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.37 -51.37 70.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.73 1.15 . . . . 0.0 108.672 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -57.73 -40.57 79.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.966 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -54.54 -54.48 40.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.577 1.535 . . . . 0.0 110.833 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.57 68.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.336 0.516 . . . . 0.0 110.702 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -61.67 -34.05 75.05 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.388 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.72 69.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.36 -49.35 76.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.477 0.711 . . . . 0.0 109.462 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -66.89 -41.78 86.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.261 0.625 . . . . 0.0 111.032 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -69.28 -31.94 70.78 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.6 m -68.47 -33.49 74.26 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.322 0.965 . . . . 0.0 111.271 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -74.97 -11.27 60.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.613 0.642 . . . . 0.0 110.757 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.21 16.22 76.92 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.274 1.416 . . . . 0.0 112.158 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.518 ' HB ' HD22 ' A' ' 81' ' ' LEU . 4.0 m -74.18 162.9 4.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 117.796 0.798 . . . . 0.0 110.99 -168.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.45 106.74 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.081 1.752 . . . . 0.0 108.136 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -134.25 169.33 17.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.224 1.41 . . . . 0.0 110.357 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -117.39 145.18 44.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.621 1.568 . . . . 0.0 107.435 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -114.01 150.15 34.33 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -134.2 88.02 32.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.609 1.564 . . . . 0.0 108.767 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.07 152.73 46.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.907 1.738 . . . . 0.0 111.855 -168.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 ' CE ' ' A' ' 43' ' ' MET . 7.2 pt . . . . . 0 C--N 1.332 -0.183 0 C-N-CA 126.131 1.772 . . . . 0.0 109.421 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.275 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -48.14 33.73 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.252 0.933 . . . . 0.0 109.012 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.23 -40.88 87.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.146 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.23 -44.31 83.69 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.671 0.788 . . . . 0.0 109.704 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.416 ' CE ' HG21 ' A' ' 33' ' ' ILE . 3.6 ttm -60.29 -18.32 48.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.868 1.267 . . . . 0.0 111.956 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -68.65 -58.58 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -61.25 -40.82 95.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.554 1.524 . . . . 0.0 111.886 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -67.03 -44.29 80.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.879 0.872 . . . . 0.0 111.565 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -126.39 -27.03 3.23 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.25 -21.36 5.13 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.692 2.568 . . . . 0.0 113.168 -168.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -87.68 -60.59 1.93 Allowed 'General case' 0 C--O 1.231 0.089 0 C-N-CA 124.45 1.1 . . . . 0.0 113.25 -168.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.3 p 75.38 15.86 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.954 2.102 . . . . 0.0 113.324 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.0 p -96.64 176.23 6.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.911 1.284 . . . . 0.0 108.484 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -136.65 154.11 76.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.139 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.11 156.02 91.2 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.604 -0.998 . . . . 0.0 110.18 -11.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.35 93.79 4.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.583 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.3 mp -81.51 143.39 12.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -130.09 127.0 38.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 129.635 3.174 . . . . 0.0 105.037 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.4 mt -130.67 126.5 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.38 55.73 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.527 2.331 . . . . 0.0 110.492 -168.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 67.04 -7.96 0.46 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 129.692 3.197 . . . . 0.0 114.175 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -81.08 117.6 21.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -172.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -63.66 101.58 0.36 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -74.07 -59.32 3.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.709 1.203 . . . . 0.0 109.49 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.48 -141.13 10.8 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.98 -170.44 32.43 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.032 1.301 . . . . 0.0 111.174 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -62.1 -40.03 94.49 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.758 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.5 -40.09 85.92 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.772 0.714 . . . . 0.0 110.015 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.77 -48.71 73.54 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.306 1.443 . . . . 0.0 110.085 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.31 -47.63 85.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.117 1.767 . . . . 0.0 111.374 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -66.13 -35.31 80.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.062 0.945 . . . . 0.0 109.228 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.34 -47.17 85.41 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.787 0.722 . . . . 0.0 110.512 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.61 -45.75 81.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.717 0.807 . . . . 0.0 110.649 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.59 -43.63 97.14 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.819 1.248 . . . . 0.0 111.394 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -25.0 67.84 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.491 0.717 . . . . 0.0 110.661 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.25 3.2 55.45 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.529 1.132 . . . . 0.0 110.669 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.7 20.89 53.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.349 0.976 . . . . 0.0 111.941 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.0 63.14 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 118.527 1.163 . . . . 0.0 111.451 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.424 HD11 HD12 ' A' ' 81' ' ' LEU . 54.6 tp -78.33 -53.18 7.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.657 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -53.25 32.24 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 127.165 2.186 . . . . 0.0 113.88 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -69.25 -1.49 8.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.846 1.697 . . . . 0.0 112.968 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 99.0 mt -112.36 -3.34 14.54 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.051 1.74 . . . . 0.0 111.727 170.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.716 HD21 HG21 ' A' ' 3' ' ' VAL . 8.1 mt . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 125.509 1.523 . . . . 0.0 114.245 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.371 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.17 132.05 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -133.02 141.86 48.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.49 1.516 . . . . 0.0 107.179 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 tt -136.99 125.42 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -103.04 127.62 50.22 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.675 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 14' ' ' CYS . 29.8 p -141.08 177.62 7.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.822 1.249 . . . . 0.0 109.747 -173.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.55 -173.47 3.97 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.895 -1.128 . . . . 0.0 108.631 173.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -56.77 9.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.938 1.695 . . . . 0.0 109.299 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -85.33 -173.58 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.638 1.175 . . . . 0.0 109.698 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t 96.34 81.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 129.664 3.186 . . . . 0.0 108.266 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.33 -27.69 71.69 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.341 2.028 . . . . 0.0 112.062 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -73.31 -31.21 63.88 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.4 -0.813 . . . . 0.0 109.185 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.426 ' HB3' HG22 ' A' ' 7' ' ' THR . 97.7 m -61.65 -48.03 82.7 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.029 -1.044 . . . . 0.0 110.245 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -53.35 -51.79 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.713 -0.66 . . . . 0.0 109.809 170.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -54.47 -43.94 72.14 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.126 0.876 . . . . 0.0 112.753 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.72 68.1 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.361 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.46 -37.17 74.92 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.425 1.466 . . . . 0.0 110.809 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.76 -39.23 90.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.116 0.566 . . . . 0.0 110.852 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tt -65.35 -45.92 82.24 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -41.09 96.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.796 0.725 . . . . 0.0 111.282 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 -36.92 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 m -72.46 -29.53 63.74 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.961 0.801 . . . . 0.0 112.68 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mmmp? -75.29 -15.2 60.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.198 0.908 . . . . 0.0 110.377 169.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.07 47.18 61.0 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HB ' HD22 ' A' ' 81' ' ' LEU . 3.1 m -103.24 170.72 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.231 0.613 . . . . 0.0 110.641 -176.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -104.44 117.12 33.38 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.061 1.744 . . . . 0.0 108.104 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -134.35 163.39 29.76 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.606 0.763 . . . . 0.0 110.182 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -95.61 139.54 31.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.48 133.74 55.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.77 106.96 31.55 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.88 1.272 . . . . 0.0 107.931 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.02 153.21 41.49 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.92 1.746 . . . . 0.0 108.828 173.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 40' ' ' ARG . 16.9 mm . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 123.55 0.74 . . . . 0.0 110.799 174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 tptt . . . . . 0 CA--C 1.516 -0.363 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HB2' HG23 ' A' ' 33' ' ' ILE . 5.9 tmm_? -55.45 -49.93 71.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 110.057 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -68.55 -31.71 71.12 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.103 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -61.03 -39.13 88.6 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.247 1.385 . . . . 0.0 110.476 169.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 ttm -56.04 -12.59 1.52 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.841 1.657 . . . . 0.0 112.303 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mt -63.98 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -69.47 -20.05 63.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.835 1.652 . . . . 0.0 112.168 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -21.55 61.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.312 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.1 p -134.76 -15.65 2.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.012 1.733 . . . . 0.0 114.982 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.85 69.12 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.023 1.297 . . . . 0.0 112.167 -168.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.42 ' HB2' HE22 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -116.55 -72.94 0.66 Allowed 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 125.346 1.459 . . . . 0.0 110.084 -169.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 86.63 -4.78 0.71 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 130.797 3.639 . . . . 0.0 111.616 -168.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.5 p -106.2 162.85 13.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.566 1.547 . . . . 0.0 108.073 -172.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.99 163.05 42.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.226 0.61 . . . . 0.0 109.95 -168.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -65.43 161.67 70.05 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.082 1.065 . . . . 0.0 112.387 -4.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.42 HE22 ' HB2' ' A' ' 49' ' ' ARG . 2.7 mt-30 -139.57 140.66 37.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.564 168.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.478 HD11 ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -125.24 146.98 30.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 168.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -122.16 133.74 54.74 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.6 mt -136.99 120.94 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 51.09 43.5 29.04 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.521 1.128 . . . . 0.0 109.192 -168.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.21 -3.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.866 2.466 . . . . 0.0 114.797 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -83.03 114.89 21.59 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.402 1.881 . . . . 0.0 108.416 -173.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -64.95 113.39 3.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.461 1.028 . . . . 0.0 108.589 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -82.93 -74.45 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.486 1.114 . . . . 0.0 109.03 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.16 -145.83 14.1 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 119.169 0.895 . . . . 0.0 113.683 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.6 -171.71 47.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.72 2.105 . . . . 0.0 113.474 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.9 -40.28 68.97 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.462 -1.611 . . . . 0.0 110.039 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -34.29 74.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.283 175.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -67.54 -49.13 64.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.569 0.699 . . . . 0.0 110.59 171.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 55' ' ' ILE . 2.8 tm? -60.49 -42.71 96.87 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.926 1.29 . . . . 0.0 111.757 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.59 -37.22 68.2 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.01 85.71 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.295 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -56.22 -47.74 77.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.531 1.059 . . . . 0.0 110.894 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.43 -33.68 76.09 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.594 -0.691 . . . . 0.0 111.738 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.04 60.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.472 1.109 . . . . 0.0 112.516 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 1.51 44.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.897 1.226 . . . . 0.0 110.982 168.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.37 23.17 77.83 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -171.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.35 -3.78 29.1 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.04 -1.422 . . . . 0.0 113.403 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 tp -80.5 -48.25 13.07 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.441 1.621 . . . . 0.0 108.342 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -49.78 85.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.717 1.207 . . . . 0.0 113.158 -174.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 -28.59 53.62 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 CA-C-N 122.22 1.829 . . . . 0.0 112.636 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.85 -14.34 58.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.008 0.822 . . . . 0.0 111.837 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 26' ' ' VAL . 5.3 mt . . . . . 0 C--O 1.236 0.388 0 C-N-CA 126.779 2.032 . . . . 0.0 109.395 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.41 HG21 ' CG ' ' A' ' 81' ' ' LEU . 93.7 t -94.71 135.4 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -129.15 139.9 51.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 tt -139.54 120.04 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.846 0.355 . . . . 0.0 110.256 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -92.33 132.29 36.84 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.0 p -140.72 168.72 19.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.156 0.982 . . . . 0.0 111.521 -169.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.11 -179.45 7.33 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.785 -1.197 . . . . 0.0 110.521 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -53.59 -39.56 64.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 128.175 2.59 . . . . 0.0 113.52 -168.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -134.25 105.83 6.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -155.93 80.09 4.04 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.754 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -57.71 -33.94 97.47 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.242 1.961 . . . . 0.0 112.139 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -73.54 -28.89 62.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.393 1.451 . . . . 0.0 110.175 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.19 -53.16 61.06 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -53.21 -44.74 68.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.345 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 38.3 mmt180 -54.39 -62.2 1.81 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.779 1.172 . . . . 0.0 110.712 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -46.16 91.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -63.08 -34.97 78.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.292 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.36 77.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.341 0.973 . . . . 0.0 110.407 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.24 -52.84 63.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.796 0.725 . . . . 0.0 109.149 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.91 -43.33 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.027 0.531 . . . . 0.0 111.191 -170.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -64.9 -35.05 79.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.304 0.642 . . . . 0.0 110.131 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.7 m -73.08 -30.72 63.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.629 0.649 . . . . 0.0 112.492 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -74.29 -10.73 59.88 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.508 1.123 . . . . 0.0 109.767 172.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.03 46.05 60.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.82 175.99 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.426 1.09 . . . . 0.0 110.227 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.5 m -133.49 99.29 4.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.593 1.187 . . . . 0.0 108.08 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -92.03 165.64 13.09 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 128.382 2.673 . . . . 0.0 107.911 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -97.3 138.44 34.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -115.92 136.29 53.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.547 0.739 . . . . 0.0 109.419 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.64 106.17 20.92 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.761 1.625 . . . . 0.0 110.439 -168.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.97 144.79 19.15 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.577 1.518 . . . . 0.0 111.992 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.4 mm . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 168.002 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.571 0.224 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -54.09 -62.78 1.43 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.065 1.746 . . . . 0.0 109.218 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.08 -21.48 56.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.165 0.439 . . . . 0.0 111.149 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.98 -32.28 70.69 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.461 -0.774 . . . . 0.0 109.842 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ttp -59.95 -20.89 60.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.06 -1.025 . . . . 0.0 112.681 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.27 -58.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -19.42 64.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.015 . . . . 0.0 112.165 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -91.42 -56.02 3.29 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.77 -1.206 . . . . 0.0 110.931 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.0 p -90.32 -21.91 21.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.926 1.239 . . . . 0.0 113.834 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.66 22.22 63.77 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.963 -0.909 . . . . 0.0 112.204 -168.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -136.17 -57.72 0.76 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.155 1.477 . . . . 0.0 112.723 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.283 0.0 OUTLIER 67.88 -0.15 2.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.912 2.085 . . . . 0.0 113.872 -171.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.9 p -76.87 176.28 8.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.282 1.833 . . . . 0.0 107.507 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.58 158.99 73.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.99 -0.444 . . . . 0.0 111.786 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.07 167.4 78.84 Favored 'Cis proline' 0 C--N 1.347 0.454 0 N-CA-C 109.605 -0.96 . . . . 0.0 109.605 -11.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -128.83 112.08 13.76 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -99.7 143.15 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -134.84 142.31 46.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 128.693 2.797 . . . . 0.0 105.536 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.407 HG12 HG22 ' A' ' 3' ' ' VAL . 49.7 mt -138.5 119.09 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.256 1.2 m-20 52.71 37.53 23.9 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.956 0.884 . . . . 0.0 111.306 -168.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 62.98 2.84 1.08 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.719 2.408 . . . . 0.0 114.382 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -73.79 119.31 17.84 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -69.08 107.74 3.29 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 108.978 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.5 mm -73.94 -63.79 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.41 -138.13 5.7 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.77 -165.06 30.38 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.592 2.044 . . . . 0.0 111.14 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 5.0 t80 -57.66 -46.15 84.6 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.885 -0.773 . . . . 0.0 110.541 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.03 -32.38 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.679 0.792 . . . . 0.0 109.604 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -73.16 -45.02 59.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.87 1.268 . . . . 0.0 111.957 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.33 -53.69 55.31 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.93 -39.23 80.98 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.68 -46.44 89.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.894 0.878 . . . . 0.0 112.55 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 tp -56.82 -46.71 81.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.762 1.164 . . . . 0.0 110.919 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.26 -38.9 92.68 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.636 1.174 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.895 0.878 . . . . 0.0 111.659 172.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.09 -0.68 57.72 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.909 1.284 . . . . 0.0 112.084 170.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.88 4.12 13.28 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.194 0.907 . . . . 0.0 112.985 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.79 -3.78 89.2 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 119.306 1.553 . . . . 0.0 112.265 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.5 tp -74.25 -51.47 15.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.988 1.315 . . . . 0.0 109.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -56.08 22.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.457 1.503 . . . . 0.0 112.235 -170.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.85 -4.82 15.84 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.205 1.937 . . . . 0.0 113.375 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -100.71 -0.54 37.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.352 0.978 . . . . 0.0 111.107 172.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.41 ' CG ' HG21 ' A' ' 3' ' ' VAL . 6.5 mt . . . . . 0 C--O 1.23 0.074 0 C-N-CA 125.648 1.579 . . . . 0.0 113.726 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.155 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 57' ' ' ILE . 94.8 t -91.92 134.35 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.42 150.78 46.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.3 tt -144.27 110.71 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.233 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.52 124.53 28.58 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 107.614 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -144.25 169.16 18.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.39 1.076 . . . . 0.0 112.347 -171.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.467 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -133.76 173.94 10.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.036 1.335 . . . . 0.0 109.138 176.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.38 -28.81 68.51 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.106 1.762 . . . . 0.0 111.695 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -133.33 110.18 9.87 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.8 91.43 0.67 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 124.946 1.298 . . . . 0.0 108.578 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.12 -40.21 62.61 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.661 2.241 . . . . 0.0 111.049 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.51 -31.93 63.97 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.921 -1.112 . . . . 0.0 110.672 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m -61.98 -46.18 90.38 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 119.185 0.902 . . . . 0.0 109.507 170.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -55.48 -47.71 75.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.335 -0.84 . . . . 0.0 109.997 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -56.08 -50.09 71.98 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.659 1.118 . . . . 0.0 111.158 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.1 -53.95 50.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.634 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -61.75 -36.03 79.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.795 0.725 . . . . 0.0 110.856 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -47.68 82.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.64 -49.5 77.28 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.58 -39.84 84.86 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.051 -0.406 . . . . 0.0 111.217 -174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -67.97 -34.04 75.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.879 0.763 . . . . 0.0 110.276 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -69.72 -27.97 65.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.499 1.045 . . . . 0.0 111.657 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -80.94 -11.53 59.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.215 1.006 . . . . 0.0 110.547 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.94 43.56 49.11 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.762 1.172 . . . . 0.0 110.779 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -98.91 169.04 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.966 0.888 . . . . 0.0 112.066 -170.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.41 128.39 35.92 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.839 2.056 . . . . 0.0 105.819 169.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -155.14 164.51 38.73 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -112.69 139.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.359 1.864 . . . . 0.0 106.875 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.08 146.99 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.66 125.29 19.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.14 138.42 18.08 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.192 1.261 . . . . 0.0 109.578 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 169.329 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -61.84 -50.9 70.42 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.146 0.978 . . . . 0.0 108.669 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -41.53 90.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.288 1.435 . . . . 0.0 111.536 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.46 -33.31 75.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.392 0.677 . . . . 0.0 110.839 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.8 ttp -63.98 -26.28 68.51 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.569 -0.707 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -67.05 -53.44 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 6.89 0.09 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.551 1.94 . . . . 0.0 114.675 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.34 -28.72 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 120.643 1.565 . . . . 0.0 112.703 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -116.02 -22.1 9.15 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.157 1.344 . . . . 0.0 112.898 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -9.64 0.88 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.083 1.802 . . . . 0.0 113.465 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -91.24 -56.12 3.27 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.512 1.156 . . . . 0.0 111.378 -169.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 80.99 -1.53 1.78 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.005 1.322 . . . . 0.0 111.605 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.2 p -80.18 177.09 9.19 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 131.262 3.825 . . . . 0.0 108.58 168.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.467 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -136.84 159.23 71.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 169.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.5 166.9 80.66 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-O 121.718 0.632 . . . . 0.0 111.391 -8.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -126.34 100.28 6.21 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 102.098 -3.297 . . . . 0.0 102.098 168.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -87.37 146.67 6.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 170.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -137.01 150.88 48.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.334 2.254 . . . . 0.0 107.453 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 3' ' ' VAL . 69.9 mt -135.86 109.04 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 51.57 43.69 29.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.636 -1.29 . . . . 0.0 110.764 -169.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.04 -1.78 2.88 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.013 2.925 . . . . 0.0 114.665 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.93 103.09 4.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.995 1.718 . . . . 0.0 106.826 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -66.62 109.04 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.11 -59.24 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.95 -133.28 6.81 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.71 -175.13 38.38 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.372 1.463 . . . . 0.0 111.601 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.45 -41.69 81.03 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.557 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.98 -34.83 78.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.565 0.62 . . . . 0.0 110.799 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -66.33 -48.29 70.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 109.773 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.28 -43.75 97.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.351 1.061 . . . . 0.0 111.161 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.73 -37.7 73.51 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.41 94.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.793 0.724 . . . . 0.0 110.711 170.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.79 -49.13 76.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.395 0.998 . . . . 0.0 110.573 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -36.92 78.11 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 111.51 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.55 -22.44 63.55 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.39 -3.58 56.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.55 1.14 . . . . 0.0 110.018 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.53 37.95 92.9 Favored Glycine 0 C--O 1.225 -0.406 0 O-C-N 120.634 -1.291 . . . . 0.0 110.192 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.07 -1.57 58.31 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.845 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.21 -67.77 0.77 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.935 1.294 . . . . 0.0 108.847 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.296 0.0 OUTLIER -45.07 -51.25 24.45 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-O 116.564 -1.684 . . . . 0.0 114.263 177.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.65 3.67 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 CA-C-N 123.526 2.295 . . . . 0.0 113.612 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -109.83 -38.61 5.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.36 0.982 . . . . 0.0 110.258 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 CA--C 1.535 0.392 0 O-C-N 121.201 -0.937 . . . . 0.0 113.124 178.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.214 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 81' ' ' LEU . 95.1 t -131.51 107.01 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 173.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.19 128.77 44.03 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -169.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -130.22 104.89 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.153 0.502 . . . . 0.0 109.908 -171.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -74.95 131.21 40.5 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -143.39 -179.42 6.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.402 0.681 . . . . 0.0 112.146 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.47 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -133.72 175.94 9.0 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.93 1.692 . . . . 0.0 108.815 168.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -18.68 4.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.271 3.028 . . . . 0.0 115.168 -169.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -137.02 -83.92 0.34 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 168.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 t 56.73 97.5 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.687 1.595 . . . . 0.0 112.463 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.91 42.85 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.777 2.985 . . . . 0.0 113.907 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -150.6 -42.83 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.771 2.828 . . . . 0.0 106.046 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -53.83 -50.52 66.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 109.548 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -52.73 -51.46 60.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.562 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.449 ' HD3' ' CE2' ' A' ' 65' ' ' TYR . 18.0 mtt-85 -56.69 -50.22 72.79 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.563 0.62 . . . . 0.0 110.786 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.19 -43.55 94.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.982 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.33 -47.12 84.76 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.081 1.309 . . . . 0.0 110.261 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.95 79.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.67 0.388 . . . . 0.0 110.46 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.28 -46.71 82.47 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.606 0.763 . . . . 0.0 110.17 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.53 -38.43 89.62 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.204 0.602 . . . . 0.0 110.005 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -64.35 -35.43 80.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.401 0.68 . . . . 0.0 110.793 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 t -67.3 -35.35 79.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.734 0.814 . . . . 0.0 109.65 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -80.58 -6.77 58.76 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.588 0.631 . . . . 0.0 111.937 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.01 28.59 66.34 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.148 0.885 . . . . 0.0 111.462 170.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG21 HD13 ' A' ' 81' ' ' LEU . 5.8 m -93.15 167.7 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 121.907 -0.76 . . . . 0.0 112.241 -168.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.3 p -98.49 130.12 45.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -145.91 164.27 32.52 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.434 1.094 . . . . 0.0 108.176 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -104.94 136.52 44.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.189 2.195 . . . . 0.0 107.17 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -116.39 139.14 50.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.644 1.178 . . . . 0.0 109.337 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.26 87.81 49.72 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 125.045 1.338 . . . . 0.0 110.702 -169.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.79 141.85 67.31 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.185 1.923 . . . . 0.0 111.701 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 124.938 1.295 . . . . 0.0 112.214 170.826 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.627 0.251 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -59.0 -43.58 91.5 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 120.76 -1.213 . . . . 0.0 110.733 170.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.06 -22.47 55.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.732 0.696 . . . . 0.0 111.869 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -60.25 -24.07 64.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.917 1.235 . . . . 0.0 109.714 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.7 tpp -54.44 -26.66 32.23 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.922 0.783 . . . . 0.0 112.372 173.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -74.38 -40.92 49.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -77.55 -31.36 53.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.443 -0.785 . . . . 0.0 112.208 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -74.9 -38.5 61.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 112.665 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.8 p -133.27 -12.31 2.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -168.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.21 -8.47 70.72 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.945 -168.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -127.54 -161.93 1.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.703 1.752 . . . . 0.0 111.337 -168.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 51' ' ' THR . 2.3 m -155.68 -23.79 0.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.708 2.403 . . . . 0.0 109.948 -170.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 50' ' ' THR . 13.6 p -74.08 163.01 28.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.93 1.692 . . . . 0.0 110.857 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG21 ' HG2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -139.65 161.97 53.65 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 0.0 109.135 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 59.4 Cg_endo -66.98 153.8 84.29 Favored 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.242 1.122 . . . . 0.0 112.116 2.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -130.63 103.37 6.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 105.761 -1.941 . . . . 0.0 105.761 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.672 HD12 ' H ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -84.65 146.87 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 168.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.91 119.25 27.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 168.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -125.28 129.41 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.697 1.59 . . . . 0.0 107.53 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 48.0 32.82 3.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.639 1.975 . . . . 0.0 110.102 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.26 4.68 4.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 131.107 3.763 . . . . 0.0 115.793 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.84 123.45 24.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -65.13 113.97 4.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.88 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.183 0.993 . . . . 0.0 109.546 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.08 -136.83 8.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -168.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.02 -175.93 43.86 Favored Glycine 0 CA--C 1.521 0.456 0 O-C-N 124.231 0.607 . . . . 0.0 112.483 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 16' ' ' ARG . 2.9 t80 -52.02 -49.71 62.84 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.603 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.3 -25.15 65.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.357 0.663 . . . . 0.0 110.627 -170.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -71.39 -51.88 21.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.528 1.131 . . . . 0.0 110.426 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -61.55 -51.22 69.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.892 1.277 . . . . 0.0 110.012 176.115 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -51.05 -38.97 54.73 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.138 1.375 . . . . 0.0 111.413 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.0 91.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 117.882 -1.056 . . . . 0.0 111.746 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.75 -51.02 70.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.467 1.03 . . . . 0.0 109.131 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.79 -42.79 80.09 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.373 1.069 . . . . 0.0 110.433 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -22.81 61.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.175 0.99 . . . . 0.0 112.566 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -88.58 4.47 46.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.188 0.995 . . . . 0.0 112.26 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.85 71.59 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.592 0.633 . . . . 0.0 112.243 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.79 -17.1 80.19 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.477 1.138 . . . . 0.0 112.056 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 81' ' ' LEU . 41.3 tp -77.95 -39.73 41.74 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.004 0.902 . . . . 0.0 110.68 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.26 -56.22 22.1 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.269 1.428 . . . . 0.0 109.921 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.56 -0.75 8.72 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.5 2.133 . . . . 0.0 113.508 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.56 -9.9 15.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 112.26 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 3' ' ' VAL . 11.5 mt . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 126.258 1.823 . . . . 0.0 112.623 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.632 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.651 HG21 HD21 ' A' ' 81' ' ' LEU . 94.7 t -125.43 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.3 135.91 52.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 tt -135.0 107.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.282 0.563 . . . . 0.0 110.49 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -73.57 136.14 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.438 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 73.2 p -141.29 179.07 6.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.135 1.374 . . . . 0.0 109.106 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -160.37 -179.62 7.84 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -48.62 -29.96 4.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.773 3.229 . . . . 0.0 113.924 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -138.41 86.55 2.17 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.203 1.001 . . . . 0.0 111.044 -173.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -156.75 91.23 2.51 Favored Pre-proline 0 CA--C 1.539 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 110.354 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.18 -27.55 72.85 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.361 2.041 . . . . 0.0 112.067 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -73.46 -29.47 62.55 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 7' ' ' THR . 74.1 m -66.75 -47.74 71.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.178 0.899 . . . . 0.0 108.902 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.19 -53.68 26.17 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.784 168.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -53.61 55.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.6 1.091 . . . . 0.0 111.174 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.34 76.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.936 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -60.61 -39.8 89.5 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.672 1.124 . . . . 0.0 110.935 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.3 68.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.208 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp -66.2 -54.34 26.38 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.61 -35.37 80.29 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -68.97 -35.31 76.59 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 109.66 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -74.04 -11.6 60.37 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.14 -0.975 . . . . 0.0 112.167 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -92.28 -27.4 17.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.519 1.054 . . . . 0.0 108.59 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.33 54.03 7.17 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 HD22 ' A' ' 81' ' ' LEU . 15.9 m -112.93 167.47 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.295 0.638 . . . . 0.0 112.088 -172.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.7 m -82.55 120.18 25.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.375 . . . . 0.0 107.308 169.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.87 169.7 17.55 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 109.286 169.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.45 147.29 44.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.77 155.08 28.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.641 0.655 . . . . 0.0 110.557 170.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.49 93.86 27.81 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 124.651 1.181 . . . . 0.0 108.848 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.84 145.98 91.18 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.221 1.948 . . . . 0.0 109.063 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 118.761 0.709 . . . . 0.0 109.1 168.677 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt . . . . . 0 C--O 1.231 0.115 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -67.11 -52.07 46.38 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -32.37 73.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.964 0.802 . . . . 0.0 109.41 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -23.42 66.33 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.291 -0.88 . . . . 0.0 111.917 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.44 -26.38 19.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.002 0.819 . . . . 0.0 112.308 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.39 -56.7 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -61.67 7.51 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.437 2.295 . . . . 0.0 116.125 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.12 -32.2 0.47 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.057 1.299 . . . . 0.0 110.517 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.3 p -129.29 -10.35 4.67 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.476 1.489 . . . . 0.0 113.108 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.84 -14.86 34.85 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.657 1.599 . . . . 0.0 114.322 -171.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -131.99 162.44 30.71 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 126.211 1.804 . . . . 0.0 109.01 -169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -105.45 4.46 30.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 112.645 170.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.2 p -73.69 175.26 7.33 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.877 1.271 . . . . 0.0 109.8 172.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.456 HG21 ' CG ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -143.98 164.49 29.34 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.976 1.31 . . . . 0.0 110.509 176.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.51 162.12 80.81 Favored 'Cis proline' 0 N--CA 1.454 -0.807 0 CA-C-N 119.151 0.732 . . . . 0.0 110.503 -7.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -127.36 99.6 5.71 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.1 mp -88.85 139.82 16.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.22 129.29 47.52 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 128.988 2.915 . . . . 0.0 104.935 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.63 123.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 53.75 30.14 10.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.452 1.024 . . . . 0.0 111.476 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.3 -1.11 2.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.722 3.209 . . . . 0.0 114.691 -172.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -73.95 114.39 12.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.316 1.846 . . . . 0.0 108.055 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -69.85 106.64 3.22 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.667 -0.645 . . . . 0.0 110.045 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.4 mm -73.96 -63.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.786 0.835 . . . . 0.0 109.04 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.87 -142.13 9.84 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.23 -173.31 38.78 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.472 1.51 . . . . 0.0 111.384 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.83 -38.83 76.3 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.598 -0.942 . . . . 0.0 110.625 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.54 -41.82 95.25 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.433 0.693 . . . . 0.0 110.276 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.58 -48.56 66.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.437 1.095 . . . . 0.0 110.052 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -49.86 71.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.861 1.264 . . . . 0.0 110.3 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -67.91 -27.78 66.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.83 69.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.188 0.995 . . . . 0.0 111.674 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.7 tp -56.34 -41.43 76.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.052 1.296 . . . . 0.0 109.94 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.62 -35.48 77.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.274 1.03 . . . . 0.0 112.845 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.95 -29.06 68.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.375 0.534 . . . . 0.0 110.809 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 -74.59 -10.76 59.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.177 0.991 . . . . 0.0 110.784 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.56 3.65 54.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.094 -0.837 . . . . 0.0 111.427 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.9 -6.08 89.25 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.916 1.246 . . . . 0.0 112.368 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 tp -73.5 -44.36 58.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.56 -46.99 99.77 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-O 116.7 -1.619 . . . . 0.0 113.494 -169.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 -12.63 35.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.541 1.943 . . . . 0.0 113.087 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -99.67 0.05 41.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.168 0.894 . . . . 0.0 111.506 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 3' ' ' VAL . 8.1 mt . . . . . 0 C--O 1.234 0.239 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.527 HG21 HD21 ' A' ' 81' ' ' LEU . 96.5 t -139.47 118.84 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -113.88 147.22 38.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.319 1.047 . . . . 0.0 108.324 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.65 110.45 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.279 0.491 . . . . 0.0 111.284 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 4.1 m-85 -79.94 140.02 36.83 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.654 -0.654 . . . . 0.0 110.713 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -152.81 178.58 9.49 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.311 2.645 . . . . 0.0 109.223 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.24 -173.56 4.28 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 119.608 -1.933 . . . . 0.0 110.322 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.03 -35.31 24.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.949 1.7 . . . . 0.0 111.578 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -138.27 160.44 39.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.678 2.391 . . . . 0.0 105.651 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 t 163.61 105.9 0.02 OUTLIER Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 127.733 2.413 . . . . 0.0 106.603 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.53 -40.38 30.91 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.846 2.364 . . . . 0.0 110.628 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -73.38 -26.83 61.16 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.99 -1.069 . . . . 0.0 110.306 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.2 m -64.87 -45.14 87.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.24 -0.913 . . . . 0.0 109.805 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -56.11 -47.62 77.72 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.827 -1.083 . . . . 0.0 110.124 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -54.24 -52.64 60.72 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.05 1.295 . . . . 0.0 111.199 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.38 -49.83 75.32 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.686 -0.634 . . . . 0.0 112.037 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -64.43 -32.63 74.33 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.035 0.834 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.52 -28.24 69.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.006 0.821 . . . . 0.0 110.951 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -60.3 2.65 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.02 -41.63 83.56 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.589 0.755 . . . . 0.0 111.356 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -67.77 -26.77 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.047 0.539 . . . . 0.0 110.702 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m -75.98 -29.29 58.18 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.551 -0.718 . . . . 0.0 111.183 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -77.42 -17.3 58.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.852 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.73 43.45 94.14 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.77 156.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.467 0.651 . . . . 0.0 111.575 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.06 117.63 22.98 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -134.13 163.66 29.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 168.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -103.62 144.05 31.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.33 146.86 42.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.88 134.48 26.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -95.38 162.83 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.559 2.172 . . . . 0.0 113.012 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.288 1.2 mt . . . . . 0 C--O 1.236 0.374 0 C-N-CA 126.623 1.969 . . . . 0.0 108.196 167.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -86.07 -60.82 1.9 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.76 -32.76 72.05 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 124.054 0.846 . . . . 0.0 111.339 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.01 -40.01 79.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.105 -0.372 . . . . 0.0 110.988 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -70.33 -17.88 63.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 121.136 -0.977 . . . . 0.0 112.597 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.32 -56.52 13.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 168.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.6 -25.52 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.615 0.766 . . . . 0.0 112.271 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -95.33 -33.62 12.47 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.625 -1.655 . . . . 0.0 113.107 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.5 p -124.07 -24.95 4.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.564 1.984 . . . . 0.0 114.876 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.73 -10.08 20.11 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.073 2.273 . . . . 0.0 114.486 -169.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -94.54 -63.94 1.13 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -168.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 86.71 0.42 0.56 Allowed 'General case' 0 CA--C 1.54 0.567 1 C-N-CA 131.844 4.058 . . . . 0.0 111.718 -168.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.4 p -111.4 161.52 16.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.465 1.506 . . . . 0.0 108.225 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.71 166.8 23.4 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 125.531 1.532 . . . . 0.0 113.833 -168.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.52 163.55 77.73 Favored 'Cis proline' 0 C--N 1.354 0.864 0 CA-C-N 120.847 1.338 . . . . 0.0 110.638 -2.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 15.3 mm-40 -146.03 84.48 1.65 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -168.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.61 142.1 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -137.1 85.16 2.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.021 2.128 . . . . 0.0 105.913 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.7 mt -92.93 132.41 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.42 24.61 2.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.408 1.083 . . . . 0.0 110.882 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.65 12.88 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.762 2.025 . . . . 0.0 115.562 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.49 128.0 33.08 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 168.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -69.48 114.05 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mm -76.13 -58.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.524 1.13 . . . . 0.0 110.461 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -157.72 27.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -169.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.34 -168.63 43.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.819 1.676 . . . . 0.0 110.96 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -62.63 -43.98 97.43 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.271 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.63 -34.48 77.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.598 1.09 . . . . 0.0 110.307 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -70.19 -46.32 64.85 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.115 0.966 . . . . 0.0 109.996 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.28 -50.13 74.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 127.543 2.337 . . . . 0.0 111.528 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -67.54 -29.27 68.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -40.3 71.82 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.54 169.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 tp -56.31 -41.43 75.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.956 1.253 . . . . 0.0 109.762 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.43 -32.39 73.99 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.69 -30.68 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.308 -0.87 . . . . 0.0 111.427 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -80.14 -5.15 55.5 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.821 0.737 . . . . 0.0 110.944 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.48 19.12 79.59 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.372 -0.682 . . . . 0.0 111.436 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.34 -3.5 65.0 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.306 1.053 . . . . 0.0 112.646 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.48 -50.92 7.31 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.637 1.219 . . . . 0.0 110.283 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -44.46 99.64 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.247 -176.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.14 7.43 3.31 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 123.311 2.218 . . . . 0.0 113.003 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.18 -2.13 13.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.535 1.534 . . . . 0.0 110.428 168.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 3' ' ' VAL . 12.0 mt . . . . . 0 C--N 1.331 -0.229 0 C-N-CA 126.185 1.794 . . . . 0.0 110.903 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 81' ' ' LEU . 99.4 t -112.18 89.72 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.55 135.18 37.24 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.875 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -136.64 113.14 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 124.462 1.105 . . . . 0.0 109.128 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.88 142.23 46.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.887 0.875 . . . . 0.0 108.779 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -150.01 166.1 30.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.056 1.342 . . . . 0.0 110.669 -169.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 176.55 12.54 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.891 -1.13 . . . . 0.0 108.715 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -56.37 -30.13 62.31 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.763 2.425 . . . . 0.0 113.853 -170.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 109.66 9.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -164.89 84.94 1.11 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -63.67 -26.1 68.89 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.836 1.691 . . . . 0.0 111.986 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -73.43 -30.48 63.24 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.074 -1.016 . . . . 0.0 109.419 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -66.33 -43.96 84.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 119.23 0.923 . . . . 0.0 108.968 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -53.25 -47.8 68.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.94 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -54.8 -59.3 4.91 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.598 1.545 . . . . 0.0 112.076 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.16 89.71 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.069 0.395 . . . . 0.0 110.27 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.771 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.26 99.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -59.66 -49.69 76.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.707 0.685 . . . . 0.0 110.229 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.99 -43.51 95.47 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.265 1.026 . . . . 0.0 111.048 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -59.03 -42.73 90.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.717 0.807 . . . . 0.0 109.167 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 t -69.69 -30.93 68.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.113 0.965 . . . . 0.0 110.416 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -78.18 -15.48 58.79 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.154 0.888 . . . . 0.0 111.453 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 47.95 23.58 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 124.991 1.282 . . . . 0.0 110.043 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 81' ' ' LEU . 13.8 m -104.43 171.5 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.038 0.535 . . . . 0.0 112.271 -170.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.4 p -94.35 126.99 39.95 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.32 170.4 16.38 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.433 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -128.92 124.43 35.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.617 1.567 . . . . 0.0 108.105 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.402 HD23 ' HE3' ' A' ' 39' ' ' LYS . 1.8 mp -116.68 113.58 40.22 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.33 146.94 20.02 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.159 1.906 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 125.495 1.518 . . . . 0.0 109.743 175.71 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HE3' HD23 ' A' ' 31' ' ' LEU . 9.4 ttmm . . . . . 0 C--O 1.222 -0.383 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -56.99 -50.74 71.78 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.118 0.872 . . . . 0.0 109.191 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.54 -30.28 68.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.299 0.499 . . . . 0.0 110.888 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.79 -37.77 88.61 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.868 -0.52 . . . . 0.0 110.507 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.2 ttm -61.94 -18.95 62.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.681 1.592 . . . . 0.0 112.36 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.59 -57.94 9.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -59.17 -44.29 92.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.101 -0.374 . . . . 0.0 111.15 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.55 -34.39 72.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.828 -171.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -121.16 -21.68 6.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.8 1.182 . . . . 0.0 114.029 -171.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.52 8.79 57.0 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.703 -168.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -129.89 -52.4 1.14 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.255 1.528 . . . . 0.0 112.708 -170.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m 76.72 6.97 3.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.297 1.439 . . . . 0.0 111.492 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.6 p -86.13 173.2 10.0 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 110.076 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.1 154.01 64.21 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 122.793 0.437 . . . . 0.0 110.856 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.68 157.67 81.47 Favored 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 106.574 -2.125 . . . . 0.0 106.574 -11.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -136.3 118.64 15.67 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 169.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.0 OUTLIER -97.42 145.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 O-C-N 125.118 1.511 . . . . 0.0 107.499 -174.069 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -137.1 111.59 8.62 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.396 2.678 . . . . 0.0 105.903 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -103.46 111.6 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.34 56.02 8.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.327 1.451 . . . . 0.0 107.809 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.27 -14.09 0.41 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.152 3.381 . . . . 0.0 114.24 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -77.83 112.58 14.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.693 0.797 . . . . 0.0 109.565 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.53 105.73 3.2 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.281 1.032 . . . . 0.0 110.394 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -74.42 -53.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.103 0.961 . . . . 0.0 108.659 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.54 -139.84 14.4 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -170.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.28 -173.29 47.31 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.011 1.767 . . . . 0.0 114.207 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -54.68 -50.89 67.16 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 122.225 -0.574 . . . . 0.0 110.238 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -73.77 -17.98 61.03 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.055 0.388 . . . . 0.0 110.717 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.39 -48.51 55.87 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 109.385 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -60.29 -49.77 76.29 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.814 1.646 . . . . 0.0 111.108 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.34 -37.68 81.4 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.606 1.562 . . . . 0.0 110.806 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.67 -44.22 78.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.678 0.791 . . . . 0.0 111.223 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.3 tp -56.58 -43.99 80.6 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 110.396 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.08 -35.58 81.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.021 0.528 . . . . 0.0 111.577 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.02 -26.47 66.79 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.905 0.482 . . . . 0.0 111.946 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -4.85 47.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.296 -0.877 . . . . 0.0 112.437 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.4 29.08 70.59 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.15 -28.3 13.76 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 118.339 1.07 . . . . 0.0 111.446 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -73.6 -52.5 13.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.045 0.923 . . . . 0.0 109.045 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.49 -55.92 22.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.23 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -9.27 25.4 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 122.135 1.798 . . . . 0.0 114.056 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 mt -83.41 -46.85 12.06 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 120.031 1.287 . . . . 0.0 108.813 169.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 3' ' ' VAL . 13.8 mt . . . . . 0 C--O 1.239 0.531 0 C-N-CA 124.462 1.105 . . . . 0.0 113.921 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.368 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 81' ' ' LEU . 80.9 t -130.36 130.29 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -130.17 144.29 51.27 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.86 1.264 . . . . 0.0 108.67 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 tt -141.49 113.21 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.116 0.484 . . . . 0.0 110.058 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -73.8 129.28 37.59 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -141.18 174.52 10.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.41 1.484 . . . . 0.0 110.75 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 173.47 11.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.76 -20.72 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.672 0.789 . . . . 0.0 112.128 -174.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 t -133.49 77.85 1.74 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.815 1.646 . . . . 0.0 107.411 -168.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.6 87.34 4.83 Favored Pre-proline 0 N--CA 1.443 -0.78 0 C-N-CA 124.764 1.226 . . . . 0.0 108.289 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.17 -31.0 92.57 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.65 1.567 . . . . 0.0 111.362 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.46 -36.49 65.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.56 1.527 . . . . 0.0 110.806 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.7 m -58.0 -46.42 85.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -60.23 -43.8 95.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.09 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.85 -51.81 64.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.163 1.801 . . . . 0.0 110.89 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -60.19 -55.98 27.15 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.923 0.889 . . . . 0.0 110.129 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -63.29 -29.75 71.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.28 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.55 -46.08 87.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.345 0.975 . . . . 0.0 109.228 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.0 -40.57 95.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.058 0.845 . . . . 0.0 110.235 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.44 -40.43 97.13 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.374 -0.828 . . . . 0.0 111.07 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -67.74 -30.43 69.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 110.678 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -71.23 -34.41 70.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.962 0.905 . . . . 0.0 111.238 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -73.79 -17.93 61.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.516 0.598 . . . . 0.0 109.474 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.92 23.11 67.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.137 1.351 . . . . 0.0 111.751 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 m -89.92 157.13 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 118.068 0.934 . . . . 0.0 112.751 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -85.22 136.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 168.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.45 165.81 28.28 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.48 1.912 . . . . 0.0 106.012 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -107.02 140.18 40.23 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.7 145.22 30.39 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -128.3 118.49 20.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 151.93 54.2 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.451 1.434 . . . . 0.0 108.984 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 125.463 1.505 . . . . 0.0 110.034 170.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp . . . . . 0 C--O 1.227 -0.129 0 N-CA-C 111.303 0.112 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -58.93 -53.23 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.793 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.03 -28.12 64.17 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.676 1.125 . . . . 0.0 112.424 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.6 -39.39 76.73 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.019 0.827 . . . . 0.0 108.94 169.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -65.32 -26.0 67.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.443 -0.785 . . . . 0.0 110.996 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.0 mt -74.27 -46.41 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.13 -63.79 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.332 0.969 . . . . 0.0 109.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -64.62 -42.56 95.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.704 2.402 . . . . 0.0 112.806 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -1.2 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -168.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.45 46.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.284 0.947 . . . . 0.0 113.251 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -136.72 -167.5 2.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.433 1.493 . . . . 0.0 109.6 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 p -155.9 3.46 0.17 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 129.565 3.146 . . . . 0.0 109.911 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.6 p -101.0 175.94 5.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.133 2.573 . . . . 0.0 110.343 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.93 158.21 62.59 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.6 163.09 82.3 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.776 -1.344 . . . . 0.0 108.639 -11.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.92 98.84 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 171.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.13 145.07 8.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -131.91 132.18 43.37 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 126.861 2.064 . . . . 0.0 106.04 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 HG22 ' A' ' 3' ' ' VAL . 3.2 mp -125.54 122.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 41.66 47.22 3.37 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.554 1.542 . . . . 0.0 112.486 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.96 3.46 4.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.543 2.337 . . . . 0.0 114.539 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -75.88 105.78 7.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -62.41 122.79 16.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -92.24 -75.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.74 -138.78 5.77 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 -162.25 19.61 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 126.504 2.002 . . . . 0.0 111.027 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -61.34 -42.07 98.08 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.089 0.945 . . . . 0.0 110.666 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.16 -38.52 91.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.392 0.433 . . . . 0.0 110.341 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.07 -48.86 64.42 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.411 1.084 . . . . 0.0 109.968 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.46 HD13 ' HB1' ' A' ' 17' ' ' ALA . 4.5 tt -54.29 -52.21 62.17 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 126.581 1.953 . . . . 0.0 110.571 172.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -68.75 -37.95 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.3 99.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.686 -0.673 . . . . 0.0 111.213 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.82 -42.43 79.59 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.057 1.298 . . . . 0.0 110.399 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.57 -37.51 87.81 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.274 1.03 . . . . 0.0 110.957 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.0 -21.82 65.03 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.425 -0.797 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -82.58 -7.23 59.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.876 1.271 . . . . 0.0 111.168 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.03 19.96 68.4 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.41 8.49 66.72 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.429 1.115 . . . . 0.0 112.014 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -110.3 -52.8 2.75 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.986 1.314 . . . . 0.0 109.192 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.33 -55.63 9.53 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.517 1.527 . . . . 0.0 113.782 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.53 -12.54 31.61 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.67 1.58 . . . . 0.0 113.216 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.98 -10.55 18.88 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.038 0.935 . . . . 0.0 111.34 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.564 ' CD2' HG21 ' A' ' 3' ' ' VAL . 13.5 mt . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 119.415 1.007 . . . . 0.0 112.319 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.52 ' CG2' HD21 ' A' ' 81' ' ' LEU . 70.9 t -123.88 128.96 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -122.87 121.91 37.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -168.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.25 18.6 tt -133.17 102.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 121.823 0.82 . . . . 0.0 110.935 -169.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.08 136.2 43.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -143.67 175.71 9.77 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.833 1.653 . . . . 0.0 110.793 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.507 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -134.25 173.52 11.52 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.872 1.669 . . . . 0.0 107.343 168.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -29.46 68.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.655 0.782 . . . . 0.0 111.915 -174.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -87.79 -129.08 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 168.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.9 t 74.73 88.05 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.563 2.345 . . . . 0.0 111.058 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.73 -36.74 83.27 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.198 1.932 . . . . 0.0 110.992 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -73.55 -27.08 61.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.482 -0.761 . . . . 0.0 111.151 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -63.13 -49.83 72.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -55.5 -46.87 76.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.313 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -54.84 -52.87 61.39 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 119.261 0.937 . . . . 0.0 111.374 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.56 -51.84 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.275 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -60.61 -34.96 75.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.714 1.143 . . . . 0.0 111.551 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.89 82.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.658 0.663 . . . . 0.0 110.068 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.38 -46.59 86.06 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.044 0.938 . . . . 0.0 110.077 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.26 -45.32 73.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.453 1.101 . . . . 0.0 111.329 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -69.5 -27.69 65.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.083 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -63.6 -41.95 98.29 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.049 0.84 . . . . 0.0 109.696 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -74.65 -6.63 49.77 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.627 0.649 . . . . 0.0 111.596 175.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.57 27.28 72.78 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.68 171.69 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 117.501 0.65 . . . . 0.0 110.476 -172.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 m -102.04 131.26 48.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -140.96 173.1 11.8 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.691 0.796 . . . . 0.0 108.883 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -125.24 126.65 45.49 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 128.101 2.56 . . . . 0.0 105.69 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.23 140.0 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -124.88 116.4 26.2 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.092 . . . . 0.0 110.799 -168.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -68.55 146.01 66.24 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.016 1.81 . . . . 0.0 109.115 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.465 0.304 0 C-N-CA 124.33 1.052 . . . . 0.0 110.864 169.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt . . . . . 0 C--O 1.224 -0.254 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -74.03 -32.64 63.44 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.633 1.106 . . . . 0.0 110.47 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.17 -43.39 67.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.695 169.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -62.21 -31.51 72.05 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.696 -0.628 . . . . 0.0 110.435 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.2 -19.86 63.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.605 -1.31 . . . . 0.0 112.484 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -64.1 -58.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.33 -31.8 72.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.917 1.687 . . . . 0.0 111.016 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -95.33 -40.89 9.3 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.381 1.473 . . . . 0.0 112.83 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -103.34 -26.71 12.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.285 1.402 . . . . 0.0 112.526 -173.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.7 33.2 76.53 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.47 -1.183 . . . . 0.0 112.063 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -143.66 -52.6 0.35 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.23 1.515 . . . . 0.0 113.335 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.406 62.5 p 68.29 4.99 4.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.483 2.713 . . . . 0.0 115.51 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -81.44 176.08 10.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -141.97 160.72 54.53 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.328 168.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 72.6 Cg_endo -69.1 160.35 86.18 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.65 0.911 . . . . 0.0 112.078 -0.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.75 99.64 5.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 168.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.51 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.6 mp -86.59 141.5 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 171.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.69 136.31 49.55 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 129.228 3.011 . . . . 0.0 105.248 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.439 HG12 HG22 ' A' ' 3' ' ' VAL . 56.3 mt -128.89 110.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 46.0 48.8 12.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.866 0.866 . . . . 0.0 111.814 -169.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.71 -6.74 1.86 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 129.531 3.132 . . . . 0.0 114.8 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.06 105.65 5.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -70.14 105.71 3.02 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.85 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.67 -144.03 13.09 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 -169.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.04 -161.04 24.59 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.986 1.755 . . . . 0.0 111.177 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -61.52 -45.58 93.61 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 121.808 -0.819 . . . . 0.0 110.496 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.44 -27.19 65.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.842 0.746 . . . . 0.0 109.2 -169.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.99 -55.32 11.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.288 2.235 . . . . 0.0 110.229 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.08 -47.33 86.32 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.302 1.841 . . . . 0.0 111.061 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.76 -41.22 90.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.219 1.408 . . . . 0.0 108.831 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.79 -34.96 76.43 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.004 0.82 . . . . 0.0 112.494 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.68 -51.96 66.75 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.992 1.269 . . . . 0.0 110.662 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -66.15 -28.01 68.46 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.146 0.978 . . . . 0.0 111.267 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.17 -8.58 56.41 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.481 -1.387 . . . . 0.0 112.328 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.37 -3.53 28.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.715 170.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.07 18.71 79.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.143 0.883 . . . . 0.0 110.913 -171.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.38 -1.32 69.19 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.546 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.3 -46.07 7.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.035 1.417 . . . . 0.0 111.044 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER -47.64 -49.24 57.05 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 174.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.72 -5.62 14.78 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 CA-C-N 121.905 1.716 . . . . 0.0 113.234 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.77 -55.82 2.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.723 1.209 . . . . 0.0 109.519 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.52 HD21 ' CG2' ' A' ' 3' ' ' VAL . 8.1 mt . . . . . 0 C--O 1.236 0.362 0 C-N-CA 125.82 1.648 . . . . 0.0 114.764 -169.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.68 160.95 5.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -154.42 112.91 3.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.81 110.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 118.512 0.596 . . . . 0.0 112.561 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -89.62 124.49 34.61 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -141.36 173.2 11.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.808 0.843 . . . . 0.0 111.336 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 -178.19 5.51 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.973 -1.079 . . . . 0.0 111.145 -172.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -31.55 68.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.958 1.303 . . . . 0.0 112.065 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -134.17 148.5 50.94 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t 163.8 89.87 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 129.288 3.035 . . . . 0.0 106.125 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.92 -30.7 90.49 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 111.533 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.32 -31.97 64.32 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.264 -0.897 . . . . 0.0 110.02 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -65.09 -46.72 79.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -51.85 -52.3 50.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.404 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -54.26 -50.33 67.48 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.194 1.361 . . . . 0.0 111.751 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.25 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.721 0.692 . . . . 0.0 111.472 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -62.46 -37.21 85.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.489 1.041 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.81 98.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.516 0.726 . . . . 0.0 109.604 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.5 -48.53 80.51 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.59 0.632 . . . . 0.0 109.529 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.63 -38.23 90.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.164 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.6 m -69.92 -30.64 68.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.5 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.6 m -66.22 -36.28 82.62 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 120.262 1.392 . . . . 0.0 110.202 172.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -77.15 -12.93 60.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.848 -0.533 . . . . 0.0 111.673 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.75 26.65 71.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.73 168.31 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.326 1.063 . . . . 0.0 109.779 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -91.62 124.13 35.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 170.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -150.13 168.46 23.89 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 122.638 0.375 . . . . 0.0 111.37 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -132.47 132.57 42.85 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.06 148.37 38.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.157 0.911 . . . . 0.0 109.646 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.27 92.65 31.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 125.272 1.429 . . . . 0.0 109.221 -168.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.11 129.38 21.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.181 2.588 . . . . 0.0 109.692 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.705 0 C-N-CA 125.008 1.323 . . . . 0.0 109.474 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 ttt-85 -78.78 -50.42 11.36 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.8 -26.41 68.34 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.771 0.714 . . . . 0.0 110.897 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.17 -51.76 68.22 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.2 ttp -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -65.08 -51.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.643 -1.286 . . . . 0.0 108.908 169.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -57.57 -36.49 71.75 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.308 0.958 . . . . 0.0 112.282 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -92.32 -28.84 16.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.623 -169.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -124.17 -18.49 5.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.833 1.197 . . . . 0.0 112.855 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.98 -16.08 1.64 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.843 1.687 . . . . 0.0 112.734 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -91.57 -71.02 0.66 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 126.45 1.9 . . . . 0.0 112.453 -168.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.385 0.6 OUTLIER 71.72 1.73 4.0 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 129.984 3.314 . . . . 0.0 113.903 -168.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.4 p -74.28 176.32 6.78 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.607 1.563 . . . . 0.0 107.716 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.09 158.95 74.53 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.8 161.42 79.51 Favored 'Cis proline' 0 C--N 1.348 0.519 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 -11.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.14 97.37 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 170.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -89.94 146.42 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -131.56 148.55 52.63 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.284 3.034 . . . . 0.0 106.11 170.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.88 116.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 168.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 62.31 40.7 11.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 110.279 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 75.0 -8.64 1.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.666 3.187 . . . . 0.0 114.246 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -74.35 101.12 3.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.63 1.972 . . . . 0.0 105.872 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -60.98 106.34 0.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.3 mm -74.36 -56.61 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.263 1.025 . . . . 0.0 108.847 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.61 -141.9 12.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.14 -169.67 26.02 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.053 1.787 . . . . 0.0 111.334 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -57.17 -42.51 81.28 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.526 -0.985 . . . . 0.0 111.437 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.45 -37.85 88.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.248 0.476 . . . . 0.0 109.786 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.0 -47.35 74.79 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.652 1.181 . . . . 0.0 109.901 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -55.19 29.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.337 1.855 . . . . 0.0 110.31 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.75 -34.5 77.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.79 88.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.189 0.904 . . . . 0.0 111.912 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.84 -46.35 81.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.875 1.216 . . . . 0.0 110.28 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.67 -41.03 98.86 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.16 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.92 71.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.71 1.204 . . . . 0.0 110.94 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -17.1 61.1 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.119 0.968 . . . . 0.0 110.439 176.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 25.62 41.28 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -169.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.86 -7.19 48.09 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.62 -1.1 . . . . 0.0 113.322 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.19 -48.77 8.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.985 1.392 . . . . 0.0 108.442 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.48 96.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.204 1.402 . . . . 0.0 112.111 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 -12.06 34.45 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 123.266 2.202 . . . . 0.0 113.238 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.43 -48.82 4.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.814 0.846 . . . . 0.0 110.181 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 N--CA 1.463 0.193 0 C-N-CA 125.669 1.588 . . . . 0.0 114.58 -168.197 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.43 90.15 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -104.64 124.67 49.75 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.531 -1.668 . . . . 0.0 108.328 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -126.82 101.85 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 0.0 111.389 -171.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -73.82 142.38 46.14 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.433 -0.792 . . . . 0.0 109.14 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.9 p -151.6 171.09 18.15 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.53 1.132 . . . . 0.0 111.199 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.545 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -135.67 174.04 11.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.499 1.52 . . . . 0.0 107.138 168.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -38.4 68.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.084 1.354 . . . . 0.0 113.057 -168.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.64 145.11 48.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t 172.69 103.45 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.561 2.344 . . . . 0.0 104.793 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -65.93 -30.11 48.88 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.148 1.899 . . . . 0.0 110.853 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -73.63 -37.23 65.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.021 0.929 . . . . 0.0 110.43 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -61.65 -47.36 85.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.855 0.752 . . . . 0.0 109.043 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -53.48 -53.42 51.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.02 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.48 -50.75 70.85 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.867 1.212 . . . . 0.0 112.068 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.02 -49.83 66.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.77 0.714 . . . . 0.0 110.9 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -61.71 -37.2 83.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.495 1.043 . . . . 0.0 110.787 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.68 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.043 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.81 -48.61 81.01 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.36 -42.15 79.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.438 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.5 m -70.91 -30.64 67.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.957 0.798 . . . . 0.0 111.056 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -70.31 -35.44 73.67 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.313 0.961 . . . . 0.0 110.824 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -75.08 -15.09 60.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.234 0.925 . . . . 0.0 110.704 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.38 24.43 75.16 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.334 1.445 . . . . 0.0 112.206 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 81' ' ' LEU . 7.9 m -83.14 154.78 3.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.22 1.01 . . . . 0.0 110.35 -172.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 m -81.2 115.51 20.64 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.249 1.82 . . . . 0.0 107.931 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -137.49 175.91 9.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 109.157 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -124.85 144.51 50.27 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.019 2.527 . . . . 0.0 106.561 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -116.14 152.44 33.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.633 0.652 . . . . 0.0 110.363 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.32 81.28 61.2 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.29 1.036 . . . . 0.0 109.735 -172.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.14 148.26 84.94 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.362 2.041 . . . . 0.0 112.074 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 pt . . . . . 0 CA--C 1.533 0.296 0 C-N-CA 126.412 1.885 . . . . 0.0 110.636 169.585 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . 0.259 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.48 -45.98 88.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.259 -1.526 . . . . 0.0 110.898 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -29.91 70.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.902 -177.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -55.76 -37.48 68.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.819 0.848 . . . . 0.0 110.465 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.1 ttm -61.89 -18.39 60.01 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.333 1.053 . . . . 0.0 112.782 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.49 -65.53 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -59.74 -28.16 67.12 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 121.476 1.944 . . . . 0.0 112.295 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -68.45 -45.08 73.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.604 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.3 p -121.72 -22.69 5.74 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.94 5.22 79.45 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.702 1.62 . . . . 0.0 112.376 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.438 ' HB2' HE22 ' A' ' 54' ' ' GLN . 11.2 mtp180 -124.85 -55.37 1.61 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.779 2.289 . . . . 0.0 114.951 -168.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.378 0.7 OUTLIER 69.15 13.67 8.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.676 2.79 . . . . 0.0 114.707 -173.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.9 p -75.99 175.59 8.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.113 1.765 . . . . 0.0 109.109 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.545 HG21 ' HG2' ' A' ' 8' ' ' LYS . 1.2 m -142.94 164.43 32.12 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.857 172.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.85 159.92 78.84 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.377 1.17 . . . . 0.0 109.639 -9.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.438 HE22 ' HB2' ' A' ' 49' ' ' ARG . 8.2 mt-30 -136.43 103.11 5.16 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 172.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 143.74 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 171.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -133.53 119.31 19.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.125 1.77 . . . . 0.0 106.369 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.438 HG21 HD13 ' A' ' 80' ' ' LEU . 26.4 mm -113.16 97.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 49.44 65.71 1.32 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.193 0.997 . . . . 0.0 111.054 -168.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 73.23 -13.99 0.66 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 128.444 2.698 . . . . 0.0 114.488 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -74.81 96.8 3.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.736 2.414 . . . . 0.0 108.457 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -64.03 110.55 2.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.94 -64.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.31 -145.14 14.07 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.21 -163.96 38.85 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.232 1.396 . . . . 0.0 111.798 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -65.15 -41.5 94.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.095 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.27 -45.26 80.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.033 0.833 . . . . 0.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -63.93 -48.33 77.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.666 1.186 . . . . 0.0 110.097 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.51 -48.58 78.93 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.85 1.26 . . . . 0.0 111.893 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.24 -33.82 75.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 123.589 0.756 . . . . 0.0 109.313 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -43.18 83.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.931 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.5 -44.91 81.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.18 1.355 . . . . 0.0 110.543 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.7 -42.08 91.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.048 0.539 . . . . 0.0 111.22 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.14 70.52 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.769 -0.582 . . . . 0.0 110.373 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -73.85 -19.77 60.63 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.898 1.279 . . . . 0.0 109.291 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 23.7 68.81 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.7 -13.53 40.39 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.769 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.4 -49.2 12.72 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.665 1.233 . . . . 0.0 109.8 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.96 -54.34 20.9 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 112.502 -173.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.0 3.09 5.35 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.898 2.398 . . . . 0.0 113.275 -175.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 HG21 ' A' ' 57' ' ' ILE . 96.2 mt -110.67 -3.86 15.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.958 -1.089 . . . . 0.0 110.571 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.414 HD12 ' HB ' ' A' ' 26' ' ' VAL . 3.8 mm? . . . . . 0 C--O 1.233 0.197 0 C-N-CA 123.943 0.897 . . . . 0.0 112.391 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.35 93.54 9.56 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.897 0.879 . . . . 0.0 110.513 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.669 HG21 HD21 ' A' ' 81' ' ' LEU . 73.3 t -127.62 128.02 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 118.854 0.752 . . . . 0.0 109.79 -171.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.13 145.34 45.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 124.095 0.872 . . . . 0.0 109.599 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -139.47 115.59 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -75.4 144.68 42.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -147.23 172.14 14.29 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.279 1.032 . . . . 0.0 113.2 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -146.15 173.97 11.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.637 169.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -49.68 -39.54 36.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.125 2.57 . . . . 0.0 111.331 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.7 p -133.62 88.25 2.46 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -168.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.1 t -148.81 86.66 5.69 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.05 -37.16 78.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.291 1.994 . . . . 0.0 110.394 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -73.45 -24.78 60.27 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.143 -0.973 . . . . 0.0 111.549 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 75.1 m -63.14 -51.96 64.4 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 120.264 1.393 . . . . 0.0 108.968 169.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.75 -41.93 74.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.912 -1.042 . . . . 0.0 111.053 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -54.45 -56.04 22.82 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.345 1.429 . . . . 0.0 110.924 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.98 -49.34 76.49 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.393 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.786 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.16 90.06 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.003 0.82 . . . . 0.0 110.19 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 tt -64.99 -47.68 76.66 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.551 0.614 . . . . 0.0 109.468 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.9 -35.01 79.27 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.386 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.3 m -75.18 -28.94 60.25 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.65 0.78 . . . . 0.0 111.631 174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -40.15 92.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.359 0.982 . . . . 0.0 109.328 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -73.35 -25.57 60.66 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.766 -1.209 . . . . 0.0 108.921 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.5 32.32 59.84 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.889 1.709 . . . . 0.0 111.03 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.69 171.37 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.281 0.562 . . . . 0.0 110.117 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.08 121.64 42.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -141.73 165.02 28.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.578 1.151 . . . . 0.0 110.131 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.53 144.62 35.94 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.181 1.392 . . . . 0.0 108.385 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.57 143.72 44.92 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.444 1.498 . . . . 0.0 108.068 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.44 103.56 16.4 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.912 1.285 . . . . 0.0 110.0 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.92 144.35 27.25 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.854 1.703 . . . . 0.0 110.26 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.441 ' HA ' ' HB3' ' A' ' 36' ' ' ASN . 6.7 mt -104.72 6.73 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 122.131 0.967 . . . . 0.0 109.994 172.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.66 95.67 2.88 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.369 2.267 . . . . 0.0 108.903 -171.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.14 -1.87 84.97 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.875 0.75 . . . . 0.0 113.243 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 33' ' ' ILE . 13.6 t-20 -83.4 168.47 16.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.623 1.569 . . . . 0.0 107.299 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.1 -47.31 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.37 2.268 . . . . 0.0 108.267 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.9 83.61 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.784 1.174 . . . . 0.0 111.039 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -81.09 -17.64 49.34 Favored 'General case' 0 N--CA 1.462 0.152 0 O-C-N 120.708 -1.245 . . . . 0.0 111.079 174.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -67.64 -39.12 84.64 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.296 -1.502 . . . . 0.0 108.751 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -63.07 -40.78 98.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.506 0.723 . . . . 0.0 109.962 171.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -52.77 -45.7 67.24 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.425 0.557 . . . . 0.0 109.934 172.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.51 -24.96 66.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.088 0.955 . . . . 0.0 113.366 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mt -65.0 -54.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.51 -36.98 85.57 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 119.605 -0.236 . . . . 0.0 110.843 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -75.66 -56.28 4.84 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.541 0.736 . . . . 0.0 111.282 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -91.09 -38.73 12.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.596 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.84 38.55 89.4 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -148.05 -58.09 0.24 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.359 1.464 . . . . 0.0 110.696 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.259 3.6 m 83.16 10.87 0.52 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.729 1.612 . . . . 0.0 111.909 171.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 81.1 p -109.35 171.89 7.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.454 2.702 . . . . 0.0 108.129 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.454 HG21 ' HG2' ' A' ' 8' ' ' LYS . 1.1 m -140.19 166.02 26.49 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.56 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.417 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 73.2 Cg_endo -63.28 148.7 64.84 Favored 'Cis proline' 0 CA--C 1.509 -0.738 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 -6.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -138.02 108.17 6.41 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.0 mp -94.28 145.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 125.271 1.607 . . . . 0.0 107.083 -176.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -128.36 124.15 35.68 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.806 2.842 . . . . 0.0 103.793 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 HG13 ' A' ' 3' ' ' VAL . 29.0 mm -120.96 117.99 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.255 0.6 OUTLIER 49.32 52.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.335 1.454 . . . . 0.0 110.659 -172.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.03 0.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.62 2.768 . . . . 0.0 114.329 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -86.59 108.17 18.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.253 1.421 . . . . 0.0 107.244 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -63.1 109.3 1.46 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.943 0.897 . . . . 0.0 109.071 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -78.38 -56.44 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.79 0.836 . . . . 0.0 109.292 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.1 -141.72 12.94 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.04 -165.8 30.16 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 118.885 1.343 . . . . 0.0 113.343 -168.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.0 -43.21 91.46 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.241 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.84 -35.84 82.41 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.733 0.697 . . . . 0.0 109.823 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -45.86 70.25 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.734 1.613 . . . . 0.0 111.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.45 -48.51 79.32 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 127.471 2.309 . . . . 0.0 111.363 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -69.51 -29.4 67.01 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -44.17 81.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.156 0.582 . . . . 0.0 110.941 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.77 -37.74 71.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.403 1.001 . . . . 0.0 110.801 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.38 -40.82 89.92 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.185 -0.947 . . . . 0.0 111.97 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.19 68.12 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.742 1.217 . . . . 0.0 112.171 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -89.22 3.84 50.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.814 1.246 . . . . 0.0 112.445 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 18.3 69.33 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.424 0.557 . . . . 0.0 112.154 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.86 -12.4 43.54 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.643 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.5 tp -73.65 -49.17 27.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.262 1.031 . . . . 0.0 109.511 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.87 -51.77 73.81 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.424 1.49 . . . . 0.0 112.33 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.36 -8.5 23.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.803 2.335 . . . . 0.0 114.707 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 mt -91.07 -49.52 6.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.669 HD21 HG21 ' A' ' 3' ' ' VAL . 4.9 mt -82.59 -22.31 34.86 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -173.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-N 120.07 1.304 . . . . 0.0 109.209 -168.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 121.0 19.76 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 169.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.608 HG21 HD21 ' A' ' 81' ' ' LEU . 93.8 t -126.84 132.88 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -136.59 127.37 27.32 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -168.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 tt -128.73 110.77 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.01 143.52 45.52 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -147.54 179.9 7.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.433 1.093 . . . . 0.0 111.725 -171.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.492 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -150.15 -172.56 4.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.245 -1.534 . . . . 0.0 107.929 168.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 10' ' ' THR . 1.1 pt-20 -35.76 -64.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.664 3.586 . . . . 0.0 111.259 170.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.438 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 14.7 t -134.13 124.21 25.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.0 t -169.6 101.11 0.47 Allowed Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.44 -35.73 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.971 1.781 . . . . 0.0 109.872 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -73.27 -32.8 64.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.778 -0.576 . . . . 0.0 109.811 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -61.59 -51.14 69.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.043 0.838 . . . . 0.0 109.15 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -54.54 -45.75 73.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.562 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -59.71 -49.77 76.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.525 1.511 . . . . 0.0 111.688 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.51 94.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.61 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -57.26 -51.52 69.03 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.495 1.043 . . . . 0.0 109.819 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.83 -22.58 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.655 0.782 . . . . 0.0 111.599 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -75.98 -50.61 14.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.101 1.36 . . . . 0.0 110.011 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.03 -42.52 98.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.25 1.02 . . . . 0.0 111.021 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.3 m -67.52 -28.14 67.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.809 1.644 . . . . 0.0 110.995 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -42.56 99.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HE3' ' OD1' ' A' ' 72' ' ' ASP . 66.2 mmtt -84.25 -6.55 59.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.004 0.82 . . . . 0.0 112.081 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.46 34.73 80.05 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 124.659 1.123 . . . . 0.0 111.901 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 81' ' ' LEU . 18.0 m -90.65 157.44 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 123.331 0.653 . . . . 0.0 110.912 -169.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -95.4 98.99 10.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' HD1' HG23 ' A' ' 26' ' ' VAL . 36.9 p90 -106.51 165.92 10.93 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.822 0.849 . . . . 0.0 108.781 169.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.22 144.19 31.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.178 1.791 . . . . 0.0 106.407 168.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.71 144.84 31.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mt -129.94 69.77 81.83 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.937 1.295 . . . . 0.0 108.495 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.58 140.3 47.03 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 N-CA-C 108.59 -1.35 . . . . 0.0 108.59 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 pt -98.98 -2.71 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.478 1.111 . . . . 0.0 111.324 170.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.3 -24.83 66.7 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.467 1.507 . . . . 0.0 114.104 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.88 34.94 2.15 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.12 1.819 . . . . 0.0 110.738 169.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.409 HD21 ' HB3' ' A' ' 39' ' ' LYS . 1.3 t30 -144.71 74.86 1.43 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.999 1.32 . . . . 0.0 108.886 -172.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.52 -17.28 64.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.72 -62.28 1.6 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.343 0.974 . . . . 0.0 109.877 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 36' ' ' ASN . 0.7 OUTLIER -77.84 -13.5 59.87 Favored 'General case' 0 C--O 1.225 -0.204 0 O-C-N 121.816 -0.552 . . . . 0.0 110.798 -174.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -54.27 -44.59 72.0 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 168.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -73.01 -42.33 63.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.163 0.585 . . . . 0.0 109.965 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.67 -32.1 72.26 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.659 -0.65 . . . . 0.0 110.956 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.4 ttp -55.75 -16.01 3.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.873 1.269 . . . . 0.0 113.235 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.73 -70.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 170.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -66.91 -27.6 67.63 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 120.194 1.361 . . . . 0.0 112.314 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HD2' ' CE2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -66.2 -50.87 62.37 Favored 'General case' 0 CA--C 1.524 -0.047 0 CA-C-N 119.17 0.895 . . . . 0.0 109.735 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.9 p -105.31 -31.89 8.86 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.671 1.123 . . . . 0.0 112.875 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.93 24.29 75.77 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 121.452 -0.78 . . . . 0.0 112.196 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -136.36 -53.13 0.73 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.99 1.316 . . . . 0.0 110.573 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m 75.72 2.66 3.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.448 1.099 . . . . 0.0 110.927 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 p -84.22 177.15 8.31 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.99 3.316 . . . . 0.0 107.873 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.1 m -129.5 161.12 60.84 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.129 169.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.26 166.51 79.75 Favored 'Cis proline' 0 N--CA 1.456 -0.698 0 CA-C-N 119.396 0.82 . . . . 0.0 110.675 -10.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -132.94 104.29 6.49 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 168.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.22 142.78 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CE2' ' HD2' ' A' ' 46' ' ' ARG . 96.7 m-85 -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.338 2.255 . . . . 0.0 106.871 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 3' ' ' VAL . 68.1 mt -132.83 119.66 38.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.281 14.8 m-20 45.6 45.51 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.805 0.812 . . . . 0.0 112.566 -169.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.37 -0.16 2.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.557 2.743 . . . . 0.0 114.249 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.24 109.58 7.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.9 113.48 3.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.9 mm -77.38 -55.02 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 108.872 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.68 -144.91 13.02 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.28 -163.67 26.5 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.421 2.438 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -57.17 -47.62 80.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.107 0.953 . . . . 0.0 112.022 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -64.77 -33.46 76.03 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.181 0.446 . . . . 0.0 109.939 -170.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.0 -44.57 72.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.924 1.69 . . . . 0.0 110.914 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.72 -51.13 70.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.889 1.276 . . . . 0.0 109.806 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.41 -30.33 70.06 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -40.97 85.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.138 1.375 . . . . 0.0 112.327 169.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.0 tp -56.25 -45.71 79.91 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.8 1.637 . . . . 0.0 110.322 171.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.411 ' OD1' ' HE3' ' A' ' 24' ' ' LYS . 27.5 t70 -62.83 -34.68 77.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.965 0.506 . . . . 0.0 112.106 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.15 -15.58 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.772 1.229 . . . . 0.0 112.135 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -5.25 59.23 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.368 1.067 . . . . 0.0 111.224 168.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.07 15.83 70.05 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -168.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.57 -9.34 55.07 Favored Glycine 0 C--N 1.341 0.843 0 C-N-CA 124.697 1.142 . . . . 0.0 112.868 -170.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.431 HD11 HD12 ' A' ' 81' ' ' LEU . 57.4 tp -73.94 -47.93 34.12 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.329 1.065 . . . . 0.0 109.844 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -54.78 35.84 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.892 1.277 . . . . 0.0 112.156 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.21 -1.91 8.86 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.396 2.064 . . . . 0.0 113.889 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.38 -3.13 19.9 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.806 1.243 . . . . 0.0 111.428 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.608 HD21 HG21 ' A' ' 3' ' ' VAL . 26.6 mt -137.65 18.25 2.88 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.971 1.308 . . . . 0.0 111.303 -178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp . . . . . 0 C--O 1.246 0.902 0 CA-C-O 116.686 -1.626 . . . . 0.0 108.412 174.253 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.508 ' HB1' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.62 123.11 26.21 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.197 0.908 . . . . 0.0 109.031 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.639 HG21 HD21 ' A' ' 81' ' ' LEU . 70.1 t -133.72 120.07 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 119.355 0.98 . . . . 0.0 108.844 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -129.52 146.97 51.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.14 0.976 . . . . 0.0 109.462 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 tt -140.72 118.37 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 124.509 1.124 . . . . 0.0 108.226 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.782 ' HB3' HD11 ' A' ' 33' ' ' ILE . 34.6 m-85 -78.94 135.58 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.25 1.02 . . . . 0.0 108.812 171.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -144.11 -177.18 5.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.456 1.502 . . . . 0.0 111.501 -168.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -157.5 177.67 11.16 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 119.661 -1.899 . . . . 0.0 107.889 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.66 -25.23 38.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.836 1.654 . . . . 0.0 112.325 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.89 120.6 20.6 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 172.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.0 t -167.77 93.68 0.65 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.022 0.929 . . . . 0.0 111.342 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -64.11 -39.63 30.45 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.509 2.14 . . . . 0.0 112.033 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -73.58 -29.21 62.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.316 1.871 . . . . 0.0 110.084 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -59.3 -52.71 64.47 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 119.924 1.238 . . . . 0.0 108.239 169.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -54.56 -40.14 68.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.254 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -59.84 -54.01 51.21 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.004 1.274 . . . . 0.0 111.777 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.19 93.12 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.862 -0.523 . . . . 0.0 110.233 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -63.48 -36.51 84.0 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.202 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -26.77 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 120.268 1.394 . . . . 0.0 110.906 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.05 -55.14 11.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 26' ' ' VAL . 90.9 mt -64.87 -43.27 93.49 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.001 1.32 . . . . 0.0 112.081 -173.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -69.94 -30.81 68.29 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.496 1.118 . . . . 0.0 109.674 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -66.05 -39.87 90.47 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.474 1.033 . . . . 0.0 109.593 169.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -73.72 -9.35 58.57 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.222 0.919 . . . . 0.0 110.763 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.0 81.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 125.603 1.573 . . . . 0.0 110.446 172.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 81' ' ' LEU . 20.0 m -90.55 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.596 0.713 . . . . 0.0 112.838 -168.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.3 p -105.75 116.92 32.75 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.69 1.996 . . . . 0.0 105.792 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.467 ' HD2' HG23 ' A' ' 26' ' ' VAL . 50.8 p90 -134.78 167.75 20.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -112.73 133.36 54.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.24 111.53 20.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.438 1.895 . . . . 0.0 107.424 -168.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.85 102.37 50.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.328 1.451 . . . . 0.0 111.381 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.85 137.0 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.01 2.474 . . . . 0.0 113.892 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 6' ' ' TYR . 15.5 mt -117.86 49.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 127.322 2.249 . . . . 0.0 107.365 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.81 53.55 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.39 1.876 . . . . 0.0 111.63 174.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.73 22.29 39.68 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 119.44 -2.038 . . . . 0.0 113.851 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.555 HD21 ' HA ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -83.4 125.54 31.79 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 -168.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.02 -29.07 68.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.081 0.855 . . . . 0.0 112.049 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.14 -50.04 71.99 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.671 1.188 . . . . 0.0 110.081 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.454 ' HB2' HD22 ' A' ' 36' ' ' ASN . 1.0 OUTLIER -79.9 -18.53 50.39 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.996 176.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -60.63 -59.34 5.55 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.54 1.064 . . . . 0.0 108.581 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.07 -41.88 89.05 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.393 0.433 . . . . 0.0 110.908 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.61 -56.19 15.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.386 1.474 . . . . 0.0 109.558 173.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.719 ' CE ' HD13 ' A' ' 33' ' ' ILE . 1.3 ttm -67.12 -26.35 66.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.837 -0.54 . . . . 0.0 112.184 -174.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.38 -54.28 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -60.83 -46.46 90.47 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.93 1.241 . . . . 0.0 112.245 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -79.88 -30.75 40.24 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 117.431 -1.271 . . . . 0.0 112.508 -169.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.2 p -116.15 -27.79 6.78 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.078 1.308 . . . . 0.0 113.458 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.03 23.88 53.04 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.482 1.037 . . . . 0.0 113.497 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -130.52 -57.9 1.05 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.271 1.035 . . . . 0.0 110.186 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.263 3.4 m 74.23 37.78 0.58 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 123.237 1.494 . . . . 0.0 110.989 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.1 p -142.09 176.91 8.59 Favored 'General case' 0 C--N 1.329 -0.325 1 C-N-CA 132.27 4.228 . . . . 0.0 105.902 -176.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.527 ' CG1' HD12 ' A' ' 33' ' ' ILE . 1.1 m -132.71 160.17 69.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.35 167.87 78.59 Favored 'Cis proline' 0 CA--C 1.534 0.514 0 N-CA-C 110.233 -0.718 . . . . 0.0 110.233 -10.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -130.47 96.21 4.07 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 168.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.555 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -81.15 144.26 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -133.04 125.1 28.92 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.561 2.744 . . . . 0.0 104.964 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.7 mm -125.28 120.99 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER 50.92 40.89 26.17 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.722 1.249 . . . . 0.0 111.789 -174.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.31 0.28 0.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.874 2.87 . . . . 0.0 114.45 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.7 121.07 20.18 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -75.01 98.86 3.71 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.41 -49.21 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 -132.19 6.8 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.51 -178.16 45.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.474 1.035 . . . . 0.0 111.264 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -54.23 -42.95 70.43 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.437 -1.037 . . . . 0.0 110.721 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -34.77 71.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.856 0.862 . . . . 0.0 111.87 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -71.69 -44.22 64.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.194 0.598 . . . . 0.0 110.993 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -62.13 -48.6 79.42 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.309 1.044 . . . . 0.0 110.619 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -59.77 -39.26 84.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.125 1.77 . . . . 0.0 109.197 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.1 81.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.189 0.596 . . . . 0.0 110.976 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 tp -56.66 -45.32 81.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.969 0.804 . . . . 0.0 110.121 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.58 -38.78 91.45 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.984 0.914 . . . . 0.0 112.181 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.32 69.77 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.429 0.559 . . . . 0.0 110.716 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -5.44 56.47 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.083 -1.011 . . . . 0.0 110.58 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.94 21.28 79.09 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.275 -0.89 . . . . 0.0 111.081 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.24 -28.19 28.59 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.12 0.96 . . . . 0.0 111.662 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.4 tp -74.21 -50.87 17.29 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.324 1.062 . . . . 0.0 110.81 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.46 -55.77 20.36 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.791 0.836 . . . . 0.0 113.133 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.7 11.86 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.825 2.35 . . . . 0.0 113.427 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.7 mt -112.35 -2.87 14.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.15 1.38 . . . . 0.0 110.396 168.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.639 HD21 HG21 ' A' ' 3' ' ' VAL . 54.5 mt -126.06 10.37 7.54 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 110.088 170.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.913 0 C-N-CA 127.745 2.418 . . . . 0.0 107.126 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.47 94.03 2.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 164.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 81' ' ' LEU . 92.5 t -106.02 133.92 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.71 144.27 33.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 123.854 0.721 . . . . 0.0 109.56 -169.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.73 117.44 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.468 0.707 . . . . 0.0 110.142 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -78.04 140.3 39.13 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -146.99 177.46 9.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.045 0.938 . . . . 0.0 112.487 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.411 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -157.73 -177.06 6.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.942 1.297 . . . . 0.0 110.899 169.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.57 -24.27 3.12 Favored 'General case' 0 CA--C 1.52 -0.187 1 C-N-CA 132.555 4.342 . . . . 0.0 114.538 -168.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -133.32 -83.47 0.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.9 t 33.99 75.99 0.43 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.752 2.021 . . . . 0.0 112.173 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.66 -24.28 74.83 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.362 2.041 . . . . 0.0 111.34 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -73.1 -37.46 66.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.957 1.253 . . . . 0.0 109.71 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -60.7 -46.86 88.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -54.39 -50.6 67.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.173 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 49.9 mtp180 -54.47 -49.73 69.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.14 1.336 . . . . 0.0 110.919 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.07 39.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.173 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -60.09 -32.05 70.6 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.617 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.91 75.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.736 1.153 . . . . 0.0 109.271 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.75 -44.66 93.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 26' ' ' VAL . 95.6 mt -69.4 -40.77 77.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.633 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -71.57 -31.93 67.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.966 0.803 . . . . 0.0 110.745 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -62.64 -44.92 95.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 3.8 mmpt? -73.7 -15.71 61.22 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.52 0.6 . . . . 0.0 110.416 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.34 18.85 78.92 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.768 1.652 . . . . 0.0 112.546 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 21' ' ' LEU . 3.2 m -73.59 160.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 118.278 1.039 . . . . 0.0 111.746 -168.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.7 m -94.56 120.98 35.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -134.16 -172.66 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.531 1.933 . . . . 0.0 107.693 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.45 137.0 48.42 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -109.62 135.57 50.37 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.498 0.719 . . . . 0.0 109.092 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.11 77.27 75.56 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.632 1.173 . . . . 0.0 108.962 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.53 152.4 80.39 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.794 2.33 . . . . 0.0 110.868 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pt -133.52 22.72 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.794 1.238 . . . . 0.0 112.507 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -70.07 138.65 52.24 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.03 -13.81 0.9 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.612 1.101 . . . . 0.0 114.707 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.419 HD21 ' N ' ' A' ' 40' ' ' ARG . 5.4 t30 -83.88 177.49 8.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 128.513 2.725 . . . . 0.0 109.485 -171.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.26 -45.23 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.167 1.787 . . . . 0.0 108.4 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.75 57.78 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.069 0.85 . . . . 0.0 110.971 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -78.13 -6.77 55.76 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.449 -0.782 . . . . 0.0 112.426 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.419 ' N ' HD21 ' A' ' 36' ' ' ASN . 31.0 ttp180 -82.85 -43.31 16.76 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -60.61 -33.48 72.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.07 -38.1 72.79 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.493 -0.755 . . . . 0.0 110.296 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -20.61 62.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.942 0.897 . . . . 0.0 111.643 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.1 mt -73.58 -42.65 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.26 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -30.74 37.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.982 1.719 . . . . 0.0 112.258 173.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -70.62 -44.97 66.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.387 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.51 -11.77 3.12 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -168.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.01 -20.22 47.21 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.613 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -138.56 148.03 43.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.29 1.545 . . . . 0.0 111.811 -169.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -88.17 -5.9 58.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 131.37 3.868 . . . . 0.0 113.189 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -76.56 168.52 19.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.22 1.408 . . . . 0.0 111.35 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.411 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -143.62 166.17 21.08 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.615 0.766 . . . . 0.0 110.15 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.14 155.42 73.42 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.224 1.116 . . . . 0.0 109.589 -8.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -134.1 91.92 2.88 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -86.17 150.49 3.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 46' ' ' ARG . 58.9 m-85 -141.75 145.51 34.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.369 2.668 . . . . 0.0 108.523 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.71 116.49 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 43.55 51.64 6.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.741 1.616 . . . . 0.0 112.133 -172.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.3 -0.07 2.31 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.87 2.468 . . . . 0.0 114.234 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -75.5 108.86 8.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -65.82 110.19 2.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.79 -58.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.33 -143.69 11.6 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -173.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.62 -172.49 41.14 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.635 2.064 . . . . 0.0 111.327 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 17.9 t80 -56.38 -46.2 80.21 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.93 -0.747 . . . . 0.0 111.154 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.74 -32.0 73.36 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.959 0.345 . . . . 0.0 110.436 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.56 -46.0 64.35 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.692 0.758 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.2 -50.21 74.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.852 1.261 . . . . 0.0 111.004 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -68.31 -28.65 67.36 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.61 82.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 110.447 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.7 tp -56.7 -46.05 81.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.735 1.152 . . . . 0.0 109.926 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.51 -43.29 89.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.635 0.774 . . . . 0.0 111.259 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.15 63.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.943 0.897 . . . . 0.0 112.123 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.87 6.84 26.5 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.232 1.413 . . . . 0.0 111.713 169.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.93 17.92 68.1 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.043 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.08 -8.53 41.53 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.862 1.331 . . . . 0.0 113.008 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -75.24 -55.48 5.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.877 1.338 . . . . 0.0 109.5 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.78 -50.99 74.53 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.68 -17.69 30.01 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.928 2.419 . . . . 0.0 114.806 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -104.8 -1.52 25.99 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.996 1.318 . . . . 0.0 111.115 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.405 HD21 HG21 ' A' ' 3' ' ' VAL . 11.7 mt -117.83 16.85 14.35 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.322 -1.486 . . . . 0.0 112.005 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.25 2.22 . . . . 0.0 112.859 -168.086 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.57 93.98 3.93 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 81' ' ' LEU . 58.7 t -101.03 99.41 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -123.45 148.06 46.54 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.583 0.552 . . . . 0.0 111.58 -168.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.97 114.94 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.244 0.545 . . . . 0.0 110.546 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -74.31 140.37 44.84 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -150.82 172.65 15.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.905 1.682 . . . . 0.0 110.832 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.488 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -149.41 174.81 12.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.782 1.233 . . . . 0.0 107.862 168.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -18.87 61.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.1 1.36 . . . . 0.0 113.842 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 106.75 7.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -167.0 85.63 0.83 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.664 0.786 . . . . 0.0 108.932 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.78 -33.91 96.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.633 1.555 . . . . 0.0 111.424 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -73.46 -27.57 61.48 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.769 -1.207 . . . . 0.0 109.832 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.47 -49.32 74.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 121.023 -1.048 . . . . 0.0 108.93 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -54.75 -46.55 74.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.946 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -54.56 -52.77 61.05 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 120.225 1.375 . . . . 0.0 111.335 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.23 71.35 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.527 0.603 . . . . 0.0 110.39 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -58.54 -38.1 77.08 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.39 0.996 . . . . 0.0 111.474 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.98 95.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.112 0.565 . . . . 0.0 109.706 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 tp -62.55 -48.28 80.18 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.139 0.576 . . . . 0.0 109.875 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.1 mt -65.09 -42.14 94.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 110.734 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 t -65.12 -36.34 83.95 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.512 1.125 . . . . 0.0 110.226 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.3 t -70.22 -34.4 72.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.219 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -80.92 -5.29 57.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.462 1.028 . . . . 0.0 111.424 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 23.32 77.11 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 124.609 1.1 . . . . 0.0 111.686 173.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.86 162.93 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 118.181 0.991 . . . . 0.0 110.283 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -100.53 113.54 26.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 172.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.76 170.18 16.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.124 1.77 . . . . 0.0 109.207 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -123.44 140.81 52.63 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.61 143.0 39.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.18 113.83 23.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.09 158.76 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.927 2.418 . . . . 0.0 110.393 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mm -125.97 -9.69 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.849 1.26 . . . . 0.0 110.778 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.04 119.76 11.95 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 168.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.9 -34.3 1.9 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.247 0.927 . . . . 0.0 112.729 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 39' ' ' LYS . 10.1 t30 -87.45 53.98 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 123.336 1.541 . . . . 0.0 107.831 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 -18.74 63.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.154 -1.591 . . . . 0.0 110.973 168.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.03 -69.69 0.1 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.991 1.716 . . . . 0.0 109.657 169.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' HB3' HD21 ' A' ' 36' ' ' ASN . 6.2 ttmm -74.79 -12.24 60.35 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.407 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.3 -45.21 94.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.959 1.254 . . . . 0.0 110.339 168.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.7 -39.55 93.84 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.779 0.718 . . . . 0.0 110.098 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -58.01 -36.96 73.43 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.605 -0.684 . . . . 0.0 110.377 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.8 ttm -64.4 -16.05 61.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.922 1.689 . . . . 0.0 112.513 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.28 -58.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -55.08 -50.13 69.93 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.403 0.62 . . . . 0.0 110.567 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.74 -39.99 73.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.426 -168.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.8 p -112.03 -25.37 9.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 112.865 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.0 21.73 63.97 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.353 -168.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -136.54 -57.03 0.74 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.307 1.554 . . . . 0.0 113.011 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 79.3 -6.34 1.86 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 129.755 3.222 . . . . 0.0 113.612 -172.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.4 p -73.79 176.4 6.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.772 2.029 . . . . 0.0 107.92 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.488 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -140.3 159.42 63.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 O-C-N 121.849 -0.532 . . . . 0.0 110.033 176.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.36 165.79 81.94 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 125.591 -0.587 . . . . 0.0 111.395 -5.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -132.89 104.44 6.58 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 168.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.487 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.8 mp -81.12 141.79 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 171.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -127.69 128.76 45.98 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 128.332 2.653 . . . . 0.0 104.953 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.527 HG21 ' HB3' ' A' ' 80' ' ' LEU . 68.3 mt -119.44 104.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 52.22 52.14 14.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.295 1.038 . . . . 0.0 109.175 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.19 -13.49 0.9 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 130.565 3.546 . . . . 0.0 114.428 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -74.7 108.75 7.65 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -67.55 110.24 3.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -74.25 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.14 -145.9 13.82 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -168.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.78 -168.74 36.67 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.169 1.366 . . . . 0.0 112.016 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -61.51 -39.98 92.96 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.682 -0.893 . . . . 0.0 110.214 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.54 -35.92 82.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -65.7 -45.78 81.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.941 1.296 . . . . 0.0 110.701 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.26 -48.32 70.85 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 126.188 1.795 . . . . 0.0 111.087 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -64.96 -34.68 79.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.705 1.202 . . . . 0.0 109.541 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.17 77.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.233 0.613 . . . . 0.0 110.824 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.62 -39.33 73.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.858 0.863 . . . . 0.0 109.839 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.24 -34.18 70.54 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.527 -0.733 . . . . 0.0 112.722 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.28 -34.05 75.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.224 1.009 . . . . 0.0 110.781 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -90.53 6.77 42.18 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 124.799 1.24 . . . . 0.0 112.888 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.95 3.86 52.95 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.273 0.939 . . . . 0.0 112.463 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.12 -17.62 80.22 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.376 0.988 . . . . 0.0 112.047 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.54 -40.39 61.75 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.242 1.017 . . . . 0.0 111.61 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -56.21 24.83 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.154 0.982 . . . . 0.0 112.398 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.49 16.32 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.197 3.264 . . . . 0.0 112.227 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB3' HG21 ' A' ' 57' ' ' ILE . 67.3 mt -115.96 -17.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.038 -1.039 . . . . 0.0 111.967 171.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 3' ' ' VAL . 6.5 mt -111.79 23.04 14.29 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.534 1.061 . . . . 0.0 112.527 -175.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.255 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 C-N-CA 127.282 2.233 . . . . 0.0 115.73 -168.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.44 0.638 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.46 142.75 46.83 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 164.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -133.48 142.96 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 119.866 1.212 . . . . 0.0 108.159 170.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -140.87 120.57 13.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.27 14.2 tt -134.72 101.75 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.609 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -77.58 141.97 39.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.984 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 14' ' ' CYS . 41.7 p -147.5 -176.97 5.45 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.261 1.425 . . . . 0.0 112.442 -169.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.19 -170.01 2.62 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.393 -1.442 . . . . 0.0 108.241 169.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.32 -5.98 12.49 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -140.9 -119.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.423 1.489 . . . . 0.0 107.911 -168.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t 58.52 85.68 0.18 Allowed Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 127.451 2.3 . . . . 0.0 111.284 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.94 -38.88 86.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.174 2.583 . . . . 0.0 112.941 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -74.22 -34.19 63.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.205 1.366 . . . . 0.0 110.925 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.473 ' HB3' HG22 ' A' ' 7' ' ' THR . 68.7 m -58.57 -48.14 81.92 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.61 1.095 . . . . 0.0 109.108 169.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -60.79 -39.65 89.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.073 -1.442 . . . . 0.0 110.97 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 23.9 mmt85 -54.3 -53.0 59.71 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.831 1.65 . . . . 0.0 109.699 173.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.95 79.57 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.354 0.525 . . . . 0.0 110.968 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -62.51 -40.2 95.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.248 0.931 . . . . 0.0 111.051 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.06 99.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.826 0.851 . . . . 0.0 109.75 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.54 -52.43 65.42 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.97 -36.5 83.5 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.373 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 m -69.46 -34.6 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.211 0.605 . . . . 0.0 110.773 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -64.7 -38.08 89.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.428 0.691 . . . . 0.0 109.337 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -86.06 0.14 54.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.932 -0.48 . . . . 0.0 111.453 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.02 21.4 69.72 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.721 2.105 . . . . 0.0 111.416 169.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -74.5 163.2 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -169.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -99.07 118.1 35.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -143.73 166.68 24.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.471 1.908 . . . . 0.0 109.512 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -113.57 140.15 48.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -109.08 145.23 36.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.451 1.9 . . . . 0.0 106.674 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.415 ' CD2' ' HE2' ' A' ' 39' ' ' LYS . 1.8 mp -128.19 83.26 66.63 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 108.669 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.52 142.03 98.27 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.321 2.014 . . . . 0.0 109.193 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.1 mt -84.72 -28.3 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 120.222 1.374 . . . . 0.0 107.855 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -56.3 113.0 1.39 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 169.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.11 -0.53 81.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.847 1.689 . . . . 0.0 113.856 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.417 HD21 ' HB2' ' A' ' 39' ' ' LYS . 9.1 t30 -144.47 38.45 1.25 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.624 1.57 . . . . 0.0 110.266 -168.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.63 63.99 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.85 1.66 . . . . 0.0 108.541 168.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.87 -59.82 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 128.001 2.52 . . . . 0.0 107.153 -169.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HB2' HD21 ' A' ' 36' ' ' ASN . 25.5 mtpp -69.46 -15.03 63.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 118.476 -1.29 . . . . 0.0 109.615 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -59.45 -48.93 79.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -56.67 -46.76 80.92 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.352 1.061 . . . . 0.0 110.258 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -55.98 -33.03 64.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.112 0.565 . . . . 0.0 110.926 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ttp -62.79 -12.92 27.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.848 1.259 . . . . 0.0 113.967 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mt -63.91 -55.21 23.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 169.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -71.97 -36.24 69.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.2 -0.937 . . . . 0.0 111.776 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -35.16 80.17 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.259 -1.353 . . . . 0.0 112.289 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -129.04 -16.14 4.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.086 1.312 . . . . 0.0 114.355 -170.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.7 -5.65 11.09 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.044 -1.42 . . . . 0.0 113.458 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.68 -54.59 2.5 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.89 1.845 . . . . 0.0 111.69 -169.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m 86.1 -9.91 0.71 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.867 3.267 . . . . 0.0 111.823 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.9 p -74.06 176.66 6.31 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 130.486 3.515 . . . . 0.0 109.441 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.02 158.84 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.642 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.73 156.95 98.91 Favored 'Cis proline' 0 C--N 1.349 0.559 0 CA-C-N 120.248 1.124 . . . . 0.0 111.482 0.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -130.0 99.42 5.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.462 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.1 mp -87.84 142.15 13.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -129.3 141.66 51.04 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 128.339 2.655 . . . . 0.0 105.575 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.86 136.49 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.09 35.97 26.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.028 0.931 . . . . 0.0 111.052 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.78 -0.21 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.659 2.384 . . . . 0.0 114.476 -173.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -80.83 121.33 25.82 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -63.76 119.38 9.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 mm -82.77 -66.73 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.7 -125.2 1.87 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.24 -172.18 14.06 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.858 2.171 . . . . 0.0 110.771 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 36.4 t80 -56.02 -46.0 78.93 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.081 -173.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.48 -36.9 81.78 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.847 1.203 . . . . 0.0 110.447 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.8 -51.08 64.12 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.185 0.994 . . . . 0.0 109.727 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.73 -48.86 75.35 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.401 2.281 . . . . 0.0 111.393 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -61.29 -42.09 98.06 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.12 0.968 . . . . 0.0 109.018 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.27 96.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.955 0.798 . . . . 0.0 110.884 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.7 tp -56.68 -41.21 76.94 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.232 0.924 . . . . 0.0 110.58 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.69 -37.93 79.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.687 -0.633 . . . . 0.0 112.282 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.49 -25.23 66.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.605 1.162 . . . . 0.0 111.363 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -73.8 -20.72 60.38 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.377 1.071 . . . . 0.0 110.148 172.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.77 27.01 59.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -168.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.86 -9.11 23.28 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.192 1.377 . . . . 0.0 112.753 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -74.77 -42.59 57.88 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.854 1.327 . . . . 0.0 109.4 170.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -56.35 29.59 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.632 1.573 . . . . 0.0 109.543 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.64 -8.24 23.15 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.525 2.15 . . . . 0.0 113.957 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.5 -58.48 2.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mt -63.68 -54.38 36.57 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 111.737 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.5 mttt . . . . . 0 C--O 1.246 0.909 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.56 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.481 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.778 -0.082 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.63 98.75 2.92 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 158.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.513 HG21 HD21 ' A' ' 81' ' ' LEU . 59.9 t -96.41 97.52 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -102.62 122.11 43.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.259 19.7 tt -129.75 107.96 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.527 0.679 . . . . 0.0 112.208 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -74.04 149.74 41.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.664 1.186 . . . . 0.0 110.926 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -155.42 -177.66 6.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.036 1.335 . . . . 0.0 113.3 -169.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -173.77 4.55 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 168.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.26 -25.9 25.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.43 2.692 . . . . 0.0 114.711 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -138.82 -82.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.4 t 45.43 88.35 0.1 Allowed Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.349 1.86 . . . . 0.0 110.841 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 43.67 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 125.062 3.841 . . . . 0.0 113.415 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.21 -50.23 0.38 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 131.164 3.786 . . . . 0.0 105.243 171.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.08 -50.54 66.56 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.657 1.183 . . . . 0.0 110.69 170.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -51.49 -55.24 19.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.342 1.027 . . . . 0.0 109.801 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -54.04 -47.24 71.79 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.858 0.863 . . . . 0.0 111.456 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.2 66.44 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.553 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -30.8 70.58 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.534 1.516 . . . . 0.0 115.058 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.35 93.27 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 119.911 1.232 . . . . 0.0 108.867 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.38 -53.83 52.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.764 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.2 -37.65 87.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.398 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -73.73 -28.45 61.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.615 0.643 . . . . 0.0 110.193 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -68.61 -28.84 67.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.197 0.908 . . . . 0.0 110.501 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -89.97 -8.32 51.97 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.853 1.206 . . . . 0.0 111.567 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.36 25.59 72.53 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.804 1.669 . . . . 0.0 111.963 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.451 HG21 HD13 ' A' ' 81' ' ' LEU . 13.2 m -73.94 158.63 5.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 121.876 -0.779 . . . . 0.0 112.963 -168.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 107.63 8.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.161 1.784 . . . . 0.0 108.824 168.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -135.07 170.25 16.19 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.428 1.091 . . . . 0.0 108.147 172.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -118.32 135.57 54.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.02 135.98 41.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.67 117.84 33.87 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -84.17 155.06 12.78 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.392 2.062 . . . . 0.0 111.184 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt -134.4 0.55 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.297 1.439 . . . . 0.0 108.832 168.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.95 105.8 4.0 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 168.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.66 20.65 68.33 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.216 0.912 . . . . 0.0 114.247 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -113.78 153.75 28.55 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 118.758 1.279 . . . . 0.0 108.39 169.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.95 -28.35 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.753 1.621 . . . . 0.0 109.79 -172.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.43 -49.23 78.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.784 0.72 . . . . 0.0 110.299 169.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -85.62 -8.39 58.28 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.318 -0.864 . . . . 0.0 112.376 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.09 -45.42 67.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.209 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.66 -28.87 67.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.465 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.89 -41.56 87.47 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.783 0.72 . . . . 0.0 109.248 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -60.76 -22.33 63.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.127 -0.983 . . . . 0.0 113.414 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.48 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 172.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -68.82 -27.09 65.54 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.366 0.984 . . . . 0.0 112.588 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -74.21 -40.18 62.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.326 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.3 p -124.32 -21.52 4.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -3.54 10.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.156 1.836 . . . . 0.0 113.791 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -90.92 -70.64 0.67 Allowed 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 119.413 1.607 . . . . 0.0 114.004 -168.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 p 83.0 -8.55 1.14 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.877 3.271 . . . . 0.0 110.719 -168.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 p -74.13 171.02 14.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.873 1.269 . . . . 0.0 107.9 169.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 161.19 40.97 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.165 0.986 . . . . 0.0 110.072 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 159.2 88.82 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.687 0.567 . . . . 0.0 110.937 -4.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.42 99.99 5.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 174.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -84.1 142.5 13.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -128.38 135.73 49.95 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.996 2.518 . . . . 0.0 104.577 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -130.67 110.24 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 1' ' ' ALA 0.27 14.0 m-20 43.04 63.74 1.41 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.803 1.241 . . . . 0.0 111.981 -168.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.78 -10.54 0.48 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.605 2.762 . . . . 0.0 113.636 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -84.94 108.18 17.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -62.78 114.53 3.67 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.947 0.899 . . . . 0.0 109.059 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.0 -65.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.396 1.078 . . . . 0.0 110.267 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' HD12 ' A' ' 55' ' ' ILE . . . 155.85 -138.03 5.83 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -169.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.46 -166.28 12.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.752 1.644 . . . . 0.0 111.595 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.61 -39.6 77.23 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 118.35 1.075 . . . . 0.0 112.706 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -61.08 -44.13 97.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.652 0.66 . . . . 0.0 109.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.18 -38.72 91.39 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.678 -0.639 . . . . 0.0 111.296 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.62 -43.5 76.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.637 1.175 . . . . 0.0 111.131 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.65 -32.59 62.31 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.04 87.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.948 0.499 . . . . 0.0 109.719 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 tp -56.52 -44.06 80.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.817 0.735 . . . . 0.0 110.308 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -37.79 88.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.992 0.517 . . . . 0.0 111.884 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.51 -35.03 79.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.659 -0.65 . . . . 0.0 111.026 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -78.58 -1.0 31.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.95 21.21 75.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.672 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -97.65 -7.1 56.99 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.058 -0.857 . . . . 0.0 112.094 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 tp -77.93 -50.03 12.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.317 1.059 . . . . 0.0 108.972 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.94 -53.52 20.91 Favored Pre-proline 0 N--CA 1.464 0.263 0 C-N-CA 125.872 1.669 . . . . 0.0 113.993 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.94 -16.83 36.96 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 121.255 1.484 . . . . 0.0 113.037 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.29 -1.87 55.58 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.573 1.149 . . . . 0.0 110.921 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 3' ' ' VAL . 26.1 mt -122.18 44.0 2.72 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.314 1.446 . . . . 0.0 108.737 170.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 tttt . . . . . 0 C--O 1.248 1.014 0 C-N-CA 125.908 1.683 . . . . 0.0 107.465 169.442 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.462 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.71 135.35 33.96 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 158.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.553 HG21 HD21 ' A' ' 81' ' ' LEU . 49.4 t -136.16 88.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -91.27 143.6 26.48 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.38 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt -140.44 113.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.115 0.483 . . . . 0.0 110.651 175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.69 124.21 26.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.763 0.825 . . . . 0.0 109.1 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -142.22 169.05 18.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.6 0.76 . . . . 0.0 111.236 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.86 174.4 15.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.961 1.304 . . . . 0.0 109.483 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.69 -68.63 0.3 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.599 1.56 . . . . 0.0 109.856 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.7 m -86.22 90.63 8.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.8 t -155.52 91.15 2.82 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.43 -44.74 30.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.579 2.186 . . . . 0.0 110.959 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -73.3 -27.13 61.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.631 -0.668 . . . . 0.0 110.501 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.7 m -60.81 -57.0 14.5 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.676 1.126 . . . . 0.0 109.368 170.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -54.47 -42.4 70.64 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.828 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -56.71 -51.64 68.02 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.126 1.33 . . . . 0.0 111.624 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.22 77.88 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.452 0.569 . . . . 0.0 110.887 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -58.33 -41.4 84.52 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.939 0.791 . . . . 0.0 110.562 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.96 77.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.611 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.07 -48.75 77.31 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.201 0.91 . . . . 0.0 108.859 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.93 -44.39 85.28 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 122.002 -0.436 . . . . 0.0 111.314 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.2 m -64.12 -35.64 81.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.937 0.495 . . . . 0.0 110.487 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -68.13 -34.16 75.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.601 0.761 . . . . 0.0 110.371 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -76.27 -13.39 60.16 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.93 0.786 . . . . 0.0 111.17 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.79 42.4 70.53 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 81' ' ' LEU . 15.7 m -99.63 161.85 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.456 0.703 . . . . 0.0 110.447 -175.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 p -87.7 137.07 32.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -150.22 168.41 24.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.433 1.493 . . . . 0.0 108.187 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -114.89 147.62 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -115.66 142.93 46.07 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.06 92.9 47.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.81 147.65 44.85 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.974 2.449 . . . . 0.0 110.455 -169.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.496 ' HA ' HD22 ' A' ' 36' ' ' ASN . 21.2 mt -121.5 -2.08 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.404 1.482 . . . . 0.0 109.725 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -63.8 122.19 15.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 120.959 -1.088 . . . . 0.0 108.573 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 21.48 79.71 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 119.447 -0.641 . . . . 0.0 112.546 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.496 HD22 ' HA ' ' A' ' 33' ' ' ILE . 2.9 t30 -128.78 165.62 20.59 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.933 1.293 . . . . 0.0 110.216 -171.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.01 -49.79 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.148 2.179 . . . . 0.0 108.404 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.21 -50.88 68.27 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.331 0.514 . . . . 0.0 111.363 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -78.03 -8.74 58.58 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.841 -1.162 . . . . 0.0 110.925 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -74.37 -56.91 4.33 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -22.82 63.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.834 0.743 . . . . 0.0 111.818 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -55.78 -27.63 52.0 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.805 -1.184 . . . . 0.0 111.586 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.2 ttm -52.52 -22.76 5.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 113.325 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.91 -45.52 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.882 0.873 . . . . 0.0 109.217 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -75.07 -35.38 61.83 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 121.05 1.75 . . . . 0.0 111.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -66.8 -42.28 86.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.79 -10.53 1.81 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.793 1.237 . . . . 0.0 113.232 -168.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.99 1.25 84.84 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.998 -168.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -130.9 -161.71 1.15 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.977 2.388 . . . . 0.0 110.376 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.76 8.35 0.3 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.844 2.458 . . . . 0.0 110.55 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.04 158.34 18.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.759 2.823 . . . . 0.0 110.314 -173.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.31 166.58 24.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -167.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.52 168.95 68.73 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 119.898 0.999 . . . . 0.0 110.043 -7.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.76 102.81 5.6 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.0 136.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.51 95.58 4.73 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 168.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.1 mm -90.08 111.86 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER 52.0 60.84 3.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.929 1.292 . . . . 0.0 113.011 -179.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.47 15.54 6.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.301 1.441 . . . . 0.0 113.282 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.26 109.72 14.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -60.32 112.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 108.909 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.9 mm -76.67 -73.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.51 -138.44 6.82 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.2 -171.09 47.2 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.899 1.714 . . . . 0.0 111.677 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -62.3 -36.97 83.77 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.489 -1.243 . . . . 0.0 110.944 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.76 -43.94 94.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.721 1.146 . . . . 0.0 109.14 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.3 -46.72 79.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.987 1.315 . . . . 0.0 109.701 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.51 -47.97 76.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 126.444 1.898 . . . . 0.0 111.869 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -67.01 -33.3 75.25 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.016 0.926 . . . . 0.0 108.599 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.07 82.33 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.493 1.042 . . . . 0.0 111.217 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -56.52 -44.08 80.43 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.931 0.787 . . . . 0.0 110.317 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.5 -36.14 80.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.689 1.196 . . . . 0.0 111.812 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.84 -26.29 65.08 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.584 1.154 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -20.52 60.5 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.129 0.572 . . . . 0.0 111.201 170.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.95 7.03 88.65 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -168.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.4 -9.42 84.93 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 117.967 0.884 . . . . 0.0 111.685 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.3 tp -74.51 -39.16 62.57 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.243 1.021 . . . . 0.0 110.302 170.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.74 -53.14 27.38 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 -4.96 13.89 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.509 2.139 . . . . 0.0 113.527 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.5 mt -114.47 3.1 14.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.997 1.719 . . . . 0.0 110.982 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 3' ' ' VAL . 11.3 mt -137.71 7.55 2.77 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.6 tttt . . . . . 0 C--O 1.247 0.941 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -177.724 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 121.443 0.64 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.2 134.34 38.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.406 2.683 . . . . 0.0 105.54 163.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.716 HG21 HD21 ' A' ' 81' ' ' LEU . 99.0 t -130.49 120.67 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -135.57 128.37 31.12 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -131.33 109.39 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -73.92 138.07 44.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -149.19 -179.44 7.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.222 1.409 . . . . 0.0 110.818 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.14 173.94 12.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -66.72 -16.36 64.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -136.97 127.42 26.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 168.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 t -168.5 95.45 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.67 -39.61 90.15 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.669 2.246 . . . . 0.0 112.618 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.79 -30.04 56.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.819 0.736 . . . . 0.0 111.09 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.37 -51.37 70.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.73 1.15 . . . . 0.0 108.672 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -57.73 -40.57 79.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.966 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -54.54 -54.48 40.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.577 1.535 . . . . 0.0 110.833 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.57 68.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.336 0.516 . . . . 0.0 110.702 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -61.67 -34.05 75.05 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.388 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.72 69.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.36 -49.35 76.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.477 0.711 . . . . 0.0 109.462 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -66.89 -41.78 86.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.261 0.625 . . . . 0.0 111.032 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -69.28 -31.94 70.78 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.6 m -68.47 -33.49 74.26 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.322 0.965 . . . . 0.0 111.271 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -74.97 -11.27 60.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.613 0.642 . . . . 0.0 110.757 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.21 16.22 76.92 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.274 1.416 . . . . 0.0 112.158 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.518 ' HB ' HD22 ' A' ' 81' ' ' LEU . 4.0 m -74.18 162.9 4.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 117.796 0.798 . . . . 0.0 110.99 -168.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.45 106.74 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.081 1.752 . . . . 0.0 108.136 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -134.25 169.33 17.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.224 1.41 . . . . 0.0 110.357 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -117.39 145.18 44.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.621 1.568 . . . . 0.0 107.435 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -114.01 150.15 34.33 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -134.2 88.02 32.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.609 1.564 . . . . 0.0 108.767 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.07 152.73 46.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.907 1.738 . . . . 0.0 111.855 -168.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 ' CE ' ' A' ' 43' ' ' MET . 7.2 pt -126.65 47.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 126.131 1.772 . . . . 0.0 109.421 168.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -58.26 -143.36 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.779 3.232 . . . . 0.0 109.141 168.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.6 64.09 0.63 Allowed Glycine 0 CA--C 1.531 1.065 0 O-C-N 119.024 -2.298 . . . . 0.0 109.833 169.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.496 HD21 ' CG ' ' A' ' 39' ' ' LYS . 4.5 t30 -153.76 91.41 1.47 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.753 2.021 . . . . 0.0 108.783 -168.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.61 -22.39 66.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.75 -1.119 . . . . 0.0 113.877 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.2 -54.04 43.68 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 120.568 1.531 . . . . 0.0 109.822 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' CG ' HD21 ' A' ' 36' ' ' ASN . 0.0 OUTLIER -67.89 -23.56 65.13 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.017 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -48.14 33.73 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.252 0.933 . . . . 0.0 109.012 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.23 -40.88 87.27 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.146 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.23 -44.31 83.69 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.671 0.788 . . . . 0.0 109.704 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.416 ' CE ' HG21 ' A' ' 33' ' ' ILE . 3.6 ttm -60.29 -18.32 48.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.868 1.267 . . . . 0.0 111.956 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -68.65 -58.58 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -61.25 -40.82 95.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.554 1.524 . . . . 0.0 111.886 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -67.03 -44.29 80.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.879 0.872 . . . . 0.0 111.565 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -126.39 -27.03 3.23 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.25 -21.36 5.13 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.692 2.568 . . . . 0.0 113.168 -168.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -87.68 -60.59 1.93 Allowed 'General case' 0 C--O 1.231 0.089 0 C-N-CA 124.45 1.1 . . . . 0.0 113.25 -168.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.3 p 75.38 15.86 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.954 2.102 . . . . 0.0 113.324 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.0 p -96.64 176.23 6.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.911 1.284 . . . . 0.0 108.484 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -136.65 154.11 76.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.139 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.11 156.02 91.2 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.604 -0.998 . . . . 0.0 110.18 -11.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.35 93.79 4.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.583 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.3 mp -81.51 143.39 12.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -130.09 127.0 38.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 129.635 3.174 . . . . 0.0 105.037 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.4 mt -130.67 126.5 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.38 55.73 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.527 2.331 . . . . 0.0 110.492 -168.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 67.04 -7.96 0.46 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 129.692 3.197 . . . . 0.0 114.175 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -81.08 117.6 21.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -172.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -63.66 101.58 0.36 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -74.07 -59.32 3.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.709 1.203 . . . . 0.0 109.49 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.48 -141.13 10.8 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.98 -170.44 32.43 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.032 1.301 . . . . 0.0 111.174 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -62.1 -40.03 94.49 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.758 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.5 -40.09 85.92 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.772 0.714 . . . . 0.0 110.015 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.77 -48.71 73.54 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.306 1.443 . . . . 0.0 110.085 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.31 -47.63 85.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.117 1.767 . . . . 0.0 111.374 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -66.13 -35.31 80.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.062 0.945 . . . . 0.0 109.228 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.34 -47.17 85.41 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.787 0.722 . . . . 0.0 110.512 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.61 -45.75 81.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.717 0.807 . . . . 0.0 110.649 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.59 -43.63 97.14 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.819 1.248 . . . . 0.0 111.394 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -25.0 67.84 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.491 0.717 . . . . 0.0 110.661 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.25 3.2 55.45 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.529 1.132 . . . . 0.0 110.669 177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.7 20.89 53.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.349 0.976 . . . . 0.0 111.941 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.0 63.14 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 118.527 1.163 . . . . 0.0 111.451 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.424 HD11 HD12 ' A' ' 81' ' ' LEU . 54.6 tp -78.33 -53.18 7.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.657 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -53.25 32.24 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 127.165 2.186 . . . . 0.0 113.88 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -69.25 -1.49 8.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.846 1.697 . . . . 0.0 112.968 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 99.0 mt -112.36 -3.34 14.54 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.051 1.74 . . . . 0.0 111.727 170.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.716 HD21 HG21 ' A' ' 3' ' ' VAL . 8.1 mt -123.07 4.7 9.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.509 1.523 . . . . 0.0 114.245 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.185 0 C-N-CA 125.341 1.456 . . . . 0.0 108.429 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.41 93.58 7.24 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.17 132.05 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -133.02 141.86 48.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.49 1.516 . . . . 0.0 107.179 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 tt -136.99 125.42 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -103.04 127.62 50.22 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.675 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 14' ' ' CYS . 29.8 p -141.08 177.62 7.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.822 1.249 . . . . 0.0 109.747 -173.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.55 -173.47 3.97 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.895 -1.128 . . . . 0.0 108.631 173.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -56.77 9.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.938 1.695 . . . . 0.0 109.299 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -85.33 -173.58 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.638 1.175 . . . . 0.0 109.698 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t 96.34 81.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 129.664 3.186 . . . . 0.0 108.266 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.33 -27.69 71.69 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.341 2.028 . . . . 0.0 112.062 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -73.31 -31.21 63.88 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.4 -0.813 . . . . 0.0 109.185 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.426 ' HB3' HG22 ' A' ' 7' ' ' THR . 97.7 m -61.65 -48.03 82.7 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.029 -1.044 . . . . 0.0 110.245 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -53.35 -51.79 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.713 -0.66 . . . . 0.0 109.809 170.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -54.47 -43.94 72.14 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.126 0.876 . . . . 0.0 112.753 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.72 68.1 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.361 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.46 -37.17 74.92 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.425 1.466 . . . . 0.0 110.809 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.76 -39.23 90.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.116 0.566 . . . . 0.0 110.852 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tt -65.35 -45.92 82.24 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -41.09 96.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.796 0.725 . . . . 0.0 111.282 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 -36.92 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 m -72.46 -29.53 63.74 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.961 0.801 . . . . 0.0 112.68 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mmmp? -75.29 -15.2 60.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.198 0.908 . . . . 0.0 110.377 169.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.07 47.18 61.0 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HB ' HD22 ' A' ' 81' ' ' LEU . 3.1 m -103.24 170.72 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.231 0.613 . . . . 0.0 110.641 -176.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -104.44 117.12 33.38 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.061 1.744 . . . . 0.0 108.104 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -134.35 163.39 29.76 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.606 0.763 . . . . 0.0 110.182 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -95.61 139.54 31.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.48 133.74 55.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.77 106.96 31.55 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.88 1.272 . . . . 0.0 107.931 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.02 153.21 41.49 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.92 1.746 . . . . 0.0 108.828 173.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 40' ' ' ARG . 16.9 mm -116.5 -12.76 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.55 0.74 . . . . 0.0 110.799 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -69.34 116.03 9.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.05 18.34 74.54 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.751 -1.027 . . . . 0.0 112.628 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -135.45 39.7 2.85 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 123.509 1.623 . . . . 0.0 106.67 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.17 -16.41 63.96 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 119.982 -1.699 . . . . 0.0 113.696 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.66 81.65 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.835 1.198 . . . . 0.0 109.508 169.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -66.43 -34.55 78.19 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.729 -0.607 . . . . 0.0 111.345 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HB2' HG23 ' A' ' 33' ' ' ILE . 5.9 tmm_? -55.45 -49.93 71.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 110.057 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -68.55 -31.71 71.12 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.103 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -61.03 -39.13 88.6 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.247 1.385 . . . . 0.0 110.476 169.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 ttm -56.04 -12.59 1.52 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.841 1.657 . . . . 0.0 112.303 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mt -63.98 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -69.47 -20.05 63.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.835 1.652 . . . . 0.0 112.168 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -21.55 61.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.312 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.1 p -134.76 -15.65 2.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.012 1.733 . . . . 0.0 114.982 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.85 69.12 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.023 1.297 . . . . 0.0 112.167 -168.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.42 ' HB2' HE22 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -116.55 -72.94 0.66 Allowed 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 125.346 1.459 . . . . 0.0 110.084 -169.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 86.63 -4.78 0.71 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 130.797 3.639 . . . . 0.0 111.616 -168.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.5 p -106.2 162.85 13.29 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.566 1.547 . . . . 0.0 108.073 -172.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.99 163.05 42.0 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.226 0.61 . . . . 0.0 109.95 -168.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -65.43 161.67 70.05 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 120.082 1.065 . . . . 0.0 112.387 -4.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.42 HE22 ' HB2' ' A' ' 49' ' ' ARG . 2.7 mt-30 -139.57 140.66 37.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.564 168.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.478 HD11 ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -125.24 146.98 30.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 168.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -122.16 133.74 54.74 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.6 mt -136.99 120.94 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 51.09 43.5 29.04 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.521 1.128 . . . . 0.0 109.192 -168.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.21 -3.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.866 2.466 . . . . 0.0 114.797 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -83.03 114.89 21.59 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.402 1.881 . . . . 0.0 108.416 -173.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -64.95 113.39 3.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.461 1.028 . . . . 0.0 108.589 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -82.93 -74.45 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.486 1.114 . . . . 0.0 109.03 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.16 -145.83 14.1 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 119.169 0.895 . . . . 0.0 113.683 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.6 -171.71 47.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.72 2.105 . . . . 0.0 113.474 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -71.9 -40.28 68.97 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.462 -1.611 . . . . 0.0 110.039 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -34.29 74.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.283 175.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -67.54 -49.13 64.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.569 0.699 . . . . 0.0 110.59 171.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 55' ' ' ILE . 2.8 tm? -60.49 -42.71 96.87 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.926 1.29 . . . . 0.0 111.757 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.59 -37.22 68.2 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.01 85.71 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.295 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -56.22 -47.74 77.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.531 1.059 . . . . 0.0 110.894 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.43 -33.68 76.09 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.594 -0.691 . . . . 0.0 111.738 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.04 60.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.472 1.109 . . . . 0.0 112.516 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 1.51 44.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.897 1.226 . . . . 0.0 110.982 168.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.37 23.17 77.83 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -171.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.35 -3.78 29.1 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.04 -1.422 . . . . 0.0 113.403 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 tp -80.5 -48.25 13.07 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.441 1.621 . . . . 0.0 108.342 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -49.78 85.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.717 1.207 . . . . 0.0 113.158 -174.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 -28.59 53.62 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 CA-C-N 122.22 1.829 . . . . 0.0 112.636 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.85 -14.34 58.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.008 0.822 . . . . 0.0 111.837 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.421 HD22 ' HB ' ' A' ' 26' ' ' VAL . 5.3 mt -139.2 -97.27 0.17 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.779 2.032 . . . . 0.0 109.395 -174.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.3 mttt . . . . . 0 C--O 1.25 1.118 0 C-N-CA 129.248 3.019 . . . . 0.0 107.141 -176.644 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.99 93.86 2.29 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.158 0.89 . . . . 0.0 113.02 -171.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.41 HG21 ' CG ' ' A' ' 81' ' ' LEU . 93.7 t -94.71 135.4 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -129.15 139.9 51.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 tt -139.54 120.04 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.846 0.355 . . . . 0.0 110.256 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -92.33 132.29 36.84 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.0 p -140.72 168.72 19.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.156 0.982 . . . . 0.0 111.521 -169.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.11 -179.45 7.33 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.785 -1.197 . . . . 0.0 110.521 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -53.59 -39.56 64.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 128.175 2.59 . . . . 0.0 113.52 -168.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -134.25 105.83 6.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -155.93 80.09 4.04 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.754 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -57.71 -33.94 97.47 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.242 1.961 . . . . 0.0 112.139 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -73.54 -28.89 62.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.393 1.451 . . . . 0.0 110.175 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.19 -53.16 61.06 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -53.21 -44.74 68.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.345 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 65' ' ' TYR . 38.3 mmt180 -54.39 -62.2 1.81 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.779 1.172 . . . . 0.0 110.712 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -46.16 91.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -63.08 -34.97 78.72 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 118.109 -0.948 . . . . 0.0 111.292 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.36 77.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.341 0.973 . . . . 0.0 110.407 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.24 -52.84 63.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.796 0.725 . . . . 0.0 109.149 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.91 -43.33 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.027 0.531 . . . . 0.0 111.191 -170.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -64.9 -35.05 79.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.304 0.642 . . . . 0.0 110.131 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.7 m -73.08 -30.72 63.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.629 0.649 . . . . 0.0 112.492 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -74.29 -10.73 59.88 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.508 1.123 . . . . 0.0 109.767 172.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.03 46.05 60.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.82 175.99 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.426 1.09 . . . . 0.0 110.227 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.5 m -133.49 99.29 4.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.593 1.187 . . . . 0.0 108.08 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -92.03 165.64 13.09 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 128.382 2.673 . . . . 0.0 107.911 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -97.3 138.44 34.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -115.92 136.29 53.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.547 0.739 . . . . 0.0 109.419 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.64 106.17 20.92 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.761 1.625 . . . . 0.0 110.439 -168.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.97 144.79 19.15 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.577 1.518 . . . . 0.0 111.992 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.4 mm -101.05 -15.8 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -66.99 132.61 48.28 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.12 12.03 59.74 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.699 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -125.83 138.24 53.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.473 1.636 . . . . 0.0 108.405 -174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.95 55.44 0.19 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.724 2.01 . . . . 0.0 105.735 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -163.12 -51.89 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.092 2.157 . . . . 0.0 108.906 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -86.21 -7.87 58.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.779 1.172 . . . . 0.0 110.614 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -54.09 -62.78 1.43 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.065 1.746 . . . . 0.0 109.218 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.08 -21.48 56.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.165 0.439 . . . . 0.0 111.149 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.98 -32.28 70.69 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.461 -0.774 . . . . 0.0 109.842 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ttp -59.95 -20.89 60.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.06 -1.025 . . . . 0.0 112.681 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.27 -58.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -19.42 64.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.015 . . . . 0.0 112.165 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -91.42 -56.02 3.29 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.77 -1.206 . . . . 0.0 110.931 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.0 p -90.32 -21.91 21.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.926 1.239 . . . . 0.0 113.834 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.66 22.22 63.77 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.963 -0.909 . . . . 0.0 112.204 -168.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -136.17 -57.72 0.76 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.155 1.477 . . . . 0.0 112.723 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.283 0.0 OUTLIER 67.88 -0.15 2.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.912 2.085 . . . . 0.0 113.872 -171.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.9 p -76.87 176.28 8.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.282 1.833 . . . . 0.0 107.507 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.58 158.99 73.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.99 -0.444 . . . . 0.0 111.786 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.07 167.4 78.84 Favored 'Cis proline' 0 C--N 1.347 0.454 0 N-CA-C 109.605 -0.96 . . . . 0.0 109.605 -11.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -128.83 112.08 13.76 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -99.7 143.15 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -134.84 142.31 46.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 128.693 2.797 . . . . 0.0 105.536 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.407 HG12 HG22 ' A' ' 3' ' ' VAL . 49.7 mt -138.5 119.09 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.256 1.2 m-20 52.71 37.53 23.9 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.956 0.884 . . . . 0.0 111.306 -168.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 62.98 2.84 1.08 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.719 2.408 . . . . 0.0 114.382 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -73.79 119.31 17.84 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -69.08 107.74 3.29 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 108.978 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.5 mm -73.94 -63.79 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.41 -138.13 5.7 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.77 -165.06 30.38 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.592 2.044 . . . . 0.0 111.14 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 5.0 t80 -57.66 -46.15 84.6 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.885 -0.773 . . . . 0.0 110.541 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.03 -32.38 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.679 0.792 . . . . 0.0 109.604 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -73.16 -45.02 59.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.87 1.268 . . . . 0.0 111.957 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.33 -53.69 55.31 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.93 -39.23 80.98 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.68 -46.44 89.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.894 0.878 . . . . 0.0 112.55 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 tp -56.82 -46.71 81.46 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.762 1.164 . . . . 0.0 110.919 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.26 -38.9 92.68 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.636 1.174 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.895 0.878 . . . . 0.0 111.659 172.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.09 -0.68 57.72 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.909 1.284 . . . . 0.0 112.084 170.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.88 4.12 13.28 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.194 0.907 . . . . 0.0 112.985 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.79 -3.78 89.2 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 119.306 1.553 . . . . 0.0 112.265 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.5 tp -74.25 -51.47 15.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.988 1.315 . . . . 0.0 109.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -56.08 22.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.457 1.503 . . . . 0.0 112.235 -170.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.85 -4.82 15.84 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.205 1.937 . . . . 0.0 113.375 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -100.71 -0.54 37.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.352 0.978 . . . . 0.0 111.107 172.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.41 ' CG ' HG21 ' A' ' 3' ' ' VAL . 6.5 mt -134.55 3.02 3.27 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 125.648 1.579 . . . . 0.0 113.726 -174.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.8 mttp . . . . . 0 C--O 1.248 0.982 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.906 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 118.272 -0.871 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.85 93.57 2.18 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 172.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 57' ' ' ILE . 94.8 t -91.92 134.35 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.42 150.78 46.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.3 tt -144.27 110.71 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.233 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.52 124.53 28.58 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 107.614 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -144.25 169.16 18.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.39 1.076 . . . . 0.0 112.347 -171.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -133.76 173.94 10.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.036 1.335 . . . . 0.0 109.138 176.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.38 -28.81 68.51 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.106 1.762 . . . . 0.0 111.695 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -133.33 110.18 9.87 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.8 91.43 0.67 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 124.946 1.298 . . . . 0.0 108.578 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.12 -40.21 62.61 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.661 2.241 . . . . 0.0 111.049 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.51 -31.93 63.97 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.921 -1.112 . . . . 0.0 110.672 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m -61.98 -46.18 90.38 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 119.185 0.902 . . . . 0.0 109.507 170.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -55.48 -47.71 75.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.335 -0.84 . . . . 0.0 109.997 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -56.08 -50.09 71.98 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.659 1.118 . . . . 0.0 111.158 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.1 -53.95 50.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.634 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -61.75 -36.03 79.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.795 0.725 . . . . 0.0 110.856 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -47.68 82.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.64 -49.5 77.28 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.58 -39.84 84.86 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.051 -0.406 . . . . 0.0 111.217 -174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -67.97 -34.04 75.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.879 0.763 . . . . 0.0 110.276 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -69.72 -27.97 65.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.499 1.045 . . . . 0.0 111.657 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -80.94 -11.53 59.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.215 1.006 . . . . 0.0 110.547 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.94 43.56 49.11 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.762 1.172 . . . . 0.0 110.779 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -98.91 169.04 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.966 0.888 . . . . 0.0 112.066 -170.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.41 128.39 35.92 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.839 2.056 . . . . 0.0 105.819 169.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -155.14 164.51 38.73 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.191 -0.943 . . . . 0.0 109.406 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -112.69 139.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.359 1.864 . . . . 0.0 106.875 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.08 146.99 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.66 125.29 19.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.14 138.42 18.08 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.192 1.261 . . . . 0.0 109.578 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.4 ' HA ' HD21 ' A' ' 36' ' ' ASN . 2.2 pp -121.24 6.33 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 169.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.42 73.78 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.781 2.033 . . . . 0.0 111.09 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.43 11.17 67.75 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.163 1.84 . . . . 0.0 114.725 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' A' ' 33' ' ' ILE 0.282 0.0 OUTLIER -83.59 102.82 12.44 Favored 'General case' 0 C--O 1.241 0.648 1 N-CA-C 96.389 -5.412 . . . . 0.0 96.389 -177.654 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.59 -33.95 64.39 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -168.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.43 -55.06 38.12 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 119.374 0.988 . . . . 0.0 110.221 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -71.86 -25.74 62.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.48 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -61.84 -50.9 70.42 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.146 0.978 . . . . 0.0 108.669 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -41.53 90.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.288 1.435 . . . . 0.0 111.536 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.46 -33.31 75.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.392 0.677 . . . . 0.0 110.839 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.8 ttp -63.98 -26.28 68.51 Favored 'General case' 0 N--CA 1.441 -0.886 0 O-C-N 121.569 -0.707 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -67.05 -53.44 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 6.89 0.09 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.551 1.94 . . . . 0.0 114.675 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.34 -28.72 0.54 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 120.643 1.565 . . . . 0.0 112.703 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -116.02 -22.1 9.15 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.157 1.344 . . . . 0.0 112.898 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -9.64 0.88 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.083 1.802 . . . . 0.0 113.465 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -91.24 -56.12 3.27 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.512 1.156 . . . . 0.0 111.378 -169.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 80.99 -1.53 1.78 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.005 1.322 . . . . 0.0 111.605 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.2 p -80.18 177.09 9.19 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 131.262 3.825 . . . . 0.0 108.58 168.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.467 HG21 ' CG ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -136.84 159.23 71.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 169.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.5 166.9 80.66 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-O 121.718 0.632 . . . . 0.0 111.391 -8.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -126.34 100.28 6.21 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 102.098 -3.297 . . . . 0.0 102.098 168.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -87.37 146.67 6.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 170.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -137.01 150.88 48.39 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.334 2.254 . . . . 0.0 107.453 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 3' ' ' VAL . 69.9 mt -135.86 109.04 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 51.57 43.69 29.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.636 -1.29 . . . . 0.0 110.764 -169.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 76.04 -1.78 2.88 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.013 2.925 . . . . 0.0 114.665 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.93 103.09 4.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.995 1.718 . . . . 0.0 106.826 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -66.62 109.04 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.11 -59.24 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.95 -133.28 6.81 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.71 -175.13 38.38 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 125.372 1.463 . . . . 0.0 111.601 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.45 -41.69 81.03 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.557 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.98 -34.83 78.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.565 0.62 . . . . 0.0 110.799 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -66.33 -48.29 70.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 109.773 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.28 -43.75 97.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.351 1.061 . . . . 0.0 111.161 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.73 -37.7 73.51 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.41 94.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.793 0.724 . . . . 0.0 110.711 170.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.79 -49.13 76.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.395 0.998 . . . . 0.0 110.573 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -36.92 78.11 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 111.51 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.55 -22.44 63.55 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.39 -3.58 56.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.55 1.14 . . . . 0.0 110.018 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.53 37.95 92.9 Favored Glycine 0 C--O 1.225 -0.406 0 O-C-N 120.634 -1.291 . . . . 0.0 110.192 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.07 -1.57 58.31 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.845 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.21 -67.77 0.77 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.935 1.294 . . . . 0.0 108.847 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.296 0.0 OUTLIER -45.07 -51.25 24.45 Favored Pre-proline 0 C--O 1.225 -0.227 0 CA-C-O 116.564 -1.684 . . . . 0.0 114.263 177.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.65 3.67 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 CA-C-N 123.526 2.295 . . . . 0.0 113.612 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -109.83 -38.61 5.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.36 0.982 . . . . 0.0 110.258 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.79 -16.1 56.17 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.201 -0.937 . . . . 0.0 113.124 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp . . . . . 0 C--O 1.25 1.079 0 C-N-CA 124.992 1.317 . . . . 0.0 107.889 171.662 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.62 93.6 6.15 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 81' ' ' LEU . 95.1 t -131.51 107.01 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 173.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.19 128.77 44.03 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -169.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -130.22 104.89 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.153 0.502 . . . . 0.0 109.908 -171.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -74.95 131.21 40.5 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -143.39 -179.42 6.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.402 0.681 . . . . 0.0 112.146 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.47 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -133.72 175.94 9.0 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.93 1.692 . . . . 0.0 108.815 168.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -18.68 4.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.271 3.028 . . . . 0.0 115.168 -169.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -137.02 -83.92 0.34 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 168.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 t 56.73 97.5 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.687 1.595 . . . . 0.0 112.463 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.91 42.85 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.777 2.985 . . . . 0.0 113.907 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -150.6 -42.83 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.771 2.828 . . . . 0.0 106.046 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -53.83 -50.52 66.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 109.548 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -52.73 -51.46 60.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.562 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.449 ' HD3' ' CE2' ' A' ' 65' ' ' TYR . 18.0 mtt-85 -56.69 -50.22 72.79 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.563 0.62 . . . . 0.0 110.786 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.19 -43.55 94.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.982 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.33 -47.12 84.76 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.081 1.309 . . . . 0.0 110.261 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.95 79.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.67 0.388 . . . . 0.0 110.46 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.28 -46.71 82.47 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.606 0.763 . . . . 0.0 110.17 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.53 -38.43 89.62 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.204 0.602 . . . . 0.0 110.005 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -64.35 -35.43 80.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.401 0.68 . . . . 0.0 110.793 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 t -67.3 -35.35 79.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.734 0.814 . . . . 0.0 109.65 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -80.58 -6.77 58.76 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.588 0.631 . . . . 0.0 111.937 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.01 28.59 66.34 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.148 0.885 . . . . 0.0 111.462 170.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG21 HD13 ' A' ' 81' ' ' LEU . 5.8 m -93.15 167.7 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 121.907 -0.76 . . . . 0.0 112.241 -168.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.3 p -98.49 130.12 45.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -145.91 164.27 32.52 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.434 1.094 . . . . 0.0 108.176 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -104.94 136.52 44.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.189 2.195 . . . . 0.0 107.17 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -116.39 139.14 50.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.644 1.178 . . . . 0.0 109.337 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.26 87.81 49.72 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 125.045 1.338 . . . . 0.0 110.702 -169.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.79 141.85 67.31 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.185 1.923 . . . . 0.0 111.701 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 pt -121.18 8.92 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.938 1.295 . . . . 0.0 112.214 170.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -66.38 107.53 2.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.408 1.483 . . . . 0.0 109.624 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.59 -6.16 40.82 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 120.882 -1.136 . . . . 0.0 114.307 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.24 164.13 20.31 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 40' ' ' ARG . . . -162.75 -39.75 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.705 1.202 . . . . 0.0 110.796 -168.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.93 74.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.571 0.748 . . . . 0.0 111.547 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -86.18 -22.11 27.16 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.056 -1.027 . . . . 0.0 110.66 173.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 70.9 ttt-85 -59.0 -43.58 91.5 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 120.76 -1.213 . . . . 0.0 110.733 170.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.06 -22.47 55.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.732 0.696 . . . . 0.0 111.869 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -60.25 -24.07 64.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.917 1.235 . . . . 0.0 109.714 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.7 tpp -54.44 -26.66 32.23 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.922 0.783 . . . . 0.0 112.372 173.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.1 mt -74.38 -40.92 49.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -77.55 -31.36 53.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.443 -0.785 . . . . 0.0 112.208 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -74.9 -38.5 61.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 112.665 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.8 p -133.27 -12.31 2.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -168.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.21 -8.47 70.72 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.945 -168.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -127.54 -161.93 1.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.703 1.752 . . . . 0.0 111.337 -168.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 51' ' ' THR . 2.3 m -155.68 -23.79 0.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.708 2.403 . . . . 0.0 109.948 -170.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 50' ' ' THR . 13.6 p -74.08 163.01 28.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.93 1.692 . . . . 0.0 110.857 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG21 ' HG2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -139.65 161.97 53.65 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 0.0 109.135 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 59.4 Cg_endo -66.98 153.8 84.29 Favored 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 120.242 1.122 . . . . 0.0 112.116 2.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -130.63 103.37 6.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 105.761 -1.941 . . . . 0.0 105.761 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.672 HD12 ' H ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -84.65 146.87 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 168.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.91 119.25 27.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 168.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -125.28 129.41 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.697 1.59 . . . . 0.0 107.53 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 48.0 32.82 3.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.639 1.975 . . . . 0.0 110.102 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.26 4.68 4.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 131.107 3.763 . . . . 0.0 115.793 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.84 123.45 24.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -65.13 113.97 4.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.88 -64.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.183 0.993 . . . . 0.0 109.546 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.08 -136.83 8.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -168.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.02 -175.93 43.86 Favored Glycine 0 CA--C 1.521 0.456 0 O-C-N 124.231 0.607 . . . . 0.0 112.483 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 16' ' ' ARG . 2.9 t80 -52.02 -49.71 62.84 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.603 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.3 -25.15 65.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.357 0.663 . . . . 0.0 110.627 -170.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -71.39 -51.88 21.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.528 1.131 . . . . 0.0 110.426 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -61.55 -51.22 69.5 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.892 1.277 . . . . 0.0 110.012 176.115 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -51.05 -38.97 54.73 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.138 1.375 . . . . 0.0 111.413 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.0 91.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 117.882 -1.056 . . . . 0.0 111.746 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.75 -51.02 70.49 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.467 1.03 . . . . 0.0 109.131 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.79 -42.79 80.09 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.373 1.069 . . . . 0.0 110.433 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -22.81 61.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.175 0.99 . . . . 0.0 112.566 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -88.58 4.47 46.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.188 0.995 . . . . 0.0 112.26 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.85 71.59 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.592 0.633 . . . . 0.0 112.243 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.79 -17.1 80.19 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.477 1.138 . . . . 0.0 112.056 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 81' ' ' LEU . 41.3 tp -77.95 -39.73 41.74 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.004 0.902 . . . . 0.0 110.68 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.26 -56.22 22.1 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.269 1.428 . . . . 0.0 109.921 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.56 -0.75 8.72 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.5 2.133 . . . . 0.0 113.508 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.56 -9.9 15.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 112.26 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 3' ' ' VAL . 11.5 mt -133.09 7.29 3.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.258 1.823 . . . . 0.0 112.623 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 117.271 -1.347 . . . . 0.0 108.572 -169.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.4 96.49 4.68 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.916 -0.49 . . . . 0.0 109.703 -166.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.651 HG21 HD21 ' A' ' 81' ' ' LEU . 94.7 t -125.43 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.3 135.91 52.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 tt -135.0 107.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.282 0.563 . . . . 0.0 110.49 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -73.57 136.14 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.438 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 73.2 p -141.29 179.07 6.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.135 1.374 . . . . 0.0 109.106 -176.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' CG ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -160.37 -179.62 7.84 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -48.62 -29.96 4.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.773 3.229 . . . . 0.0 113.924 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -138.41 86.55 2.17 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.203 1.001 . . . . 0.0 111.044 -173.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -156.75 91.23 2.51 Favored Pre-proline 0 CA--C 1.539 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 110.354 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.18 -27.55 72.85 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.361 2.041 . . . . 0.0 112.067 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -73.46 -29.47 62.55 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.243 -0.91 . . . . 0.0 110.125 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 7' ' ' THR . 74.1 m -66.75 -47.74 71.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.178 0.899 . . . . 0.0 108.902 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.19 -53.68 26.17 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.784 168.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.42 -53.61 55.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.6 1.091 . . . . 0.0 111.174 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.34 76.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.936 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -60.61 -39.8 89.5 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.672 1.124 . . . . 0.0 110.935 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.3 68.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.208 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp -66.2 -54.34 26.38 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.61 -35.37 80.29 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -68.97 -35.31 76.59 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 109.66 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -74.04 -11.6 60.37 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.14 -0.975 . . . . 0.0 112.167 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -92.28 -27.4 17.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.519 1.054 . . . . 0.0 108.59 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.33 54.03 7.17 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 HD22 ' A' ' 81' ' ' LEU . 15.9 m -112.93 167.47 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.295 0.638 . . . . 0.0 112.088 -172.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.7 m -82.55 120.18 25.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.375 . . . . 0.0 107.308 169.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.87 169.7 17.55 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 109.286 169.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.45 147.29 44.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.77 155.08 28.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.641 0.655 . . . . 0.0 110.557 170.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.49 93.86 27.81 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 124.651 1.181 . . . . 0.0 108.848 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.84 145.98 91.18 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.221 1.948 . . . . 0.0 109.063 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mt -87.72 -32.73 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.761 0.709 . . . . 0.0 109.1 168.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -62.42 102.71 0.34 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.594 1.558 . . . . 0.0 109.084 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.7 -20.73 7.71 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.273 1.892 . . . . 0.0 111.929 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.07 -179.45 7.24 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.027 1.731 . . . . 0.0 110.815 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.31 -64.7 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.357 2.663 . . . . 0.0 105.223 169.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.77 83.39 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.004 0.82 . . . . 0.0 110.872 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -77.87 -17.4 57.38 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 118.927 0.785 . . . . 0.0 112.835 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -67.11 -52.07 46.38 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -32.37 73.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.964 0.802 . . . . 0.0 109.41 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -23.42 66.33 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.291 -0.88 . . . . 0.0 111.917 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.44 -26.38 19.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.002 0.819 . . . . 0.0 112.308 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -68.39 -56.7 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -61.67 7.51 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.437 2.295 . . . . 0.0 116.125 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.12 -32.2 0.47 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.057 1.299 . . . . 0.0 110.517 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.3 p -129.29 -10.35 4.67 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.476 1.489 . . . . 0.0 113.108 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.84 -14.86 34.85 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.657 1.599 . . . . 0.0 114.322 -171.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -131.99 162.44 30.71 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 126.211 1.804 . . . . 0.0 109.01 -169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -105.45 4.46 30.66 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.295 1.838 . . . . 0.0 112.645 170.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.2 p -73.69 175.26 7.33 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.877 1.271 . . . . 0.0 109.8 172.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.456 HG21 ' CG ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -143.98 164.49 29.34 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.976 1.31 . . . . 0.0 110.509 176.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.51 162.12 80.81 Favored 'Cis proline' 0 N--CA 1.454 -0.807 0 CA-C-N 119.151 0.732 . . . . 0.0 110.503 -7.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -127.36 99.6 5.71 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.1 mp -88.85 139.82 16.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.22 129.29 47.52 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 128.988 2.915 . . . . 0.0 104.935 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.63 123.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 53.75 30.14 10.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.452 1.024 . . . . 0.0 111.476 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.3 -1.11 2.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.722 3.209 . . . . 0.0 114.691 -172.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -73.95 114.39 12.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.316 1.846 . . . . 0.0 108.055 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -69.85 106.64 3.22 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.667 -0.645 . . . . 0.0 110.045 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.4 mm -73.96 -63.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.786 0.835 . . . . 0.0 109.04 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.87 -142.13 9.84 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.23 -173.31 38.78 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.472 1.51 . . . . 0.0 111.384 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.83 -38.83 76.3 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.598 -0.942 . . . . 0.0 110.625 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.54 -41.82 95.25 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.433 0.693 . . . . 0.0 110.276 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.58 -48.56 66.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.437 1.095 . . . . 0.0 110.052 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -49.86 71.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.861 1.264 . . . . 0.0 110.3 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -67.91 -27.78 66.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.83 69.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.188 0.995 . . . . 0.0 111.674 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.7 tp -56.34 -41.43 76.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.052 1.296 . . . . 0.0 109.94 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.62 -35.48 77.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.274 1.03 . . . . 0.0 112.845 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.95 -29.06 68.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.375 0.534 . . . . 0.0 110.809 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 -74.59 -10.76 59.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.177 0.991 . . . . 0.0 110.784 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.56 3.65 54.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.094 -0.837 . . . . 0.0 111.427 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.9 -6.08 89.25 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.916 1.246 . . . . 0.0 112.368 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 tp -73.5 -44.36 58.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.56 -46.99 99.77 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-O 116.7 -1.619 . . . . 0.0 113.494 -169.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 -12.63 35.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.541 1.943 . . . . 0.0 113.087 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -99.67 0.05 41.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.168 0.894 . . . . 0.0 111.506 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 3' ' ' VAL . 8.1 mt -141.73 -28.16 0.64 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -173.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 80' ' ' LEU . . . . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.57 139.31 45.5 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 167.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.527 HG21 HD21 ' A' ' 81' ' ' LEU . 96.5 t -139.47 118.84 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -113.88 147.22 38.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.319 1.047 . . . . 0.0 108.324 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 tt -140.65 110.45 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.279 0.491 . . . . 0.0 111.284 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 4.1 m-85 -79.94 140.02 36.83 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.654 -0.654 . . . . 0.0 110.713 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -152.81 178.58 9.49 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.311 2.645 . . . . 0.0 109.223 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.24 -173.56 4.28 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 119.608 -1.933 . . . . 0.0 110.322 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.03 -35.31 24.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.949 1.7 . . . . 0.0 111.578 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -138.27 160.44 39.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.678 2.391 . . . . 0.0 105.651 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 t 163.61 105.9 0.02 OUTLIER Pre-proline 0 C--O 1.238 0.478 0 C-N-CA 127.733 2.413 . . . . 0.0 106.603 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.53 -40.38 30.91 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.846 2.364 . . . . 0.0 110.628 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -73.38 -26.83 61.16 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.99 -1.069 . . . . 0.0 110.306 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.2 m -64.87 -45.14 87.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.24 -0.913 . . . . 0.0 109.805 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -56.11 -47.62 77.72 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.827 -1.083 . . . . 0.0 110.124 171.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -54.24 -52.64 60.72 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.05 1.295 . . . . 0.0 111.199 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.38 -49.83 75.32 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.686 -0.634 . . . . 0.0 112.037 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -64.43 -32.63 74.33 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.035 0.834 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.52 -28.24 69.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.006 0.821 . . . . 0.0 110.951 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -60.3 2.65 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -58.02 -41.63 83.56 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.589 0.755 . . . . 0.0 111.356 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -67.77 -26.77 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.047 0.539 . . . . 0.0 110.702 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m -75.98 -29.29 58.18 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.551 -0.718 . . . . 0.0 111.183 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -77.42 -17.3 58.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.852 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.73 43.45 94.14 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.77 156.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.467 0.651 . . . . 0.0 111.575 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.06 117.63 22.98 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -134.13 163.66 29.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 168.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -103.62 144.05 31.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.33 146.86 42.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.88 134.48 26.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -95.38 162.83 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.559 2.172 . . . . 0.0 113.012 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.288 1.2 mt -132.19 37.93 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.623 1.969 . . . . 0.0 108.196 167.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.06 60.73 0.11 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.405 2.682 . . . . 0.0 110.71 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.68 52.87 5.69 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.078 1.323 . . . . 0.0 112.308 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -83.92 179.95 7.42 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.94 0.87 . . . . 0.0 111.627 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.93 -52.72 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.368 2.267 . . . . 0.0 106.797 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.12 -57.2 13.91 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 168.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -83.8 13.7 4.59 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 120.838 -1.163 . . . . 0.0 110.424 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -86.07 -60.82 1.9 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.76 -32.76 72.05 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 124.054 0.846 . . . . 0.0 111.339 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.01 -40.01 79.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.105 -0.372 . . . . 0.0 110.988 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -70.33 -17.88 63.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 121.136 -0.977 . . . . 0.0 112.597 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.32 -56.52 13.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 168.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.6 -25.52 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.615 0.766 . . . . 0.0 112.271 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -95.33 -33.62 12.47 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.625 -1.655 . . . . 0.0 113.107 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.5 p -124.07 -24.95 4.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.564 1.984 . . . . 0.0 114.876 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.73 -10.08 20.11 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.073 2.273 . . . . 0.0 114.486 -169.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -94.54 -63.94 1.13 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -168.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.9 p 86.71 0.42 0.56 Allowed 'General case' 0 CA--C 1.54 0.567 1 C-N-CA 131.844 4.058 . . . . 0.0 111.718 -168.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.4 p -111.4 161.52 16.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.465 1.506 . . . . 0.0 108.225 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.71 166.8 23.4 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 125.531 1.532 . . . . 0.0 113.833 -168.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.52 163.55 77.73 Favored 'Cis proline' 0 C--N 1.354 0.864 0 CA-C-N 120.847 1.338 . . . . 0.0 110.638 -2.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 15.3 mm-40 -146.03 84.48 1.65 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -168.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.61 142.1 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -137.1 85.16 2.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.021 2.128 . . . . 0.0 105.913 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.7 mt -92.93 132.41 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 51.42 24.61 2.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.408 1.083 . . . . 0.0 110.882 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.65 12.88 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.762 2.025 . . . . 0.0 115.562 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.49 128.0 33.08 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 168.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -69.48 114.05 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mm -76.13 -58.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.524 1.13 . . . . 0.0 110.461 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -157.72 27.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -169.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.34 -168.63 43.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.819 1.676 . . . . 0.0 110.96 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -62.63 -43.98 97.43 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.271 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.63 -34.48 77.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.598 1.09 . . . . 0.0 110.307 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -70.19 -46.32 64.85 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.115 0.966 . . . . 0.0 109.996 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.28 -50.13 74.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 127.543 2.337 . . . . 0.0 111.528 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -67.54 -29.27 68.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -40.3 71.82 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.54 169.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 tp -56.31 -41.43 75.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.956 1.253 . . . . 0.0 109.762 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.43 -32.39 73.99 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.69 -30.68 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.308 -0.87 . . . . 0.0 111.427 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -80.14 -5.15 55.5 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.821 0.737 . . . . 0.0 110.944 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.48 19.12 79.59 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.372 -0.682 . . . . 0.0 111.436 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.34 -3.5 65.0 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.306 1.053 . . . . 0.0 112.646 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.48 -50.92 7.31 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.637 1.219 . . . . 0.0 110.283 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -44.46 99.64 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.247 -176.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.14 7.43 3.31 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 123.311 2.218 . . . . 0.0 113.003 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 1' ' ' ALA . 92.8 mt -114.18 -2.13 13.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.535 1.534 . . . . 0.0 110.428 168.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 3' ' ' VAL . 12.0 mt -125.99 8.01 7.36 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.185 1.794 . . . . 0.0 110.903 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.3 tttt . . . . . 0 C--O 1.256 1.396 0 C-N-CA 125.712 1.605 . . . . 0.0 108.042 -169.045 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.37 108.43 7.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.15 1.78 . . . . 0.0 107.848 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 81' ' ' LEU . 99.4 t -112.18 89.72 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -78.55 135.18 37.24 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.875 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 tt -136.64 113.14 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 124.462 1.105 . . . . 0.0 109.128 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.88 142.23 46.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.887 0.875 . . . . 0.0 108.779 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -150.01 166.1 30.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.056 1.342 . . . . 0.0 110.669 -169.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 176.55 12.54 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.891 -1.13 . . . . 0.0 108.715 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -56.37 -30.13 62.31 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.763 2.425 . . . . 0.0 113.853 -170.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 109.66 9.2 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -164.89 84.94 1.11 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -63.67 -26.1 68.89 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.836 1.691 . . . . 0.0 111.986 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -73.43 -30.48 63.24 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.074 -1.016 . . . . 0.0 109.419 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -66.33 -43.96 84.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 119.23 0.923 . . . . 0.0 108.968 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -53.25 -47.8 68.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.94 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -54.8 -59.3 4.91 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.598 1.545 . . . . 0.0 112.076 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.16 89.71 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.069 0.395 . . . . 0.0 110.27 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.771 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.26 99.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -59.66 -49.69 76.77 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.707 0.685 . . . . 0.0 110.229 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.99 -43.51 95.47 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.265 1.026 . . . . 0.0 111.048 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -59.03 -42.73 90.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.717 0.807 . . . . 0.0 109.167 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 t -69.69 -30.93 68.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.113 0.965 . . . . 0.0 110.416 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -78.18 -15.48 58.79 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.154 0.888 . . . . 0.0 111.453 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 47.95 23.58 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 124.991 1.282 . . . . 0.0 110.043 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 81' ' ' LEU . 13.8 m -104.43 171.5 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.038 0.535 . . . . 0.0 112.271 -170.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.4 p -94.35 126.99 39.95 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.32 170.4 16.38 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.433 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -128.92 124.43 35.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.617 1.567 . . . . 0.0 108.105 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.402 HD23 ' HE3' ' A' ' 39' ' ' LYS . 1.8 mp -116.68 113.58 40.22 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.33 146.94 20.02 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.159 1.906 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mm -124.78 -5.64 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 125.495 1.518 . . . . 0.0 109.743 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 9' ' ' GLU . 5.9 p-10 -66.31 113.19 4.42 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.805 2.042 . . . . 0.0 107.441 168.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.3 -32.38 0.96 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.136 1.351 . . . . 0.0 113.173 -173.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.533 HD21 ' CB ' ' A' ' 39' ' ' LYS . 9.1 t30 -83.51 73.29 10.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 123.233 1.492 . . . . 0.0 108.955 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.67 -19.05 65.68 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.831 168.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.73 -57.63 11.17 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 120.203 1.365 . . . . 0.0 109.725 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.533 ' CB ' HD21 ' A' ' 36' ' ' ASN . 9.4 ttmm -74.75 -15.83 60.75 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.998 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -56.99 -50.74 71.78 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.118 0.872 . . . . 0.0 109.191 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.54 -30.28 68.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.299 0.499 . . . . 0.0 110.888 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.79 -37.77 88.61 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.868 -0.52 . . . . 0.0 110.507 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.2 ttm -61.94 -18.95 62.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.681 1.592 . . . . 0.0 112.36 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.59 -57.94 9.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -59.17 -44.29 92.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.101 -0.374 . . . . 0.0 111.15 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.55 -34.39 72.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.828 -171.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -121.16 -21.68 6.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.8 1.182 . . . . 0.0 114.029 -171.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.52 8.79 57.0 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.703 -168.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -129.89 -52.4 1.14 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.255 1.528 . . . . 0.0 112.708 -170.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m 76.72 6.97 3.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.297 1.439 . . . . 0.0 111.492 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.6 p -86.13 173.2 10.0 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 110.076 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.1 154.01 64.21 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 122.793 0.437 . . . . 0.0 110.856 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.68 157.67 81.47 Favored 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 106.574 -2.125 . . . . 0.0 106.574 -11.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -136.3 118.64 15.67 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 169.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.0 OUTLIER -97.42 145.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 O-C-N 125.118 1.511 . . . . 0.0 107.499 -174.069 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -137.1 111.59 8.62 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.396 2.678 . . . . 0.0 105.903 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -103.46 111.6 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.34 56.02 8.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.327 1.451 . . . . 0.0 107.809 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.27 -14.09 0.41 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.152 3.381 . . . . 0.0 114.24 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -77.83 112.58 14.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.693 0.797 . . . . 0.0 109.565 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.53 105.73 3.2 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.281 1.032 . . . . 0.0 110.394 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mm -74.42 -53.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.103 0.961 . . . . 0.0 108.659 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.54 -139.84 14.4 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -170.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.28 -173.29 47.31 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.011 1.767 . . . . 0.0 114.207 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -54.68 -50.89 67.16 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 122.225 -0.574 . . . . 0.0 110.238 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -73.77 -17.98 61.03 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.055 0.388 . . . . 0.0 110.717 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.39 -48.51 55.87 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 109.385 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -60.29 -49.77 76.29 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.814 1.646 . . . . 0.0 111.108 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.34 -37.68 81.4 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.606 1.562 . . . . 0.0 110.806 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.67 -44.22 78.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.678 0.791 . . . . 0.0 111.223 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.3 tp -56.58 -43.99 80.6 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 110.396 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.08 -35.58 81.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.021 0.528 . . . . 0.0 111.577 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.02 -26.47 66.79 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.905 0.482 . . . . 0.0 111.946 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -4.85 47.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.296 -0.877 . . . . 0.0 112.437 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.4 29.08 70.59 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.15 -28.3 13.76 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 118.339 1.07 . . . . 0.0 111.446 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -73.6 -52.5 13.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.045 0.923 . . . . 0.0 109.045 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.49 -55.92 22.48 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.23 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -9.27 25.4 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 122.135 1.798 . . . . 0.0 114.056 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 mt -83.41 -46.85 12.06 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 120.031 1.287 . . . . 0.0 108.813 169.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 3' ' ' VAL . 13.8 mt -83.15 -0.28 48.53 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.462 1.105 . . . . 0.0 113.921 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 C-N-CA 125.089 1.356 . . . . 0.0 110.972 -171.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.46 ' HB1' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.0 125.58 28.59 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.178 -0.951 . . . . 0.0 110.383 -175.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 81' ' ' LEU . 80.9 t -130.36 130.29 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -130.17 144.29 51.27 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.86 1.264 . . . . 0.0 108.67 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 tt -141.49 113.21 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 121.116 0.484 . . . . 0.0 110.058 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -73.8 129.28 37.59 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -141.18 174.52 10.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.41 1.484 . . . . 0.0 110.75 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 173.47 11.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.76 -20.72 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.672 0.789 . . . . 0.0 112.128 -174.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 t -133.49 77.85 1.74 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.815 1.646 . . . . 0.0 107.411 -168.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.6 87.34 4.83 Favored Pre-proline 0 N--CA 1.443 -0.78 0 C-N-CA 124.764 1.226 . . . . 0.0 108.289 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.17 -31.0 92.57 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.65 1.567 . . . . 0.0 111.362 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.46 -36.49 65.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.56 1.527 . . . . 0.0 110.806 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.7 m -58.0 -46.42 85.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -60.23 -43.8 95.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.09 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.85 -51.81 64.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.163 1.801 . . . . 0.0 110.89 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -60.19 -55.98 27.15 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.923 0.889 . . . . 0.0 110.129 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -63.29 -29.75 71.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.28 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.55 -46.08 87.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.345 0.975 . . . . 0.0 109.228 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.0 -40.57 95.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.058 0.845 . . . . 0.0 110.235 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.44 -40.43 97.13 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.374 -0.828 . . . . 0.0 111.07 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -67.74 -30.43 69.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 110.678 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -71.23 -34.41 70.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.962 0.905 . . . . 0.0 111.238 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -73.79 -17.93 61.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.516 0.598 . . . . 0.0 109.474 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.92 23.11 67.37 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.137 1.351 . . . . 0.0 111.751 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.0 m -89.92 157.13 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 118.068 0.934 . . . . 0.0 112.751 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -85.22 136.26 33.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 168.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.45 165.81 28.28 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.48 1.912 . . . . 0.0 106.012 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -107.02 140.18 40.23 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.7 145.22 30.39 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -128.3 118.49 20.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.42 151.93 54.2 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.451 1.434 . . . . 0.0 108.984 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.44 25.4 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.463 1.505 . . . . 0.0 110.034 170.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.61 64.0 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.845 2.058 . . . . 0.0 113.243 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.47 9.7 86.81 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.842 1.687 . . . . 0.0 113.699 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.52 103.76 13.12 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -168.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.48 -25.7 68.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.351 -0.843 . . . . 0.0 112.4 -172.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.16 -54.48 29.08 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.022 0.828 . . . . 0.0 109.872 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -71.53 -23.77 61.83 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 121.239 -0.913 . . . . 0.0 111.303 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -58.93 -53.23 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.793 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.03 -28.12 64.17 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.676 1.125 . . . . 0.0 112.424 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.6 -39.39 76.73 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.019 0.827 . . . . 0.0 108.94 169.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ttm -65.32 -26.0 67.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.443 -0.785 . . . . 0.0 110.996 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.0 mt -74.27 -46.41 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.13 -63.79 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.332 0.969 . . . . 0.0 109.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -64.62 -42.56 95.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.704 2.402 . . . . 0.0 112.806 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -1.2 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -168.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.45 46.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 119.284 0.947 . . . . 0.0 113.251 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -136.72 -167.5 2.09 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.433 1.493 . . . . 0.0 109.6 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 p -155.9 3.46 0.17 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 129.565 3.146 . . . . 0.0 109.911 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.6 p -101.0 175.94 5.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.133 2.573 . . . . 0.0 110.343 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.93 158.21 62.59 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.6 163.09 82.3 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.776 -1.344 . . . . 0.0 108.639 -11.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.92 98.84 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 171.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.13 145.07 8.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -131.91 132.18 43.37 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 126.861 2.064 . . . . 0.0 106.04 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 HG22 ' A' ' 3' ' ' VAL . 3.2 mp -125.54 122.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.46 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 15.9 m-20 41.66 47.22 3.37 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.554 1.542 . . . . 0.0 112.486 -172.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.96 3.46 4.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.543 2.337 . . . . 0.0 114.539 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -75.88 105.78 7.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -62.41 122.79 16.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 169.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -92.24 -75.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.74 -138.78 5.77 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 -162.25 19.61 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 126.504 2.002 . . . . 0.0 111.027 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -61.34 -42.07 98.08 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.089 0.945 . . . . 0.0 110.666 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.16 -38.52 91.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.392 0.433 . . . . 0.0 110.341 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.07 -48.86 64.42 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.411 1.084 . . . . 0.0 109.968 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.46 HD13 ' HB1' ' A' ' 17' ' ' ALA . 4.5 tt -54.29 -52.21 62.17 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 126.581 1.953 . . . . 0.0 110.571 172.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -68.75 -37.95 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.3 99.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.686 -0.673 . . . . 0.0 111.213 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.82 -42.43 79.59 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.057 1.298 . . . . 0.0 110.399 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.57 -37.51 87.81 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.274 1.03 . . . . 0.0 110.957 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.0 -21.82 65.03 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.425 -0.797 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -82.58 -7.23 59.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.876 1.271 . . . . 0.0 111.168 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.03 19.96 68.4 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.41 8.49 66.72 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.429 1.115 . . . . 0.0 112.014 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -110.3 -52.8 2.75 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.986 1.314 . . . . 0.0 109.192 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.33 -55.63 9.53 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.517 1.527 . . . . 0.0 113.782 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.53 -12.54 31.61 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.67 1.58 . . . . 0.0 113.216 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.98 -10.55 18.88 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.038 0.935 . . . . 0.0 111.34 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.564 ' CD2' HG21 ' A' ' 3' ' ' VAL . 13.5 mt -94.49 10.17 35.61 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.415 1.007 . . . . 0.0 112.319 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mttp . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.054 1.341 . . . . 0.0 108.281 174.912 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.31 126.46 30.17 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 165.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.52 ' CG2' HD21 ' A' ' 81' ' ' LEU . 70.9 t -123.88 128.96 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -122.87 121.91 37.36 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -168.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.25 18.6 tt -133.17 102.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 121.823 0.82 . . . . 0.0 110.935 -169.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.08 136.2 43.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -143.67 175.71 9.77 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.833 1.653 . . . . 0.0 110.793 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.507 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -134.25 173.52 11.52 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.872 1.669 . . . . 0.0 107.343 168.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -29.46 68.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.655 0.782 . . . . 0.0 111.915 -174.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -87.79 -129.08 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 168.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.9 t 74.73 88.05 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.563 2.345 . . . . 0.0 111.058 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.73 -36.74 83.27 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.198 1.932 . . . . 0.0 110.992 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -73.55 -27.08 61.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.482 -0.761 . . . . 0.0 111.151 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -63.13 -49.83 72.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -55.5 -46.87 76.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.313 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -54.84 -52.87 61.39 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 119.261 0.937 . . . . 0.0 111.374 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.56 -51.84 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.275 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -60.61 -34.96 75.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.714 1.143 . . . . 0.0 111.551 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.89 82.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.658 0.663 . . . . 0.0 110.068 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.38 -46.59 86.06 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.044 0.938 . . . . 0.0 110.077 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.26 -45.32 73.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.453 1.101 . . . . 0.0 111.329 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -69.5 -27.69 65.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.083 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -63.6 -41.95 98.29 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.049 0.84 . . . . 0.0 109.696 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -74.65 -6.63 49.77 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.627 0.649 . . . . 0.0 111.596 175.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.57 27.28 72.78 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.68 171.69 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 117.501 0.65 . . . . 0.0 110.476 -172.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 m -102.04 131.26 48.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -140.96 173.1 11.8 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.691 0.796 . . . . 0.0 108.883 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -125.24 126.65 45.49 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 128.101 2.56 . . . . 0.0 105.69 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.23 140.0 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -124.88 116.4 26.2 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.092 . . . . 0.0 110.799 -168.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -68.55 146.01 66.24 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.016 1.81 . . . . 0.0 109.115 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -125.15 -11.77 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 124.33 1.052 . . . . 0.0 110.864 169.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.05 129.49 39.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.89 -42.67 1.35 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.09 0.853 . . . . 0.0 112.842 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.405 HD21 ' HB2' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -83.1 91.03 7.13 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 125.197 1.399 . . . . 0.0 107.493 -171.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.84 -36.18 81.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.049 -1.032 . . . . 0.0 113.268 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.04 -55.4 23.99 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.982 0.913 . . . . 0.0 111.787 -168.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 36' ' ' ASN . 20.7 mtpt -86.63 -10.79 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -74.03 -32.64 63.44 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.633 1.106 . . . . 0.0 110.47 169.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.17 -43.39 67.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.695 169.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -62.21 -31.51 72.05 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.696 -0.628 . . . . 0.0 110.435 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.3 ttp -62.2 -19.86 63.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.605 -1.31 . . . . 0.0 112.484 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -64.1 -58.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.33 -31.8 72.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.917 1.687 . . . . 0.0 111.016 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -95.33 -40.89 9.3 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.381 1.473 . . . . 0.0 112.83 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -103.34 -26.71 12.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.285 1.402 . . . . 0.0 112.526 -173.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.7 33.2 76.53 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.47 -1.183 . . . . 0.0 112.063 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -143.66 -52.6 0.35 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.23 1.515 . . . . 0.0 113.335 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.406 62.5 p 68.29 4.99 4.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.483 2.713 . . . . 0.0 115.51 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -81.44 176.08 10.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -141.97 160.72 54.53 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.328 168.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 72.6 Cg_endo -69.1 160.35 86.18 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.65 0.911 . . . . 0.0 112.078 -0.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.75 99.64 5.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 168.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.51 HD12 ' H ' ' A' ' 55' ' ' ILE . 1.6 mp -86.59 141.5 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 171.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -129.69 136.31 49.55 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 129.228 3.011 . . . . 0.0 105.248 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.439 HG12 HG22 ' A' ' 3' ' ' VAL . 56.3 mt -128.89 110.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 46.0 48.8 12.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.866 0.866 . . . . 0.0 111.814 -169.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.71 -6.74 1.86 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 129.531 3.132 . . . . 0.0 114.8 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.06 105.65 5.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -70.14 105.71 3.02 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.85 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.67 -144.03 13.09 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 -169.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.04 -161.04 24.59 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.986 1.755 . . . . 0.0 111.177 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -61.52 -45.58 93.61 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 121.808 -0.819 . . . . 0.0 110.496 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.44 -27.19 65.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.842 0.746 . . . . 0.0 109.2 -169.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.99 -55.32 11.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.288 2.235 . . . . 0.0 110.229 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.08 -47.33 86.32 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.302 1.841 . . . . 0.0 111.061 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.76 -41.22 90.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.219 1.408 . . . . 0.0 108.831 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.79 -34.96 76.43 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.004 0.82 . . . . 0.0 112.494 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.68 -51.96 66.75 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.992 1.269 . . . . 0.0 110.662 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -66.15 -28.01 68.46 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.146 0.978 . . . . 0.0 111.267 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.17 -8.58 56.41 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.481 -1.387 . . . . 0.0 112.328 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.37 -3.53 28.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.715 170.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.07 18.71 79.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.143 0.883 . . . . 0.0 110.913 -171.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.38 -1.32 69.19 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.546 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.3 -46.07 7.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.035 1.417 . . . . 0.0 111.044 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER -47.64 -49.24 57.05 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 174.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.72 -5.62 14.78 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 CA-C-N 121.905 1.716 . . . . 0.0 113.234 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.77 -55.82 2.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.723 1.209 . . . . 0.0 109.519 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.52 HD21 ' CG2' ' A' ' 3' ' ' VAL . 8.1 mt -89.98 19.69 4.73 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.82 1.648 . . . . 0.0 114.764 -169.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.4 tttm . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.297 1.039 . . . . 0.0 110.064 -176.549 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.48 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.256 0.074 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.32 104.31 7.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 128.111 2.565 . . . . 0.0 109.255 -177.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.68 160.95 5.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -154.42 112.91 3.58 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.81 110.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 118.512 0.596 . . . . 0.0 112.561 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -89.62 124.49 34.61 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -141.36 173.2 11.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.808 0.843 . . . . 0.0 111.336 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 -178.19 5.51 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.973 -1.079 . . . . 0.0 111.145 -172.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -31.55 68.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.958 1.303 . . . . 0.0 112.065 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -134.17 148.5 50.94 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t 163.8 89.87 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 129.288 3.035 . . . . 0.0 106.125 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.92 -30.7 90.49 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 111.533 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.32 -31.97 64.32 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.264 -0.897 . . . . 0.0 110.02 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -65.09 -46.72 79.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -51.85 -52.3 50.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.404 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -54.26 -50.33 67.48 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.194 1.361 . . . . 0.0 111.751 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.3 -50.25 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.721 0.692 . . . . 0.0 111.472 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -62.46 -37.21 85.04 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.489 1.041 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.81 98.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.516 0.726 . . . . 0.0 109.604 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.5 -48.53 80.51 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 118.59 0.632 . . . . 0.0 109.529 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.63 -38.23 90.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.164 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.6 m -69.92 -30.64 68.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.5 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.6 m -66.22 -36.28 82.62 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 120.262 1.392 . . . . 0.0 110.202 172.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -77.15 -12.93 60.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.848 -0.533 . . . . 0.0 111.673 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.75 26.65 71.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.73 168.31 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.326 1.063 . . . . 0.0 109.779 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -91.62 124.13 35.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 170.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -150.13 168.46 23.89 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 122.638 0.375 . . . . 0.0 111.37 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -132.47 132.57 42.85 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.06 148.37 38.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.157 0.911 . . . . 0.0 109.646 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.27 92.65 31.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 125.272 1.429 . . . . 0.0 109.221 -168.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.11 129.38 21.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.181 2.588 . . . . 0.0 109.692 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.37 5.09 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.008 1.323 . . . . 0.0 109.474 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -76.03 135.71 39.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.477 1.111 . . . . 0.0 109.742 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.43 34.68 76.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.33 169.74 17.01 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.647 1.979 . . . . 0.0 109.477 -168.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.74 -33.0 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.581 1.152 . . . . 0.0 110.723 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.83 -55.62 25.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.262 1.392 . . . . 0.0 111.067 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.61 -10.0 59.26 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.507 -1.37 . . . . 0.0 111.927 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 ttt-85 -78.78 -50.42 11.36 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.8 -26.41 68.34 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.771 0.714 . . . . 0.0 110.897 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.17 -51.76 68.22 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.2 ttp -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -65.08 -51.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.643 -1.286 . . . . 0.0 108.908 169.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -57.57 -36.49 71.75 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.308 0.958 . . . . 0.0 112.282 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -92.32 -28.84 16.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.623 -169.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -124.17 -18.49 5.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.833 1.197 . . . . 0.0 112.855 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.98 -16.08 1.64 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.843 1.687 . . . . 0.0 112.734 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -91.57 -71.02 0.66 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 126.45 1.9 . . . . 0.0 112.453 -168.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.385 0.6 OUTLIER 71.72 1.73 4.0 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 129.984 3.314 . . . . 0.0 113.903 -168.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.4 p -74.28 176.32 6.78 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.607 1.563 . . . . 0.0 107.716 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.09 158.95 74.53 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.8 161.42 79.51 Favored 'Cis proline' 0 C--N 1.348 0.519 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 -11.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.14 97.37 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 170.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 55' ' ' ILE . 2.3 mp -89.94 146.42 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -131.56 148.55 52.63 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.284 3.034 . . . . 0.0 106.11 170.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.88 116.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 168.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 6.9 m-20 62.31 40.7 11.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 110.279 176.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 75.0 -8.64 1.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.666 3.187 . . . . 0.0 114.246 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -74.35 101.12 3.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.63 1.972 . . . . 0.0 105.872 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -60.98 106.34 0.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.3 mm -74.36 -56.61 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.263 1.025 . . . . 0.0 108.847 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.61 -141.9 12.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.14 -169.67 26.02 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.053 1.787 . . . . 0.0 111.334 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -57.17 -42.51 81.28 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.526 -0.985 . . . . 0.0 111.437 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.45 -37.85 88.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.248 0.476 . . . . 0.0 109.786 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.0 -47.35 74.79 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.652 1.181 . . . . 0.0 109.901 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -55.19 29.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.337 1.855 . . . . 0.0 110.31 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.75 -34.5 77.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.79 88.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 119.189 0.904 . . . . 0.0 111.912 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.84 -46.35 81.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.875 1.216 . . . . 0.0 110.28 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.67 -41.03 98.86 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.898 0.479 . . . . 0.0 111.16 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.92 71.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.71 1.204 . . . . 0.0 110.94 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -17.1 61.1 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.119 0.968 . . . . 0.0 110.439 176.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 25.62 41.28 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -169.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.86 -7.19 48.09 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.62 -1.1 . . . . 0.0 113.322 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.19 -48.77 8.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.985 1.392 . . . . 0.0 108.442 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.48 96.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.204 1.402 . . . . 0.0 112.111 -169.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 -12.06 34.45 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 123.266 2.202 . . . . 0.0 113.238 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.43 -48.82 4.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.814 0.846 . . . . 0.0 110.181 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -115.84 7.78 14.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.669 1.588 . . . . 0.0 114.58 -168.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 C--O 1.25 1.104 0 C-N-CA 126.948 2.099 . . . . 0.0 112.722 178.917 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.26 134.49 44.27 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 152.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.43 90.15 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -104.64 124.67 49.75 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.531 -1.668 . . . . 0.0 108.328 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -126.82 101.85 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 0.0 111.389 -171.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -73.82 142.38 46.14 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.433 -0.792 . . . . 0.0 109.14 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.9 p -151.6 171.09 18.15 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.53 1.132 . . . . 0.0 111.199 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.545 ' HG2' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -135.67 174.04 11.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.499 1.52 . . . . 0.0 107.138 168.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.08 -38.4 68.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.084 1.354 . . . . 0.0 113.057 -168.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.64 145.11 48.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t 172.69 103.45 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.561 2.344 . . . . 0.0 104.793 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -65.93 -30.11 48.88 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.148 1.899 . . . . 0.0 110.853 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -73.63 -37.23 65.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.021 0.929 . . . . 0.0 110.43 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -61.65 -47.36 85.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.855 0.752 . . . . 0.0 109.043 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -53.48 -53.42 51.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.02 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.48 -50.75 70.85 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.867 1.212 . . . . 0.0 112.068 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.02 -49.83 66.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.77 0.714 . . . . 0.0 110.9 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -61.71 -37.2 83.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.495 1.043 . . . . 0.0 110.787 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.68 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.043 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.81 -48.61 81.01 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.36 -42.15 79.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.438 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.5 m -70.91 -30.64 67.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.957 0.798 . . . . 0.0 111.056 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -70.31 -35.44 73.67 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.313 0.961 . . . . 0.0 110.824 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -75.08 -15.09 60.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.234 0.925 . . . . 0.0 110.704 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.38 24.43 75.16 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.334 1.445 . . . . 0.0 112.206 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 81' ' ' LEU . 7.9 m -83.14 154.78 3.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.22 1.01 . . . . 0.0 110.35 -172.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 m -81.2 115.51 20.64 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.249 1.82 . . . . 0.0 107.931 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -137.49 175.91 9.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 109.157 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -124.85 144.51 50.27 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.019 2.527 . . . . 0.0 106.561 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -116.14 152.44 33.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.633 0.652 . . . . 0.0 110.363 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.32 81.28 61.2 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.29 1.036 . . . . 0.0 109.735 -172.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.14 148.26 84.94 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.362 2.041 . . . . 0.0 112.074 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 pt -124.98 15.75 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.412 1.885 . . . . 0.0 110.636 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.39 128.17 35.11 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 168.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.16 29.43 29.01 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.658 0.646 . . . . 0.0 114.027 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.541 HD21 ' HB3' ' A' ' 39' ' ' LYS . 4.5 t30 -146.97 80.87 1.54 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.545 1.172 . . . . 0.0 110.786 -168.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.85 -28.5 68.4 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 120.812 -1.18 . . . . 0.0 111.549 168.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.54 -55.32 35.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.379 0.672 . . . . 0.0 111.242 -169.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' HB3' HD21 ' A' ' 36' ' ' ASN 0.259 0.1 OUTLIER -86.44 -7.31 58.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.49 0.716 . . . . 0.0 111.62 176.364 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.48 -45.98 88.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.259 -1.526 . . . . 0.0 110.898 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -29.91 70.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.902 -177.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -55.76 -37.48 68.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.819 0.848 . . . . 0.0 110.465 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.1 ttm -61.89 -18.39 60.01 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.333 1.053 . . . . 0.0 112.782 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.49 -65.53 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -59.74 -28.16 67.12 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 121.476 1.944 . . . . 0.0 112.295 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -68.45 -45.08 73.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.604 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.3 p -121.72 -22.69 5.74 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.94 5.22 79.45 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.702 1.62 . . . . 0.0 112.376 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.438 ' HB2' HE22 ' A' ' 54' ' ' GLN . 11.2 mtp180 -124.85 -55.37 1.61 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.779 2.289 . . . . 0.0 114.951 -168.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.378 0.7 OUTLIER 69.15 13.67 8.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.676 2.79 . . . . 0.0 114.707 -173.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.9 p -75.99 175.59 8.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.113 1.765 . . . . 0.0 109.109 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.545 HG21 ' HG2' ' A' ' 8' ' ' LYS . 1.2 m -142.94 164.43 32.12 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.857 172.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.85 159.92 78.84 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.377 1.17 . . . . 0.0 109.639 -9.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.438 HE22 ' HB2' ' A' ' 49' ' ' ARG . 8.2 mt-30 -136.43 103.11 5.16 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 172.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 143.74 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 171.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -133.53 119.31 19.35 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.125 1.77 . . . . 0.0 106.369 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.438 HG21 HD13 ' A' ' 80' ' ' LEU . 26.4 mm -113.16 97.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 49.44 65.71 1.32 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.193 0.997 . . . . 0.0 111.054 -168.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 73.23 -13.99 0.66 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 128.444 2.698 . . . . 0.0 114.488 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -74.81 96.8 3.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.736 2.414 . . . . 0.0 108.457 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -64.03 110.55 2.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 mm -73.94 -64.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.31 -145.14 14.07 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.21 -163.96 38.85 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.232 1.396 . . . . 0.0 111.798 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -65.15 -41.5 94.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.095 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.27 -45.26 80.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.033 0.833 . . . . 0.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -63.93 -48.33 77.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.666 1.186 . . . . 0.0 110.097 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.51 -48.58 78.93 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.85 1.26 . . . . 0.0 111.893 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.24 -33.82 75.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 123.589 0.756 . . . . 0.0 109.313 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -43.18 83.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.931 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.5 -44.91 81.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.18 1.355 . . . . 0.0 110.543 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.7 -42.08 91.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.048 0.539 . . . . 0.0 111.22 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.14 70.52 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.769 -0.582 . . . . 0.0 110.373 177.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -73.85 -19.77 60.63 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.898 1.279 . . . . 0.0 109.291 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 23.7 68.81 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.7 -13.53 40.39 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.769 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.4 -49.2 12.72 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.665 1.233 . . . . 0.0 109.8 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.96 -54.34 20.9 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 112.502 -173.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.0 3.09 5.35 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.898 2.398 . . . . 0.0 113.275 -175.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 HG21 ' A' ' 57' ' ' ILE . 96.2 mt -110.67 -3.86 15.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.958 -1.089 . . . . 0.0 110.571 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD12 ' HB ' ' A' ' 26' ' ' VAL . 3.8 mm? -108.07 5.42 26.03 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.943 0.897 . . . . 0.0 112.391 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? . . . . . 0 C--O 1.245 0.836 0 C-N-CA 124.995 1.318 . . . . 0.0 108.441 -175.582 . . . . . . . . 0 0 . 1 stop_ save_